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A key function of the gastrointestinal tract is to break down ingested food and absorb the 
contained nutrients and water. Within the intestinal tract are a number of specialised epithelial 
cells that aid in this process as well as maintaining immune homeostasis through their 
functioning as a physical barrier, and secretion of antimicrobial peptides. The intestinal tract 
has one of the highest turnover rates within organisms, so because of this, and the variety of 
functions these cells can carry out, it is essential that the balance of proliferation and cell 
death is regulated to maintain homeostasis. There are several conserved signalling pathways 
that are responsible for the proliferation of intestinal cells. Suppressor of cytokine signalling 3 
(SOCS3) is produced upon activation of the Janus kinase/Signal transducer and activator of 
transcription (Jak/Stat) pathway and this is an inducer of negative feedback inhibition and is 
implicated in regulation of intestinal homeostasis, with SOCS3 dysregulation reported in 
intestinal pathologies, such as cancer and inflammatory bowel disease. Intestinal epithelial 
cells are also in close proximity to the commensal gut microbiota and they too are known to 
regulate intestinal turnover. In the work presented here, we assessed the role of SOCS3 in 
normal intestinal homeostasis and how microbe-mediated proliferation impacts upon this. 
These experiments were performed in three different biological models, allowing us to assess 
the impact of SOCS3-regulated homeostasis at the molecular level, the tissue level, and at an 
organismal level, and also determine whether the function of SOCS proteins is conserved 
across different biological systems. 
 
Using in vitro human intestinal epithelial cells, mice and Drosophila melanogaster, we 
observed consistent negative effects upon reduction of SOCS3, which affected proliferation 
and cytokine profiles, tumour tolerance and, survival and the gut-brain axis, in our respective 
models. In both in vivo models, we were able to discover functional outcomes due to reduced 
SOCS3 expression, in the form of facilitation of helminth expulsion and increased stress 
resistance in mice and Drosophila, respectively, thus suggesting potential benefits of reduced 
SOCS3 in young animals whose ability to adapt to homeostatic changes is higher. Overall, we 
were able to deduce that SOCS3 is responsible for maintaining normal intestinal homeostasis, 
and ultimately host health, at a number of levels within multiple biological systems. However, 
our results also indicated that SOCS3 is a complex, multi-functional protein, with much 
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Biomedical research has proven invaluable in determining factors that contribute to human 
health, and also the development and manifestation of diseases. However, dependent on the 
area of research and experimental design, it is not always possible to actually conduct the 
research in human subjects. For instance, there are much higher ethical considerations using 
human samples or participants compared with other species. Additionally, compared with in 
vitro and in vivo models, it is much harder to control genetic and environmental conditions in 
humans, so therefore it is not surprising that inconsistent results are obtained. Furthermore, 
some studies may require long-term sampling and follow ups, such as those investigating 
chronic conditions, ageing or drug testing, which may be difficult due to changes in the 
participants’ circumstances (health, job, living location for instance). Therefore, a multitude of 
biological models have been developed and utilised in the hope of expanding the depth of 
research that can be carried out. For instance, in vitro models (which translates to “within the 
glass”) only uses certain parts of organisms which are capable of division (such as intestinal 
stem cells, or those derived from tumours) within petri dishes and culture flasks. Although 
there are numerous cells that can be cultured and studied in vitro, there is a much larger range 
of in vivo models that exist, and these can be divided into prokaryotic or eukaryotic 
organisms. Eukaryotes can then be further subdivided into vertebrates and invertebrates, with 
both of these also able to be subdivided into classes (e.g. insects can be found within 
invertebrates, mammals and fish are found within vertebrates). In short, this project will be 
investigating the role of the Suppressor of Cytokine Signalling 3 (SOCS3) in intestinal 
homeostasis and using models to determine whether the functions of this protein are 
conserved. Our experiments will be performed using in vitro models (human intestinal cell 
lines), and two in vivo models (mice, and fruit flies- Drosophila melanogaster). 
 
To consider in vitro models first, they have many advantages for their use in scientific 
research as they are much cheaper, have a higher throughput and have reduced ethical 
considerations when compared to in vivo models. In vitro models are also considered to be 
much “simpler” than in vivo systems and this can allow easier dissection and manipulation of 
signalling processes (Fritz et al. 2013), due to focussing on a single cell line, for example. 
Furthermore, there are a large number of normal and transformed cell lines that are 
commercially available, and this allows research into both healthy and disease states. 
However, when using cultured cells, it is difficult to replicate all conditions found within in 
vivo organisms, and with regards to the gut, these can include: presence of luminal contents/ 
microbiota, oxygen levels (cells are typically cultured in 21% O2, whereas physiological 
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levels are between 1 and 10%), pH, the gut-specific immune system, the constant flow of 
luminal contents, and also the proximity of other cells, nerves and, blood and lymphatic 
vessels, to name a few (Fritz et al. 2013). 
 
Although mice are more expensive to maintain compared to Drosophila, and are associated 
with higher ethical considerations and limitations in relation to both Drosophila and cultured 
cells, one large advantage of their use in biomedical research is that the mouse genome has 
been fully sequenced and they have been found to share 99% of their genes with humans 
(Mouse Genome Sequencing Consortium 2002, Fritz et al. 2013, Kostic et al. 2013). In 
relation to our focus on the gastrointestinal (G.I) tract, mice also exhibit similarities in their 
anatomy, cell signalling pathways and the composition and function of their microbiota 
(Kostic et al. 2013). Mice are small in size so are therefore relatively easy to handle and can 
be housed with several mice in a single cage (depending on the experiment). The gestational 
time for the generation of mice is also substantially shorter than that of humans and other 
higher mammals, which results in quicker turnover of animals. Compared with humans, mice 
also have much shorter lifespans (approximately 2-3 years in the laboratory), and this makes 
lifespan and longitudinal studies more feasible (Fritz et al. 2013). However, one limitation 
that is particularly important when studying the G.I tract, is that environmental conditions, 
such as diet and housing, differ considerably between mice and humans (Fritz et al. 2013), 
and extrinsic, non-genetic factors are known to influence microbiota composition and can also 
impact on G.I disease susceptibility and severity (Hanauer 2006). 
 
Finally, Drosophila have been used as model organisms for several decades and particular 
contributions to research include genetics, development and ageing. Like mice, Drosophila 
have very short generation times (approximately 10 days from egg to adult fly, at 25°C), and 
females are able to lay at least 1 egg every 2 hours, so this can result in the large number of 
progeny in a small period of time. Compared to both mice and humans, fruit flies have very 
short lifespans (approximately 60-80 days, although this is genotype dependent), also 
permitting ageing and longitudinal experiments to be carried out more easily, and potentially 
allowing multiple/repeated experiments to be performed in a relatively short period of time 
(Helfand and Rogina 2003). Drosophila are the easiest organism to genetically manipulate 
compared to humans and mice, and due to the vast number of commercially available fly 
lines, it is possible to target deletion or overexpression of target genes in particular cells or 
tissues. They have also proven to be useful models in intestinal research due to similarities in 
intestinal cell composition and conservation of cell renewal signalling pathways (such as 
4 
 
Janus kinase/Signal transducer and activator of transcription- Jak/Stat), although a 
disadvantage compared to vertebrate in vivo models is that they do not possess an adaptive 
immune system, thus limiting the study of immune homeostasis and immunological disorders 
(Apidianakis and Rahme 2011, Kostic et al. 2013). Additionally, female are able to reproduce 
with multiple male flies, so when generating experimental flies, it is essential that virgin 
females are used, and are bred with the appropriate male genotype.  
 
To conclude, when conducting scientific research into health and disease, it is important to 
investigate the pathway/ molecule/ tissue etc. of interest in multiple models in order to achieve 
translatable results. Even where components are conserved, (such as those of the Jak/Stat 
pathway), and manipulated in the same way within each model (e.g. increased signalling 
activity), the responses may not be identical due to the clear differences between models. For 
instance, research animals will induce different and additional responses to those obtained in 
vitro due to crosstalk with other pathways/tissues etc. and also the involvement of the brain 
for instance, in regulation of certain behaviours. Therefore, in vivo responses may be different 
to those obtained in vitro so results should not always be generalised. It is also incredibly 
important for drug development to use a multitude of models, starting “low” with in vitro 
models as they can be used to ascertain molecule and pathway interactions, toxicity and 
permeability for example. Thus, in vitro studies allow valuable information to be obtained 
before investigating the effects in animals.  
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1.2 The Gastrointestinal Tract 
1.2.1 Intestinal Structure 
In the three organisms that are the focus of this literature review and overall project- humans, 
mice and Drosophila- the intestines are the site of food digestion. Concentrating on humans 
and mice first due the high level of similarity in their anatomy, their G.I tracts can be divided 
into two parts; the upper G.I tract, and lower G.I tract. The upper G.I tract consists of the 
oesophagus, stomach and duodenum, with the lower G.I tract comprising of the small 
intestine, cecum, large intestine, and anus. The major functions of the small and large 
intestines are to absorb macronutrients (i.e carbohydrates, fats and proteins), and water and 
minerals from ingested food, respectively. Although the function and general tissue structure 
of the intestines are alike in both mice and humans (reviewed by Nguyen et al. 2015), there 
are some differences between these two species (as demonstrated in figure 1.1). For instance, 
whilst the human cecum is relatively small in size with no distinct function, the murine cecum 
is considered to be large in relation to the size of the whole G.I tract and is responsible for 
production of certain vitamins and, digestion and fermentation of plant matter (Treuting and 
Dintzis 2011). Additionally, the human colon is comprised of different sections, consisting of 
the ascending colon, the transverse colon, the descending colon and finally the sigmoid colon 
before reaching the rectum (cited by Kararli 1995), with these sections so named based on 
their orientation and direction of the flow of luminal contents. However, the murine colon 
exists as more of a smooth continuous tract, rather than compartmentalised like the human 
colon, and this may explain the differences in colon microbiota (reviewed by Nguyen et al. 
2015). Despite these differences, the small intestine in humans and mice is similar, consisting 
of the duodenum, the jejunum and the ileum (Treuting and Dintzis 2011). 
 
The entire G.I tract is made up of 4 layers, and these consist of: the mucosa, the submucosa, 
the muscularis and, the serosa and adventitia, with both mice and humans displaying the same 
type and arrangement of these muscle layers (Nguyen et al. 2015). Regarding the intestinal 
tract, the mucosa is further divided into the epithelium, which is the closest layer to the lumen, 
the underlying lamina propria which consists of immune cells and connective tissue, and the 
muscularis mucosae; a thin layer of smooth muscle. The submucosa however, consists of one 
layer and is made up of connective tissue, along with blood vessels, nerves and lymphatic 
vessels that serve the adjacent mucosa and muscularis layers. The muscularis comprises of 
two smooth muscle layers, with the muscular circular layer situated closest to the submucosa, 
and below this is the muscular longitudinal layer, with these two layers differing in the 
orientation of their muscle fibres. Contraction of the muscular sublayers leads to decreased 
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luminal diameter and decreased luminal length, respectively, and these contractions are 
coordinated to propel contents within the lumen down the G.I tract in a process referred to as 
peristalsis. The final layer is the serosa and adventita, and like the submucosa, comprises of 










Figure 1.1: Comparison of gastrointestinal tracts between mice and humans, 
demonstrating similarities in organs present, as well as differences in organ size. The 
primary function of the gastrointestinal tract is to digest food, and extract nutrients and water. 
Any indigestible contents are then excreted as waste through the anus. (Image from Nguyen et 
al. 2015).  
 
The lumen passes through the entirety of the intestinal tract and it is essentially a tube through 
which food for digestion, and pathogens pass. The lumen is also where a mucin layer and 
commensal bacteria reside, on top of the epithelial layer, and this layer acts as a physical 
barrier, separating the luminal contents from the adjacent lamina propria. The mucin layer can 
be further divided into an inner layer and an outer layer. The outer layer is thinner than the 
inner layer and contains an abundance of microorganisms. The inner layer however, is 
situated above the epithelial layer and under normal circumstances, is devoid of bacteria. This 
is due to the secretion of the antibody, IgA, by plasma B-lymphocytes in the lamina propria, 
and also antimicrobial peptides (AMPs) by intestinal epithelial cells (IECs), and this aims to 
inhibit microorganisms from associating and adhering to the epithelial layer and potentially 
penetrating the IECs to reach the underlying tissue (Hooper and Macpherson 2010). 
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Therefore, mucins have a vital role in maintaining immune homeostasis and the health of the 
host, and this is evident from studies using Muc2-deficient mice. Muc2 is a major constituent 
of the intestinal mucin layer, and these mice did not possess an inner layer devoid of bacteria, 
and thus, developed spontaneous inflammation in their intestinal tract (Van der Sluis et al. 


















Figure 1.2: Comparison of structure and cell types of the intestinal epithelium in (A) 
humans, and (B) Drosophila. Both organisms possess an intestinal epithelial layer consisting 
of intestinal stem cells and, absorptive and secretory epithelial cells, with the epithelium 
acting as a barrier between underlying tissue and the luminal contents, which consists of 
commensal microbiota, as well as digested food. However, in humans, the epithelium consists 
of crypts, with cells migrating into the villi following differentiation. In Drosophila, the 
epithelial cells are situated on a basement membrane. There is an overlying peritrophic matrix, 
which is the equivalent of the mammalian mucin layer. (Note: The mouse epithelium also 
resembles that of humans). (Image from Wong et al. 2016). 
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The epithelial barrier consists of invaginations, called the crypts of Lieberkühn, and 
protrusions, called villi, although these villi are exclusive to the small intestine (Kirkwood 
2004) (shown above in figure 1.2), and are in fact taller in mice than in humans (reviewed by 
Nguyen et al. 2015). Despite the size differences, mice and humans do exhibit similarities in 
villus shape, which may be expected, although the villi in rats are reported to be more 
“tongue-shaped” compared to the typically assumed “finger-shaped” villi normally described 
(Kararli 1995). Both organisms however, do possess microvilli on the surface of their IECs, 
which greatly increases the surface area of the small intestine. The intestinal epithelium is 
made up of four main cell types, all of which are derived from intestinal stem cells (ISCs), 
located just above the base of the crypts of Lieberkühn (reviewed by Wright 2000), with there 
being approximately 6-10 crypts for every villus (Potten 1991). Each ISC is capable of 
undergoing mitosis, and as each ISC divides, the cells migrate up the crypt and become more 
differentiated the further they move up the crypt (Schmidt et al. 1988, Marshman et al. 2002). 
Once differentiated cells reach the villi at the top of the epithelium, they are sloughed off into 
the lumen, with the whole renewal process taking 5-7 days. Each ISC typically divides 
asymmetrically to produce another ISC and a transit-amplifying (T.A) cell. T.A cells are only 
capable of dividing 4-5 times before differentiating into one of the four main cell types. There 
are three types of secretory cells; Paneth cells, goblet cells, enteroendocrine cells (EECs), and 
enterocytes (ECs), which have absorptive functions (reviewed by van der Flier and Clevers 
2009). In addition to the secretory and absorptive functions of the IECs stated here (which 
will be discussed further in sections 1.2.3-1.2.6), all cells of the intestinal epithelium possess a 
range of cell junctions located on their lateral sides, and their overall aim is control transport 
of various small molecules (such as ions, nutrients and water) and uphold the barrier function, 
preventing (paracellular) translocation of luminal contents. Intestinal integrity is maintained 
through the presence of tight junctions, gap junctions, adherens junctions and desmosomes. 
Although adherens junctions and desmosomes help maintain adherence of neighbouring IECs, 
it is the tight junctions that play a more crucial role in intestinal permeability, as these are 
located nearest the lumen, at the apical end of lateral membranes, so therefore are one of the 
first physical barriers in the intestinal tract microorganisms will encounter that does not 
comprise of mucin or the microbiota. Increased permeability as a result of impaired function 
of tight junctions is detrimental to biological systems as it leads to increased translocation of 
both commensal and non-commensal microorganisms, thus inducing immune and 
inflammatory responses. If sustained, this can cause tissue damage, and potentially 
inflammatory and/or autoimmune disorders, such as inflammatory bowel disease (IBD) 
(Suzuki 2013). Furthermore, gap junctions are the most basal of the 4 lateral cell junctions and 
these are implicated in “horizontal” rather than “vertical” transport of molecules, permitting 
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the passage of ions and electrical impulses for example, between two neighbouring cells 
(Kleinzeller et al. 1999, Barreau and Hugot 2014). 
 
1.2.2 Intestinal Stem Cells 
ISCs are defined as proliferating, undifferentiated cells capable of producing progeny that 
continue to proliferate or differentiate into IECs, so are therefore classed as multipotent 
(Potten 1998, Wright 2000). These cells have an important role in the intestines as they are 
not only responsible for their own maintenance but also formation of the multi-functional 
IECs (discussed in more detail later) (shown in figure 1.3), and because of this, ISCs must be 
able to detect changes in cell populations within the intestine and respond appropriately. It is 
thought that in extreme situations, the differentiated IECs may de-differentiate in order to 
replenish ISC populations (Booth and Potten 2000). ISCs are found at the base of the crypts of 
Lieberkühn in both the small and large intestine, although their distribution differs between 
these two tissues. Crypt cell position 1 is in the centre of the very base of the crypt, and in the 
small intestine, ISCs can be found anywhere between position 2 and 7 amongst the Paneth 
cells, although on average, they are found at position 4. In the large intestine however, ISCs 
are also located at the base of the crypts but they originate from position 1 (Potten 1998). It is 
often described that the ISCs exist in their own intestinal niche, based on differences in the 
expression of receptors, growth factors and extracellular matrix proteins, and this is also 
reflected by the contrast in location, morphology, function and behaviour of the ISCs and the 
4 main differentiated epithelial cell types (Booth and Potten 2000), thus creating a crypt-villus 
axis. Additionally, the basement membrane on which these cells lie is permeable, allowing 
secretion of various molecules, and also interaction between the ISCs and the cells underlying 
this membrane, which include fibroblasts, innate and adaptive immune cells and smooth 
muscle cells (Potten et al. 2009). Cell markers also differ between the proliferating and 
differentiated intestinal cells. For instance, expression of Leucine-rich-repeat containing G 
protein-coupled receptor 5 (Lgr5) is exclusively found at the base of intestinal crypts, in the 
ISCs (Barker et al. 2007), with the marker Ki67 associated with all proliferating crypt cells.  
 
In the intestines, there are thought to be 4-6 “ultimate/true” stem cells and these make up the 
lowest level of proliferating crypt cells. These cells are the most sensitive to damage 
(particularly radiation, which was often used in the early intestinal studies, as cited in Potten 
and Loeffler 1990, and Potten 1998) and following cell death, the next layer of proliferative 
cells up the crypt assume the role of stem cells, in order to maintain intestinal homeostasis. 
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These cells are also known as clonogenic stem cells, and there are multiple layers of these in 
the crypts, with approximately 36 clonogenic stem cells in total. These cells are able to take 
over stem cell functions following loss of the underlying layer, with resistance to damage and 
radiation increasing with increasing position of the clonogenic stem cells too (Potten 1998). 
The T.A cells are situated above the clonogenic stem cells, and although they are also able to 













Figure 1.3:  The differentiated cells of the intestinal epithelium. All differentiated 
intestinal epithelial cells originate from Lgr5+ stem cells located at the base of the crypts. 
Following proliferation, cells differentiate into one of the seven cell types shown and are 
found dispersed throughout the epithelium, with the predominant cell type being enterocytes. 
(Image from Gerbe et al. 2012). 
 
 
1.2.3 Paneth Cells 
Paneth cells are exclusive to the small intestine (as well as the cecum and occasionally the 
proximal colon in humans, Nguyen et al. 2015), and are located at the very base of the crypts 
with the first non-Paneth cell (i.e. ISC) situated, on average, at position 4, although this can 
range from 2 to 7 (Potten 1998). There are approximately 30 Paneth cells per intestinal crypt 
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(Potten 1998), and these are the only type of IEC that migrate downwards, rather than up the 
crypts during differentiation. Also unlike the three other main IECs, Paneth cells have the 
longest lifespan, with a duration of at least three weeks (Bjerknes and Cheng 1981). The role 
of Paneth cells in the intestines is to aid in innate immunity due to their phagocytic properties 
and the possession of large secretory granules that can release proteins such as lysozyme and 
tumour necrosis factor (TNF), which elicit antimicrobial effects (Wright 2000, van der Flier 
and Clevers 2009). 
 
1.2.4 Goblet Cells 
Goblet cells, unlike Paneth cells, are located in both the small and large intestine in both 
organisms, although there are differences in distribution. In mice, the largest population of 
goblet cells is located in the proximal colon, with lower numbers found in the distal colon and 
rectum. In humans however, there are fewer goblet cells in the proximal small intestine 
compared with the distal, although they are abundant from the cecum, throughout the large 
intestine to the rectum (Treuting and Dintzis 2011, Nguyen et al. 2015). The proportion of 
goblet cells within the whole IEC population increases from approximately 4% at the start of 
the small intestine, the duodenum, to around 16% in the descending colon (van der Flier and 
Clevers 2009). Similarly, moving along the large intestine, from proximal to distal, the ratio 
of goblet cells to ECs, the most abundant intestinal epithelium cell type, also increases 
(Treuting and Dintzer 2011). Goblet cells are so named due to their shape, and are responsible 
for secreting mucins and trefoil proteins, and these provide protection and lubrication to the 
mucosa surrounding the intestinal lumen, aid in the passage and expulsion of contents in the 
gut, and help to maintain epithelial integrity and contribute to repair processes (Wright 2000, 
Taupin and Podolsky 2003, van der Flier and Clevers 2009). There are approximately 20 
identified mucins, with 9 of these expressed by both humans and mice. They can also either 
be secreted or remain bound to cell membranes (Natividad and Verdu 2013). 
 
1.2.5 Enteroendocrine Cells 
EECs are the final secretory cell type of the four main types of IEC and there are 15 different 
types, despite only making up 1% of the cells lining the lumen (Cheng and Leblond 1974). 
Each EEC type can be defined by its morphology, its location, the hormones/peptides they 
secrete and/or their expression of genetic markers (Cheng and Leblond 1974, van der Flier 
and Clevers 2009). For instance, N cells are found in the small and large intestine and they 
secrete neurotensin which inhibits intestinal contractions, whereas I cells are located in the 
12 
 
proximal small intestine and they secrete serotonin, which stimulates release of enzymes from 
the pancreas (Furness et al. 2013). Following recognition of environmental changes through 
communication with the central nervous system (CNS) and/or the intestinal lumen, EECs may 
then bind with and/or produce and secrete peptides to instigate further responses, such 
changes in appetite and food intake, and release of digestive enzymes (Wright 2000, Furness 
et al. 2013). 
 
1.2.6 Enterocytes 
ECs are the final cell type of the main four that make up the intestinal epithelium and are the 
only absorptive cells. They are polarised, columnar cells and they make up more than 80% of 
the cells lining the epithelium (Wright 2000, van der Flier and Clevers 2009). These cells are 
crucial to the epithelium as they have a brush border consisting of microvilli, which greatly 
increase the surface area, and are the site of digestion and absorption, due to the secretion of 
hydrolytic enzymes (Wright 2000, Radtke and Clevers 2005). This brush border also consists 
of glycoproteins similar to mucins (also termed the glycocalyx) that aid to protect the 
epithelium from contact with pathogens (Neutra 1998). 
 
1.2.7 Additional Cells of the Intestinal Epithelium 
In addition to these cells, there are also three other cell types that make up a small proportion 
of the intestinal epithelium. First, there are microfold, or M cells, that exhibit immune 
functions through transcytosis (transcellular transport) of pathogens from the apical surface to 
the underlying tissues, where immune cells such as dendritic cells, macrophages and T 
lymphocytes reside. Where M cells possess a brush border, the number of microvilli is lower 
than that of ECs, with a more irregular arrangement. If cells also have a glycocalyx, this is 
also not as thick as that found on the apical surface of ECs, along with the cell membrane, in 
order to allow close proximity to luminal contents (Neutra 1998). Next are cup cells, which 
are so named due to a depression in the apical cell surface causing the resulting chalice-like 
shape (Madara 1982).  These cells are actually more numerous than EECs, and can comprise 
up to 6% of cells in the ileal epithelium (Gerbe et al. 2012).  Like M cells, cup cells also 
exhibit a smaller brush border than ECs, as well as reduced activity of the enzyme, alkaline 
phosphatase- a hydrolytic enzyme involved in the removal of phosphate groups. However, 
despite these findings, the explicit functions of these cells are not currently known (Madara 
1982, Gerbe et al. 2012). The final type of epithelial cells is tuft cells and these make up a 
smaller proportion of IECs than EECs, at 0.4%. These cells are named from the group of 
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microtubules that are attached to long, thick microvilli on the apical side of the cell protruding 
into the lumen, which resembles a “tuft.” Similar to cup cells though, the functions of these 
cells have yet to be fully elucidated (Gerbe et al. 2012). 
 
 











Figure 1.4: The gastrointestinal tracts of humans and Drosophila. (Colour coding depicts 
equivalent, homologous tissues between the two organisms). (WWW, Manchester University 
Fly Facility). 
 
Considering Drosophila now, the anatomy of the GI tract shows some similarities to those in 
mammalian systems (shown in figure 1.4)- following the ingestion of food, this then travels 
down the foregut (oesophagus equivalent) where it may be stored in the crop momentarily 
(stomach equivalent) (Apidianakis and Rahme 2011). From the crop, it then passes through 
the midgut, which is similar to the mammalian small intestine (Ohlstein and Spradling 2006) 
and the main site of digestion ((Shanbhag and Tripathi 2009), and this is divided into the 
anterior, middle and posterior midgut. Finally, the digested food reaches the hindgut, the fruit 
fly equivalent of the large intestine (Ohlstein and Spradling 2006), and as in mammals, this is 
also the site of water, ion and electrolyte exchanges. Any indigestible food that remains in the 
tract will then be excreted from the anus. Also, located at the junction between the midgut and 
the hindgut are the Malpighian tubules, and these are the equivalent of the mammalian 
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kidneys (cited by Buchon et al. 2013a). As stated, the Drosophila midgut is the primary site of 
food digestion in Drosophila, and is a major defensive barrier against pathogens after the 
exoskeleton. It is also the first barrier against ingested pathogens. This is a particularly 
important function due to the main constituent of the Drosophila diet being microbe-
containing rotting fruit and other food, so therefore an array of pathogens will be consumed 
on a frequent basis (Apidianakis and Rahme 2011). In mice and humans, the pH of the entire 
G.I tract is variable, with different pHs reported for each organ. Starting with the stomach, it 
is very acidic, ranging between pH 1-4, although this increases to 4-5 in the duodenum. By the 
end of the small intestine, at the ileum, the pH is higher still at 6.5-7.5. There is a decrease to 
approximately 5.7 in the cecum, although this increases to around 6.7 at the end of the G.I 
tract, in the rectum (Fallingborg 1999). The region-specific differences in pH can also be seen 
in the midgut of Drosophila, with the anterior midgut being fairly neutral. The middle midgut 
is very acidic due to the presence and functioning of iron and copper cells. The posterior 
midgut then becomes more alkaline due to secretion of bases into the lumen (Royet 2011). 
 
Next, exploring the structure of the midgut, fruit flies do possess an epithelial barrier that also 
separates the luminal contents from the underlying tissue, along with a peritrophic matrix 
(shown in figure 1.2). This matrix consists of glycoproteins and chitin, and is situated above 
the IECs. It has similar functions to the mucin layer that lines the mammalian intestinal 
epithelium, protecting the lining from damage and pathogens, and lubricating food for passage 
through the tract, as well as having selective, semi-permeable properties (Lehane 1997). 
Despite the similarities, the actual arrangement of the Drosophila midgut epithelium differs 
from that in mice and humans. First, there are ISCs in the Drosophila midgut, although these 
are situated on a basement membrane, as there are no crypt structures (Micchelli and Perrimon 
2006). ISCs are abundant, with approximately 800-1000 in the posterior midgut amongst a 
total of approximately 10,000 cells, although they are often located in certain areas of the 
midgut, due to different demands between niches (Ohlstein and Spradling 2006). As in 
mammals, Drosophila ISCs are the only proliferating cells found in the midgut, and these are 
also multipotent, capable of differentiating into multiple cell types. In mammalian systems, 
following proliferation of ISCs and, differentiation and migration of cells up the intestinal 
crypts to the tip of villi, cells undergo cell death and are shed from the tips of villi into the 
intestinal lumen. Drosophila ISCs also typically divide asymmetrically, producing another 
ISC and an additional midgut progenitor cell, known as an enteroblast (EB), although unlike 
T.A cells in mammals, EBs do not go on to proliferate themselves. However, it has been 
suggested that during the first few days following eclosion, all ISC divisions are symmetrical 
in order to generate sufficient numbers of ISCs to be maintained during the flies’ lifespan 
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(Lucchetta and Ohlstein 2012). Depending on the level of Notch signalling, EBs will then 
differentiate into either one of the two IEC types, an EC or an EEC (Ohlstein and Spradling 
2006), as there are no goblet cells or Paneth cells in Drosophila. Both of these cell types 
exhibit similar functions to their mammalian counterparts- ECs make up approximately 90% 
of the cells in the midgut epithelium (Ohlstein and Spradling 2007), with their primary 
function also consisting of digestion and absorption of food, aided by the presence of 
microvilli (Morgan et al. 1995). However, unlike EECs, and also ECs found in mice and 
humans, Drosophila ECs are able to endoreplicate, increasing their genome to 2-3 times its 
original size, and this also increases the size of these cells too, and may aid their absorptive 
function through increased surface area (Jiang and Edgar 2011). Similar to mammalian ECs 
though, those found in Drosophila are also capable of exhibiting apical-basal polarity 
(Micchelli and Perrimon 2006). Drosophila EECs maintain their secretory functions, releasing 
an array of response-inducing peptides dependent on the stimulus/environmental change in the 
CNS or the midgut, thus facilitating communication within and between the different tissues. 
However, whereas EECs can be found in both the small and large intestines in mammalian 
systems, they are exclusive to the Drosophila midgut (Veenstra et al. 2008). The type of 
peptide each EEC produces also dictates their specific location in the midgut. For instance, 
Marianes and Spradling (2013) found that short neuropeptide F (sNPF)-expressing EECs were 
located in the anterior midgut, with ion transfer peptide (Itp)-expressing cells confined to the 
middle midgut. (sNPF is a peptide involved in sugar metabolism, feeding behaviours and 
circadian rhythms, whereas Itp is implicated in locomotion, sleeping behaviours, in addition to 
circadian rhythms, cited on  WWW, Flybase). The variabilities in EEC location are thought to 
either stem from differences in differentiation between region-specific ISCs, or from region 
specific signals and requirements influencing ISCs (Marianes and Spradling 2013). 
 
The midgut renewal process in Drosophila is similar to that in mammalian systems, with 
Drosophila IECs also capable of undergoing apoptosis following differentiation and 
eventually being shed into the lumen. Under homeostatic conditions, the whole process from 
ISC proliferation to cell death takes approximately one week, similar to rates reported in mice 
and humans (Ohlstein and Spradling 2006). As seen in mammals, the structure and integrity 
of the midgut relies upon the presence and correct functioning of ISCs, and this was shown by 
Jiang et al. (2009), who found that ablation of ISCs led to the loss of all ISCs, EBs, EECs and 
several ECs, subsequently causing a decrease in midgut size. However, loss of ECs had less of 
a negative effect and midguts had regained their original size after 60 hours through 
proliferation of ISCs, verifying that IECs emanate from ISCs. 
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1.3 Intestinal Cell Renewal Pathways 
The intestinal epithelium is one of the most rapidly proliferating tissues within biological 
systems, with the midgut being one of the few tissues in Drosophila that is renewed, as fruit 
flies are primarily post-mitotic organisms following eclosion (cited by Rudolph 2010). As 
with any tissue though, it is important that cell numbers are maintained, and this is achieved 
through a balance of cell proliferation and cell loss, either through apoptosis or anoikis. If 
cellular proliferation increases (perhaps along with decreases in cell death), this can lead to 
hyperplasia, and in terms of the gut, an increase in crypt and villus size. If intestinal 
proliferation continues to increase and regulation of one or more of the signalling pathways 
involved in renewal is impaired, this may ultimately result in carcinogenesis. Conversely, a 
decrease in proliferation (particularly if accompanied by an increase in cell death) can lead to 
loss of crypt integrity and increased intestinal damage, and may ultimately lead to 
inflammatory bowel disease. Reduced intestinal proliferation rates, and consequently crypt 
and mucosal depths, are also a common finding amongst germ free (GF) animals, when 
compared with conventionally raised (CR) animals (Abrams et al. 1962). 
 
In terms of research concerning mammalian intestinal proliferation, a lot of our understanding 
has been obtained from the considerable number of studies that have been performed on mice, 
due to the difficulties in carrying out such invasive, tracking experiments in humans, and also 
the vast differences in lifespans when investigating proliferation changes with ageing as well, 
for instance. From said studies, we have learnt about the intestine by numbers, which may 
give us some indications about the human intestines. Starting with the murine small intestine, 
each crypt contains approximately 250 cells, with 150-160 of these being proliferative cells. 
These proliferative cells are typically found from the 4th crypt position (with Paneth cells 
occupying the lower positions), with about 16 cells per crypt ring/layer and approximately 10 
rings per crypt (Potten 1991). The bottom ring of the 10 is where the ISCs reside. Each 
proliferative cell is capable of dividing 1-2 times per day, with cell cycle durations estimated 
to be between 12 and 32 hours, although this is depends on the requirements of each crypt, or 
regions within each crypt. This results in the generation of approximately 300 new intestinal 
crypt cells per day, and therefore, around 12 per hour. In the migration process from crypt to 
villus following differentiation of T.A cells, cells are reported to move 1-2 cell positions per 
hour, with each villus consisting of ≈3500 cells. Up to 1400 cells are lost from each villus per 
day, with an approximated 2 x 108 thought to be shed from the small intestine each day 
(Potten 1998). In humans, it is thought this number could be as high as 1011 cells, with the 
number of cells per crypt found to be higher too, with ≈450 (Potten 1991). When investigating 
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the murine large intestine, Potten (1998) found higher numbers, with approximately 300-450 
cells per crypt. However, each crypt was found to have a circumference of 18 cells, which is 
only 2 more than in the small intestine. Cell cycle durations fall within the range of small 
intestinal cells too, with each proliferating colon cell dividing roughly every 20 hours (Potten 
1998). In the Drosophila midgut, there are fewer cells in total, with approximately 10,000 and 
800-1000 of these being ISCs (Ohlstein and Spradling 2006). However, this decrease is 
expected due to the substantial differences in organism size between flies, and both mice and 
humans. Additionally, the Drosophila midgut cells are situated on a basement membrane, 
rather than in crypts as found in mammalian systems (Micchelli and Perrimon 2006), and this 
could reduce the surface area of the midgut, and thus reduce the potential number of cells. 
Regarding mitotic rates of Drosophila ISCs, it is to be assumed that the cell cycle durations 
may be comparable to those in mice and humans due to their similarities in time taken for 
complete epithelium renewal. Typically, ISCs divide asymmetrically, producing another ISC 
and a maturing cell which will go onto differentiate into one of the intestinal epithelial cell 
types. However, 5% of ISC divisions are symmetrical, resulting in the production of either 
two ISCs, or two maturing cells (Loeffler and Potten 1997), so therefore the balance must be 
maintained in order to ensure there are not inappropriate increases or decreases in ISCs. It is 
important that the ISC population is constantly renewed as ISCs are sustained through the 
lifetime of many organisms (Booth and Potten 2000), including mammals and fruit flies, so 
therefore they must be protected from damage, or exhaustion from over-proliferation (Quante 
and Wang 2008). The loss of just one ISC from one crypt would result in a considerable 
decrease in the overall number of cells (Marshman et al. 2002), although ISCs are capable of 
detecting the death of one of their own cells and initiating a response accordingly (Potten 
1991). Furthermore, ISCs are the only proliferating cells in the intestines, so each ISC has the 
potential of giving rise to carcinomas (Booth and Potten 2000), so therefore must be well-
maintained. Despite this, ISCs are capable of switching between processes of differentiation, 
and, self-maintenance, depending on the needs of the crypt. Partially differentiated cells are 
also capable of de-differentiating back into stem cells if necessary (Booth and Potten 2000). 
 
In both mammals and Drosophila, there are many signalling pathways involved in initiation 
and regulation of intestinal cell renewal. Examples found in all three systems include the 
Notch/Delta, Wnt, Jun N-terminal Kinase (JNK), Hippo, Epidermal Growth Factor Receptor/ 
Extracellular Signal-Regulated Kinases (EGFR/Erk), insulin and Jak/Stat signalling pathways. 
In addition to its roles in IEC differentiation, the Wnt pathway is also one of the predominant 
pathways implicated in intestinal cell turnover. Wnt is also the name of the protein ligand 
responsible for pathway activity, and in the absence of this ligand in mammals, β-catenin (a 
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protein involved in cell adhesion and gene transcription) is phosphorylated and targeted for 
proteasomal degradation by a complex of several proteins, including the tumour suppressor, 
adenomatous polyposis coli (APC). Upon Wnt binding to the Frizzled receptors and 
lipoprotein receptor-related protein coreceptors, the proteasomal complex is inactivated, so β-
catenin accumulates in the cytoplasm and forms a transcriptional complex with other proteins, 
resulting in the transcription of Wnt target genes in the nucleus associated with cell 
proliferation. A gradient of Wnt signalling occurs within the intestine, with the highest 
amount of Wnt activity found at the base of the crypts, thus reinforcing the presence of the 
crypt-villus axis (cited by van der Flier and Clevers 2009). 
 
As stated previously, there are several other signalling pathways responsible for intestinal 
renewal, although our main focus in this project is Jak/Stat, due to the ability of SOCS3 to 
inhibit signalling in this pathway. The Jak/Stat pathway is involved in cell growth and 
differentiation, as well as apoptosis (reviewed by Krebs and Hilton 2001). In mammals, 
signalling is activated upon binding of a cytokine (for example, interleukins such as 
interleukin-6 (IL-6), and interferon-γ, IFN-γ) to cytokine receptors, which induces receptor 
dimerisation and conformational changes in the receptor structure (as shown in figure 1.5). 
Jak proteins are also recruited to the receptors and Jak activation occurs through cross- or 
auto-phosphorylation of tyrosine residues located within the protein. The activated Jak 
proteins then phosphorylate tyrosine residues on the cytosolic domain of the receptors, 
causing Src-homology 2 (SH2) domains of Stat proteins to bind to these residues. The Stat 
proteins are activated through phosphorylation of their tyrosine residues by Jaks, which is 
followed by homo- or hetero-dimerisation- dimerisation of the same or different type of Stat 
protein, respectively. The Stat dimer enters the nucleus and transcription of genes associated 
with cell proliferation, differentiation or apoptosis occurs, as well as transcription of SOCS 
genes. SOCS are negative regulators of Jak/Stat signalling, and as their activation is based 
upon activation of the Jak/Stat pathway, this produces a negative feedback loop (reviewed by 
Greenhalgh et al. 2002). There are other negative regulators in the pathway, and these are 
protein inhibitors of activated Stats (PIAS) and SH2-containing protein tyrosine phosphatases 
(SHPs). PIAS is capable of preventing transcription that results from Stat binding to DNA, 
either directly, or indirectly by inhibiting the dimerization of Stat proteins. SHPs operate by 
binding to and desphosphorylating tyrosine residues on Jaks, thus reducing their catalytic 













Figure 1.5: The mammalian Jak/Stat pathway. Ligand binding induces receptor activation 
and dimerisation, leading to recruitment and phosphorylation of Jak proteins. Jaks 
phosphorylate tyrosine residues on the receptor, recruiting Stat proteins. Stat proteins are 
activated once phosphorylated by Jak proteins, and subsequently dimerise and translocate to 
the nucleus in order carry out gene transcription. Upon activation of Jak/Stat signalling, the 
genes for SOCS are transcribed, leading to the production of SOCS proteins and suppression 
of Jak/Stat signalling (WWW, Mutagenetix, South Western Medical Centre). 
 
 
Each component of the mammalian Jak/Stat pathway has several different types. For instance, 
there are 4 types of Jak: Jaks 1, 2 and 3, and tyrosine kinase (TYK) 2, along with 7 types of 
Stat protein: Stat1, Stat2, Stat3, Stat4, Stat5a, Stat5b and Stat6 (reviewed by Krebs and Hilton 
2001). There are also 8 different SOCS: SOCS 1-7 and cytokine-inducible SH2-protein (CIS). 
Each SOCS protein can be paired with another SOCS, in relation to the homology between N-
terminal regions (reviewed by Greenhalgh et al. 2002): CIS and SOCS2, SOCS1 and SOCS3, 
SOCS4 and SOCS5, SOCS6 and SOCS7. The SOCS proteins also inhibit Jak/Stat signalling 
at different points within the pathway. SOCS 1 and 3 contain a kinase inhibitory region (KIR) 
at the N terminus and this allows them to bind to Jaks and inhibit their activity, whereas CIS 
prevents Stat proteins from binding to the cytosolic domains of the cytokine receptors. SOCS 
proteins possess an N-terminal that can comprise of 50-380 amino acids, with the length and 
amino acid composition differing between each protein (Krebs and Hilton 2001). As stated, 
the KIR domain is located within the N-terminal and this consists of 12 amino acid residues, 
and is essential for inhibition of the Jak kinase activity, particularly in SOCS3, as mutations 
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not only affected the ability to interact with the Jak proteins, but the downstream inhibitory 
effect on Stat activity was prevented as well (Sasaki et al. 1999). Adjacent to the N-terminal 
and KIR domain lies an SH2 domain, and this is able to bind to activated, tyrosine-
phosphorylated signalling molecules, such as Jaks within the Jak/Stat pathway specifically, 
and this also blocks binding sites for recruited Stat proteins (cited by Babon et al. 2006). At 
the N-terminal of the SH2 reside domains known as the N-extended SH2 domain (ESS in 
figure 1.6), and this also aids in the binding of the SH2 domain to phosphotyrosine residues as 
mutations in these domains affect the interaction that normally takes place between Jak and 
SOCS proteins (Sasaki et al. 1999). Additionally, the SH2 domain of SOCS3 specifically also 
contains an “unstructured motif insertion,” which is Proline-, Glutamic-acid-, Serine- and 
Threonine-rich, so is therefore referred to as the PEST motif (Babon et al. 2006), and is 
conserved in several mammalian species (Babon et al. 2005). Although removal of this motif 
does not affect the function of the SH2 domain or the inhibitory effects of SOCS3, its role is 
to regulate the stability of the protein, so in doing so, this decreases its turnover and increases 
the half-life of SOCS3. Furthermore, it is thought that PEST may mediate degradation of 
SOCS3 (perhaps following cessation of signalling), as phosphorylation of residues within the 
PEST motif has been reported to affect degradation, and expression of SOCS3 was higher 
following removal of PEST; both with and without the addition of a proteasomal inhibitor 
(Babon et al. 2006). Finally, within the C-terminal of all SOCS proteins (in addition to other 
non-Jak/Stat proteins) is a conserved region 40 amino acids in length known as the SOCS box 
(Krebs and Hilton 2001, Piessevaux et al. 2008). Unlike the other domains within the SOCS 
proteins, the SOCS box is not implicated in direct inhibition of the Jak/Stat pathway, but is 
involved in proteasomal degradation of SOCS3 and other proteins (Zhang et al. 1999). The 
role of the SOCS box in the degradation of SOCS (and in this case, SOCS3) was shown 
through continual increases in IL-6-induced SOCS3 proteins levels following incubation of 
cells with a proteasomal inhibitor (compared to cells that were not treated with the inhibitor) 
(Zhang et al. 1999). The degradation process involves the binding of elongins B and C to form 
a dimer which is then able to interact with the SOCS box and link the protein targeted for 
degradation to a scaffold protein known as Cullin (Piessevaux et al. 2008). A protein known 
as RING-box protein 2 interacts with Cullin and recruits the ubiquitin complex to the SOCS 
box, and this consists of: an E1 ubiquitin-activating enzyme, an E2 ubiqutin-
conjugating/transferase enzyme and an E3 ubiqutin ligase, and collectively, these all function 
to polyubiquitinate proteins (such as Jaks and SOCS) and target them for proteasomal 













Figure 1.6: The structure and domains of the mammalian SOCS proteins. Each protein 
contains an ESS and an SH2 domain, along with a conserved SOCS box at the C-terminal. 
SOCS1 and SOCS3 contain an additional domain, the KIR domain, responsible for inhibiting 
Jaks, and SOCS3 also has a PEST motif within its SH2 domain, which is implicated in protein 
stability and degradation. (KIR= Kinase Inhibitory Region, ESS= N-terminal Extended SH2 
domain) (Adapted from Piessevaux et al. 2008). 
 
 
Focusing on SOCS3 in particular, its main, well-publicised role is the inhibition of cytokine-
induced signalling (along with the other SOCS proteins), and in addition to Jak protein 
degradation, this is achieved through inhibition of Jak1, Jak2 and TYK2 proteins. SOCS3 is 
able to inhibit these proteins and not the remaining Jak- Jak3- as those 3 proteins contain a 
conserved motif consisting of glycine, glutamine and methionine residues that is not present 
in Jak3 (Babon and Nicola 2012). This process is required for limiting proliferation and 
inflammation, and often forms a negative feedback loop during this process. For instance, 
deletion of SOCS3 in multiple mouse studies has proven to not only affect cell signalling but 
also be detrimental to the health of the host. Generating mice with conditional knockout of 
SOCS3 in their haematopoietic and endothelial cells resulted in premature death due to the 
development of inflammatory lesions (cited by Croker et al. 2008). Additionally, deletion of 
SOCS3 in macrophages led to hyper-responsiveness following treatment with IL-6 and 
alterations to the usual IL-6 induced responses, in that inflammatory genes normally induced 
by IFNs and Stat1 were activated (cited by Babon and Nicola 2012). Conversely, many 
studies report elevation of SOCS3 in IBD due to increases in IL-6 and Stat3 (Suzuki et al. 
2001, Li et al. 2010). These studies therefore demonstrate the importance of appropriately 

















processes. These findings also demonstrate the significant role of SOCS3 in particular subsets 
of cells and tissues, whereas the generation of SOCS3-/- mice (as a whole) results in 
embryonic lethality due to abnormalities in the placenta and development of vessels within the 
embryo. The accumulation of these defects must lead to rapid deterioration of mice embryos 
as they appear to develop normally by day 10 in utero, although by day 12, 50% of the 
embryos had died, and by day 13.5, SOCS3-/- mouse survival was at 0% (Roberts et al. 2001). 
In order to overcome this obstacle, Croker et al. (2003) were able to utilise Cre-lox 
recombinase technology to target deletion of SOCS3 following removal of SOCS3 DNA by 
the Cre recombinase enzyme at sites either side of the target gene where loxP has associated 
(Orban et al. 1992). 
 
The Jak/Stat pathway is also conserved in Drosophila, and is required for the renewal of germ 
cells, as well as ISCs (Kiger et al. 2001). This pathway is actually simplified compared with 
the mammalian Jak/Stat pathway, and there are Drosophila homologues corresponding to 
components found in the mammalian pathway. The activator of Jak/Stat in Drosophila is 
related to mammalian IL-6 and known as Unpaired, or Upd, of which there are three: Upd1, 
Upd2 and Upd3 (Agaisse et al. 2003, Jiang et al. 2009), and this binds to the receptor, 
Domeless (Brown et al. 2001) (shown in figure 1.7). There is only one Jak protein, which is 
known as Hop, and this shows the most homology to Jak2 (Binari and Perrimon 1994). There 
is also only one Stat protein, Stat92E, which is homologous to mammalian Stat5 (Yan et al. 
1996). However, there are three SOCS proteins found in Drosophila, and these are SOCS16D, 
SOCS44A and SOCS36E (Hou et al. 2002) (shown in figure 1.8). SOCS36E is the most 
documented SOCS protein in Drosophila, and is the homologue of human and murine 
SOCS5. It acts by preventing the phosphorylation of Stat92E, and therefore Stat dimerisation. 
Despite being homologous to human SOCS5, the fact that SOCS36E can inhibit Jak/Stat 
signalling means it is functionally similar to CIS and SOCS1-3 (Callus and Mathey-Prevot 
2002). SOCS16D and SOCS44A are the homologues of human SOCS6 and 7 (Rawlings et al. 













Upd1, 2 and 3 ligands  IL-6 
Domeless Receptor IL-6 Receptor/ gp130 
Hop Jak (more specifically Jak2) 
Stat92E Stat (more specifically Stat5) 
SOCS (SOCS36E, SOCS16D, 
SOCS44A) 
SOCS (SOCS5, and SOCS6 and 
SOCS7) 
 
Figure 1.7: The Drosophila Jak/Stat pathway. This pathway is conserved in fruit flies with 
homologues of the main components shown in the table above, and is activated through 
binding of the Upd ligand to the Domeless receptor. Receptor dimerisation occurs and Hop 
proteins are recruited. Once Stat92E is recruited to Domeless and phosphorylated by Hop, 
dimerisation occurs, followed by translocation of Stat92E dimers to the nucleus where gene 
transcription occurs. Among the genes transcribed are negative regulators of the pathway, 
including genes encoding SOCS proteins (Image reproduced with permission from The 
Journal of Experimental Biology, Singh and Hou 2009). 
 
 
SOCS36E was first identified by Nicholson et al. (1999) due to the sequence homology in 
both the SH2 domain and in the 20 amino acids that precede it when compared with SOCS5. 
More specifically, Callus and Mathey-Prevot (2002) reported 68% identical homology 
between the SH2 domains and the SOCS box of SOCS36E and human SOCS5. However, no 
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homology was reported between N-termini, although this is not surprising as there is 
variability between N-termini even within the family of human SOCS proteins (Krebs and 
Hilton 2001). Interestingly, compared with Drosophila SOCS proteins, human SOCS1-3 have 
found to be at least 100 amino acid residues shorter, suggesting these differences may be 
evolutionary and arose following divergence of mammals and insects (Stec and Zeidler 2011). 
Within the SOCS36E protein, the SH2 domain is essential for the interaction of SOCS36E 
with its target molecules, such as Domeless and Hop (Rawlings et al. 2004, Stec et al. 2013), 
with maximal activity of the overall protein enhanced through the presence and appropriate 
functioning of the SOCS box (Callus and Mathey-Prevot 2002). Additionally, SOCS36E is 
able to inhibit Jak/Stat signalling not only through prevention of Stat92E activation and 
phosphorylation (and subsequent downstream signalling), but through destabilisation of the  
Domeless receptor facilitated by elongins B and C and the Cullin protein due to the conserved 
SOCS box domain (Stec et al. 2013). As in mammalian systems, expression of SOCS36E is 
initiated following activation of the Jak/Stat pathway, as larval studies revealed identical 
overlapping expression patterns for SOCS36E and the pathway ligand, Upd. Additionally, 
increases in mRNA expression of SOCS36E were observed in larvae exhibiting gain of 
function Jak/Stat mutations (Callus and Mathey-Prevot 2002). In contrast to findings of 
Roberts et al. (2001), Callus and Mathey-Prevot (2002) found that deletion of SOCS36E in 
embryos (achieved through RNA interference- RNAi- injection) did not result in embryonic 
lethality, nor were any defects observed either when compared with controls, potentially 
suggesting different roles of SOCS proteins during embryonic development between 
mammals and Drosophila. Conversely, Callus and Mathey-Prevot (2002) also expressed 
SOCS36E ubiquitously in adult flies, and this was found to lead to a shortening of lifespan 
although again, no other strong phenotypes were detected. However, despite these 
observations, one of SOCS36E’s primary roles within Drosophila is the regulation of eye and 
wing development, as defects in both have been detected following both directed expression 
and RNAi depletion of SOCS36E, along with outgrowths (Callus and Mathey-Prevot 2002, 
Herranz et al. 2012). Results suggested that these effects were mediated by the SOCS box as 











Figure 1.8: Comparison of the structure of Drosophila SOCS proteins, along with 
SOCS36E and its structural and functional mammalian homologues, SOCS5 and 
SOCS3, respectively. All Drosophila SOCS proteins lack KIR and ESS domains, but contain 
SH2 domains and a SOCS box, demonstrating the evolutionary conservation and important 
functions of these components. (Adapted from Arbouzova and Zeidler 2006, and Piessevaux 
et al. 2008).  
 
 
Although the Jak/Stat pathway is present in mammalian intestinal cells and is implicated in 
proliferation and renewal, as indicated by its dysregulation in cancers of the G.I tract 
(discussed in further detail later in the chapter), the activity of the Drosophila pathway 
appears to play a more central role in gut turnover. Jak/Stat signalling is required for initiation 
and regulation of basal levels of proliferation, and it is also induced through either infection or 
injury, as damaged cells release Upd3 (Agaisse et al. 2003, Buchon et al. 2009a, Jiang et al. 
2009). Buchon et al. (2009b) conducted several experiments investigating the role of the 
midgut Jak/Stat pathway, and did so by using the Gram-negative phytopathogen, Erwinia 
carotovora carotovora 15 (Ecc15). Ecc15 naturally infects Drosophila in the wild, but under 
normal circumstances, this infection will not lead to mortality; instead, immune and 
proliferative responses are initiated (Basset et al. 2000, Buchon et al. 2009a). However, flies 
whose Jak/Stat pathway is inhibited, or who are deficient in Upd3, succumb to Ecc15 
infection within a week of oral ingestion. Surprisingly, flies deficient in their immune 
pathway (Imd) did not exhibit Ecc15-induced mortality, indicating that proliferative, repair 
processes are more crucial to the health of Drosophila than immune responses (Buchon et al. 
2009b).  This increased susceptibility to infection was also continued in Stat RNAi flies 















In the Drosophila midgut, there appears to be more crosstalk between Jak/Stat and other 
signalling pathways, than in mammals. For example, the Drosophila Jak/Stat pathway can be 
activated by JNK signalling, (which is similar in function to Jak/Stat), with the JNK pathway 
activated in the event of stresses, such as DNA damage, reactive oxygen species (ROS), 
inflammatory cytokines and infection. Initiation of JNK signalling can result in apoptosis, and 
tissue regeneration and repair through cell proliferation; both of which are essential for long-
term tissue homeostasis (Biteau et al. 2011). Upon activation of the JNK pathway, the Jak/Stat 
ligands, Upd1-3 are induced, thus further promoting proliferation of ISCs (Jiang et al. 2009). 
Additionally, crosstalk also exists between the Drosophila Jak/Stat and Hippo signalling 
pathways. In this pathway, the activity of a growth-promoting transcriptional co-activator 
known as Yorkie is normally limited in order to prevent excess proliferation of ISCs. 
Inhibition of Yorkie activity is brought about through phosphorylation by a kinase known as 
Warts (Shaw et al. 2010). Decreased levels of Warts lift this inhibition on Yorkie and when 
active in ECs, promotes ISC proliferation through secretion of Upds (Upd3 in particular) 
(Irvine and Staley 2010). Activation of the JNK pathway also promotes Yorkie activity, so 
therefore JNK acts upstream of the Hippo pathway, which in turn is upstream of the Jak/Stat 
pathway (Irvine and Staley 2010). Furthermore, Jak/Stat is able to coordinate with the Wnt 
and Epidermal Growth Factor Receptor (EGFR) pathways, as their activation is increased 
following dysregulation and diminishing activity in one of the other pathways, to ensure 
efficient regulation of ISCs (Xu et al. 2011). Collectively, the numerous pathways involved in 
ISC proliferation and midgut renewal, along with the amount of signalling pathway crosstalk 
that has been reported, stress the importance of regulated homeostasis within Drosophila and 
also of the midgut as a whole. 
 
 
1.4 Implications of Dysregulated Intestinal Homeostasis 
Dysregulation and/or mutations within any cell signalling pathway in biological systems can 
be detrimental to the health of the host, with increases in pathways whose activation results in 
proliferation increasing the risk of developing hyperplasia, or if sustained, cancer. Cancer is a 
group of diseases characterised by the uncontrolled replication of cells, and this occurs due to 
the accumulation of genetic mutations. The accumulation of cells with uncontrolled 
proliferation also increases the chances of a mutation escaping cell checkpoint mechanisms. 
The process of carcinogenesis comprises of three steps: initiation, promotion and progression. 
Initiation consists of genetic alterations within a cell and if they are not rectified, or if they 
accumulate, then these changes could become irreversible. Promotion involves the survival 
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and replication of these cells, thereby increasing the number of cancerous cells. Finally, 
progression is the increase in growth of the tumour, and metastasis that may ensue (Rakoff-
Nahoum 2006). With respect to colorectal cancer (CRC) specifically, one of the most 
commonly mutated genes is the APC gene. APC mutations are found in approximately 80% 
of sporadic CRC cases, with heterozygous mutations inherited in 100% of familial 
adenomatous polyposis coli (FAP) cases, with the severity and onset of FAP dependent on the 
location of the mutation (Bach et al. 2000). Along with other proteins, APC normally inhibits 
transcriptional activity of β-catenin, although mutations or induced deletion (i.e in mouse 
knockout studies) of APC results in increased accumulation of β-catenin and consequently 
increased transcription-induced proliferation (van der Flier and Clevers 2009). As stated 
previously, there is a crypt-villus axis that exists within the intestines, and this is particularly 
true for Wnt signalling, with higher activity levels found at the base of the crypts of 
Lieberkühn. Therefore, it is not particularly surprising that deletion of APC in the Lgr5+ stem 
cells results in their transformation within a matter of days (cited by Potten et al. 2009). 
 
With respect to Jak/Stat signalling, one of the outcomes that results from activation of this 
pathway is also proliferation, so therefore dysregulated pathway activity (whether it is 
increased or decreased) would alter cell growth and possibly overall tissue homeostasis and 
host wellbeing. An increase in JAK/STAT signalling and/or a loss of regulation (through 
decreased SOCS for example) would lead to increased proliferation, and if sustained, could 
also lead to hyperplasia or tumourigenesis. Reductions or lack of SOCS proteins have been 
reported in a multitude of different cancer types (particularly SOCS3) as the expression levels 
are not sufficient enough to fulfil their role as tumour suppressors (He et al. 2003, Weber et al. 
2005, Ogata et al. 2006, Croker et al. 2008). Due to the release of SOCS’ inhibition on 
Jak/Stat signalling (with the pathway component differing depending on the SOCS protein 
affected), phosphorylation, dimerisation and translocation of Stat proteins is able to take 
place, although consequently gene transcription is increased. As a result, tumours with 
diminished SOCS levels also often exhibit increased levels of Stat, and phosphorylated Stat 
proteins (Croker et al. 2008, Li et al. 2010).  
 
Many studies have been conducted into the role of Jak/Stat signalling in cancer, particularly 
with respect to CRC within the G.I tract, as the colon is more susceptible to tumours than the 
ileum (Potten 1998). For instance, increased activation of Jak/Stat signalling (and Stat3 in 
particular) has been reported in multiple in vitro intestinal cancer cell lines and colon 
carcinomas, with the addition of Jak or Stat inhibitors leading to cell cycle arrest and 
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apoptosis (Lin et al. 2005, Xiong et al. 2008 Grivennikov et al. 2009). In a murine model of 
colitis-associated carcinogenesis (CAC), Rigby et al. (2007) reported an increase in 
hyperproliferation following IEC-specific deletion of SOCS3. This led to tumourigenesis, and 
these mice also exhibited increases in both number and size of tumours, when compared to 
SOCS3-sufficient mice. Although experiments by He et al. (2003) were not performed in 
intestinal cells, they also found silencing of SOCS3 (caused by promoter hypermethylation) 
occurred in multiple cancer cell lines (e.g. lung, breast and mesothelioma), and restoration of 
SOCS3 in lung cancer cells specifically, led to decreased activation of Stat3, subsequently 
suppressing tumour growth and inducing cell death by apoptosis. These results were able to 
demonstrate the potential use of SOCS3 in cancer therapy. However, a slight limitation of 
these studies is that experiments investigating effects of SOCS3 and Jak/Stat on intestinal 
homeostasis were carried out using in vitro cancer cell lines and primary samples. In these, 
carcinogenesis has already been established and it may be possible that one or more mutations 
were present anywhere within the cells. There has been very little research into the role of 
SOCS3 in normal homeostasis. Along with tumour biopsies, Corvinus et al. (2005) did 
discover increased Jak/Stat signalling as a result of increased Stat3 activity in adjacent, non-
neoplastic tissues. They suggested this event may precede the histological changes that arise 
during tumourigenesis, but it may have been the case that Stat3 increased due to the release of 
tumour-derived factors that promote Jak/Stat signalling so may not be entirely reflective of 
homeostatic changes in non-cancerous cells. 
 
Conversely, SOCS3’s role in cell turnover has also been demonstrated in overexpression 
studies. Rigby et al. (2007) overexpressed SOCS3 in two in vitro intestinal cell lines (IEC-6 
and Caco-2- rat, and human cancer cell lines respectively), and this reduced proliferation. In 
an in vivo setting, it is to be assumed that limiting Jak/Stat signalling would increase 
sensitivity to injury and infection due to a reduced ability to repair and renew cells. This was 
demonstrated by Thagia et al. (2015) who showed that wound healing was compromised 
following stimulation with the microbial component, lipopolysaccharide (LPS). This process 
of increased sensitivity and decreased cellular repair is also thought to be the mechanism 
behind increased SOCS3 levels in IBD (Suzuki et al. 2001, Li et al. 2010), and will be 
discussed further in section 1.6. 
 
As in mammals, dysregulation of midgut renewals pathways in Drosophila can also lead to 
increased or decreased signalling which in turn, results in excess proliferative and hyperplasia, 
or even increased mortality due to an inability to repair damaged or infected cells, 
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respectively. However, even in uninfected flies, overexpression of Upds in midgut cells 
induced hyperplasia, although this was able to be reversed within 2 weeks, following the 
silencing of Upd (Jiang et al. 2009, Lucchetta and Ohlstein 2012). Additionally, flies with 
constitutively active Hop kinases (e.g. as a result of gain of function mutations) display 
overproliferation and premature differentiation of haemocytes (a type of blood cell in 
Drosophila), and ultimately develop haematopoietic tumours (Arbouzova and Zeidler 2006, 
Stec and Zeidler 2011. This demonstrates a conserved outcome/function between Hop and Jak 
proteins, and strengthens the link between increased JAK/STAT signalling and uncontrolled 
cellular proliferation and tumourigenesis that has been observed in mammals. The role of 
SOCS proteins as tumour suppressors is also conserved. This was demonstrated by reductions 
in the size and number of haematopoietic tumours following overexpression of SOCS36E in 
haemocyte precursors of Hop mutant flies, and the reverse effect when SOCS36E was reduced 
using RNAi (Stec and Zeidler 2011). Herranz et al. (2012) also found microRNA responsible 
for cell proliferation regulation known as bantam, to downregulate SOCS36E, which resulted 
in tissue growth (in imaginal discs- epithelia found in larvae responsible for the formation of 
structures found in adult flies). However, the effects of reduced SOCS36E were not confined 
to proliferation as the authors also reported loss of apico-basal polarity in the disc cells, as 
well as altered cellular architecture, and these arose from a loss of cell junction proteins. As 
expected, decreased Jak/Stat signalling (due to loss of Hop) had the opposite effect and 
resulted in reduced and insufficient proliferation of the imaginal disc cells, thus producing 
discs that were smaller in size (Arbouzova and Zeidler 2006). Collectively, these summarised 
results from mammalian and Drosophila studies indicate a conserved role of Jak/Stat 
signalling and SOCS3 in the regulation of cell turnover in multiple tissues and the negative 
effects dysregulation can produce. 
 
 
1.5 The Roles of the Commensal Intestinal Microbiota 
Microbiota is the term used for the microbes that colonise organisms from birth (Hooper and 
Gordon 2001), and form a symbiotic relationship with their host. These microbes are located 
on the surface of the skin, and within the GI, respiratory and genitourinary tracts, with the 
number of microbes exceeding those of both somatic and germ cells combined at least 10-fold 
(Tancrède 1992). There are approximately 1014 microbial cells in total in the human body, 
with the total genomic content comprising of 100 times more genes (DuPont and DuPont 
2011). The microbiota is acquired from birth, although the microbes that colonise will differ 
depending on whether the method of birth was natural or by Caesarean section, and also 
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whether infants are breastfed or bottle-fed (Guarner and Malagelada 2003). However, the 
maternal commensals do heavily influence the colonisation of offspring, as siblings, in 
addition to twins, have been reported to have similar microbiota (Sekirov et al. 2010). From 
birth until approximately 1 year of age, the diversity and numbers of microbes increase, 
although in healthy individuals, these numbers will then remain relatively stable until death, 
demonstrating how important early colonisation events are in establishing the permanent 
microbiota. The intestines are the richest microbiota site in terms of both number and diversity 
(Hooper ad Gordon 2001), although the numbers do increase moving along the G.I tract, 
starting with approximately 103 microbial cells per gram of luminal contents in the duodenum, 
and reaching 1012 cells per gram in the colon (Hooper and Gordon 2001).  The colon is the 
most densely populated site, containing over 70% of the total microbes found within the 
human body (Sekirov et al. 2010). Within the gut reside bacteria, as well as some fungi and 
viruses, with approximately 500-1000 different species coexisting there (Tancrède 1992). The 
majority of the bacteria in the gut are strict anaerobes, dominating over facultative anaerobes 
and aerobes, with the whole of the gut microbiota consisting of four major phyla: 
Bacteroidetes, Firmicutes, Proteobacteria and Actinobacteria (Sekirov et al. 2010, Yurist-
Doutsch et al. 2014). Mice and humans display similar proportions of these phyla, although 
differences in diversity within each phylum have been reported (Kostic et al. 2013). 
Firmicutes and Bacteroidetes are the two most dominant phyla, making up approximately 
90% of the gut bacteria, in both humans and mice (DuPont and DuPont 2011). However, there 
will be variation at the species level, not only between individuals, as a result of differences in 
diet, hygiene and possible antibiotic use (Guarner and Malagelada 2003), but also within the 
gut of an individual, due to differences in oxygen levels and pH between the small and large 
intestines (Hooper and Gordon 2001). Interestingly, the type of bacteria found within the gut 
lumen differs too from those found within the mucus layer lining the intestinal epithelium 
(Sekirov et al. 2010). 
 
The microbiota plays several roles within the gut, one of which includes aiding in the 
digestion and absorption of food, particularly in the colon. Here, bacteria break down and 
ferment previously indigestible dietary fibre into short-chain fatty acids (SCFAs), such as 
butyrate, propionate and acetate (Nguyen et al. 2015). From in vitro studies, SCFAs have 
shown to be beneficial in an intestinal setting, in that butyrate has reported to inhibit 
proliferation of neoplastic intestinal cells, in addition to promoting cell reversion from a 
neoplastic state to a non-neoplastic state (cited by Guarner and Malagelada 2003), which if in 
an in vivo setting, would ultimately benefit the overall health of the host too. Furthermore, the 
gut microbiota also helps in the production of vitamins K and B, and in the absorption of 
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minerals such as calcium and iron. Collectively, this aims to increase levels of nutrients, 
substrates and energy for both the host and the commensal populations (Nguyen et al. 2015). 
The gut microbiota can also contribute towards protection and immunity in that their 
colonisation means they can compete with pathogens for space and nutrients. Some 
commensals can produce antimicrobials too which will defend against harmful 
microorganisms (Yurist-Doutsch et al. 2014). Additionally, from studies performed on GF 
mice, the presence of commensals has proven to be essential for proper gut functioning. For 
instance, GF mice have impaired/slower intestinal renewal (Abrams et al. 1962), and this can 
increase their sensitivity to damaging, and infectious agents, particularly as GF mice also 
possess reduced numbers of goblet cells compared to CR, colonised mice, and this can lead to 
a thinner, less stable mucus layer between the lumen and epithelium, which could be easier for 
pathogens to penetrate (Natividad and Verdu 2013, Yurist-Doutsch et al. 2014). This is further 
exacerbated by the observation that the numbers of several types of immune cell and immune 
cell by-products, such as cytokines (Rakoff-Nahoum et al. 2004), are affected in GF mice 
also. The decreased epithelium renewal results in fewer crypt cells compared with CR mice, 
ultimately resulting in reduced villus thickness, a smaller surface area in the gut and impaired 
metabolism and digestion. As such, a substantially higher calorie intake is required for GF 
animals to obtain the same body weight as CR animals (Sekirov et al. 2010). However, 
intestinal homeostasis can be altered even in CR animals if the cell signalling pathways 
responsible for recognising microbial ligands are impaired/non-functional. For instance, Toll-
Like Receptor (TLR) signalling (which will be discussed in more depth later on in this 
chapter) consists of multiple receptors; each able to recognise a different microbial 
component, and following ligand-receptor binding, several responses are induced, including 
cytokine production and cell proliferation, and therefore renewal. Rakoff-Nahoum et al. 
(2004) discovered that mice deficient in an adapter protein of the TLR signalling protein 
(Myeloid differentiation primary response gene 88- MyD88) had dysregulated proliferation 
and differentiation of IECs compared with controls, and this was in the absence of microbial 
stimulation. 
 
Despite the differences between mammals and Drosophila (some of which have been 
mentioned here), fruit flies also possess gut microbiota, although they house a lower number 
of species compared to humans (5-20, and 500-1000 respectively, Royet 2011), and the total 
number of microbial cells is lower too (approximately 3.5 x 105 cells in the midgut, compared 
to 1012 cells in each gram of luminal contents) (Ryu et al. 2010, DuPont and DuPont 2011). 
There are some similarities in the species found in Drosophila and humans, but very few 
anaerobic species reside in the Drosophila midgut (Royet 2011), and they also lack any 
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species within the Bacteroidetes phylum, which is one of the two dominant phyla in humans 
(Charroux and Royet 2012). As seen in mammals, environmental factors are a major source of 
variation in microbiota composition between flies; not only between wild and laboratory 
populations, but also between the same strains in different laboratories (Chandler et al. 2011). 
Although natural Drosophila populations tend to have a more diverse microbiota than 
laboratory strains, Enterobacteriaceae, Acetobacteraceae and Lactobacillales make up the 
majority of the gut bacteria, with either one or all three of these capable of dominating. 
Chandler et al. (2011) also found there were 5 bacterial species that could frequently be found 
in both wild and laboratory flies: Acetobacter pomorum, Acetobacter tropicalis, Lactobacillus 
brevis, Lactobacillus fructivorans and Lactobacillus plantarum.  
 
Although diet can influence the microbiota composition of mammalian systems, it is a major 
contributor in Drosophila, particularly as the natural diet for fruit flies is rotting microbe-
containing fruit (amongst other foods) (Apidianakis and Rahme 2011). Laboratory studies 
have revealed a directly proportional relationship between bacterial counts and the number of 
days between food transfers, between bacterial counts and the amount of food present in the 
Drosophila gut, and also the starting bacterial density on the food and the bacterial density 
found in the fly (Blum et al. 2013, Broderick et al. 2014). Furthermore, no bacteria were 
detected in GF flies until their food was supplemented with L. plantarum, and the gut 
microbiota of CR flies could only be maintained if they were reared on food with a rich source 
of exogenous bacteria (Blum et al. 2013). These results indicate that the commensal gut 
microbiota is not stable, and is transient and must be frequently replenished through ingestion 
of microbe-containing food. It has been suggested that the constant expulsion and 
replenishment of microbes may be a mechanism carried out to reduce infection by pathogenic 
bacteria (Blum et al. 2013), especially as wild, natural populations of fruit flies harboured 
higher levels of Serratia and Pseudomonas (Chandler et al. 2011), which have shown to 
induce IEC damage and reduce lifespan in laboratory studies (Liehl et al. 2006, Nehme et al. 
2007, Buchon et al. 2009b). 
 
The Drosophila microbiota has shown to have similar functions to those in mammalian 
systems, in particular, regarding infection and immunity, and IEC homeostasis. For instance, 
Blum et al. (2013) found flies were more resistant to infection with either Serratia marcescens 
or Pseudomonas aeruginosa, and this was further improved following supplementation with 
L. plantarum (a species that is used as a probiotic, as well as a natural constituent of the 
Drosophila microbiota). L. plantarum is also able to increase activity of proteolytic enzymes, 
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aiding digestion, with the microbiota as a whole also sustaining nutrition, as it has shown to 
promote larval growth in conditions where nutrients have been depleted (cited by Bonfini et 
al. 2016). Conversely, larvae devoid of gut bacteria displayed increased sensitivity to infection 
with the yeast, Candida albicans (Glittenberg et al. 2011). Furthermore, the presence of 
indigenous microbiota may help to maintain immune (and also midgut) homeostasis by 
inducing basal, low level inflammation which allows the innate immune system to determine 
whether ingested exogenous microbes are pathogenic or not (Bonfini et al. 2016). The 
occupation of the Drosophila midgut by commensal bacteria will also help to prevent 
colonisation by pathogenic species, by outcompeting them for space and nutrients, along with 
the production of antimicrobials. Larvae themselves can act as antimicrobials as their presence 
is able to restrict growth of pathogenic fungi and also reduce the diversity of yeasts in 
Drosophila medium (cited by Buchon et al. 2013b). Regarding midgut homeostasis, Buchon 
et al. (2009b) reported that the microbiota is involved in regulation of cell turnover, as both 
rates of renewal and number of mitotic ISCs were reduced in GF flies, compared with CR 
flies. This correlated with an absence of Upd3 (the activating ligand of the Drosophila 
Jak/Stat pathway, and initiator of midgut renewal, Agaisse et al. 2003, Buchon et al. 2009a, 
Jiang et al. 2009) in GF flies, with basal levels found in CR flies,  also indicating  that the gut 
microbiota help regulate Jak/Stat activity and Jak/Stat-induced proliferation. These findings 
were also supported by the observation that flies deficient in their immune deficiency (Imd) 
pathway harboured commensal bacterial counts that were 10-fold higher than those in 
wildtype flies, and displayed higher numbers of mitotic midgut cells too. Buchon et al. 
(2009b) also found that compared to their young 3 day old counterparts, both 30 day old 
wildtype and Imd mutant flies had higher bacterial counts and increased numbers of mitotic 
ISCs, although GF Imd mutant flies exhibited proliferation rates similar to those of young 
flies, along with preserved midgut integrity. This suggests that gut microbial populations 
increase in Drosophila with age, and that the age-associated increases in midgut proliferation 
and deterioration (as observed by Biteau et al. 2008) may be as a result (at least partially) of 
the microbiota. In addition to proliferation, gut commensals also influence differentiation of 
IECs, as GF flies have higher ratios of EECs to ECs than CR flies (Broderick et al. 2014). It 
remains unclear as to whether this affects nutrient absorption in the midgut, and ultimately 
body size (as observed in mice), particularly as Storelli et al. (2011) reported no significant 
differences in body weight between GF and L. plantarum-mono-associated flies maintained 
on either a rich yeast diet, or a poor yeast diet. However, only body weights of female flies 
were recorded, and these flies were very young (3 days old) so it is not known whether the 
same results would have been obtained using older flies (30 days old, for instance) when 
effects of increased ratios of EECs to ECs may be prominent. In addition to immunity and 
IEC homeostasis, the midgut microbiota is also implicated in mating preference in 
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Drosophila; a factor which has so far not been identified in mammalian systems. Sharon et al. 
(2010) found flies that were reared on either a starch-based diet, or a sucrose-based diet 
preferentially mated with flies that were also reared on the same diet. They were able to 
deduce that this finding was due to influences of commensal bacteria, as the mating 
preference trend was abolished following administration of antibiotics, in addition to this 
trend continuing when flies were fed bacteria that had been deposited onto the fly medium. 
This microbial-induced behaviour must be evolutionarily important as it emerged after one 
generation of flies, and could be observed for at least 37 generations.  
 
 
1.6 Dysbiosis and Microbe-Mediated Diseases 
In a healthy organism, a symbiotic relationship exists between the host and the gut microbiota, 
with each side gaining benefits from this relationship, such as facilitation in nutrient digestion, 
and a niche to exist and also obtain nutrients, respectively. Although mechanisms are in place 
to ensure the host-commensal homeostasis is maintained, dysregulation may take place, or 
external environmental factors may induce changes in the microbiota, and this shift is referred 
to as dysbiosis. Dysbiosis may either occur as a result of: a reduction or loss of beneficial 
microorganisms, increases in pathogenic/opportunistic microbes, or a reduction in the overall 
diversity of microorganisms. However, these events are not mutually exclusive and often 
occur together (DeGruttola et al. 2016). In mammals, organisms are first exposed to 
microorganisms at birth, and are colonised with maternal commensals. The proportions of 
microorganisms infants are colonised with however, are dependent on the method of birth 
used, due to differences in bacteria residing in the maternal reproductive tract and on the 
skin’s surface. For instance, Dominguez-Bello et al. (2010) reported that infants born 
naturally harboured large amounts of lactic acid bacteria, such as Lactobacillus, whereas 
infants born by caesarean section showed increased amounts of Staphylococcus, with little to 
no Bifidobacteria. Diet is also known to shape microbiota composition, with geographical 
contrasts in the standard diet and also in typical food preparation methods reflected by 
variations in bacterial proportions in different countries (Prideaux et al. 2013). However, even 
a change within an individual’s diet could alter gut commensal proportions; for instance, an 
increase/decrease in dietary fibre could result in increases/decreases in SCFA-producing 
bacteria, respectively. Ingestion of probiotic products however can have beneficial gut effects, 
such as reduction of pathogen colonisation, and this is achieved by increasing health-
promoting bacteria, such as Lactobacillus or Bifidobacterium, although the genus and species 
can vary between products (DuPont and DuPont 2011). For certain ailments, the prescription 
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of antibiotics can be essential and prove to be valuable to the individual’s health. However, 
inappropriate antibiotic use, such as prescription for a non-bacterial condition, prolonged use, 
or premature cessation of treatment, can be detrimental to the host’s health, especially 
regarding the G.I tract. Antibiotics are not able to discriminate between commensal and 
pathogenic bacteria, so although the ailment-inducing microorganism may be eradicated, 
beneficial populations may also be reduced or removed. This results in the emergence of more 
resistant strains that are normally kept at minimal levels, due to reduced competition, and this 
is the basis of antibiotic-associated diarrhoea, often caused by overgrowth of Clostridium 
difficile. Treatment for this involves cessation of the antibiotics, and administration of 
probiotics or restoration of gut microbiota by faecal transplant from a healthy individual (Du 
Pont and DuPont 2011). However, in addition to emerging pathogenic strains during 
dysbiosis, general overgrowth can also be detrimental due to increased production of bacterial 
by-products and waste which can be toxic to the host (Sekirov et al. 2010). 
 
One particular group of diseases that are microbe-mediated and associated with dysbiosis in 
the G.I tract is IBD. IBD affects approximately 0.1% of individuals in Western countries 
(Hooper and Gordon 2001) and comprises of Crohn’s disease (CD) and ulcerative colitis 
(UC). Both of these diseases are characterised by excessive inflammation of the G.I tract, 
abdominal pain, and diarrhoea but there are differences between the two. UC affects the 
colon; either particular areas or the whole colon, and is associated with destruction of the IEC 
lining and also anaemia, due to loss of blood from the G.I tract (Abraham and Cho 2009). CD 
on the other hand, can affect any part of the G.I tract (from the mouth to the anus), although 
the most commonly affected areas are the ileum and colon. Unlike UC, CD is characterised by 
transmural inflammation, intestinal blockages and ulcers, which may lead to the formation of 
fistulas if they become too deep (Abraham and Cho 2009).  
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Although IBD involves a breakdown in tolerance mechanisms towards luminal contents, 
resulting in inappropriate activation of the immune system, and also dysregulated intestinal 
homeostasis from increased inflammation-induced IEC damage and bacterial translocation, 
the exact cause is still not currently known (Duchmann et al. 1995). However, contributing 
factors have been determined, such as: 
 The adoption of a “Westernised” lifestyle, living in urban areas, being exposed to 
pollution and higher consumption of fat- and sugar-enriched foods (Hanauer 2006). 
 Sanitation, as increased hygiene reduces exposure to microorganisms, including 
helminths (Hanauer 2006, Abraham and Cho 2009). 
 Genetic predisposition; whether this is due to a first- or second-degree relative having 
IBD, or due to mutations in identified genes such as Nucleotide-Binding 
Oligomerization Domain 2 (NOD2). NOD2 is part of the NOD Pattern Recognition 
Receptor (PRR) family responsible for recognising bacterial peptidoglycan, and is 
able to exert antimicrobial effects, thus preventing pathogen invasion (Cario 2005, 
Hanauer 2006). 
 
A large volume of microbial analysis studies have been conducted in order to determine the 
changes that occur within the G.I tract during IBD. Results commonly show a decrease in 
bacterial diversity, along with reductions in the Firmicute and Bacteroidete populations, and 
Lactobacillus and Bifidobacterium in particular (affecting SCFA production as a result)  
(DuPont and DuPont 2011, Walker et al. 2011). Although it is not known whether depletion 
of bacterial populations arises from the increased inflammation or vice versa, the diminution 
of dominant commensal bacteria can encourage the growth and dominance of previously 
minor (potentially opportunistic) bacterial strains (Sekirov et al. 2010). Examples of emerging 
bacteria include C. difficile, Escherichia coli, and often Proteobacteria and Enterobacteriaceae 
in general (Sekirov et al. 2003, Martinez-Medina et al. 2006, DuPont and DuPont 2011). 
Although certain bacterial populations or strains are diminished during IBD, patients with 
either CD or UC have been reported to harbour higher bacterial counts within the ileum when 
compared with healthy controls. Individuals with CD however, tend to exhibit more 
generalised dysbiosis than individuals with UC as there are often similar bacterial strains 
found in both inflamed and non-inflamed ileal mucosal tissue (Kaur et al. 2011). Despite these 
findings, IBD comprises of complex diseases, and therefore it is more likely that there will be 
shifts in the microbiota population as a whole, rather than a select few species (DeGruttola et 
al. 2016). Results from study to study also often vary, most simply due to environmental and 
genetic differences between individuals, and also due to analysis techniques and sampling 
methods used, so therefore no “bacterial signature” as a potential biomarker is associated with 
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these diseases (Kaur et al. 2011). Changes in the microbial content of faeces are often reported 
too, although faecal microbes are known to be different from those associated with the 
mucosa, and the latter population may be more relevant in an IBD setting due to their close 
association with the epithelial barrier  (Sun et al. 2011).  
 
There are several pieces of evidence indicating that the gut microbiota is also a contributing 
factor towards IBD. For instance, IL-10-deficient mice that normally develop spontaneous 
colitis are devoid of inflammation and immune system activation when raised under GF 
conditions (Sellon et al. 1998, Madsen et al. 1999). Additionally, different types of antibiotic 
treatment have shown to be effective in ameliorating inflammation in both humans and in 
animal models (Hooper and Gordon 2001, Sekirov et al. 2010). Diversion of luminal contents 
has also proven to be a successful treatment method, although symptoms do return upon 
restoration of intestinal flow. Further evidence is derived from the presence of systemic 
antibodies against antigens associated with the gut microbiota, with one study reporting higher 
immune and antibody activity in the serum of CD patients to be associated with increased 
disease severity (Mow et al. 2004, DuPont and DuPont 2011). However, despite these 
findings, Kitajima et al. (2001) found that the commensal microbiota was beneficial during 
dextran sodium sulphate (DSS)-induced colitis, as GF mice exhibited higher frequencies of 
intestinal bleeding and mortality, and one suggestion for this may have been due to having a 
more immature immune system (Guarner and Malagelada 2003). 
 
Although the pathophysiology of IBD has been established, the cause and effects of these 
events are not known either. IBD is associated with increased inflammation that can result 
from immune responses elicited against luminal contents, with detection and translocation of 
these luminal antigens increased during dysbiosis (either through increased bacterial loads or 
increased levels of pathogenic bacteria) and when the intestinal epithelial barrier is 
compromised and more permeable  (Abraham and Cho 2009). The chronology of these 
processes is not clear but they are known to perpetuate each other and exacerbate the 
symptoms if treatment is not introduced (Sekirov et al. 2010). Intestinal renewal pathways 
may be in place in order to replenish the IECs damaged as a result of the inflammation, but if 
the rates of renewal cannot equal or overcome the rates of cell death, this can promote the 




The increased inflammation during IBD is associated with an increase in pro-inflammatory 
cytokines, including IFN-γ, TNF-α and IL-6. IFN-γ and IL-6 are both known activators of the 
Jak/Stat pathway. The anti-inflammatory cytokine, IL-10 can also initiate Jak/Stat activity and 
is reported to be increased in some cases of IBD, most likely in an attempt to inhibit 
inflammatory processes (Kucharzik et al. 1995, Autschbach et al. 1998, Murray 2006). Along 
with IL-10-/- mice, Stat3-knockout mice also develop spontaneous colitis and this is presumed 
to be due to an inability to mediate IL-10 signalling, resulting in enhanced Th1-mediated 
inflammatory responses (Takeda et al. 1999). Conversely, Suzuki et al. (2001) found that 
Stat3 was activated in various models of colitis and this was dependent on IL-6, as Stat3 
activation was reduced in IL-6-deficient mice. The level of Stat3 phosphorylation also 
correlated with the severity of the disease. Consequently, this also induced increases in 
SOCS3 and it was suggested its activation may be beneficial during IBD, in an attempt to 
inhibit inflammation-mediated Stat3 signalling. Transgenic mice with SOCS3-reducing 
mutations (along with SOCS1) showed a higher level of colitis severity compared with 
wildtype mice, following treatment with DSS, and this was demonstrated by more pronounced 
decreases in weight loss and goblet cell number, in addition to increased intestinal hyperplasia 
(cited by Greenhalgh et al. 2002). These findings suggest a protective role of SOCS3 in IBD, 
although the findings of Li et al. (2009) and Thagia et al. (2015) demonstrate how SOCS3 
may also be disadvantageous. Li et al. (2009) suggested that the increased sensitivity in mice 
to DSS-induced colitis following a reduction in IL-6-mediated Stat3 signalling, and 
constitutive expression of SOCS3 in IECs are related processes, and that the increase in 
SOCS3 in IBD may limit IL-6/Stat3-mediated renewal, thus sensitising IECs to any 
subsequent inflammation-induced damage. Thagia et al. (2015) showed that appropriate 
regulation of SOCS3 during inflammation is essential as overexpression enhanced flagellin-
induced production of TNF-α in a dose-dependent manner, and impaired wound healing 
following microbial stimulation in an intestinal epithelial cell line. 
 
As discussed, IBD can be considered a group of diseases associated with dysregulated 
intestinal homeostasis, due to an overactive immune system and shifts in bacterial 
populations, but also increased inflammation-induced cell death and compensatory increases 
in proliferation. Additionally, individuals with IBD are often susceptible to developing G.I-
associated cancers, due to the increase in cellular proliferation to compensate for the increase 
in apoptosis caused by chronic inflammation and subsequent tissue damage. For instance, IBD 
patients often display increased pro-inflammatory cytokine production, and these can drive 
intestinal proliferation through activation of cell signalling pathways. For instance, IL-6 is 
able to initiate Jak/Stat signalling as well as promote nuclear factor kappa-light-chain-
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enhancer of activated B cells (NF­κB) signalling through IL-1 and TNF-α, and cell survival 
through induction of anti-apoptotic proteins (e.g. Bcl-2) and reducing the function of the 
tumour suppressor, p53. TNF-α itself is able to promote a favourable environment for tumour 
growth, through tissue remodelling, which may aid invasion and metastasis too (Quante and 
Wang 2008). The inflammation and breakdown in commensal bacterial tolerance leads to 
activation of both innate and adaptive immune cells, and these can also produce pro-
inflammatory cytokines, thus creating a positive feedback loop, and perpetuating the 
pathogenesis of IBD. Immune cells are also capable of producing ROS and reactive nitrogen 
species against microorganisms which can result in their clearance, but if produced 
chronically (as may be the case with IBD), they can induce host cell damage, in particular 
DNA damage. If this damage accumulates and is replicated (particularly if cell survival is 
promoted), this increases the likelihood of cells mutating and resulting in tumourigenesis 
(Quante and Wang 2008). In the presence of ROS, cancer cells are also more likely to lose 
cell contacts and become detached from the basal lamina, thus increasing the chance of 
metastasis (Hold and El-Omar 2008). 
 
As well as being a contributing factor towards IBD, the gut microbiota is also able to promote 
carcinogenesis, and this can occur in a multitude of ways. When performing their various 
functions in the gut, the microbiota naturally produce metabolites and waste products, some of 
which may be damaging to cells, or even be carcinogenic. The likelihood may increase in IBD 
following the shift in bacterial populations from Lactobacillus and Bifidobacterium that can 
exert anti-inflammatory effects and prevent carcinogenesis (e.g. through the production of 
SCFA), to Bacteroides and Clostridium species that can be more harmful to the host (Guarner 
and Malagelada 2003). Further evidence is derived from mouse studies, with Rakoff-Nahoum 
and Medzhitov (2007) reporting that the microbial sensing adapter protein, MyD88, promoted 
tumour progression in both a chemically-induced intestinal model (using azoxymethane/ 
dextran sodium sulphate -AOM/DSS) and a spontaneous intestinal tumour model (using mice 
with mutated APC, referred to as APCMin/+). MyD88-sufficient APCMin/+ mice exhibited 
increased incidence and tumour size, as well as increased mortality when compared to 
MyD88-deficient APCMin/+ mice. These mice also displayed higher expression of tumour-
promoting molecules, such as TNF, IL-6, matrix metalloproteases and cyclooxygenase-2. 
However, this effect of MyD88 was not confined to intestinal tumours, as they have also been 
replicated in skin cancer and sarcoma animal models as well (Rakoff-Nahoum and Medzhitov 
2009). Additionally, the transplantation of gut microbiota from tumour-bearing mice into GF 
mice resulted in an increase in both the number and size of tumours, when compared to GF 
mice transplanted with healthy gut microbiota (Zackular et al. 2013). 
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SOCS3 and the Jak/Stat pathway have shown to be implicated in both carcinogenesis and 
IBD, so therefore their involvement in CAC should not be unexpected. Following induction of 
CAC using AOM/DSS, IEC-specific deletion of SOCS3 resulted in an increase in the number 
and size of colonic tumours, when compared with SOCS3-sufficient mice (Rigby et al. 2007). 
Induction of colitis using DSS alone also resulted in increased proliferation of crypt cells and 
hyperplasia in IEC SOCS3-deleted mice, compared with wildtypes. Li et al. (2010) discovered 
that whilst SOCS3 was significantly increased in both patients with inactive, or active UC, 
and its expression was positively correlated with the severity of colitis (along with IL-6 and 
phosphorylated Stat3), progression from UC to CAC was associated with a decline in SOCS3 
expression (similar to that found in tumours not associated with colitis- He et al. 2003, Weber 
et al. 2005, Ogata et al. 2006). This decline was linked to silencing methylation of epithelial 
genomic DNA in CAC intestinal cell samples. The progression of UC to CAC due to SOCS3 
silencing was reversed following restoration of SOCS3, and this led to decreased activation of 
Stat3, decreased tumour growth, as well as induction of apoptosis. 
 
Similarly, Drosophila are also able to display midgut dysbiosis, and as known in mammalian 
systems, one way in which this can be induced is through a change in diet, and administration 
of antibiotics (Sharon et al. 2010, Chandler et al. 2011). However, "naturally-occurring" 
midgut dysbiosis occurs simply with increasing age, with older (30 day old) flies harbouring 
higher bacterial counts than young, 3 day old flies (Buchon et al. 2009b) and this can lead to 
increased ROS production, which drives age-associated increased in proliferation, 
dysplasia,and altered midgut architecture (Biteau et al. 2008, Buchon et al. 2009b, Jiang et al. 
2009). This was also true for flies with induced bacterial increases through a mutation in their 
Imd pathway. Guo et al. (2014) discovered that one mechanism behind this increase was due 
to an age-associated decrease in a particular subtype of peptidoglycan recognition protein 
(PGRP)- PGRP-SC2- and this led to decreased suppression of the Imd pathway, consequently 
leading to hyperproliferation due to dysregulated NF-kB signalling, along with increased gut 
bacterial counts. These effects were reversed following overexpression of PGRP-SC2. 
 
The Drosophila microbiota are able to regulate basal levels of AMP production, and one way 
through which is the Imd pathway (which will be discussed in further detail in section 1.7) 
However, flies with mutations in this pathway exhibited decreased production of AMPs, and 
this resulted in higher midgut bacterial loads (Buchon et al. 2009b) and increased 
susceptibility to infection by food-borne pathogens (cited by Capo et al. 2016). Dysbiosis may 
also occur if pathways associated with AMP production are “under-regulated” and increased 
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(for instance, through gain of function mutations within the pathway or through loss of 
negative regulators, Paredes et al. 2011) and this can lead to a shift in microbiota dominance 
from a major commensal strain to a normally minor commensal strain, consequently 
negatively affecting the health of the flies, by inducing increases in both IEC death (e.g. 
through increased ROS, Lee et al. 2013) and mortality (Ryu et al. 2008, Capo et al. 2016). 
This shift also induced symptoms similar to those seen with IBD in mammals, although IBD 
cannot be fully replicated in Drosophila as they lack the array of inflammatory cytokines and 
immune cells that drive the disease processes. Conversely, the Imd pathway is also regulated 
through big bang (BBG)- a gene that encodes a gut protein found on the apical and lateral 
sides of midgut epithelial cells. BBG helps to maintain the integrity of septate junctions 
(lateral intercellular junctions also located between the epithelial barrier cells), and together 
they dampen down microbiota-induced Imd activation (Bonnay et al. 2013). However, when 
the midgut epithelium becomes compromised (as demonstrated in BBG mutant flies, for 
instance), activation of the Imd pathway is substantially increased, and this led to increases in 
commensal- and age-associated midgut proliferation, intercellular space, infection-induced 
bacterial loads, and also mortality, and this was irrespective of infection status. These effects 
are reminiscent to those seen during IBD in mammals, and similarly, antibiotic treatment was 
able to ameliorate the symptoms observed in flies (Bonnay et al. 2013). 
 
On a slightly different note, (as stated) gut dysbiosis is capable of producing a number of 
symptoms and disorders within both mammals and fruit flies. However, dysbiosis-related 
phenotypes are not confined to the G.I tract. Much research has been carried out in recent 
years into the effects that changes in the gut, and in the gut microbiota, have on CNS function 
and behaviour, and vice versa- a bidirectional relationship named the gut-brain axis. With 
regards to evidence of the CNS influencing gut responses, psychological stress in mice 
induced through food, water or bedding deprivation resulted in microbiota changes, with 
stressed mice displaying a reduction in Lactobacilli compared with unstressed controls (cited 
by Collins and Bercik 2009). These bacterial changes were also observed in infant rhesus 
monkeys that had been separated from their mothers. Maternal separation in mice also 
resulted in increased intestinal permeability and this increased susceptibility to inflammation-
inducing stimuli (Collins and Bercik 2009), for instance commensal and non-commensal 
populations, most likely due to increased translocation across the gut epithelium. Conversely, 
changes within the gut environment can induce CNS responses, with expression levels of 
various molecules (such as cytokines) and assessment of behaviour often measured to 
quantify these changes. Rats administered Bifidobacterium treatment for 14 days had 
increased (plasma) levels of tryptophan (Collins and Bercik 2009), with decreases in 
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tryptophan leading to decreased serotonin production- a common finding in mood disorders 
(Myint and Kim 2003). Additionally, changes in feeding behaviour in mice have been 
observed following infection with Helicobacter pylori, and this was found to continue even 
after the infection had been resolved (Bercik et al. 2002). Furthermore, gut disorders such as 
IBD and irritable bowel syndrome (IBS) are also bi-directional in that mood disorders can 
induce microbiota changes, possibly instigating or exacerbating these conditions. Also, due to 
the substantial amount of morbidity with IBD and IBS, and the chronicity of these disorders, it 
is common for affected individuals to suffer from depression (cited by Whitehead et al. 1980, 
and Bercik et al. 2010). Overall, these results show that regulation and changes to the gut 
microbiota are not just derived from within, and that elicited microbial responses are extended 
beyond the intestinal tissues. 
 
 
1.7 Host Recognition of Microbes 
As discussed earlier, the commensal gut microbiota has fundamental roles within humans, 
mice and Drosophila, and these functions can be affected if their levels are not appropriately 
balanced and/or if pathogens also infiltrate these organisms. Each of these three organisms 
(along with other biological living organisms) can elicit an array of mechanisms, as part of 
their immune systems, in order to maintain immune and gut homeostasis, and ultimately good 
health. Immunity can be subdivided into innate, and adaptive (or acquired) immunity, with 
innate immunity consisting of initial, quick responses that are elicited to prevent invasion and 
infection by pathogens that may occur whilst the adaptive immune system becomes fully 
activated and sufficiently expanded (and this can take at least 4-5 days) (Davies 2013). In 
short, the innate immune system comprises of physical epithelial barriers, coagulation 
processes, production of AMPs, immune cells (such as macrophages and dendritic cells –
DCs)- and PRR pathways, for example, with receptors located on a multiple of host cells 
within mammalian systems (Todd 2010, Davies 2013, Yurist-Doutsch et al. 2014). One 
example of a pathway within the PRR family is the TLR signalling pathway, and it comprises 
of several cellular receptors, with each receptor able to recognise a variety of pathogen-
associated molecular patterns (PAMPs) (shown in figure 1.9). These PAMPs are found on 
many types of microbes, such as viruses and bacteria, and are actually found on all 
microorganisms, regardless of their pathogenicity. Humans have 10 TLRs in total, with mice 
possessing 13, and these receptors are expressed on an array of immune cells, as well as IECs 
(Seya and Miyake 2009, Abreu 2010). TLR receptors contribute a significant part of gut 
immunity due to the proximity of the microbiota to the intestinal epithelium (Seya and 
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Miyake 2009), although the expression of TLRs on IECs is often lower, in order to maintain a 
state of hyporesponsiveness and appropriate immune tolerance towards commensal 
















Figure 1.9: The mammalian Toll-Like Receptor signalling pathway. Upon binding of a 
microbial ligand to its respective receptor (with examples shown above), either located within 
the cell membrane, or intracellularly within endosomes, a MyD88-dependent or –independent 
signalling cascade is initiated. These cascades ultimately result in gene transcription in the 
nucleus, leading to production of inflammatory cytokines and chemokines, activation of 
immune cells, and proliferation. (Mice have additional receptors- TLRs11, 12 and 13). 
(CD14= Cluster of Differentiation 14, CpG DNA= Cytosine-phosphate-Guanine 
deoxyribonucleic acid , dsRNA= Double-stranded ribonucleic acid, IRAK= Interleukin-1 
Receptor-Associated Kinase, IRF= Interferon Regulatory Factor, LPS= Lipopolysaccharide, 
MAPK= Mitogen-Activated Protein Kinase, MyD88= Myeloid Differentiation primary 
response gene 88, NF­κB= Nuclear Factor Kappa-light-chain-enhancer of activated B cells, 
ssRNA= Single-stranded ribonucleic acid, TLR= Toll-Like Receptor, TIRAP= Toll-
Interleukin 1 Receptor domain containing Adaptor Protein, TRAF= TNF Receptor Associated 
Factor, TRAM= TRIF-Related Adaptor Molecule, TRIF= TIR-domain-containing adapter-
inducing Interferon-β). (WWW, The Immune System in Health and Disease). 
 
The Jak/Stat pathway is also reported to be implicated in the regulation of microbial-induced 
TLR signalling. Baetz et al. (2004) discovered that multiple members of the SOCS family (i.e 
SOCS1, SOCS3 and CIS) were induced by multiple TLR ligands in a MyD88-dependent 
manner (in murine DCs) and this was thought to lead to inhibition of crosstalk between 
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pathways, such as TLR signalling and, IFN and/or IL-6 signalling pathways, with SOCS3 also 
able to inhibit MyD88 directly (Frobøse et al. 2006). As demonstrated in figure 1.9, microbial 
binding initiates activation of TLRs which then signal through MyD88 and also MyD88-
Adaptor-Like protein (MAL) to bring about Tumour-Necrosis Factor (TNF) Receptor-
Associated Factor 6 (TRAF6), and Transforming Growth Factor-β (TGF-β)-Activated Kinase 
1 (TAK1)-mediated activation of MAPK and NF­κB pathways downstream (Yoshimura et al. 
2007). Initiation of both MAPK and NF-κB signalling can result in increased proliferation and 
production of pro-inflammatory cytokines. However, SOCS3 is able to inhibit IL-1-induced 
TRAF6- and TAK1-mediated activation of these pathways, with IL-1 capable of being 
produced as a result of TLR signalling (Frobøse et al. 2006). SOCS1 however, is capable of 
inhibiting TLR-mediated MAPK and NF­κB activation (also through TRAF6 and TAK1), 
thus suggesting shared roles of SOCS proteins in limiting microbe-mediated proliferation and 
inflammation (Yoshimura et al. 2007). In IECs specifically, Thagia et al. (2015) found that 
SOCS3 was responsible for regulating flagellin (TLR5)-induced production of TNF-α, as 
SOCS3 overexpression resulted in an increase in TNF-α, relative to SOCS3-sufficient cells, 
and this was found to be associated with downregulation of TNF Receptor 2 (TNFR2). 
Additionally, Abreu et al. (2003) reported a decrease in IFN-γ-mediated TLR4 co-receptor, 
MD-2, expression following an increase in SOCS3, thus providing further evidence of SOCS 
proteins limiting inflammatory signalling. However, despite the findings of Thagia et al. 
(2015) and Abreu et al. (2003), the majority of research into TLR signalling and the Jak/Stat 
pathway is conducted in immune cells, which are known to be more responsive than IECs so 
consideration must be taken when generalising findings. This demonstrates that further 
research is needed with regards to IECs specifically, particularly as both TLR and Jak/Stat 
signalling are implicated in IBD. 
 
In the event that pathogens still persist following the induction of innate immune responses, 
the adaptive immune system becomes fully functional at least 4-5 days following pathogen 
exposure. There are large differences between the innate and adaptive immune systems, with 
the major distinctions being the constituents in that adaptive immunity consists exclusively of 
B- and T-lymphocytes. Their functions consist of: interaction with and recruitment of innate 
immune cells, production of antigen-specific antibodies (B-lymphocytes), and cytokine 
production by subsets of T-lymphocytes that are activated by particular pathogens (e.g. Th2-
mediated responses can be induced during helminth infection) (Davies 2013, Yurist-Doutsch 
et al. 2014). Memory functions are also attributed to adaptive immunity in that immune 
responses are much more rapid and enhanced if antigens are ever re-encountered, so much so 
that no symptoms may be detected by the host (Davies 2013).  
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Regarding immune responses in Drosophila now, and as seen in other invertebrates, they rely 
completely on innate mechanisms, and have no adaptive immune system, unlike mammalian 
systems. However, similar to mammals, their innate immune system is multi-layered, and 
there is some overlap in immune responses and defences possessed by these organisms, such 
as phagocytic cells and physical barriers. Additionally, as a main constituent of the 
Drosophila diet is rotting microbe-containing fruit (and other food), often the first immune 
defence the microbes will encounter is the midgut. As in mammals, this also acts as a barrier 
between (exogenously sourced) luminal contents and peripheral tissues and can act as a 
hostile environment for pathogens, due to areas of varying pHs and the secretion of lysozymes 
and digestive enzymes (Lemaitre and Hoffmann 2007). Following ingestion of microbes, an 
oxidative burst of ROS is released by Dual oxidase (Duox) in order to kill any potential 
infectious microorganisms. This process is crucial to Drosophila immunity as Duox RNAi 
prevents the midgut production of ROS, allowing ingested microbes to proliferate and persist. 
This ultimately results in increased mortality of the fly, and this was discovered with both 
midgut specific- and systemic Duox RNAi (Ha et al. 2005). In order to reduce extensive 
damage to the midgut, the ROS are then removed (or “neutralised”) by catalase. However, 
midgut cells are still damaged during the infection and oxidative burst events, and this leads to 
Upd3 release from damaged ECs, initiating ISC proliferation via the Jak/Stat pathway 
(Buchon et al. 2009a and b). Oxidative stress also activates the JNK pathway, causing further 
release of Upd3 (Hiang et al. 2009). The process of midgut epithelium renewal is also 
essential too, as flies with deficient Jak/Stat or JNK pathways, or silenced Upd3, succumb to 
infection with pathogens that are usually non-lethal under normal circumstances, whereas flies 
with deficiencies or mutations in their Imd pathway are able to survive (Buchon 2009b). 
These findings signify the importance of balancing ROS production with epithelial renewal in 
the maintenance of a healthy midgut and organism following infection. Furthermore, 
peristalsis induced by the midgut is also regarded as an immune defence mechanism as the 
contractions can help to propel pathogens into areas of the gut that are more acidic or have 
higher AMP levels, or help to eliminate them from the fly completely (Buchon et al. 2013). 
 
In addition to the involvement of Drosophila Jak/Stat in infection-induced epithelial renewal, 
this pathway is also able to produce a specific AMP, Drosomycin-like 3 (Dro3), which shares 
homology with the Drosophila antifungal peptide, Drosomycin (Buchon et al. 2009a). 
Following infection with the Gram-negative phytopathogen, Ecc15, expression of this peptide 
(along with Dro2 and Dro4) was increased, and the involvement of Jak/Stat was discovered 
when Dro3 levels decreased upon Upd3 RNAi, Stat RNAi and a loss of function mutation in 
the Hop protein. Conversely, Dro3 became strongly expressed in flies with a Hop gain of 
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function mutation. Furthermore, in contrast to bacterial infection, Jak/Stat signalling is also 
implicated in viral immunity, and the Drosophila C virus (DCV) in particular. DCV is a 
pathogenic RNA virus that is a natural pathogen of Drosophila and usually causes mortality 
within days following infection. Dostert et al. (2005) discovered that infection with DCV 
induced a different set of genes than those produced following infection with bacteria or 
fungi, and that a substantial of these DCV-induced genes required Hop. Hop was found to be 
important for viral immunity as loss of function mutations resulted in both increased viral 
loads and mortality when compared to wildtype flies. Similar findings were also obtained 
when flies were infected with a different insect virus- Flock House Virus (Dostert et al. 2005), 
demonstrating another level in Jak/Stat’s contribution to Drosophila immunity. 
 
Drosophila also have their own subset of immune cells, known as haemocytes, and these are 
located in the circulating haemolymph (equivalent to the circulatory system in mammals). 
There are three different types of haemocyte and these are known as plasmatocytes, crystal 
cells and lamellocytes (Lemaitre and Hoffmann 2007). However, due to an innate immune 
system only being present, immune responses in Drosophila are often dependent on the 
production of AMPs. These are produced through the Imd or Toll pathways (depending on the 
pathogen being targeted) either systemically by the fat body (the equivalent of the mammalian 
liver), or locally, for instance within the midgut (Lemaitre and Hoffmann 2007), and are able 
to target fungi, and Gram-positive and Gram-negative bacteria. The Toll pathway (shown in 
figure 1.10) is similar to the TLR pathway in mammals, but is responsible for recognition of 
Gram-positive and fungi only, unlike the TLR pathway which is capable of recognising an 
array of PAMPs. Additionally, Toll signalling is activated following detection of secreted 
pathogens, often in the haemolymph, whereas the TLR pathway (and Imd pathway) 
recognises membrane bound pathogens, and these differences could reflect on the detection of 
different types of microbes by these pathways (Lemaitre and Hoffmann 2007). There are nine 
Tolls encoded by the Drosophila genome, although only one is involved in host immunity. 
Upon pathogen recognition, a series of Drosophila MyD88 (dMyD88)-mediated signalling 
cascade events occur, with dMyD88 being a homologue of the mammalian TLR adaptor 
protein, MyD88. The roles of these adaptor proteins appear to be conserved as dMyD88 
mutant flies have increased sensitivity to fungal infections in particular (Takeda et al. 2003). 
Toll signalling activation ultimately results in Dorsal (a homologue of NF­κB) translocating 
into the nucleus and inducing transcription of genes, such as production of AMPs. Dorsal is 
also able to translocate with transcription factors, Dorsal-type Immune Factor (DIF) and 
Relish from the Imd pathway, indicating conserved functional outcomes between these two 


















Figure 1.10: The Drosophila Toll pathway. Recognition of microbes by PGRPs initiates a 
series of proteolytic cleavages, leading to production of Spätzle. Spätzle binds to Toll, 
triggering a chain of dMyD88-mediated cascade events. Phosphorylation-induced degradation 
of Cactus results in dissociation of Dorsal (Lemaitre and Hoffmann 2007), which is then able 
to translocate into the nucleus with transcription factors, DIF and Relish, and induce 
transcription of genes, that lead to production of antimicrobial peptides, for instance (Takeda 
et al. 2003). (DIF= Dorsal-type Immune Factor, dMyD88= Drosophila Myeloid 
Differentiation primary response gene 88, IκB= Inhibitor of NF­κB, IRAK= Interleukin-1 
Receptor-Associated Kinase, NF­κB= Nuclear Factor Kappa-light-chain-enhancer of activated 
B cells, TLR= Toll-Like Receptor) (Mammalian homologues in red). (Image adapted from 
Bowie and O’Neill 2000, and Khush et al. 2001) 
 
 
Similar to mammals, pathogens that are recognised by the Drosophila innate immune system 
can also be the same type as microbes that reside in the gut. However, there are regulatory 
mechanisms in place that both prevent overactivation of immune responses towards 
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commensals, and also limit overpopulation of these populations. For instance, PGRPs are 
responsible for recognition of both Gram-positive and Gram-negative bacteria, although a 
different group of PGRPs known as amidase PGRPs are located in the gut and these proteins 
remove peptides from the glycan chains of peptidoglycan, reducing their biological and 
immunostimulatory activity as a result. Amidase PGRPs are not only able to target pathogenic 
microorganisms, reducing their immunogenicity following recognition by the appropriate 
signalling pathway, but also the commensal microbiota, preventing inappropriate activation of 
either the Imd or Toll pathway (Lemaitre and Hoffmann 2007). Tolerance towards commensal 
populations is also induced by a transcription factor known as Caudal, that is capable of 
regulating AMP production, as inhibition of Caudal through RNAi resulted in overexpression 
in AMPs and a shift in commensal populations (Ryu et al. 2008). This dysbiosis affected the 
flies’ health, causing apoptosis of midgut cells and increased mortality, and could be rescued 
following either re-introduction of Caudal, or removal of commensal bacteria, inducing a GF 
state, thus demonstrating the importance of this gene in Drosophila gut and immune 
homeostasis, and also the importance of both gut and immune homeostasis in maintaining 




1.8 Research Aims 
The intestinal tract is one of the most rapidly proliferating tissues within an organism and 
homeostasis is achieved through a balance of proliferation and cell death, with dysregulation 
of one or both of these processes impacting on health. The Jak/Stat pathway, and SOCS3 in 
particular, are known to be implicated in intestinal homeostasis, although the majority of 
findings are more relevant in a pathological state. The gut microbiota is also known to 
influence turnover of IECs so therefore it is important that intestinal homeostasis is efficiently 
regulated by the host.  
 
In biomedical research, a multitude of models can be used, and in order to increase the 
translatability of findings to human health and disease, ideally, experiments should be carried 
out in more than one research model. Therefore, using three different models, we aimed to 
investigate: 
 The role of SOCS3 in the regulation of normal, basal IEC turnover 
 The impact of microbe-mediated proliferation on the regulation of IEC homeostasis 
by SOCS3 
 
Using our three models- an in vitro human intestinal cell line, and two in vivo models using 
mice, and Drosophila melanogaster- this allowed us to investigate the impact of SOCS3-
regulated homeostasis at the molecular level, the tissue level, and at an organismal level, 
respectively. Additionally, our experiments helped us to determine the conservation of SOCS3 































Table 2.1 –List of Reagents 
Reagent       Company 
2-Mercaptoethanol      Sigma 
5x M-MLV Reverse Transcriptase Buffer   Thermo Fisher Scientific 
Anchored Oligo-dT  Thermo Fisher Scientific 
Bradford Reagent  Sigma 
Bovine Serum Albumin  Sigma 
Clarity™ Western Enhanced Chemiluminescence  Bio-Rad 
(ECL) Substrate   
CyQUANT® Cell Proliferation Assay Kit  Thermo Fisher Scientific 
Deoxynucleotide Mix (dNTP, D7295)  Sigma 
Dimethyl Sulphoxide (DMSO) Hybri-Max®  Sigma 
Epidermal Growth Factor (EGF)  Thermo Fisher Scientific 
Flagellin (from Salmonella typhimurium)  InvivoGen 
Foetal Bovine Serum (FBS)  Thermo Fisher Scientific 
Goat Serum  Sigma 
Glycine  Sigma 
HEPES Buffer  Sigma 
Human Recombinant IFN-γ (#300-02)  Peprotech 
Human Recombinant TNF-α (#300-01)  Peprotech 
Hydrochloric Acid  Sigma 
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Hydrogen Peroxide solution (30% w/w, H2O2)  Sigma 
IGEPAL® CA-630  Sigma 
Lipopolysaccharide (LPS, from Escherichia coli,  InvivoGen 
O111:B4 strain)   
Lipoteichoic Acid (LTA, from Bacillus subtilis)  InvivoGen   
Luria Broth  Thermo Fisher Scientific 
M-MLV Reverse Transcriptase  Thermo Fisher Scientific 
Minimal Essential Medium (MEM)  Thermo Fisher Scientific 
Minimal Essential Medium Non-Essential  Thermo Fisher Scientific 
Amino Acids (MEM NEAA) 
Opti-MEM-1 + Glutamax Medium  Lonza   
Paraformaldehyde  Sigma 
Phosphate Buffered Saline (PBS)  Sigma 
Phosphatase Inhibitor Cocktail  Sigma 
Polyinosinic:Polycytidylic Acid (Poly I:C)  InvivoGen 
Propidium Iodide  Thermo Fisher Scientific 
Protease Inhibitor Cocktail  Sigma 
Puromycin  Sigma 
RevertAid 5x Reaction Buffer  Thermo Fisher Scientific 
RevertAid Reverse Transcriptase  Thermo Fisher Scientific 
Sodium Dodecyl Sulfate (SDS)  Sigma 
Sodium Chloride  Sigma 
Sodium Deoxycholate  Sigma 
SYBR® Green JumpStart™ Taq ReadyMix™  Sigma 
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TMB Stabilized Chromagen  Thermo Fisher Scientific 
TRI Reagent®       Sigma 
Tri-Sodium Citrate (Dihydrate)     Sigma 
Triton X-100       Sigma 
Trizma® Base       Sigma 
Trypan Blue Solution (0.4%)     Sigma 
Trypsin with EDTA (0.25%)     Thermo Fisher Scientific 
Tween-20       Sigma 
Vectashield® Mounting Medium    Vector Laboratories Limited 
Vectashield® Mounting Medium with DAPI   Vector Laboratories Limited 
Xylene        Thermo Fisher Scientific  
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Mouse IgG HRP 
Santa Cruz 
Biotechnology 




Life Technologies A21206 1:1000 TNT+2% FBS 
Goat Anti-
Rabbit IgG HRP 
Santa Cruz 
Biotechnology 









Life Technologies A11006 1:500 TBS+1%BSA 
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2.1.2 Buffers and Solutions 
 
Freezing Medium (10ml per flask) 
4ml FBS (= 40%) 
1ml DMSO (= 10%) 
5ml Medium (= 50%. MEM or Opti-MEM for Caco-2 and HIEC cells, respectively) 
 
RIPA Buffer (per ml) 
100µl Tris 500mM 
30µl Sodium Chloride 5M  
100µl Sodium Deoxycholate 
10µl SDS 10% 
10µl IGEPAL® CA-630 
10µl Phosphatase Inhibitor 
5µl Protease Inhibitor 
750µl Distilled Water 
 
Tris-Glycine Running Buffer (10X) 
30.3g Trizma® Base 
144g Glycine 
10g SDS 






pH to 2.2 using Hydrochloric Acid 




2.2.1Human Intestinal Epithelial Cells 
 
2.2.1.1 Cell Lines and Culture 
Human Intestinal Epithelial Cells (HIECs) are a human, foetal-derived cell line and were a 
gift from Jean-Francois Beaulieu (Université de Sherbrooke). The HIECs were maintained in 
Opti-MEM-1 + Glutamax medium, supplemented with 5% foetal bovine serum (FBS), 1% 
0.01M HEPES and 10µl 0.1mg/ml epidermal growth factor (EGF). The Caco-2 human 
Caucasian colon adenocarcinoma cell line was purchased from European Collection of 
Authenticated Cell Cultures (ECACC, catalogue #09042001), and were maintained in 
minimum essential medium (MEM), supplemented with 10% FBS and 1% MEM non-
essential amino acids (NEAA). Cells were grown in a humidified incubator at 37°C in 95% 
air: 5% CO2, and were passaged once they reached 80-90% confluency, and more frequently 
in Caco-2 cells in order to avoid them differentiating. When passaging the cells, the media 
was first discarded before washing the cells twice gently in PBS. Trypsin was used to detach 
adhered cells from the bottom of cell culture flasks, before resuspending and reseeding in a 
new flask with fresh media. 
 
2.2.1.2 Generation of SOCS3-Knockdown and Control HIEC Cell Lines (carried out by 
Dr. Matt Hodges) 
SOCS3 and non-silencing shRNA GIPZ lentiviral constructs (Thermo Scientific) were used to 
generate SOCS3 knockdown and control HIEC cell lines, respectively, with each construct 
containing a resistance marker against the antibiotic, puromycin. Both cell lines were seeded 
at a concentration of 2 x 104 cells per well and were incubated with the respective lentivirus, 
according to manufacturer’s instructions. Puromycin (puromycin dihydrochloride derived 
from Streptomyces alboniger) was used at varying concentrations to select for successfully 
transduced HIEC cells. Complete Opti-MEM media containing 1.35µg/ml of puromycin was 
then used to maintain transduced HIEC cells during culture. Cells containing the SOCS3 and 
non-silencing constructs will be further referred to as SOCS3Low and SOCS3Ev (Ev- Empty 




2.2.1.3 Cell Freezing 
All cells used were cultured for 20 passages from thawing, and to ensure there were ample 
cell stocks (stored in liquid nitrogen), cells were routinely frozen. First, media was removed 
from the flask(s) and cells were gently washed twice in PBS before incubation at 37°C in 1ml 
of trypsin. Once cells had detached, they were resuspended in freezing medium (5ml per T75 
flask used, see section 2.1.2), with the cell suspension then centrifuged for 5 minutes at 500 
RCF (using an Allegra™ X-22R centrifuge, Beckman Coulter). The supernatant was 
removed, with each cell pellet resuspended in 4ml of freezing medium. Each 4ml cell 
suspension was then divided between 4 (labelled) cryovials, with cryovials frozen overnight at 
-80°C in a Mr. Frosty freezing container (VWR) with isopropanol (Fisher Scientific), before 
being transferred to a liquid nitrogen container for long-term storage. 
 
2.2.1.4 Cell Counting 
When preparing plates for experiments, media was first removed and cells were washed twice 
using PBS, as previously stated. Following incubation in trypsin, cells were resuspended in 
complete medium (approximately 4-7ml with 1ml trypsin, depending on the confluency). A 
1:2 suspension was prepared by suspending cells in an equal volume of 1:10 diluted trypan 
blue (10-20µl). This was then used to determine the approximate number of cells, counted 
using a haemocytometer. The number of viable cells in each of the 4 corner 4x4 squares was 
counted, with an average calculated. This was then multiplied by the dilution factor (2) and 
104, to determine the number of cells per ml of suspension. The initial cell suspension was 
diluted with complete medium appropriately, according to the cell numbers desired (as stated 
below, per experiment) in a 2ml volume per well. 
 
2.2.1.5 RNA Extractions, cDNA Synthesis and Quantitative PCR 
Normal HIEC and Caco-2 cells were seeded into 6-well plates at 1 x 106 cells per well, and 
SOCS3ᴱᵛ and SOCS3ᴸᵒʷ HIEC cells were seeded into either 6- or 12-well plates at 
concentrations ranging from 1 x 105 to 1 x 106 cells per well and were incubated at 37°C for 
approximately 24 hours to allow cells to adhere to the bottom of the wells. Media was 
removed, replaced with serum-free media, and plates were incubated at 37°C for a further 12-
16 hours. For quantification of SOCS3 mRNA, cells were then released using serum-
containing media from 0 to 6 hours. For quantification of IL-10, TNF-α and indoleamine 2,3-
dioxygenase (IDO) mRNA, HIECs were treated with serum-containing media alone (no 
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treatment), or serum-containing media with 0.1µg/ml of either flagellin, LPS or Poly I:C for 2 
hours. For additional quantification of IDO mRNA, HIECs were also treated with 10ng/ml of 
IFN and 0.1mg/ml Trichuris muris excretory/secretory protein (E/S, a gift from Professor 
Kathryn Else) for 2 hours. After stimulating cells with the stated treatments and durations, 
cells were lysed in TRI-Reagent® and RNA was extracted according to manufacturer’s 
instructions. 
 
The concentration and purity of RNA was measured using the Nanodrop 2000c (Thermo 
Scientific), and nuclease-free water was used to generate 1-2µg of RNA in a volume of 9μl in 
order to generate complimentary-DNA (cDNA). 1µl of oligo-dT was added to each sample, 
which were then incubated at 70°C for 5 minutes, using the Programmable Thermal 
Controller-100™ (MJ Research Incorporated). The following master mix was then made and 
added to each sample before incubation at 42°C for 1 hour then 70°C for 10 minutes, again 
using the Programmable Thermal Controller-100™. 
 
RevertAid Reverse Transcriptase Master Mix: 
 
Reagent Volume (µl) 
RevertAid 5x Reaction Buffer 4 
10mM dNTP 2 
RevertAid Reverse Transcriptase 1 
Nuclease-Free Water 3 
 
Table 2.3: The reagents and volumes used for the RevertAid Reverse Transcriptase master 




mRNA levels of SOCS3, IL-10, TNF-α and IDO were assessed using quantitative PCR 
(qPCR), using the SYBR® Green JumpStart™ Taq ReadyMix™ and the Bio-Rad CFX96™ 
Real-Time System and C1000™ Thermal Cycler. A 20µl reaction was used for each well of a 
96-well plate, as shown below, and no template controls were included for each primer set to 
ensure that only the desired PCR product was amplified in the reaction. 
 
qPCR Master Mix: 
 
qPCR Master Mix Volume (µl) 
SYBR® Green JumpStart™ Taq 
ReadyMix™ 
10 
Forward Primer (10µM) 1 
Reverse Primer (10µM) 1 
Nuclease-Free Water 7 
cDNA Template 1 
 
Table 2.4: The reagents and volumes used within the qPCR master mix, in order to quantify 




The table below shows the different qPCR protocols for each of the primers used, including 





































Melt Curve, with increases in temperature from 65°C to 95°C with 0.5°C increments, with 
each increment lasting 5 seconds 
 
Table 2.5: Cycle times and temperatures for each of the primers used for the in vitro qPCR 
experiments. 
 
Data was analysed with Microsoft Excel, using the 2(-ΔΔCt) method, where changes in Ct value 
for each gene were normalised to those of a housekeeping gene, RPLPO (Large Ribosomal 




2.2.1.6 Primer Design and Sequences 
Primers used for qPCR were designed using the National Center for Biotechnology 
Information (NCBI) Primer-BLAST primer designing tool and ordered from Sigma Aldrich, 
UK. 
 

















Table 2.6: The forward and reverse sequences and product sizes for each of the qPCR primers 
used. 
 
2.2.1.7 Cell Lysis for Western Blotting 
Normal HIEC and Caco-2 cells, and SOCS3ᴱᵛ and SOCS3ᴸᵒʷ HIEC cells were seeded into 6-
well plates at 1 x 106 cells per well, and were incubated at 37°C for approximately 24 hours to 
allow cells to adhere to the bottom of the wells. Media was then removed, replaced with 
serum-free media, and plates were incubated at 37°C for a further 12-16 hours. For 
quantification of SOCS3 protein, cells were then released using serum-containing media from 
0 to 6 hours. After 6 hours, the media was removed and cells in each well were lysed in 200µl 
of RIPA buffer (see section 2.1.2). Using a cell scraper, cells were removed from the bottom 
of the plate and lysed, before lysates were transferred to eppendorfs and centrifuged at 
13,000g for 10 minutes at 4°C. Supernatants were transferred to new eppendorfs and either 
used straight away in a Bradford assay, or stored at -20°C. 
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2.2.1.8 Bradford Assay 
Bradford assays were carried out for protein quantification of generated cell lysate samples. 
Bovine Serum Albumin (BSA) was used to produce protein standards with a range of 
concentrations between 0 and 500µg/ml. 450µl of Bradford reagent was added to 50µl of each 
standard. Standards were thoroughly mixed, with 100µl of each transferred to a 96-well plate 
in duplicate. The plate was read on a microplate reader using Magellan 7.0 software and a 
Tecan infinite 200Pro plate reader, and a standard curve was generated from the results. This 
process was then repeated using 450µl of Bradford reagent with 50µl of each sample diluted 
1:10 with distilled water. The standard curve was then used to determine the protein 
concentration of each sample and the equivalent sample volume for 30µg of protein. 
 
2.2.1.9 Western Blotting 
Samples were prepared using 4x Laemmli Sample Buffer (Bio-Rad) and 10% 2-
Mercaptoethanol, and were then boiled at 95°C for 2 minutes. Samples were loaded into Mini-
PROTEAN® TGX Precast Gels (10%, Bio-Rad) and ran at 200V for approximately 30 
minutes, until the gel front was near the bottom of the gel. Gels were then transferred onto 
nitrocellulose membranes, using a Trans-Blot® Turbo™ Transfer System (Bio-Rad) and 
Trans-Blot® Turbo Transfer Buffer (Bio-Rad). Membranes were blocked using 5% BSA in 
Tris-Buffered Saline with 0.1% Tween (TBST) for 1 hour at room temperature. Membranes 
were then incubated in primary SOCS3 antibody overnight at 4°C (see table 2.2). 
 
Membranes were washed with TBST before being incubated with secondary antibody for 1 
hour at room temperature (see table 2.2). Membranes were washed with TBST and Clarity™ 
Western Enhanced Chemiluminescence (ECL) Substrate was used for development, before 
exposure using the ChemiDoc™ MP Imaging System (Bio-Rad). Densitometry analysis was 
carried out using Image Lab 5.2.1 software (Bio-Rad) and Microsoft Excel, to determine 
SOCS3 protein levels, normalised to those of β-actin. 
 
2.2.1.10 CyQuant Cell Proliferation Assay 
CyQuant assays were carried out to assess differences in basal and microbial-stimulated 
proliferation in normal and cancerous intestinal cell lines (HIECs and Caco-2 cells, 
respectively). Assays were also carried out to determine the role of SOCS3 in basal and 
64 
 
microbial-stimulated proliferation in SOCS3-knockdown and control HIECs. HIECs and 
Caco-2 cells were seeded into a 96-well plate at 2000 cells per well, and allowed to adhere to 
the bottom of the plate for 24 hours at 37°C. The media was then removed and replaced with 
serum-free media, and incubated at 37°C for 12 hours. Plates were treated as shown below 
(table 2.3), with 4 wells used per treatment. HIECs and Caco-2 cells were treated for 24, 48 
and 72 hours, and HIEC clones were treated for 48 hours, with treatments removed at the end 
of incubation and plates frozen at -80°C. For the 48 and 72 hour plates, half of the media was 
removed from each well and treatments were replenished after every 24 hour period. 
 
Cell proliferation was assessed according to manufacturer’s instructions, with known numbers 
of untransfected HIECs, and Caco-2 cells used to generate a standard curve in order to 
determine cell number following treatments. Fluorescence was measured using Magellan 7.0 
software and a Tecan infinite 200Pro plate reader. 
 




HIECs and Caco-2 
cells 
0.1µg/ml Poly I:C 



















0.01µg/ml Poly I:C 
0.1µg/ml Poly I:C 
1µg/ml Poly I:C 




Table 2.7: Concentrations and treatment durations of TLR ligands used to stimulate HIEC 




2.2.1.11 Data Analysis 
Microsoft Excel was used for all data analysis (unless otherwise stated) and generation of 
graphs. To determine statistical significance (p<0.05), two-tailed t-tests and ANOVA were 
performed using JMP software (version 12, SAS Institute), with Control Dunnett’s post hoc 





2.2.2.1 Generation of Mice 
As SOCS3 null mice (SOCS3-/-) are embryonic lethal (Roberts et al. 2001), conditional 
knockout mice with SOCS3 knockout specifically in IECs were used, as described in Croker 
et al. (2003) and Rigby et al. (2007). Experimental mice were generated by Dr. Elisabeth 
Shaw and were bred and reared at the animal facility at the University of Manchester. To 
create the experimental mice, first, two sequences containing loxP sites are inserted around 
the second exon of the SOCS3 gene (Croker et al. 2003). Mice homozygous for this pLox-
SOCS3 modification (HO) (on a C57/BL6 background) were mated either with C57/BL6 
mice (WT) or C57/BL6 mice hemizygous for the Villin-Cre transgene (VC), to produce 
wildtype (HO-WT) and SOCS3 knockout (HO-VC) animals, respectively. The Cre protein is 
a DNA recombinase enzyme that recognises loxP sequences and excises the DNA (belonging 
to the target gene) between them (el Marjou et al. 2004), in this case, SOCS3. This 
recombinase activity was targeted to the IECs specifically through the use of a Villin 
promoter, with Villin being an actin-binding protein located in the brush border of IECs (cited 
by Wang et al. 2008). All experiments were conducted under Home Office licence in 
accordance with the Animals in Scientific Procedures Act (1986) and PPL 40/3217 and 
40/3633. Genotyping was performed by Dr. Elisabeth Shaw as described in Rigby et al. 
(2007). 
 
2.2.2.2 Trichuris muris Infection 
The Edinburgh isolate of T. muris whipworm was maintained in Severe Combined Immune 
Deficiency (SCID) mice. HO-WT and HO-VC mice were infected by oral gavage, as 
described by Wakelin (1967), and performed by Dr. Elisabeth Shaw and Professor Kathryn 
Else. Mice were infected at 6-8 weeks of age, with 25-30 eggs (low dose). 
 
2.2.2.3 Tissue Collection and Histology 
At 35 days-post infection, all mice (regardless of infection status) were sacrificed, with cecal 
tips removed and fixed in 4% formaldehyde for 24 hours, before wax embedding and 
sectioning for immunofluorescence (Immunofluorescence, 2.3.5). Mucosal scrapes from ceca 
were also obtained using RIPA buffer (see section 2.1.2) and passed through a blunt 18-gauge 
needle (Becton Dickinson) before centrifugation at >10,000g for 10 minutes at 4°C. 
Supernatants were retained and stored at -20°C until quantification using the Bradford assay 
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(2.3.6). (Wax embedding, sectioning and retrieving of mucosal scrapes performed by Dr. 
Elisabeth Shaw). 
 
2.2.2.4 EdU Proliferation Assay 
The Click-iT® EdU assay (Invitrogen) was performed to establish differences in proliferating 
IEC between uninfected and T. muris-infected HO-WT and HO-VC. This method involves the 
incorporation of EdU (5-Ethynyl-2'-deoxyuridine, administered 90 minutes before sacrifice at 
10mg/kg), a nucleoside analogue, into the DNA of actively dividing cells, which is detected 
after addition of an Alexa Fluor® dye that binds to the EdU. In addition to quantifying 
proliferating intestinal cells, a Hoechst nuclear stain was used in order to determine cell 
position (based on crypt regions derived from Potten 1998, and Cliffe et al. 2005). Images 
were analysed blind using Zeiss LSM Image Browser software, which was also used to 
measure crypt depth. (EdU assay performed by Dr. Elisabeth Shaw, according to 
manufacturer’s instructions). 
 
2.2.2.5 Assessment of IDO Expression using Immunofluorescence 
Immunofluorescence was carried out on embedded sections of ceca from T.muris-infected 
HO-WT and HO-VC mice, and colons from AOM/DSS-treated HO-WT and HO-VC mice (a 
gift from P.K Lund, prepared as described in Rigby et al. 2007). First, deparaffinisation was 
carried out on tissue sections, which involved placing slides in xylene, then into a container 
each of 100%, 90% and 70% ethanol, each for 3 minutes, before being kept in distilled water 
until antigen retrieval. 
 
Heat-Induced Epitope Retrieval (HIER) was performed as the method of antigen retrieval, 
which involved heating slides in pH 6.0 sodium citrate buffer in a pressure cooker (Morphy 
Richards, model 48815) for 3 minutes before cooling in distilled water for 10 minutes. Slides 
were then washed in TBS+0.025% Triton X-100. A PAP pen (Sigma) was used to draw 
around each tissue section, forming a hydrophobic barrier, and slides were then blocked in 
10% normal goat serum in TBS+1% BSA for 2 hours at room temperature in a humidified 
container. Slides were then incubated in 1:400 IDO in TBS+1% BSA overnight at 4°C, in a 
humidified container. A control slide incubated in TBS+1% BSA only, and no primary 




Following primary antibody incubation, slides were washed in TBS+0.025% Triton X-100 
before being incubated in 1:500 Goat Anti-Rat IgG AlexaFluor 488 in TBS+1% BSA for 1 
hour at room temperature. Excess antibody was washed off using TBS, and slides were then 
incubated in a nuclear stain, using 1:3000 propidium iodide in PBS for 3 minutes. Slides were 
then briefly washed in PBS and mounted using Vectashield® Mounting Medium, and sealed 
with a coverslip before being viewed on a Zeiss LSM 510 confocal microscope. 
 
2.2.2.6 Bradford Assay 
Bradford assays were carried out for protein quantification of cecal protein samples. BSA was 
used to produce protein standards with a range of concentrations between 0 and 1mg/ml. 
450µl of Bradford reagent was added to 50µl of each standard. Standards were thoroughly 
mixed, with 100µl of each transferred to a 96-well plate in duplicate. The plate was read on a 
microplate reader using Magellan 7.0 software and a Tecan infinite 200Pro plate reader, and a 
standard curve was generated from the results. This process was then repeated using 450µl of 
Bradford reagent with 50µl of each sample diluted 1:10 with distilled water. The standard 
curve was then used to determine the protein concentration of each sample and the equivalent 
sample volume for 30µg of protein. 
 
2.2.2.7 Assessment of IDO Expression using Western Blotting 
Samples were prepared using 4x Laemmli Sample Buffer (Bio-Rad) and 10% 2-
Mercaptoethanol, and were then boiled at 95°C for 5 minutes. Samples were loaded into Mini-
PROTEAN® TGX Precast Gels (10%, Bio-Rad) and ran at 160V for approximately 45 
minutes, until the gel front was near the bottom of the gel. Gels were then transferred onto 
nitrocellulose membranes, using a Trans-Blot® Turbo™ Transfer System (Bio-Rad) and 
transfer buffer. Membranes were blocked using 1% BSA in TBST for 1 hour at room 
temperature. Membranes were then incubated in mouse IDO primary antibody overnight at 
4°C (see table 2.2). 
 
Membranes were washed with TBST before being incubated with secondary antibody for 1 
hour at room temperature (see table 2.2). Membranes were washed with TBST, and ECL was 
used for development, before exposure using the ChemiDoc™ MP Imaging System. 
Densitometry analysis was carried out using Image Lab 5.2.1 software (Bio-Rad) and 
Microsoft Excel, to determine IDO protein levels, normalised to those of α-tubulin, or β-actin 
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(following stripping of secondary antibody using mild stripping buffer (see section 2.1.2), and 
re-blocking before antibody incubation). 
 
2.2.2.8 Data Analysis 
All data analysis (unless otherwise stated), two-tailed t-tests (to determine statistical 
significance- p<0.05) and generation of all graphs was performed using Microsoft Excel.   
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2.2.3 Drosophila melanogaster 
 
2.2.3.1 Fly Stocks and Maintenance 
The whiteDahomey stock was obtained through backcrossing w1118 flies into the outbred wild-
type Dahomey background (Broughton et al. 2005). Both EsgGAL4, GAL80ts and UAS-
SOCS36E RNAi 1/ Cyo stocks were obtained from the Bloomington Stock Centre, and were 
backcrossed six times onto the whiteDahomey background to produce wDah; EsgGAL4, GAL80ts 
and wDah; UAS-SOCS36E RNAi 1/ Cyo, to ensure 100% of the genetic background had been 
replaced with the genetic material of wDah flies. Fly stocks were maintained at 25°C and 
constant humidity on standard sugar/yeast medium (see Appendix 9), on a 12-hour/12-hour 
light/dark cycle. 
 
2.2.3.2 Fly Genetics and Generation of Experimental Flies 
The GAL4/UAS system in Drosophila was used to produce an ISC-specific knockdown of 
SOCS36E. GAL4 is a gene that can target activation of gene transcription in specific cells or 
tissues, but this can only occur when a fly containing GAL4 is crossed to a fly containing the 
Upstream Activation Sequence (UAS). UAS is found next to the target gene and contains 
GAL4 binding sites (Brand and Perrimon 1993). In our case, we used flies with the escargot 
(Esg) ISC driver and crossed them with flies containing SOCS36E RNAi attached to UAS. 
However, knockdown of SOCS36E through RNAi is homozygous lethal, so therefore a curly-
winged balancer (Cyo) was used to ensure fly survival and prevent loss of the RNAi from the 
population. The balancer also aids selection following crosses as flies that contain the RNAi 
will not possess the balancer, and therefore will have straight, not curly wings. 
 
To generate an RNAi knockdown, double-stranded RNA is introduced into the organism and 
any mRNA that contains the same sequence will be degraded (Fire et al. 1998). Furthermore, 
the EsgGAL4 line that we used was also coupled with GAL80ts; a temperature sensitive 
GAL4 repressor (McGuire et al. 2003). GAL80ts is active at temperatures ≤18°C, thus 
repressing GAL4 and preventing gene transcription. However, at temperatures ≥28°C, 
GAL80ts function is restricted, therefore relieving inhibition of GAL4, resulting in 
transcription of the target gene downstream of UAS, i.e. SOCS36E RNAi (as shown in figure 
2.1). Once the experimental crosses were set up, eggs were left to develop at 17°C so GAL80ts 
repressed GAL4. However, once the flies had eclosed, they were kept in a 28°C incubator. 
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This ensured that the knockdown was restricted to adult flies, and that any potential effects of 
















Figure 2.1: Functioning of the UAS-GAL4 GAL80ts system. At lower temperatures, such as 
18°C, GAL80ts is bound to GAL4, preventing the transcription of target genes, i.e. SOCS36E 
RNAi. At higher temperatures, such as 28°C, GAL80ts is unable to repress GAL4, so both 
GAL4 and UAS are active, allowing transcription of SOCS36E RNAi and subsequent 
knockdown of SOCS36E to occur (Image adapted from WWW, Cold Springs Harbor 
Protocols).   
 
 
Experimental flies were reared at standard larval density and in order to achieve this, male and 
female parent flies for each experimental genotype were placed in plastic cages, sealed with a 
petri dish containing agar (consisting of 15g agar, 30ml nipagen and 3ml of propionic acid per 
litre of grape juice used) and fresh yeast in order to stimulate egg laying. Grape plates were 
replaced every 24 hours, along with fresh yeast. Cages were kept at 25°C for one week, and 
every 24 hours, the grape plates were removed and any eggs that had been laid were rinsed off 















into a falcon tube using PBS. Once the eggs had settled, they were pipetted into bottles of 
standard food in 130µl volumes until no eggs remained in the falcon tube. This was carried 
out to ensure that all bottles contained approximately the same number of eggs in each. Once 
completed, the eggs were left to develop, and ultimately eclose approximately three weeks 
later, at 17°C. 
 
After eclosing, flies were sorted by gender and phenotype (as stated in table 2.4) under brief 
CO2 anaesthesia. All experimental flies were maintained at 28°C, with 10 flies per vial, on 
standard sugar/yeast medium. Flies were transferred to vials of fresh food three times a week. 
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Table 2.8: The genotypes and phenotypes of the flies used to produce the experimental flies 
for the subsequent lifespan and behavioural experiments. 
 
2.2.3.3 Lifespan Analysis 
Survival analysis was conducted and was composed of recording the number of live, dead and 
censored flies until no living flies remained. Censors accounted for flies that did not die 
naturally (for example, flies that were stuck in the food or vial, or escaped during transferral to 
a new vial), and therefore did not count towards the overall lifespan of the flies. The number 
of deaths was used to plot survival against time, with 1 indicating 100% survival, 0.5 
representing 50% survival and the median lifespan, and 0 indicating there were no living flies 





2.2.3.4 RNA Extraction, Reverse Transcription and Quantitative PCR 
Guts from 10 day old experimental flies were dissected in 1xPBS then transferred to an 
eppendorf containing 1ml of TRI-Reagent®. Once twenty guts had been dissected and 
transferred, the eppendorf was snap frozen in liquid nitrogen. This was repeated until sixty 
guts per gender, per genotype had been obtained. RNA was extracted according to 
manufacturer’s instruction, and the concentration and purity was measured using the 
Nanodrop 2000c (Thermo Scientific). 
 
1µg of RNA was used per sample in order to generate cDNA, using the M-MLV Reverse 
Transcriptase manufacturer’s instructions, and the Programmable Thermal Controller-100™ 
(MJ Research Incorporated): 1µg of each RNA sample was diluted in nuclease-free water 
(Sigma) to give a final volume of 9µl. 1µl of 1:2 oligo-dT was added to each sample. Samples 
were incubated at 70°C for five minutes, using the Programmable Thermal Controller-100™. 
The following master mix was made and added to each sample before incubation at 37°C for 
1 hour then at 80°C for 1 minute, again using the Programmable Thermal Controller-100™: 
 
Reagent Volume (µl) 
5x M-MLV Reverse Transcriptase Buffer 4 
M-MLV Reverse Transcriptase 1 
dNTP (10mM) 1 
Nuclease-Free Water 4 
 
Table 2.9: The reagents and volumes used for the M-MLV Reverse Transcriptase master mix, 




Levels of SOCS36E mRNA in the gut of experimental flies were assessed using qPCR, using 
SYBR® Green JumpStart™ Taq ReadyMix™, and the Bio-Rad CFX96™ Real-Time System 
and C1000™ Thermal Cycler. A 96-well plate was used to carry out qPCR, and each well 
consisted of a 20µl reaction, containing the following reagents: 
 
qPCR Master Mix Volume (µl) 
SYBR® Green JumpStart™ Taq 
ReadyMix™ 
10 
Forward Primer (10µM) 1 
Reverse Primer (10µM) 1 
Nuclease-Free Water 7 
cDNA Template 1 
 
Table 2.10: The reagents and volumes used within the qPCR master mix, in order to quantify 
changes in mRNA transcription of SOCS36E within Drosophila midguts 
 
No template controls (wells containing an extra 1µl of nuclease-free water, instead of 1µl of 
cDNA) were also included to ensure that the required product was being amplified. 
 
The protocol included an initial 2 minute denaturation step at 94°C, followed by 39 cycles of a 
94°C denaturation step for 15 seconds and a 63°C annealing step for 1 minute. This was 
followed by a melt curve step, which consisted of an increase in temperature from 65°C to 
95°C, with 0.5°C increments, with each 0.5°C increment lasting 5 seconds. Data was analysed 
using Microsoft Excel, and gene expression was calculated using the R= 2(-ΔΔCt), where the Ct 




2.2.3.5 Primer Design and Sequences 
Forward and reverse primers for SOCS36E were designed using the National Center for 
Biotechnology Information (NCBI) Primer-BLAST primer designing tool and ordered from 
Sigma Aldrich, UK, and were reconstituted in nuclease-free water to a concentration of 
100µM before use, according to the data sheet supplied by the manufacturer. Primers for 
Actin 5C, as use as a housekeeping gene, were derived from Broughton et al. (2005). 
  








Table 2.11: The forward and reverse sequences, and product sizes for each of the qPCR 
primers used. 
 
2.2.3.6 Midgut Infection 
The gram-negative bacteria, Erwinia carotovora carotovora 15 (Ecc15), were aseptically 
streaked onto a Luria Broth (LB) culture plate and incubated overnight at 29°C. A single 
colony was then removed to aseptically inoculate 10ml of LB media. This suspension was left 
in a shaking incubator overnight at 29°C, shaking at 150rpm. The bacterial suspension was 
then used to inoculate 1 litre of sterile LB media, which was also incubated overnight at 29°C, 
shaking at 150rpm. Cultures were centrifuged for 20 minutes at 4000rpm (using an Avanti®   
J-26 XP centrifuge, Beckman Coulter), and after removing the supernatants, pellets were re-
suspended in 2ml of LB media and the OD600 was measured using a plate reader.  
 
The suspension was then diluted with sterile 5% sucrose. Following 2 hours of starvation on 
agar medium, flies were briefly anaesthetised with CO2 whilst a filter paper circle 
(approximately 2.5cm in diameter) was inserted into the vial and 200µl of the bacterial 
suspension was added. Flies were left to feed for two hours and were anaesthetised again 
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briefly with CO2 for transfer into vials of fresh medium. Infection with Ecc15 took place at 
approximately 1 and 2 weeks of age. In order to establish the effect of infection on health- and 
lifespan in the experimental flies, an uninfected cohort were used and during the infection 
process, these flies were on agar medium for 2 hours, before being transferred into new vials 
of standard medium. 
 
2.2.3.7 Immunofluorescence 
Instructions for Ecc15 infection were carried out as described above on female flies from all 
three experimental genotypes. Each genotype was subdivided into four groups: an uninfected 
control group that were transferred back onto standard food following two hours of starvation, 
and three infected groups whose guts were dissected in 1xPBS, either 1, 3 or 7 days post-
infection. Following dissection, guts were fixed in 4% paraformaldehyde before being washed 
in 1xPBS, TNT (0.1M Tris HCl /0.3M NaCl, 0.5% Triton X-100) and then blocked in TNT + 
4% FBS for 90 minutes at room temperature, with gentle shaking. Guts were then incubated at 
4°C overnight with rabbit anti-phospho-histone H3, diluted in TNT + 4% FBS. A control was 
included that remained in TNT+4% FBS, with no primary antibody. 
 
After the overnight incubation, guts were washed in TNT then incubated with donkey anti-
rabbit IgG AlexaFluor 488 conjugated secondary antibody diluted 1:750 in TNT + 2% goat 
serum, for 90 minutes at room temperature, with gentle shaking. Guts were then washed in 
TNT, and 1xPBS before being mounted onto microscope slides using Vectashield® Mounting 
Medium with DAPI and then sealed. Slides were visualised using a Zeiss LSM 510 confocal 
microscope.  
 
2.2.3.8 Negative Geotaxis Assay 
Negative geotaxis was carried out on a weekly basis, using a maximum of 15 flies and a 
minimum of 7 flies per tube, with a maximum of 5 tubes and a minimum of 3 tubes used per 
genotype, per gender each week. Flies were briefly anaesthetised with CO2 and allowed to 




The assay involved physically striking the bottom of the tube, forcing the flies to the bottom, 
then recording the number of flies that reached the top, and the number of flies that remained 
at the bottom of the tube after 45 seconds. This was performed three times for each tube. The 
performance index (P.I), the measure of healthspan in this assay, was generated using the 
following calculation: ½ x (Total number of flies in the tube + Number of flies that reached 
the top of the tube – Number of flies remaining at the bottom of the tube) / Total number of 
flies in the tube. The average P.I for each genotype at each time point was then calculated.  
 
2.2.3.9 Exploratory Walking Assay 
The exploratory walking assay was carried out on a weekly basis, using a maximum of 15 
flies per genotype, per gender each week. This assay was based on methods described by 
Martin (2004), and the apparatus used consisted of 4 chambers, with each chamber measuring 
4cm in diameter, and 1cm in height. Each chamber contained one fly, and an aspirator was 
used for transferring flies from vials to each chamber. The flies’ movements were recorded for 
15 minutes, with four chambers able to be recorded per video. Video analysis was conducted 
using Ethovision XT software (Noldus). Microsoft Excel was used to analyse the decline in 
each walking parameter with increasing age and to calculate the total function.  
 
2.2.3.10 Starvation Resistance (carried out by Jack Sloan as part of an Undergraduate 
research project) 
Experimental flies were reared in vials of standard sugar/yeast food until 4 days of age, when 
they were transferred into vials containing 1.5% agar medium. Flies were transferred to new 
vials of agar medium twice weekly, with survival analysis carried out daily. Each vial 
contained 10 flies, with 10 vials used per gender, per genotype.  
 
2.2.3.11 Oxidative Stress Resistance (carried out by Jack Sloan as part of an Undergraduate 
research project) 
Experimental flies were reared in vials of standard sugar/yeast food until 4 days of age, when 
they were transferred into vials containing 1.5% agar medium with 5% sugar and 5% H2O2. 
Flies were transferred to new vials of agar medium twice weekly, with survival analysis 
carried out daily. Each vial contained 10 flies, with 6 vials used per gender, per genotype.  
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2.2.3.12 Cold Stress Tolerance (carried out by Jack Sloan as part of an Undergraduate 
research project) 
Experimental flies, at 10 days of age, were placed in an ice bucket at 4°C for 4 hours, before 
being allowed to recover at 25°C. The time taken from the removal of vials from the ice 
bucket to each fly standing upright was recorded. Each vial contained 5 flies, with 10 vials 
used per gender, per genotype.  
 
2.2.3.13 Fecundity 
To measure fecundity, the number of eggs laid by experimental female flies per vial was 
counted and recorded once the females had been transferred to fresh vials of food. This was 
carried out once a week and was performed alongside lifespan analysis in order to determine 
the average number of eggs laid per female in each genotype, over a 24 hour period. 
 
2.2.3.14 “Smurf” Intestinal Integrity Assay 
This assay was performed to assess midgut integrity of experimental flies and was based on 
methods described by Rera et al. (2011). Flies were transferred into vials of standard food 
containing 2.5% w/v blue food dye (FD&C Blue #1, SPS Alfachem) for 9 hours, before 
transferral into vials of fresh standard food. Flies were briefly anaesthetised using CO2 before 
imaging using a Nikon Coolpix 990 digital camera. The dye will be incorporated in the 
proboscis and crop of healthy flies with an intact midgut. Flies that experienced a loss in 
integrity were termed “Smurf” flies and demonstrated dye incorporation in all tissues. wDah 
were used initially to optimise this assay, followed by experimental flies, with both genders 
and flies of various ages used for all genotypes. 
 
2.2.3.15 Data Analysis 
To determine statistical significance, t-tests and ANOVA were performed using JMP software 
(version 12, SAS Institute), Tukey’s post hoc test was used where appropriate. Microsoft 
Excel was used for all data analysis, and to generate all graphs and survival curves, with 







Investigating the role of SOCS3 on 
normal and microbe-mediated 
mucosal homeostasis using a novel, in 







For many decades, intestinal cell research has been carried out using various in vitro cancer 
cell lines (for example, Caco-2 and SW480) or primary animal-derived cell lines (such as 
IEC-6, which originates from rat). Although both of these have proven to be useful, neither is 
without their limitations, so caution must be taken when translating the results to normal, 
healthy (human) IECs in vivo. For instance Caco-2, a human epithelial colorectal 
adenocarcinoma cell line (Fogh and Trempe 1975), can be used as a model of proliferative 
and differentiated cells, resembling intestinal ECs (Pinto 1983) and, due to the polarisation 
and expression of various cell junctions and transporters, they are often used in barrier and 
drug absorption studies (Hidalgo et al. 1989, Artursson 1990). However, they have been 
reported to respond differently to various cytokines when compared to other transformed cell 
lines (Daig et al. 2000), and primary IECs from patients. This was also true for HT29 too, 
which is a human colon adenocarcinoma cell line (Fogh and Trempe 1975) also capable of 
differentiating (Pinto et al. 1982), as well as producing mucins (Rousset et al. 1978, Augeron 
and Laboisse 1984). IEC-6 is an untransformed small intestine rat cell line (Quaroni et al. 
1979) that resembles intestinal crypt cells and has been found to express microvilli and 
various tight junctions. They have been used extensively in animal research, although it may 
be difficult to extrapolate results into humans (Souba and Wilmore 2001). A non-cancerous, 
human, foetal-derived small intestine in vitro cell line was developed by Perreault and 
Beaulieu (1996), named the HIEC cell line, and initial studies found that these cells most 
resemble the undifferentiated cells found in the small intestinal crypts and can be continuously 
cultured; a desirable feature of the widely-used Caco-2 cells. Additionally, although our 
interests are concerning intestinal homeostasis with regards to proliferation and turnover, like 
Caco-2 cells, HIEC cells can also be used and studied as both proliferating crypt cells 
(Perreault and Beaulieu 1996), and as differentiated cells following the overexpression of 
various differentiation transcription factors (Benoit et al. 2010). However, one has to weigh 
up the pro- and contra-indications of available in vitro cell models dependent upon the 
research questions, and we chose to use the HIEC cell line as they are thought to be more 
responsive to exogenous stimuli, and also more representative of intestinal cells found in vivo 
(i.e. more physiologically relevant), as cancer cells may be regarded as autonomous, and self-
sufficient in growth, maintenance and proliferation (Hanahan and Weinberg 2000). Therefore, 
as our overall focus in the project is SOCS proteins (SOCS3 in particular in our mammalian 
models), it is not known whether manipulation of SOCS3 would have much of an effect on 




Despite the development of the HIEC cell line approximately 20 years ago, very little has 
been published on their use, especially when compared with the more commonly used SW480 
and Caco-2 cell lines. We aimed to use these cells as a model for investigating “normal” 
intestinal homeostasis, in particular looking at the role SOCS3 plays. It is well established the 
functions SOCS3 has involving regulation of proliferation, through its role as a tumour 
suppressor due to a decrease or silencing (due to hypermethylation) of SOCS3 associated with 
a multitude of cancer types (He et al. 2003, Weber et al. 2005, Ogata et al. 2006, Rigby et al. 
2007, Li et al. 2009), to a perpetuator of IBD. This is due to reports of increased IL-6 in UC 
patients, thus resulting in increased Jak/Stat and SOCS3 signalling as a consequence (Suzuki 
et al. 2001, Li et al. 2009). Increased SOCS3 has also shown to lead to both the increased 
production of the pro-inflammatory cytokine, TNF-α, as well as decreased wound healing of 
IECs following microbial stimulation (Thagia et al. 2015), which when combined, could lead 
to insufficient repair of cells following damage. However, despite these findings, little is 
known about the role SOCS3 has in normal homeostasis, so we aimed to investigate whether 
SOCS3 is involved in IEC turnover, using a potentially more physiologically relevant line, 
initially determining baseline levels of SOCS3 and proliferation and comparing them with 
those of the widely used adenocarcinoma cell line, Caco-2.  
 
3.2 Comparison of basal SOCS3 expression in a normal HIEC cell line, compared with 
Caco-2 cells 
3.2.1 HIEC cells produce more SOCS3 mRNA than Caco-2 cells following serum recovery 
In order to determine baseline SOCS3 levels, we quantified SOCS3 mRNA in both Caco-2 
and HIEC cells following serum recovery. Figure 3.1 (a) shows SOCS3 levels in HIEC cells 
alone, and shows that there was a 3-fold increase of SOCS3 mRNA within an hour of addition 
of serum (p<0.0001). When compared with HIECs (figure 3.1b), Caco-2 cells expressed lower 
levels of SOCS3 mRNA (ranging from 1.3-fold lower at 180 minutes, to 4-fold lower at 60 
minutes), both in the presence and absence of serum, and at all time points. Using a Student’s 
t-test, significance between HIEC and Caco-2 cells’ SOCS3 mRNA levels was also evident at 
all time points (p<0.05). Additionally, following addition of serum in HIEC cells (figure 
3.1a), SOCS3 mRNA levels varied noticeably over the duration of the experiment, with the 
fold-change never falling below 1.1±0.3 (at 180 minutes). However, figure 3.1 (b) shows that 
there appeared to be very little fluctuation in SOCS3 mRNA in Caco-2 cells throughout the 6 
hours, with fold-changes remaining between 0.55±0.03 (at t=0) and 0.9±0.06 (at 180 minutes, 
both relative to HIEC t=0). Therefore, in accordance with previous studies, we found that 
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Figure 3.1: The change in SOCS3 mRNA expression levels following serum recovery 
(±SEM) in (a) the normal HIEC cell line (blue), and in (b) the transformed Caco-2 cell 
line (green). Cells were seeded at 1 x 106/well and allowed to adhere overnight, before serum 
starvation overnight. Cells were then treated with serum-containing media for the times stated 
before lysis with TRI-Reagent® for RNA extraction. Expression levels of SOCS3 mRNA were 
measured using qPCR, and calculated using the 2(-ΔΔCt) method, with values relative to the 
HIEC t=0 average ratio. (# = p<0.01, ## = p<0.0001 using a one-way ANOVA with control 
Dunnett’s post-hoc test vs. HIEC t=0. * = p<0.05, ** = p<0.01, *** = p<0.001, **** = 
























































































3.2.2 Caco-2 cells have higher SOCS3 protein than HIEC cells following serum recovery 
Following the observation of more regulated, varying levels of SOCS3 mRNA in HIEC cells 
compared with Caco-2 cells, we performed western blotting to establish whether these 
differences were continued to the protein level, thereby indicating a functional regulatory role. 
Figure 3.2 (a) shows that following addition of serum over the duration of the time course, 
expression of SOCS3 protein did not significantly increase in HIEC cells (relative to serum-
starved HIEC cells), ranging between 0.5±0.04 (at 360 minutes) to 1.6±0.6 (at 240 minutes). 
Contrary to the mRNA results (figure 3.1a), serum-induced changes in SOCS3 were not seen 
to the same extent at the protein level. However, expression of SOCS3 protein (in addition to 
mRNA) was also found to fluctuate over time (figure 3.3). 
 
When compared with Caco-2 cells, SOCS3 protein levels were significantly higher in serum-
starved HIEC cells (p=0.002) (figure 3.2b). However, at 120 and 180 minutes following 
addition of serum, Caco-2 cells appeared to upregulate SOCS3 protein, although this was not 
a significance increase (p=0.252 and p=0.0821, respectively). Interestingly, at 240 and 360 
minutes, SOCS3 protein expression in the two cell lines was similar, with approximate fold-
changes of 1.6 and 0.6, respectively (relative to serum-starved cells). 
 
In conclusion, from mRNA to protein, HIECs expressed more SOCS3 than Caco-2 cells 
during serum starvation. However, following re-introduction of serum, results were more 
variable- protein levels did not match those of mRNA in that Caco-2 cells appeared to express 
more protein at 120 and 180 minutes, with both cells lines displaying similar SOCS3 protein 
levels at 240 and 360 minutes in serum. The contrasts observed at both the mRNA and protein 
level could suggest that: SOCS3 mRNA is more efficiently regulated in HIEC cells, different 
translational mechanisms are active in HIECs and Caco-2 cells, and/or that SOCS3 
























Figure 3.2: SOCS3 protein expression following serum recovery (±SEM) in (a) HIEC 
cells (blue) and compared with (b) Caco-2 cells (green). Cells were seeded at 1 x 106/well 
and allowed to adhere before serum starvation overnight. Cells were treated with serum-
containing media for the times stated before lysis with RIPA buffer. Samples were run on 
10% SDS-PAGE gels before transfer onto nitrocellulose membranes and incubation in SOCS3 
primary antibody at 1:1000 overnight. Membranes were then incubated in secondary antibody 
for 1 hour at room temperature. Membrane imaging and densitometry was carried out using a 
ChemiDoc™ MP Imaging System and Image lab software, with values relative to HIEC t=0. 







































































































Figure 3.3: Cycling of SOCS3 protein expression following serum recovery (±SEM) in 
HIEC (blue) and Caco-2 cells (green). Following serum recovery, cells were lysed, ran on 
10% SDS-PAGE gels, and transferred onto nitrocellulose membranes before incubation 
overnight in 1:1000 SOCS3 primary antibody. Membranes were then incubated in secondary 
antibody for 1 hour at room temperature, and re-blotted for β-actin as a loading control. 
Membrane imaging and densitometry was carried out using a ChemiDoc™ MP Imaging 
System and Image lab software, with values relative to HIEC t=0. (** = p<0.001, using a two-


















































































































3.3 Successful generation of a HIEC line with SOCS3 knockdown 
3.3.1 HIEC cells were successfully transduced using both SOCS3 knockdown and control 
constructs 
After establishing that Caco-2 cells produced lower amounts of SOCS3 mRNA in the basal 
state than untransformed HIECs, in accordance with previous studies demonstrating lower 
levels of SOCS3 in various tumours, we generated a SOCS3 knockdown HIEC cell line 
(SOCS3Low, alongside a control, SOCS3Ev, transduced with a non-silencing construct) to 
investigate how reduction of SOCS3 impacts upon normal intestinal cell responses to a variety 
of physiological stimuli, using a small interfering, or silencing RNA lentiviral construct 
(siRNA). We confirmed the efficacy of the knockdown using a variety of methods. First, 
images were taken of the transduced cells on a Zeiss Axiovert 35 microscope, along with 
untransduced HIECs to confirm uptake of the lentiviral construct. Both constructs contained 
GFP regions, so therefore both transduced lines should fluoresce when imaged, whereas 
untransduced HIEC should not. Figure 3.4 shows fluorescence corresponding to GFP in both 
(a) SOCS3Ev and (b) SOCS3Low transduced HIEC cells. Untransduced HIECs however, did not 
display any fluorescence (figure 3.4c, left panel), corresponding to the absence of transduction 
using a GFP-containing lentiviral construct. Therefore, this suggests that the transduction 
















Figure 3.4: Fluorescent microscopy images of transduced (a) SOCS3Ev and (b) SOCS3Low 
HIEC cell lines, along with (c) untransduced HIECs. Images displaying the GFP 
fluorescence (green) of HIEC cells (left panels) were taken along with bright-field images 
(centre panels), and then merged to demonstrate the localisation of the GFP fluorescence 
(where present) within the HIEC cells (right panels). Images of live cells were taken on a 
Zeiss Axiovert 35 microscope, at 20x magnification. (Scale bar = 20µm). 
 
 
3.3.2 SOCS3 mRNA was significantly reduced both in the presence and absence of serum in 
the SOCS3Low cell line 
After demonstrating that both SOCS3Ev and SOCS3Low HIEC lines were successfully 
transduced with their respective lentivirus constructs, we needed to confirm that baseline 
SOCS3 mRNA levels were indeed lower in SOCS3Low cells than in SOCS3Ev cells. To do this, 
we used qPCR to quantify SOCS3 mRNA produced in both transfected HIEC lines following 















increase in SOCS3 mRNA at all 5 time points, compared with t=0, although only the increases 
at 90 and 120 minutes were found to be statistically significant (p<0.05). 
 
Figure 3.5 (b) compares SOCS3 mRNA in SOCS3Low cells with SOCS3Ev cells, and shows 
that at five of the six time points, there was significantly less SOCS3 mRNA produced in 
SOCS3Low cells (p<0.05), confirming that the transfection and knockdown of SOCS3 in these 
cells was successful. When both cell lines were synchronised at t=0 in the absence of serum, 
SOCS3Low cells showed a 0.4 average fold-change in SOCS3 mRNA, compared with 1 in 
SOCS3Ev, indicating that a 60% knockdown of SOCS3 had been achieved in (serum-starved) 
SOCS3Low cells. However, when analysed using a two-tailed t-test, the difference in SOCS3 
mRNA in SOCS3Ev and SOCS3Low (serum-starved) cells did not quite reach significance 
(p=0.07). The percentage knockdown of SOCS3 was also calculated for the remaining time 
points, and overall, there was approximately a 53±4% reduction in SOCS3 mRNA in 
SOCS3Low cells when compared to SOCS3Ev. 
 
In conclusion, both figures 3.4 and 3.5 show that we were able to successfully transfect HIEC 
cells in order to produce a normal HIEC cell line with reduced SOCS3, along with a suitable 
transfected control HIEC cell line. We also found that there were still fluctuations in SOCS3 
























Figure 3.5: SOCS3 mRNA expression levels following serum recovery (±SEM) in (a) 
SOCS3Ev control HIEC cells, and in (b) both SOCS3Ev control cells and SOCS3Low 
knockdown HIEC cells. Cells were seeded at 1 x 106/well and allowed to adhere, before 
serum starvation overnight. Cells were treated with serum-containing media for the times 
stated before lysis with TRI-Reagent® for RNA extraction. Expression levels of SOCS3 
mRNA were measured using qPCR, and calculated using the 2(-ΔΔCt) method, with values 
relative to the SOCS3Ev t=0 average ratio. (# = p<0.05, ## = p<0.01 using a one-way ANOVA 
with control Dunnett’s post-hoc test vs. SOCS3Ev t=0. * = p<0.05, ** = p<0.01, using a 









































































































3.3.3 SOCS3 protein expression was consistently reduced following serum recovery in the 
SOCS3Low knockdown cells 
Following confirmation of the SOCS3 knockdown in HIEC cells using qPCR, we analysed 
protein levels of SOCS3. The time course was extended to 4 hours, rather than 2, as protein 
translation takes longer than mRNA transcription. As observed previously, serum recovery 
did not result in increases in SOCS3 protein in SOCS3Ev cells (figure 3.6a), indicating that 
translation was not affected following lentiviral transduction. However, as seen in 
untransduced HIEC cells (figure 3.2a) and also in SOCS3Ev cells at the mRNA level (figure 
3.5a), SOCS3 continued to fluctuate at the protein level in SOCS3Ev HIECs (figure 3.6a). 
 
As seen with mRNA, figure 3.6 (b) shows that in the absence and presence of serum, 
SOCS3Low cells produced lower amounts of SOCS3 protein at all time points, compared to 
SOCS3Ev. The lower levels of SOCS3 protein in SOCS3Low cells were found to be statistically 
significant at t=0 and 180 minutes (p=0.001 and p=0.007, respectively). As seen in figure 3.5 
(b), both cell lines had fluctuating levels of SOCS3 protein, although they exhibited different 
patterns of oscillation (figure 3.7), due to the increase in SOCS3 protein in SOCS3Low at t=60 
minutes, compared with a decrease in SOCS3Ev. As with SOCS3 mRNA expression in the 
transduced HIECs, the percentage reduction in SOCS3 protein was calculated for each time 
point of the serum recovery time course, and overall, there was approximately a 52±10% 
reduction in SOCS3 protein in SOCS3Low HIECs, relative to SOCS3Ev. Despite the slight 
increase in variability calculated for SOCS3 protein levels, the reduction does fall within the 
range of percentage of reduced mRNA, which indicates that overall, the transduction-induced 
knockdown in SOCS3 mRNA also translated to protein as well. 
 
In conclusion, we found that SOCS3Low cells produced lower amounts of SOCS3 protein 
when compared to SOCS3Ev cells, thus confirming knockdown of SOCS3 in SOCS3Low at 
both the mRNA and protein levels. We also calculated that the percentage reductions in 
SOCS3 mRNA and protein expression in SOCS3Low cells were very similar, with 53±4% and 
52±10%, respectively. Therefore, as these cells were confirmed as physiologically responsive 
and we were able to knockdown our protein of interest, SOCS3, we deemed these transduced 
























Figure 3.6: SOCS3 protein expression following serum recovery (±SEM) in (a) SOCS3ᴱᵛ 
control cells and (b) compared with SOCS3ᴸᵒʷ knockdown HIEC cells. Cells were seeded 
at 2.5 x 105/well and allowed to adhere before serum starvation overnight. Cells were treated 
with serum-containing media for the times stated before lysis with RIPA buffer. Samples were 
run on 10% SDS-PAGE gels before transfer onto nitrocellulose membranes and incubated in a 
SOCS3 primary antibody at 1:1000 overnight. Membranes were then incubated in secondary 
antibody for 1 hour at room temperature. Membrane imaging and densitometry was carried 
out using a ChemiDoc™ MP Imaging System and Image lab software, with values relative to 




















































































































Figure 3.7: Cycling of SOCS3 protein following serum recovery (±SEM) in SOCS3ᴱᵛ 
control cells and SOCS3ᴸᵒʷ knockdown HIEC cells. Following serum recovery, cells were 
lysed, ran on 10% SDS-PAGE gels, and transferred onto nitrocellulose membranes before 
incubation overnight in 1:1000 SOCS3 primary antibody. Membranes were then incubated in 
secondary antibody for 1 hour at room temperature, and re-blotted for β-actin as a loading 
control. Membrane imaging and densitometry was carried out using a ChemiDoc™ MP 
Imaging System and Image lab software, with values relative to SOCS3Ev t=0. (** = p<0.01 




































































































































3.4 Proliferation of HIEC vs. Caco-2 cells in response to microbial stimulation 
As discussed previously, the Caco-2 cell line has been widely used, and is useful for many 
aspects of biomedical research. However, characterisation of the cell cycle, renewal and 
homeostasis cannot be completely translated to those of normal/untransformed systems, due 
to the cell line being transformed and originally derived from a colon adenocarcinoma, with 
cancer being a disease associated with increased cellular proliferation due to gain of 
mutations, or loss of regulation at cell cycle checkpoints. As well as cellular renewal and 
homeostasis being controlled from within the cell, for example through gene transcription and 
nuclear mitosis, intestinal homeostasis specifically is also controlled through the close 
proximity of commensal microbiota in the intestinal lumen. Interaction of different microbial 
components with cellular receptors, such as TLRs on IECs, is essential for intestinal 
homeostasis. For example, mice deficient in MyD88 (an adapter molecule within the TLR 
signalling pathway, Medzhitov et al. 1998) have dysregulated proliferation and differentiation 
of IECs compared with controls, as well as increased colonic bleeding and mortality following 
intestinal injury using DSS (along with TLR2-/- and TLR4-/-, to a lesser extent). Additionally, 
wildtype mice depleted of their commensal microflora, failed to produce protective cytokines 
(such as IL-6 and TNF-α) following DSS administration. However, mice that were also given 
water containing either LPS or LTA were protected from the DSS-induced mortality seen in 
other animals (Rakoff-Nahoum et al. 2004).  These are in addition to early findings that GF 
mice had lower intestinal proliferation rates as well as reduced crypt and mucosal depths, 
compared to CR animals (Abrams et al. 1962). Therefore, we aimed to assess the suitability of 
using the normal HIEC cell line as a model for intestinal proliferation, and to determine 
baseline and microbial-induced proliferation levels in comparison with those of Caco-2 cells. 
This was performed by treating both cell lines either with media only, or with media 
containing different TLR ligands at varying concentrations, for 24, 48 and 72 hours. Changes 
in proliferation were measured using the CyQuant cell proliferation assay. We hypothesised 
that the Caco-2 cells may have higher unstimulated, basal proliferation rates, but may be less 
responsive to TLR ligands as in an in vivo setting, it would be assumed this would involve 
activation of the immune system, which would be disadvantageous as cancer cells would want 




3.4.1 Caco-2 cells are more proliferative than HIEC cells, both unstimulated and following 
stimulation with TLR ligands. 
Figure 3.8 shows the changes in (a) unstimulated and (b)-(j) microbially-stimulated 
proliferation rates of both HIEC and Caco-2 cells, after 24, 48 and 72 hours. With the 
exception of 0.1μg/ml LTA (figure 3.8j), fold-changes in proliferation between HIECs and 
Caco-2 cells were very similar 24 hours after either no treatment or treatment with TLR 
ligands.  At 48 hours, both cell lines either exhibited no considerable changes in cell number, 
or decreases in cell number, indicative of a decrease in proliferation (with the exception of 
0.1μg/ml FLA in Caco-2s, where there was a 1.4±0.1 fold increase, p=0.0002 vs. HIECs, 
figure 3.8b). Greater decreases were seen in HIEC cells, with significance found vs Caco-2 
cells with 1μg/ml FLA (p=0.013), 0.01μg/ml LTA (p=0.024) and 0.1μg/ml LTA (p=0.026). 
 
There were increases in cell number observed with all treatments at 72 hours signifying 
increases in proliferation, and these were seen in both HIECs and Caco-2 cells. However, the 
differences in proliferation from 48 to 72 hours were much greater in Caco-2 cells, with 
statistical significance found between both cell lines in all conditions at 72 hours (p<0.05). 
Collectively, these results suggest that cells could become susceptible by 48 hours due to 
decreases in cell number seen, corresponding to cell death. Any surviving cells would be more 
resilient and therefore keep proliferating, with the possibility of more space and nutrients 
being available due to a reduction in competing cells. This theory applies to both cell lines, 
but overall, Caco-2 cells were found to proliferate more than HIECs, not only following no 
treatment, but also following treatment with all concentrations of TLR ligands used, with their 



















































































































































































































Figure 3.8: Differences in proliferation between a normal (HIEC, blue) and a 
transformed (Caco-2, green) intestinal epithelial cell line, both following no treatment (a- 
No Tx) and addition of TLR ligands (b-j) (±SEM). Cells were seeded at 2000/well in a 96-
well plate and allowed to adhere, before serum starvation for 12 hours. Cells were treated with 
the stated TLR ligands for 24, 48 and 72 hours. Cell proliferation was measured using the 
CyQuant cell proliferation assay, with cell number changes relative to the No Tx 24 hour 
average within each cell line. (* = p<0.05, ** = p<0.01, *** = p<0.001, using a two-tailed t-




























































































































































































3.4.2 SOCS3 limited microbe-mediated proliferation in HIEC cells 
It has been previously shown that SOCS3 can be induced by TLR ligands along with various 
cytokines (although this was in peritoneal macrophages, Baetz et al. 2004), as well as by IL-
10 (Ito et al. 1999), which is known to have anti-inflammatory effects and suppress gene 
transcription following signalling through TLRs (cited by Yoshimura et al. 2007). Frobøse et 
al. (2006) also found that SOCS3 is able to inhibit MAPK and NF-κB responses downstream 
of the TLRs, and this was through preventing the interaction between TNF-Receptor-
Associated Factor 6 (TRAF6) and Transforming Growth Factor-β (TGF-β)-Activated Kinase 
(TAK1)- normally activated by MyD88 (Yoshimura et al. 2007) (although this was discovered 
in a human pancreatic β cell line and a human embryonic kidney cell line). Following in vivo 
experiments where SOCS3 was also found to limit IEC proliferation (Rigby et al. 2007), we 
aimed to further investigate how SOCS3 impacts on unstimulated and microbial-induced 
proliferation, using SOCS3Ev and SOCS3Low HIEC cells. As we showed that Caco-2 cells had 
lower SOCS3 expression levels and higher proliferation rates than the normal HIEC cell line, 
we aimed to determine whether knockdown of SOCS3 in the non-transformed cells would 
produce a cancer cell like-proliferative phenotype, thus replicating that seen in Caco-2 cells. 
 
Figure 3.9 (a) shows the fold-change in cell number in SOCS3Ev control HIECs, following 
treatment with different TLR ligands, with respect to no treatment (No Tx). Fold-increases in 
cell number were observed in all conditions, with the greatest increase seen with 0.02µg/ml 
LTA, although this was only 1.7±0.3 fold-higher than No Tx. There was also some variability, 
which can be seen by the large error bars. A one-way ANOVA (with control Dunnett’s post-
hoc test) revealed there were no significant differences between any of the treatment 
conditions and no treatment alone (p>0.05). 
 
Figure 3.9 (b) shows the fold-changes in cell number in SOCS3Low cells following stimulation 
with various TLR ligands, with fold-changes in cell number observed upon addition of each 
concentration of all 4 TLR ligands used, ranging between 1.3 (0.01µg/ml FLA) and 2.1 
(0.2µg/ml LTA). When compared to SOCS3Low No Tx, fold-changes in cell number were 
significantly higher with 7 out of the 11 treatments (p<0.05-p<0.0001), in particular, at the 2 




Figure 3.9 (c) shows the fold-changes in cell number in both SOCS3Ev and SOCS3Low cells 
following stimulation with various TLR ligands. Following No Tx, there were increases in 
cell number in SOCS3Low compared with SOCS3Ev (data not shown), although unfortunately, 
this was not quite significant (p=0.06, using a Student’s t-test).  Upon addition of all 4 TLR 
ligands used, there were higher increases in cell number in SOCS3Low than those seen in 
SOCS3Ev- fold-increases in cell number ranged from approximately 1.3-2.1 and 1.2-1.7% 
respectively, although the highest and lowest fold-changes were obtained with the same 
ligands in both cell lines (LTA and FLA, respectively). Despite these observations, no 
statistical significance was found between SOCS3Ev and SOCS3Low at each treatment (using a 
two-tailed t-test). In summary, these results suggest that following knockdown of SOCS3, 
cells become more responsive in terms of proliferation following microbial challenge. More 
specifically, SOCS3 appears to be responsible for regulating TLR2, 3 and 4-mediated 
proliferative responses.  
 
It appears that knockdown of SOCS3 induced a microbe-mediated proliferation profile similar 
to that of Caco-2 cells, so to verify this, we compared the fold-changes in cell number of 
Caco-2 and SOCS3Low cells, following stimulation with multiple TLR ligands for 48 hours. 
Although there are small, visible differences in cell number between cell lines for each ligand, 
only addition of 1µg/ml Poly I:C led to significant differences, with increased cell numbers 
found in SOCS3Low cells compared with Caco-2 cells (p=0.029, figure 3.9d). These results 
confirmed that knockdown of SOCS3 in untransformed HIEC cells altered the microbial-
induced proliferative responses and induced a proliferative phenotype comparable to that of 
Caco-2 adenocarcinoma cells. Subsequently, we then determined the percentage reduction of 
both SOCS3 mRNA and protein in Caco-2 and SOCS3Low cells to ascertain if the similarities 
in proliferation profiles were associated with comparable SOCS3 expression levels. On 
average, SOCS3 mRNA levels were reduced by similar amounts in SOCS3Low cells compared 
with Caco-2s (as shown in figure 3.10a), with percentage reductions calculated as 68±5% and 
62±9%, respectively (shown in figure 3.10c), and as expected, any variances between the two 
cell lines were not statistically significant (p>0.05, using a two-tailed Student’s t-test). 
However, as figures 3.2 (b) and 3.10 (b) demonstrate, the low expression levels of SOCS3 
mRNA in Caco-2 cells were not observed at the protein level, although SOCS3Low cells 
continued to exhibit low SOCS3 expression, compared to both Caco-2 and SOCS3-sufficient 
HIEC cells. Relative to SOCS3-sufficient HIECs, SOCS3Low cells exhibited an overall 
reduction in SOCS3 protein of approximately 71±12%, unlike Caco-2 cells who displayed an 
overall reduction of approximately 28±9% (shown in figure 3.10c). This time however, the 
differences observed between these two cell lines did reach statistical significance, with a p-
101
value of p=0.02 generated (using a Student’s two-tailed t-test). Therefore, although results for 
SOCS3 protein in Caco-2 cells were unexpected, possibly reflecting differentially regulated 
protein translation mechanisms, SOCS3 mRNA levels and microbial-mediated changes in cell 
number were very similar between Caco-2 and SOCS3Low cells, providing a link between the 


















































































































































































































































































































Figure 3.9: The effects of TLR ligands on proliferation (±SEM) in (a) SOCS3ᴱᵛ control 
cells, (b) SOCS3ᴸᵒʷ knockdown HIEC cells, (c) both SOCS3ᴱᵛ and SOCS3ᴸᵒʷ HIEC cell 
lines, and (d) Caco-2 and SOCS3ᴸᵒʷ HIEC cells. Cells were seeded at 2000/well in a 96-
well plate and allowed to adhere for 24 hours, before serum starvation for 12 hours. Cells 
were treated with the stated TLR ligands at varying concentrations for 48 hours. Cell 
proliferation was measured using the CyQuant cell proliferation assay, with fold changes 
relative to the No Tx average within each cell line. (* = p<0.05, ** = p<0.01, *** = p<0.001, 
**** = p<0.0001, using a one-way ANOVA with control Dunnett’s post-hoc test vs. 




















































































































































































Figure 3.10: Differences in expression of (a) SOCS3 mRNA and (b) SOCS3 protein over 
time, and (c) overall percentage reduction in SOCS3, in normal, untransduced HIEC 
cells (blue), Caco-2 cells (green) and SOCS3ᴸᵒʷ HIEC cells (red) (±SEM). (a) SOCS3 
mRNA levels were measured using qPCR and calculated using the 2(-ΔΔCt) method. (n= 4). (b) 
For assessment of SOCS3 protein, cell lysates were run on an SDS-PAGE gel and incubated 
in a SOCS3 primary antibody overnight. Membrane imaging and densitometry was carried out 
using a ChemiDoc™ MP Imaging System and Image lab software. (n=3). (c) * = p<0.05, 




























































































































3.5 The impact of SOCS3 on IEC microbial-induced cytokine responses 
Jak/Stat signalling can be activated by a range of stimuli (such as IFNs, IL-6, TNF-α, LPS), 
which if not regulated efficiently by SOCS proteins (for instance, as well as other Jak/Stat 
inhibitors, such as PIAS), could lead to excess inflammation (reviewed by Akhtar and 
Benveniste 2011). Activation of TLR signalling (in some cases by the same ligand, e.g. LPS) 
results in the transcription of various pro- and anti-inflammatory genes by the transcription 
factor, NF-κB, with the genes transcribed often dependent on the TLR involved, and also the 
site of the TLR expression (reviewed by Zhang and Schluesener 2006). Pro-inflammatory 
cytokines, such as TNF-α in particular, are produced to induce inflammation in order to elicit 
an effective immune response against a particular challenge (through TLR signalling for 
instance) within the body. In addition to immune responses, production of pro-inflammatory 
cytokines, such as TNF-α and IL-6, can initiate cell proliferation, alterations in the 
extracellular matrix and angiogenesis (reviewed by Zhang and Schluesener 2006); all 
processes also exhibited by cancer cells. Therefore, sustained/dysregulated increases in these 
cytokines may promote carcinogenesis, especially in already mutated cells. For instance, with 
respect to Jak/Stat, IL-6 is able to induce proliferation through activation of Jak/Stat 
signalling, both in vitro and in vivo (Starr et al. 1997). However, many cancers are associated 
with decreased SOCS3, and therefore increased Stat3 activity, so IL-6 is able to drive Stat3-
mediated proliferation in cells with diminished negative feedback. This is also supported by 
findings that addition of hyper-IL-6 in IECs led to increases in both tumour size and number, 
respectively. Based on findings of IEC IL-6-/- vs. wildtype mice, IL-6 was also found to 
promote intestinal cell survival, through decreased numbers of apoptotic cells, increased 
expression of anti-apoptotic proteins and enhanced proliferation through increased expression 
proliferating cell nuclear antigen (PCNA) as well (Grivennikov et al. 2009). 
 
Anti-inflammatory cytokines, such as IL-10 for instance, are capable of preventing the 
production and activity of both pro-inflammatory cytokines and chemokines, and nitric oxide. 
IL-10 in particular, can also inhibit antigen presentation which can prevent T-cell-induced 
responses, in addition to promotion of immune cells that can exert anti-tumour effects 
(reviewed by Meager and Wadhwa 2013). However, it is important that production of both 
classes of cytokines are efficiently regulated as insufficient expression of pro-inflammatory 
cytokines and/or overexpression of anti-inflammatory cytokines may result in pathogens 
evading the immune system and causing damage and disease. Additionally, increases in IL-10 
have been found in many tumours, with expression levels positively correlated with disease 
severity and poor prognosis (Mocellin et al. 2005, Itakura et al. 2011, Wang et al. 2011, Oft 
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2014). High levels of IL-10 during cancer will prevent inflammatory responses but in turn, 
induce tumour tolerance, along with possible enhanced cellular proliferation, as examples of 
downstream targets of IL-10 are Stat1 and Stat3 (Mocellin et al. 2005, Oft 2014). On the other 
hand, over-production of pro-inflammatory cytokines and/or insufficient production of anti-
inflammatory cytokines, can eventually lead to autoimmune diseases, such as rheumatoid 
arthritis and IBD. For example, CR, IL-10 knockout mice spontaneously develop colitis 
(which has resulted in these mice being used a model to further investigate IBD in vivo) 
(Kühn et al. 1993). However GF, IL-10 knockout mice do not go on to develop colitis (Sellon 
et al. 1998), demonstrating the crucial function of IL-10 and how sufficient levels are needed 
in order to prevent immune activation against commensal bacteria. CR IL-10-/- mice are also 
susceptible to developing G.I tumours (Berg et al. 1996), with one presumed mechanism 
being the inability to limit inflammation-mediated proliferation. 
 
As previous experiments, cited by Yoshimura et al. (2007) and those shown here, have found 
that SOCS3 is able to inhibit NF-κB signalling, and limit proliferation induced upon 
interaction of microbial ligands with multiple TLRs, respectively, we used HIEC cells to first 
characterise their anti-inflammatory response (through production of the cytokine, IL-10) both 
in untreated, and TLR ligand-treated conditions, and also in SOCS3Low cells to investigate 
how SOCS3 mediates this response. Using donor neutrophils, Cassatella et al. (1999) 
demonstrated that IL-10 is capable of inducing expression of SOCS3, independent of both 
Stat1 and Stat3 activity. As IL-10 can be produced following activation of TLR pathways, and 
SOCS3 can inhibit microbe-mediated Jak/Stat- and NF-κB-induced proliferation, it may be 
assumed that knockdown of SOCS3 may lead to increased IL-10, due to a reduction in 
negative feedback mechanisms. 
 
Recent findings showed that SOCS3 is essential for regulation of microbial induced-TNF-α as 
overexpression in Caco-2 cells led to an increase following stimulation with FLA in a dose-
dependent manner, and this was due to downregulation of TNFR2 (Thagia et al. 2015), which 
has more implications in IBD, as increases of TNF-α and SOCS3 separately are well 
publicised (reviewed by Rogler and Andus 1998, Suzuki et al. 2001). Therefore, we used 
HIEC cells to characterise TNF-α responses in normal intestinal cells and also to investigate 
whether SOCS3 is implicated in microbial-induced pro-inflammatory cytokine production, 
and whether there would be a dampened response, with knockdown of SOCS3 leading to 
decreased TNF-α- the converse of findings published by Thagia et al. (2015). 
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3.5.1 Knockdown of SOCS3 led to a decrease in the expression of the anti-inflammatory 
cytokine, IL-10, at the basal level and following TLR ligand stimulation 
Figure 3.11 (a) shows the quantification of IL-10 mRNA levels in SOCS3Ev cells following 
either no treatment, or stimulation with FLA, LPS or Poly I:C, and shows that when 
normalised to no treatment, there was little difference in IL-10 mRNA expression following 
addition of LPS. After treatment with Poly I:C and FLA, there were 1.5±0.2 - and 1.7±0.4 -
fold increases, respectively, although neither of these were found to be statistically significant 
when analysed using a one-way ANOVA (p>0.05). 
 
Figure 3.11 (b) displays IL-10 mRNA levels of SOCS3Low cells compared with SOCS3Ev, and 
shows that following both no treatment and stimulation with TLR ligands, IL-10 mRNA 
expression was significantly reduced, with approximately 0.4-0.6 –fold increases compared to 
SOCS3Ev no treatment. A Student’s t-test produced p-values of p<0.05 and p<0.001 when 
SOCS3Low FLA, and SOCS3Low No Tx, LPS and Poly I:C respectively, were compared to the 
equivalent treatments in SOCS3Ev. Additionally, although IL-10 mRNA levels were all 
relatively similar in SOCS3Low cells, stimulation with FLA did lead to a significant increase in 
IL-10 mRNA (p=0.0239) when compared to No Tx, and this mirrors the results observed in 
figure 3.11 (a). 
 
In conclusion, knockdown of SOCS3 was found to lead to decreased IL-10 mRNA 
expression, both in unstimulated cells and following treatment with multiple TLR ligands, 





Figure 3.11: Quantification of IL-10 mRNA levels (±SEM) in (a) SOCS3ᴱᵛ control HIEC 
cells, and in (b) both SOCS3ᴱᵛ control cells and SOCS3ᴸᵒʷ knockdown HIEC cells, at the 
basal level and following treatment with various TLR ligands. Cells were seeded at 5 x 
105/well in a 12-well plate, and allowed to adhere, before serum starvation overnight. Cells 
were treated as stated for 2 hours, before lysis with TRI-Reagent® for RNA extraction. IL-10 
mRNA levels were measured using qPCR, and calculated using the 2(-ΔΔCt) method, with 
values relative to the SOCS3ᴱᵛ No Tx average ratio.  (* = p<0.05, ** = p<0.01, *** = p<0.001 
using a two-tailed t-test vs. SOCS3ᴱᵛ. # = p<0.05 using a one-way ANOVA with control 
Dunnett’s post-hoc test vs. SOCS3ᴸᵒʷ No Tx) (n=6). 
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3.5.2 Knockdown of SOCS3 led to an increase in TLR3- and TLR5-induced production of the 
pro-inflammatory cytokine, TNF-α 
Following stimulation with multiple ligands of the TLR pathway, the amount of TNF-α 
mRNA produced in response increased in SOCS3Ev cells, when compared to no treatment 
(figure 3.12a). LPS and Poly I:C led to 2.7±0.3- and 1.4±0.3-fold increases respectively, 
although these were not found to be statistically significant when data was analysed using a 
one-way ANOVA (p>0.05). Treatment with FLA however, substantially increased TNF-α 
mRNA 21.1±6.8-fold, resulting in a p-value of p=0.002. These findings indicate that multiple 
activators of the TLR pathway are capable of inducing TNF-α in HIEC cells, with FLA being 
the most potent inducer. 
 
Figure 3.12 (b) demonstrates the effect knockdown of SOCS3 had on unstimulated and 
microbial-induced TNF-α by comparing SOCS3Low to SOCS3Ev cells, and shows that even 
following no treatment, SOCS3Low cells had higher TNF-α mRNA expression levels 
(p=0.009). As seen in figure 3.12 (a), addition of LPS, and Poly I:C in SOCS3Low cells, also 
increased TNF-α mRNA (compared to No Tx), although in these cells, there was only a 
significant increase when Poly I:C was compared to its SOCS3Ev counterpart (p=0.006). 
Conversely, after treating with FLA, there was an increase in TNF-α expression when 
compared to both SOCS3Ev and SOCS3Low No Tx (p=0.0034 vs. SOCS3Low No Tx), but when 
compared to SOCS3Ev FLA, it had reduced from 21.1±6.8- to a 9.8±2.9-fold increase. Due to 
the variability within each cell line, no statistical significance was found when using a 
Student’s t-test (p>0.05). Collectively, the results in figure 3.12 indicate that out of the three 
TLR ligands used in HIEC cells, the most prevalent inducer of TNF-α was FLA, activating the 
TLR pathway through interaction with TLR5. Figure 3.12 (b) suggests that in the absence of 
stimulation, and upon recognition of Poly I:C, SOCS3 is responsible for limiting TNF-α. 
Therefore, it appears from both the proliferative and cytokine profiles that reduction of 
SOCS3 in HIEC cells is more representative of SOCS3 levels seen in Caco-2 cells, thereby 





















Figure 3.12: Quantification of TNF-α mRNA levels (±SEM) in (a) SOCS3ᴱᵛ control HIEC 
cells, and in (b) both SOCS3ᴱᵛ control cells and SOCS3ᴸᵒʷ knockdown HIEC cells, at the 
basal level and following treatment with various TLR ligands. Cells were seeded at 5 x 
105/well, and allowed to adhere for 24 hours, before serum starvation overnight. Cells were 
treated as stated for 2 hours, before lysis with TRI-Reagent® for RNA extraction. TNF-α 
mRNA levels were measured using qPCR, and calculated using the 2(-ΔΔCt) method, with 
values relative to the SOCS3ᴱᵛ No Tx average ratio.  (** = p<0.01, using a two-tailed t-test vs. 
SOCS3ᴱᵛ. # = p<0.05, ## = p<0.01 using a one-way ANOVA with control Dunnett’s post-hoc 






























































































3.6 Potential relevance of SOCS3 in mediating cancer and tolerance mechanisms  
Our findings, as well as in the literature (Hamilton et al. 2011, Thagia et al. 2015), 
demonstrate a role for SOCS3 in the regulation of cytokine expression. SOCS3 and regulation 
of TNF-α may be implicated in cancer and IBD- SOCS3 is found to be increased in IBD, and 
this is linked with increased TNF-α and, decreased TNFR2 expression and wound healing in 
response to microbial challenge (Thagia et al. 2015). Conversely, SOCS3 is decreased in 
several cancer types, resulting in an inability to limit proliferation as well as increases in 
Stat3-mediated expression of TNFR2 (Hamilton et al. 2011). TNF-α is also known to promote 
angiogenesis, and proliferation in both untransformed and tumour cells (Balkwill et al. 2002, 
Zhang and Schluesener 2006), suggesting that TNF-α promotes a pro-tumourigenic 
environment. Moore et al. (1999) found that mice that were deficient in TNF-α become 
resistant to skin carcinogenesis. Cancer and IBD are both diseases associated with immune 
tolerance. In cancer, mutated cells exhibit increased, uncontrolled proliferation, and tolerance 
of the host towards the tumour cells allows evasion of the immune system. Conversely in 
IBD, there appears to be a breakdown in tolerance mechanisms, with the immune system 
eliciting inappropriate responses against commensal microflora, coupled with dysregulated 
intestinal homeostasis due to an inability to repair damaged IECs sufficiently. In addition to 
SOCS3 and TNF-α, another protein implicated in immune tolerance, including cancer and 
IBD, is indoleamine 2,3-dioxygenase (IDO). IDO is an enzyme involved in the catabolism of 
the essential amino acid, tryptophan (Higuchi and Hayaishi 1967), and has found to be crucial 
in tolerance, indeed IDO inhibition leads to foetal rejection in mice (Munn et al. 1998). 
Increased IDO is also a common feature in IBD (Wolf et al. 2004), and in many cancers, 
including those in the GI tract (Uyttenhove et al. 2003), with IDO able to exert anti-
proliferative effects on nearby T-cells through tryptophan depletion and the increase in 
tryptophan catabolites that ensues (Fallarino et al. 2002, Frumento et al. 2002), thereby 
dampening down the immune system towards tumour cells. 
 
Many cancer types are associated with increases in IDO and concomitant decreases in SOCS3, 
so it could be hypothesised that the two processes may be connected. We used our HIEC 
model to investigate whether a relationship exists between SOCS3 and IDO, and determine 
whether this is a potential mechanism in promoting tumourigenesis. IDO mRNA expression 
was investigated using qPCR in both SOCS3Ev and SOCS3Low cells in response to microbial 
ligands. IFN-γ and excretory/secretory (E/S) antigens were used (along with FLA), as IDO 
has been shown to be induced by IFN in both mice (Yoshida et al. 1981) and humans (Yasui 
et al. 1986, Ozaki et al. 1987) and also by T. muris infection (Bell and Else 2011). T. muris is 
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the murine equivalent of Trichuris trichiura whipworm infection in humans, with E/S being 
one of the antigens of the T. muris whipworm, which induces an immune response in mice 
(Else and Wakelin 1989). 
 
3.6.1 Knockdown of SOCS3 enhanced IFN-γ -induced IDO mRNA expression 
Figure 3.13 (a) shows differences in IDO mRNA levels following treatment with FLA, IFN-γ 
and E/S in SOCS3Ev cells (relative to SOCS3Ev No Tx). There were slight fold-increases in 
IDO mRNA following addition of FLA and E/S (1.5±0.6 and 2.9±1.5, respectively), although 
they were minimal compared with No Tx, and due to variability and overlapping error bars, 
these increases were not statistically significant (p>0.05). Upon treatment with IFN-γ 
however, there was a 10.8±3.2-fold increase of IDO, supporting previous findings that IFN-γ 
is a potent inducer of IDO, and showing that IDO can be induced by IFN-γ in an 
untransformed HIEC cell line. Relative to SOCS3Ev No Tx, this IFN-γ -induced IDO 
expression was found to be statistically significant (p=0.0054). 
 
Figure 3.13 (b) shows that in SOCS3Low cells, there were 2.5±0.4- and 4.4±0.7-fold increases 
in IDO following No Tx and addition of FLA, respectively, and these increases were also 
significantly higher when compared to their SOCS3Ev counterparts (p=0.03 and p=0.01, 
respectively). As in SOCS3Ev cells, treatment with IFN-γ led to production of IDO in 
SOCS3Low cells, although when compared with SOCS3Ev No Tx, there was a 65.7±19.8-fold 
increase. Compared with SOCS3Ev IFN-γ, knockdown of SOCS3 enhanced IDO mRNA 
expression by 6-fold (p=0.02), suggesting SOCS3 is involved in limiting IFN-γ -induced IDO. 
Finally, treatment with the T. muris antigen, E/S did lead to an 8±4.3 fold-increase in IDO in 
SOCS3Low, which is higher than the fold-changes seen in SOCS3Low No Tx and SOCS3Ev E/S, 
although significance was not found when compared with either of these. This is possibly due 
to the variability of IDO expression exhibited by SOCS3Low following E/S treatment, as 
indicated by the large error bar. 
 
To summarise, IFN-γ was capable of inducing IDO in HIEC cells, both in control cells and 
following knockdown of SOCS3, in line with induction of IDO by IFN-γ in other tissues and 
systems. The increases in IDO in SOCS3Low cells indicates that SOCS3 may play a role in 
limiting production of IDO, at least in the intestine, both at an unstimulated, “healthy/normal” 
state, and following interaction with various microbial ligands, in particular IFN-γ. 
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Additionally, the higher IDO mRNA levels in the cancer-like SOCS3Low cells (compared with 
SOCS3Ev) also supports previous findings of increased IDO in a multitude of cancer types, 




















Figure 3.13: Quantification of IDO mRNA levels (±SEM) in (a) SOCS3ᴱᵛ control HIEC 
cells, and in (b) both SOCS3ᴱᵛ control cells and SOCS3ᴸᵒʷ knockdown HIEC cells, at the 
basal level and following various treatments. Cells were seeded at 1 x 105/well in a 12-well 
plate, and allowed to adhere for 24 hours, before serum starvation overnight. Cells were 
treated as stated for 2 hours, before lysis with TRI-Reagent® for RNA extraction. IDO mRNA 
levels were measured using qPCR, and calculated using the 2(-ΔΔCt) method, with values 
relative to the SOCS3ᴱᵛ No Tx average ratio.  (* = p<0.05, using a two-tailed t-test vs. 
SOCS3ᴱᵛ. # = p<0.001, using a one-way ANOVA with control Dunnett’s post-hoc test vs. a) 
SOCS3ᴱᵛ No Tx, and b) SOCS3ᴸᵒʷ No Tx) (n=6). (Figure 3.13b modified from Shaw et al., 


































































































3.6.2 SOCS3 may be responsible for limiting microbial-induced IDO 
The previous experiment was repeated to further investigate the role of SOCS3 in production 
of IDO, and to see whether IDO is implicated in innate immunity and potential tolerance of 
intestinal commensals, mediated by interaction of microbial ligands through TLR receptors on 
the surface of IECs. Figure 3.14 (a) shows that following treatment with FLA in SOCS3Ev 
cells, there was a visible decrease in IDO mRNA, compared to SOCS3Ev No Tx (0.9±0.4 and 
1±0.4, respectively), although due to the similarities in fold-differences, this was not found to 
be significant. There were 1.2±0.5- and 1.3±0.5-fold increases in IDO mRNA, relative to 
SOCS3Ev No Tx, following treatment with LPS, and Poly I:C, respectively. Due to these small 
increases, and the variability in IDO mRNA as depicted by the large, overlapping error bars, 
no statistical significance was found within the SOCS3Ev cell line. It can be concluded that in 
SOCS3-sufficient HIEC cells, signalling through TLRs 3, 4 and 5 did not lead to increases in 
IDO mRNA. 
 
Similar to figure 3.13 (b), figure 3.14 (b) shows that in all four conditions, there was an 
increase in IDO mRNA following knockdown of SOCS3. Treatment with FLA and Poly I:C 
led to 4.7±1.9- and 4.6±2.3-fold increases in IDO, respectively, with No Tx and LPS leading 
to 5.2±3.2- and 7.2±3.6-fold increases, respectively (relative to SOCS3Ev No Tx). Despite 
these increases, there was a substantial amount of variability in IDO levels within each 
condition in SOCS3Low cells, unlike in figure 3.13 (b). Statistical significance was achieved 
however, when comparing SOCS3Ev and SOCS3Low cells following addition of LPS (p=0.03). 
Due to variability in the repeated experiment, significance was not reached upon treatment 
with FLA, Poly I:C and in unstimulated cells, although results consistently indicate IDO 
expression is increased in SOCS3Low cells.  
 
In conclusion, TLR ligands did not induce IDO in control cells, but knockdown of SOCS3 























Figure 3.14: Quantification of IDO mRNA levels (±SEM) in (a) SOCS3ᴱᵛ control HIEC 
cells, and in (b) both SOCS3ᴱᵛ control cells and SOCS3ᴸᵒʷ knockdown HIEC cells, at the 
basal level and following treatment with TLR ligands. Cells were seeded at 5 x 105/well in 
a 12-well plate, and allowed to adhere for 24 hours, before serum starvation overnight. Cells 
were treated as stated for 2 hours, before lysis with TRI-Reagent® for RNA extraction. IDO 
mRNA levels were measured using qPCR, and calculated using the 2(-ΔΔCt) method, with 









































































































A great deal of in vitro research into characteristics and processes of intestinal cells has been 
carried out using transformed cell lines (such as Caco-2 and HT29 cells), or cells obtained 
from primary cancerous tissue, and although they have advantageous features (such as the use 
of Caco-2 cells in drug absorption and barrier studies, due to expression of various 
transporters, Hidalgo et al. 1989, Artursson 1990) and have provided useful information 
regarding cells of the intestinal tract, the results cannot be completely translated to normal, in 
vivo settings. However, a human intestinal epithelial cell (HIEC) line has been developed 
more recently by Perreault and Beaulieu (1996), which is an untransformed line derived from 
normal, foetal, ileal tissue, with cells closely resembling the proliferating crypt cells of the 
small intestine. Although still relatively novel with regards to their use in intestinal studies 
(especially when compared to cell lines such as Caco-2), they have contributed to the field of 
intestinal homeostasis, particularly regarding processes involved in proliferation, 
differentiation and apoptosis (Pageot et al. 2000). Therefore, we aimed to characterise this 
recently developed HIEC cell line to compare against the commonly used Caco-2 cell line. 
Additionally, we wanted to use the HIEC cells as a model for investigating normal and 
microbial-mediated intestinal homeostasis and the involvement of SOCS3, as previous 
research has focused on the associations of reduced and increased expression of SOCS3 in 
diseases such as cancer and IBD, respectively (Rigby et al. 2007, Li et al. 2009).  
 
Our initial experiments aimed to establish SOCS3 mRNA levels in HIEC cells and compare 
these against Caco-2 cells, and we found that during serum recovery, the expression of 
SOCS3 mRNA in HIEC cells fluctuated over the course of the experiment. The results 
obtained are similar to those of Yoshiura et al. (2007), who reported oscillations in SOCS3 
mRNA following serum recovery in a mouse fibroblast cell line, so therefore our data extends 
their findings and shows SOCS3 mRNA also fluctuates in an untransformed human cell line 
in an ostensibly estimated state. These fluctuations are most likely due to the transcription of 
SOCS3 mRNA upon activation of Jak/Stat, which, once translated into protein, will then lead 
to inhibition of Jak/Stat signalling and reduced transcription of SOCS3 mRNA, thus 
producing a negative feedback loop. Once the inhibitory action of SOCS3 has receded, re-
activation of the Jak/Stat pathway may then occur, leading to further transcription of SOCS3 
mRNA, thus accounting for the variations in SOCS3 mRNA levels.  However, it is also 
possible that decreases in SOCS3 mRNA as a result of reduced/inhibited Jak/Stat signalling 
may arise due to the activity of other negative regulators of the Jak/Stat pathway, such as 
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protein tyrosine phosphatases (PTPs) and protein inhibitors of Stats (PIAS), or in fact one of 
the other seven members of the SOCS family. 
 
When compared against the colon adenocarcinoma cell line, Caco-2, we found higher levels 
of SOCS3 mRNA in serum-starved HIEC cells, and following serum recovery. This was 
reassuring and is supported by several studies that report low levels of SOCS3 in tumours, or 
tumour cell lines, both at the mRNA and protein level (He et al. 2003, Ogata et al. 2006).  
Using western blotting to determine whether our findings for mRNA also translated to 
protein, we found that SOCS3 protein levels also fluctuated over the course of the experiment, 
again similar to findings of Yoshiura et al. (2007), who showed SOCS3 is capable of 
oscillating at both the mRNA and protein level. However, our results suggested that following 
serum recovery, Caco-2 cells may express more SOCS3 protein than HIECs, which was not 
anticipated. Cancer is a disease associated with increased, unregulated cellular proliferation, 
with SOCS3 known to be reduced or silenced. Therefore, the lower protein levels observed in 
HIEC cells could be as a result of more active degradation processes. It may also be possible 
that there are less active translation mechanisms in HIEC cells or increased degradation of 
mRNA, and this could arise through the activity of microRNAs. MicroRNAs are considered 
as noncoding RNA, and are not completely complementary to the nucleotides of the mRNA, 
leading to mismatch base-pairing and ultimately prevention of protein translation (reviewed 
by Ambros 2004). MicroRNAs are capable of regulating considerable numbers of mRNA 
with this process, with each individual mRNA also possessing a large number of target sites 
for microRNAs (reviewed by Morris and Mattick 2014). SOCS3 has been reported to be 
regulated by microRNAs, with either silencing or overexpression of certain microRNAs 
(depending on the specific type, or cell type being studied) resulting in reduced SOCS3 
expression, through promoter methylation-induced silencing, or through inhibition of Stat3 
(Boosani and Agrawal 2015). Additionally, as one or more pathways responsible for cell 
proliferation may be dysregulated or non-functional in cancer, it may be that other regulatory 
pathways may not be efficiently regulated as well. With respect to our western blot findings, 
these pathways may be involved in the degradation of SOCS3 protein, perhaps either by 
autophagy, or through proteasomal degradation. Autophagy involves the formation of a 
lysosome with an autophagosome (a double-membraned structure that contains engulfed 
cellular contents), to become an autophagolysosome. Degradation of the consumed cellular 
components then occurs due to the activity of lysosomal enzymes (reviewed by Levine et al. 
2011). It can be considered as a cellular defence mechanism as degradation of specific cellular 
components may prevent replication of damaged and mutated cells, which if allowed to 
accumulate, could lead to cancer. Additionally, autophagy can also result in engulfment and 
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subsequent degradation of intracellular pathogens (reviewed by Levine et al. 2011). Regarding 
the Jak/Stat pathway, Stat3 in particular is implicated in the autophagy pathway, with 
expression associated with decreased autophagy, and vice versa (reviewed by Zouein et al. 
2013). Essentially, we found “normal” cells to have higher SOCS3 mRNA than transformed 
cells which initially could have resulted in more mRNA translated into protein. However, as 
this was not the case, signalling pathways are more likely to be efficiently regulated in the 
HIEC cells, compared with Caco-2, with Stat3 levels potentially decreasing due to the 
presence of SOCS3, causing an increase in autophagy, thus leading to the degradation of 
SOCS3. Cancer cells may have dysregulated autophagy pathways or reduced activity, thus 
promoting survival and replication of mutated cells (reviewed by Zouein et al. 2013), 
especially as normal-high Stat3 levels suppress autophagy and this can arise through lack of 
regulation due to diminished SOCS3 levels. However, to confirm this hypothesis, we would 
first have to establish differences in Stat3 levels between the two cell lines. One way in which 
we could test whether autophagy is increased in HIEC cells is to measure the conversion of 
microtubule-associated protein light chain 3 (LC3) from LC3-I to LC3-II which occurs during 
formation of the autophagosome (Kabeya et al. 2000). Furthermore, to determine if 
proteasomal degradation was responsible for decreased SOCS3 protein levels in HIECs, we 
would expect accumulation/increased levels of SOCS3, perhaps more similar to those of 
Caco-2 cells, following addition of a proteasomal inhibitor, such as epoxomicin and MG132 
which have shown to prevent degradation of SOCS3 (in several human cell lines, Lee et al. 
2008). SOCS3 proteins also contain a PEST motif (rich in Proline, Glutamic-acid, Serine and 
Threonine) which has shown to be involved in its stability and degradation as removal 
resulted in increased SOCS3 levels due to increases in its half-life; both with and without the 
additional of a proteasomal inhibitor (Babon et al. 2006). Therefore, it may be possible that 
the PEST motif is less abundant or perhaps not as functionally efficient in Caco-2 cells 
compared with HIEC cells.  
 
SOCS proteins are also implicated in proteasomal degradation mediated through the SOCS 
box- a C-terminus domain that is conserved in all eight members of the SOCS family. The 
SOCS box binds with elongins B and C, and the scaffold protein, Cullin 2/5 to form a 
complex that is capable of ubiquitinylating substrates for degradation by the proteasome 
(Zhang et al. 1999). Regarding results obtained here, it may be that SOCS box activity is 
higher or more efficiently regulated in the HIEC cells, with other components of the Jak/Stat 
pathway targeted for degradation to cease signalling following sufficient activation. For 
instance, if the activated Jaks or Stats were degraded, transcription of target genes (such as 
SOCS3) would no longer take place, thus leading to decreased SOCS3 protein levels as a 
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result. Additionally, SOCS3 itself can be degraded- phosphorylation of SOCS3 on tyrosine 
residues (Tyr204 and Tyr221) leads to protein destabilisation, resulting in dissociation from 
elongin C as a result, causing rapid proteasomal degradation to take place (Haan et al. 2003). 
In Caco-2 cells, it may be that SOCS3-mediated ubiquitinylation and subsequent degradation 
is taking place, but of proteins whose removal will promote survival and proliferation of the 
cell (for example, pro-apoptotic proteins). To test these hypotheses, as stated previously, cells 
could be treated with a proteasomal inhibitor, with the expectation that protein levels of 
SOCS3 would increase in cells that rely on SOCS box-mediated proteasomal degradation of 
SOCS3. We could also measure levels of pro-apoptotic proteins for example (such as 
caspases) to determine whether their degradation by Caco-2 cells is a mechanism for the 
survival of these cells. Furthermore, as the SOCS box mediates proteasomal degradation, 
antibodies against this domain could be used with the assumption HIEC cells may have higher 
abundance or perhaps an intact, and therefore functional SOCS box, compared with Caco-2 
cells. If the lower SOCS3 protein levels in HIEC cells are as a result of SOCS box-mediated 
degradation, then we would also expect increased SOCS3 expression in these cells (relative to 
Caco-2 cells) if the SOCS box were to be deleted. 
 
TLR signalling has shown to be essential for intestinal homeostasis, as MyD88-/- mice 
exhibited dysregulated proliferation and differentiation of IECs, and succumbed to intestinal 
insult (using DSS) due to an inability to repair and replenish damaged cells (Rakoff-Nahoum 
et al. 2004). GF mice were found to have lower rates of proliferation as well as reduced crypt 
and mucosal depths when compared to CR mice (Abrams et al. 1962), also demonstrating the 
importance of the interaction with IECs and commensal microflora, which is mediated 
through TLRs. Furthermore, Cario et al. (2004) reported that induction of TLR signalling 
through TLR2 in human IEC lines, led to tightening of zona occludens-1 (ZO-1, a tight 
junction protein), thus demonstrating that TLR signalling helps to maintain intestinal 
epithelial integrity. As one of the major features of cancer is dysregulated proliferation, it was 
hypothesised that Caco-2 cells would proliferate more than HIECs in the absence of 
stimulation, but that HIECs may be more responsive to the TLR ligands, as in an in vivo 
setting, recognition of TLR ligands may lead to immune activation, which could be 
undesirable for cancer cells. In HIEC cells, fold-increases in cell number were observed after 
24 hours, irrespective of the treatment and concentration, proving HIEC cells are able to 
respond to different TLR ligands. Caco-2 cells unexpectedly exhibited similar fold-increases 
with each respective treatment. At 48 hours, both cell lines either exhibited no considerable 
change in cell number, or decreases in cell number, indicative that microbial stimulation did 
not rapidly induce proliferation. Increases in cell number were observed in both cell lines at 
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72 hours, regardless of treatment and concentration of TLR ligands. However, when 
comparing fold-changes in cell number from 48 to 72 hours, the proportional increases in 
proliferation were much greater in Caco-2 cells, which was unexpected, as it was 
hypothesised that cancer cells are less responsive to exogenous stimuli.  
 
In addition to greater decreases in cell number in HIECs 48 hours after treatment, compared 
with Caco-2 cells, more pronounced increases in cell number were observed in Caco-2 cells 
after 72 hours of TLR stimulations, and this may also be indicative of a reduction in 
apoptosis. Supporting findings of previous studies (He et al. 2003, Ogata et al. 2006), our 
initial experiments showed that HIECs consistently expressed higher levels of SOCS3 mRNA 
than the Caco-2 cancer cell line. Collectively, this could suggest that SOCS3 levels are 
connected with apoptosis, with lower SOCS3 levels (as observed in many cancers) resulting 
in reduced apoptosis, and higher SOCS3 levels (as demonstrated in HIECs, vs. Caco-2 cells) 
increasing the cells’ susceptibility to apoptosis, or more likely to induce cell death pathways 
during damage and stress. Many studies have been published that support this hypothesis. For 
instance, deletion of SOCS3 in murine myocardial cells inhibited apoptosis following a 
myocardial infarction (Oba et al. 2009). Sitko et al. (2008) found that knockout of SOCS3 
using in vitro fibroblasts, prevented cell cycle arrest at the G1 checkpoint following damage 
with ionising radiation, indicating a role for SOCS3 in DNA damage. The use of SOCS3 
siRNA in preadipocytes was also found to inhibit apoptosis induced following treatment with 
TNF- α (Zhao et al. 2012). Conversely, overexpression of SOCS3 in adipocytes promoted 
TNF-α-induced apoptosis, through increased production of the pro-apoptotic proteins, Bax 
and Caspases 3 and 9, and downregulation of Bcl-2, which is anti-apoptotic (Liu et al. 2015). 
Additionally, overexpression of SOCS3 (as well as SOCS1) led to increased cell death of 
mouse embryonic stem cells (Duval et al. 2000). More specific to our interests, Wei et al. 
(2014) found that inhibition of Jak/Stat3 signalling in colorectal cancer cells, through 
overexpression of SOCS3, induced apoptosis and prevented tumour cell growth, both in vitro 
and in vivo. Comparison of expression of both pro- and anti-apoptotic proteins in these two 
cell lines could be tested to determine whether decreased apoptosis was a potential cause of 
increases in proliferation of Caco-2 cells, and this could potentially reveal an association 
between SOCS3 and apoptosis specifically in the two intestinal cell lines we studied. 
 
Our hypothesis that differences in SOCS3 expression between Caco-2 and HIEC cells were 
responsible for the differences in proliferation are supported by our SOCS3 knockdown HIEC 
cells (referred to as SOCS3Low, with controls named SOCS3Ev) in order to investigate the 
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effects of reduced SOCS3 in a normal, untransformed intestinal cell line. We performed 
serum recovery experiments to confirm the knockdown, with SOCS3 reduced in SOCS3Low 
cells compared to SOCS3Ev, both at the mRNA and protein level. Similar to our initial serum 
recovery experiments, expression levels of SOCS3 were found to fluctuate over the course of 
the experiments, as reported by Yoshiura et al. (2007) using a mouse fibroblast cell line. 
Although the oscillation amplitudes and wavelengths observed here varied from those of 
Yoshiura et al. (2007), this may have been due to the use of different time points, and also 
using cells of a different origin and type so the culturing conditions would not have been the 
same. However, despite the slight dissimilarities, we were able to show that SOCS3 mRNA 
and protein expression continued to fluctuate even following transduction. 
 
As with HIECs vs. Caco-2 cells, we then assessed the proliferative responses of both 
transduced HIEC cell lines. In the control, SOCS3-sufficient HIECs (SOCS3Ev), no significant 
increases in cell number were observed following treatment with multiple TLR ligands. In the 
literature, it has been reported that normal IECs generally are hyporesponsive to the 
commensal bacteria and their products, located in the gut lumen, as being hyperresponsive 
and generating a pro-inflammatory response to these commensal populations would be 
disadvantageous and detrimental to the host. Studies revealed that this IEC unresponsiveness 
was due to low expression levels of TLR2, TLR4 and its co-receptor, MD-2, with regards to 
LTA and LPS, respectively (Abreu et al. 2003, Otte et al. 2004). Otte et al. (2004) found that 
the hyporesponsive state was present following prolonged exposure to TLR ligands and was 
detected just 6 hours post-treatment. Acute, short-term exposure however, was capable of 
inducing expression of pro-inflammatory cytokines from IECs. The HIECs in our experiments 
were treated for 48 hours so the phenotype displayed by SOCS3Ev fits these findings. Abreu et 
al. (2003) also found that IFN-γ was able to increase expression of MD-2, although this was 
decreased following an increase in SOCS3, indicating that SOCS3 is implicated in TLR-
mediated tolerance and that one mechanism through which SOCS3 inhibits TLR and 
subsequent NF-κB signalling may be through downregulation of the MD-2 coreceptor. This 
finding also supports results of SOCS3Low cells, where there was a tendency of increased cell 
number, and thus proliferation and responsiveness compared with SOCS3Ev, following 
addition of TLR ligands. This suggests that SOCS3 is capable of regulating and limiting 
microbial-induced proliferation mediated by signalling through multiple TLRs in HIEC cells. 
Additionally, as we observed enhanced proliferation following addition of multiple TLR 
ligands following knockdown of SOCS3- a phenotype also seen in Caco-2 cells- this could 
suggest that even a reduction in SOCS3 (not a complete knockout) could induce a more 
“cancer-like” phenotype in what are assumed to be otherwise normal IECs. 
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In SOCS3-sufficient HIECs, with the exception of flagellin (which is known to induce TNF-α, 
Ciacci-Woolwine et al. 1998, Thagia et al. 2015), microbe-mediated signalling through TLRs 
3 and 4 did not induce significant increases in expression of TNF-α, and this is possible 
further evidence of normal IECs, and in this case HIEC cells, being hyporesponsive to 
components of the commensal microbiota, due to the undesirable effects increased pro-
inflammatory cytokine production would have in a non-pathological setting. Following 
knockdown of SOCS3, we observed significant increases in TNF-α with LPS, Poly I:C and 
also in untreated cells, which may provide further evidence that SOCS3 is capable of limiting 
microbial-induced production of TNF-α. Interestingly, mice that were deficient in SOCS1 also 
exhibited increased TNF-α production following stimulation with LPS, and reduced tolerance 
to this TLR ligand (Nakagawa et al. 2002). Also, SOCS3 is required for IL-10-mediated 
inhibition of TNF-α, so therefore it is to be assumed that the reduction of SOCS3 in 
SOCS3Low cells would hinder this inhibitory effect, thus resulting in increased TNF-α mRNA 
(Berlato et al. 2002). However (as soon to be discussed), when assessing mRNA expression of 
IL-10 in the same experiment, we found that knockdown of SOCS3 decreased IL-10 levels, 
regardless of treatment, so the fact that less SOCS3 is present to mediate IL-10 inhibition of 
TNF-α appears redundant, unless the two events are related. In previous in vitro research also 
using IECs, Thagia et al. (2015) found that overexpression of SOCS3 led to increases in FLA-
induced TNF-α. The correct balance of SOCS3 is essential in intestinal homeostasis, as 
reduced expression can lead to hyperplasia and potentially carcinogenesis, with 
overexpression of SOCS3 implicated in inflammatory disorders, such as IBD. Although 
experiments carried out by Thagia et al. (2015) involved the use of the colon adenocarcinoma 
cell line, SW480, our combined findings may suggest that regulation of SOCS3 and TNF-α 
could be linked, as TNF-α has been found to drive both carcinogenesis and IBD.  
 
Similar to our findings of TNF-α expression in SOCS3-sufficient HIECs, microbe-mediated 
production of the anti-inflammatory cytokine, IL-10, was also not significant following 
stimulation with ligands for TLRs 3, 4 and 5, and was not too dissimilar from levels observed 
in untreated SOCS3Ev cells, possibly to maintain an appropriate level of tolerance towards 
microbes associated with the commensal gut flora. Additionally, substantial amounts of TNF-
α mRNA were not expressed by these cells so transcription of IL-10 mRNA does not need to 
be upregulated in order to counteract this. Knockdown of SOCS3 however, led to significant 
decreases in IL-10 expression, regardless of treatment. Initially, this result was surprising as 
Niemand et al. (2003) discovered that SOCS3 can be strongly induced by IL-10, but is not 
capable of inhibiting IL-10-mediated signalling as SOCS3 is not able to bind to any 
phosphorylated tyrosine residues on the IL-10 receptor. However, their experiments were 
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performed in monocytes derived from human blood samples, so perhaps may not translate to 
our findings.  
 
Evidence for a relationship between decreased IL-10 expression as a result of reduced SOCS3 
implicates another protein of interest- indoleamine 2,3-dioxygenase (IDO). As described 
previously, IDO is an enzyme involved in catabolism of the essential amino acid, tryptophan 
(Higuchi and Hayaishi 1967). IDO activity results in tryptophan depletion and a subsequent 
increase in tryptophan metabolites, which in turn induces anti-proliferative effects, both 
towards an array of microbes (such as Toxoplasma gondii and, Streptococci and Chlamydia 
species, cited by Thomas and Stocker 1999), as well as host T-cells (Fallarino et al. 2002, 
Frumento et al. 2002). An important function of IDO is the induction of immune tolerance and 
this came to light when inhibition of IDO resulted in T-cell mediated foetal rejection in mice 
(Munn et al. 1998). Consequently, IDO is implicated in immune tolerance, and can be 
involved during disease processes, or as a result of disease, such as with cancer and IBD, 
respectively. With regards to cancer, tumour cells are capable of expressing their own IDO 
and due to its anti-proliferative effects on T-cells, the immune system is dampened down, 
promoting evasion of the tumour cells. This may be further exacerbated during inflammation-
associated carcinogenesis as IFN-γ is a potent inducer of IDO (Yasui et al. 1986, Ozaki et al. 
1987), and may be one of the inflammation-driving cytokines. Similarly, during IBD, IDO 
activity will be higher than in non-IBD sufferers, due to increases in pro-inflammatory 
cytokines; some of which are capable of activating IDO, such as TNF-α, along with IFN-γ. 
However, in this case, decreased proliferation (and potentially numbers) of T-cells is favoured 
in order to limit immune responses elicited against non-pathogenic, non-self entities, such as 
food and commensal microbiota in the gut lumen (Ferdinande et al. 2008). Metghalchi et al. 
(2015) discovered that deletion of IDO resulted in a more severe state in the IL-10-/- murine 
model of spontaneous colitis, compared with IDO-sufficient IL-10-/- mice. IL-10-/- mice were 
also found to exhibit higher IDO activity in their serum, spleens and mesenteric lymph nodes, 
when compared with IL-10+/+ mice. Conversely, in a murine model of atherosclerosis (another 
disease characterised by inflammation), the authors found IDO-/- mice to have higher levels of 
circulating IL-10 (relative to IDO+/+), in addition to increased IL-10 in the spleen and 
peritoneal macrophages. This increase was continued in both IDO-/- macrophages and 
dendritic cells as well, in unstimulated and LPS+ IFN-γ treated cells. These results suggest a 
conserved, indirectly proportional relationship between IL-10 and IDO across tissues and 
diseases, and this may act to ensure sufficient levels of anti-inflammatory and tolerance-
related responses are induced. Our findings showed that IL-10 mRNA expression was 
consistently decreased regardless of treatment in SOCS3Low cells, compared with SOCS3Ev. In 
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addition to IL-10, we also investigated IDO mRNA responses following cytokine and 
microbial treatments (and how SOCS3 is implicated) in our HIEC model. We found that 
reduction of SOCS3 increased IDO mRNA compared to SOCS3Ev cells, also irrespective of 
treatment. Although we observed both decreased IL-10 and increased IDO mRNA, this was 
only found in SOCS3Low cells, which may stress the importance of regulated IL-10 and IDO 
responses in disease states with reduced SOCS3. This relationship may be of particular 
importance during cancer. For instance, many cancers, including those in the G.I tract, can be 
associated with decreased SOCS3, as this dysregulation of the Jak/Stat pathway can help drive 
proliferation of tumour cells. As demonstrated here, a reduction in SOCS3 may lead to 
increased IDO expression. IDO within tumours helps the cells evade detection (and possible 
damage or removal) by the host’s immune system through suppression of T-cell proliferation. 
This could ultimately result in apoptosis of T-cells. Through IDO and/or SOCS, IL-10 
expression is also decreased, reducing anti-inflammatory responses which could in turn, 
increase pro-inflammatory responses (i.e. through increased TNF-α, as shown here) and 
potentially drive inflammation-associated carcinogenesis. Activation of IL-10 can also lead to 
further immune responses, for example through increased B- and T-cell activity and 
production of antibodies. Therefore, downregulation of IL-10, as achieved here, would also 
aid evasion of the immune system by tumour cells. 
 
Regarding IDO primarily, we used our HIEC model to determine whether a potential tumour-
promoting mechanism existed between SOCS3 and IDO, following individual decreases and 
increases in these respective proteins in several cancer types, including those of the G.I tract 
(He et al. 2003, Uyttenhove et al. 2003, Weber et al. 2005, Ogata et al. 2006, Rigby et al. 
2007, Li et al. 2009). In SOCS3Ev cells, only treatment with IFN-γ significantly increased IDO 
mRNA expression, compared to no treatment. IFN-γ is known to be a strong inducer of IDO 
so therefore this result was not unexpected (Yasui et al. 1986, Ozaki et al. 1987). However, 
stimulation with multiple TLR ligands did not induce substantial fold-increases in IDO. 
Similar to the cytokine profile assessment in our HIEC model, large amounts of IDO may not 
be expressed following recognition of TLR ligands as this may result in increased tolerance 
towards pathogens that share microbial components with gut commensal populations, such as 
LPS- a component of the cell wall in Gram-negative bacteria. On the other hand, fold-changes 
in IDO lower than those of untreated cells could be detrimental and result in a breakdown in 
tolerance mechanisms in distinguishing “self” from “non-self.” However, knockdown of 
SOCS3 resulted in significantly higher fold-changes in IDO regardless of treatment (relative 
to SOCS3Ev), suggesting a role for SOCS3 in limiting IDO expression. In terms of 
carcinogenesis, SOCS3’s role as a tumour suppressor appears to be divided into its ability to 
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suppress multiple signalling pathways and thereby regulating cell proliferation, and ensuring 
immune surveillance is maintained by limiting IDO expression.  
 
Our findings in SOCS3Low cells of increased IDO following knockdown of SOCS3 are similar 
to those of Orabona et al. (2004,) who found that in SOCS3-silenced cells, transcription and 
activation of IFN-induced genes (such as IDO) was increased following stimulation with IL-6. 
Although this study was performed using murine dendritic cells, the similarity in results of 
increased IDO following reduction of SOCS3 suggests the role of SOCS3 in limiting IDO 
may be conserved across cell types and perhaps organisms. Conversely, the same group also 
discovered that SOCS3 is responsible for ubiquitinylation of IDO, as kynurenine production 
increased following addition of a proteasomal inhibitor regardless of treatment with the 
SOCS3-inducer, IL-6 (Orabona et al. 2008), indicative of an increase in IDO activity. They 
also found that IDO contains two sites, known as immunoreceptor tyrosine-based inhibitory 
motifs (ITIMs), and these allow SOCS3 to bind and induce proteasomal degradation of IDO. 
These results support our findings in SOCS3Ev cells, in that these cells are SOCS3-sufficient, 
so following translation of SOCS3 mRNA into protein, it is able to instigate IDO proteasomal 
degradation. Hence, this provides an explanation as to why small fold-increases were 
observed in TLR- and E/S-treated SOCS3Ev cells, in relation to unstimulated cells. 
 
Knockdown of SOCS3 led to increases in IDO mRNA in absence of microbial stimulation 
and following treatment with IFN and TLR ligands, but not E/S- contrasting results of Bell 
and Else (2011). Relative to unstimulated cells, they observed an approximate 10-fold 
increase in IDO, following stimulation with E/S, and at a lower concentration than that used 
here. However, although Bell and Else (2011) also used a human intestinal cell line (LS174T 
cells specifically), it is a goblet cell adenocarcinoma cell line so therefore it is to be expected 
that these cells would express more IDO than an untransformed cell line, especially when 
stimulated. For instance, following treatment with IFN-γ, we observed an approximate 11-fold 
increase in IDO, compared to a 100-fold increase in LS174T cells (Bell and Else 2011). 
Additionally, whilst our results here and those in other studies have shown IECs other than 
goblet cells are capable of expressing IDO (Ferdinande et al. 2008), it may be that goblet cells 
are more sensitive to E/S. 
 
Collectively, findings from this chapter revealed how reduction of SOCS3 (through siRNA 
knockdown) in an otherwise ostensibly normal intestinal cell line, induced a more “cancer-
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like” phenotype, as they exhibited similar SOCS3 expression levels and microbial-mediated 
rates of proliferation to the adenocarcinoma cell line, Caco-2. Our results demonstrated a 
multi-faceted role of SOCS3 in intestinal cells in processes implicated in inflammation, 
carcinogenesis and immune tolerance. Although the sequence of events are yet to be 
determined, it appears that reduction of SOCS3 promotes carcinogenesis not only as a result 
of increased proliferation and dysregulated Jak/Stat signalling, but also through increased 
sensitivity to TLR signalling demonstrated through increased microbial-mediated 
proliferation. Expression of pro-inflammatory cytokines, with respect to TNF-α specifically, 
were increased which may be due to lack of regulation by SOCS3 and/or as a result of 
increased TLR signalling. This in turn may potentiate proliferation and in an in vivo setting, 
could potentially drive inflammation-associated carcinogenesis. If sustained, this situation 
may be further exacerbated by the low expression of IL-10 we observed following SOCS3 
knockdown. Furthermore, the enzyme, IDO was also increased in SOCS3Low cells, regardless 
of stimulation conditions and this would be key to carcinogenesis in an in vivo setting through 
catabolism of tryptophan, leading to suppression of T-cells and thereby dampening down the 
immune system. Increased IDO could then facilitate microbial-mediated proliferation due to 
decreased immune responses elicited towards both commensal and non-commensal 
populations. Therefore, we have shown that the HIEC cell line is a suitable model, although 
many further experiments are needed to elucidate the full extent of the “cancer-like” 






The use of an in vivo model to 
investigate the role of SOCS3 on 





For many decades, mice have been used as an in vivo model organism, proving very useful in 
biomedical research, particularly regarding human health and disease. Although associated 
ethical and monetary costs are higher with mice than using cultured cell lines in vitro, or 
lower organisms such as Drosophila or the invertebrate nematode, Caenorhabditis elegans, 
their benefits greatly outweigh these disadvantages. For instance, there is a high level of 
similarity between mice and humans, not only at an anatomical level, but also at a genomic 
level, as 99% of mouse genes have homologues in humans (Mouse Genome Sequencing 
Consortium 2002). Mice have short lifespans and gestational periods, allowing for 
longitudinal studies, with feasible turnover of offspring and litter sizes (cited by WWW, 
Transgenic Animal Web). Regarding the G.I tract specifically, it is possible to replicate and 
study many diseases similar to those seen in humans, such as IBD, cancers of the G.I tract and 
colitis-associated carcinogenesis (CAC) (Lin and Hackam 2011). The similarities in gut 
microbiota between humans and mice, and the facilities and techniques available allow the 
study of GF-, gnotobiotic- and human-derived flora associated mice, thus enabling insight into 
microbial-derived effects and host-microbe interactions (Sekirov et al. 2010). Furthermore, 
since the mouse genome was mapped in 2002 (Mouse Genome Sequencing Consortium 
2002), researchers are able to utilise genetic tools to identify genetic similarities between mice 
and humans, including Cre-Lox recombinase technology (as described in section 2.2.2.1 in 
Chapter 2), allowing genetic manipulation (i.e. deletion or insertion) of target genes in specific 
tissues or cells (Orban et al. 1992). 
 
Our in vitro experiments investigating the role of SOCS3 in normal IEC homeostasis found 
that SOCS3 was responsible for limiting proliferation following stimulation with multiple 
TLR ligands. SOCS3 also regulated expression of IL-10, TNF-α and IDO in response to 
various cytokine and microbial treatments. In vivo intestinal research using mouse models 
have proven useful and revealed SOCS3 is responsible for perpetuating inflammation through 
inhibition of Stat3 signalling (in a spontaneous intestinal inflammation model, Mitsuyama et 
al. 2006), as well as limiting proliferation and development of hyperplasia in an AOM/DSS 
model of colitis-associated colorectal cancer in mice (Rigby et al. 2007). However, there is 
currently little research into the role of SOCS3 in normal intestinal homeostasis, in vivo. 
Therefore, utilising the IEC-specfic Villin-driven-Cre recombinase system, we generated a 
mouse model of IEC-specific deletion of SOCS3 (as SOCS3-/- mice are embryonic lethal, 
Roberts et al. 2001), and aimed to investigate how SOCS3 impacts on cell proliferation in a 
physiologically relevant model. We selected the Trichuris muris model as T. muris is known 
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to increase proliferation of intestinal crypt cells (Artis et al. 1999), and naturally infects mice 
(cited by Cliffe and Grencis 2004), and so is a more physiologically relevant model of 
intestinal turnover, compared with chemically inducing proliferation. 
 
Cliffe et al. (2005) found that when coupled with increased cell migration (determined 
through crypt cell position), increased proliferation led to higher IEC turnover and more 
efficient expulsion of T. muris- a mechanism which was termed the “epithelial escalator.” 
Increases in proliferation without the increased cell migration led to chronic infection, as well 
as crypt hyperplasia. Our initial experiments were to see if SOCS3 is implicated in normal and 
T. muris-mediated homeostasis, and whether SOCS3 has a role in the “epithelial escalator” 
response. We chose to look at the cecum of these mice as this is the site T. muris larvae 
become associated with following hatching (Fahmy 1954). To establish differences in 
proliferation between control and IEC SOCS3-deficient mice, with and without infection, we 
quantified proliferating intestinal cells, determined the crypt position of these cells and 
measured crypt depth. The regions used for crypt position were based on parameters described 
by Potten (1998) and Cliffe et al. (2005), with positions 0-10 at the base of crypts defined as 















Figure 4.1: A representation of the structure of the epithelial crypts in the cecum, depicting 
the crypt positions and regions used to determine the proportion of proliferating cecal cells 
within each zone in wildtype (HO-WT) and conditional SOCS3 knockdown mice (HO-VC). 
(Adapted from Cliffe et al. 2005). 
 
 
4.2 Assessment of IEC SOCS3 deficiency on IEC proliferation and cecal crypt 
morphology 
4.2.1 IEC-specific deletion of SOCS3 had little effect on crypt properties in uninfected mice 
Figure 4.2 shows the number of actively proliferating crypt cells (a), the position of the 
highest proliferating cell (b), the distribution of proliferating cells (c) and the depth of the 
crypts (d) in ceca from uninfected wildtype mice (HO-WT) and mice with IEC deletion of 
SOCS3 (HO-VC). Figure 4.2 (a) shows that on average, both HO-WT and HO-VC mice 
contained six proliferating cells within each cecal crypt, although taking the error bars into 
















When determining whether IEC deletion of SOCS3 increased migration of cells in the crypt 
and led to higher cell turnover, there was also very little difference in the highest EdU-positive 
cell position between the two genotypes (figure 4.2b), with their highest EdU-positive cell 
situated, on average, at position 9 (HO-WT: 9.4±1.2, HO-VC: 9.5±1.5) As there are no Paneth 
cells in the ceca of mice, position 1 is located at the very base of the crypts (Treuting and 
Dintzis 2011). 
 
Although no differences were observed in crypt position of the highest EdU-positive cell, this 
did not give us an indication of the distribution of proliferating cells within the crypts. 
Therefore, we then determined the percentage of EdU-positive cells in crypt regions as 
described previously (shown in figure 4.1). Figure 4.2 (c) shows that in both uninfected 
genotypes, the majority of proliferating cells were located within the stem cell region, with 
92.0±2.2% and 88.5±3.4% calculated for HO-WT and HO-VC mice, respectively. 
Consequently, the remaining 8.0±2.2% and 11.5±3.4% of proliferating cells (in HO-WT and 
HO-VC, respectively) were then found in the T.A region. However, due to overlapping 
variability within both cell regions, and lack of statistical significance when the data were 
analysed (using a two-way Student’s t-test), this indicates there were no differences in crypt 
cell migration between HO-WT and HO-VC mice. 
 
IEC-specific deletion of SOCS3 had little effect on IEC homeostasis, using the parameters 
assessed in figure 4.2 (a)-(c), as neither number nor position of proliferating cells were 
significantly increased at the basal state. There was a tendency of HO-VC mice to have 
slightly larger crypt depths, although this could possibly be confirmed with larger sample 
sizes, or more equal group sizes. Figure 4.2 (d) may indicate that the average crypt depth in 
HO-VC mice may have been slightly larger than that in HO-WT mice, with approximate 
depths of 137±3μm and 129±6μm, respectively, but statistical significance was not reached, 
with a p-value of p=0.08 obtained. Together these results suggest that loss of SOCS3 had little 









































































































































Figure 4.2: Differences in (a) the number of proliferating cells, (b) the position of the 
highest proliferating cell, (c) distribution of proliferating cells within cecal crypts and (d) 
crypt depth between uninfected wildtype (HO-WT) and conditional SOCS3 knockdown 
mice (HO-VC) (±SEM). At 6-8 weeks + 35 days, ceca were removed and following paraffin 
embedding and sectioning, the Click-iT® EdU assay was performed according to 
manufacturer’s instructions for assessment of cecal crypt proliferation. Confocal images were 
analysed blind on a Zeiss confocal microscope, using multiple crypts per mouse (≥7), with 







































































4.2.2 Infection with T. muris increased cell proliferation, migration and crypt depth in ceca 
Figure 4.3 shows the comparison of crypt properties in both uninfected and infected HO-WT 
and HO-VC mice, to demonstrate the effect of T. muris infection had on these mice. The 
infected mice were given a low dose of 25-30 T. muris eggs as mice generate inappropriate 
Th1 responses to low doses, (such as the production of IFN-γ and IL-2, Mosmann et al. 1986, 
Else and Grencis 1991), with a reduction of Th2 responses, resulting in failure to expel worms 
in mice strains either susceptible or resistance when administered higher doses of T. muris 
eggs (Bancroft et al. 1994, Wakelin 1973). Mice in our experiments were infected for 35 days 
following low dose egg administration as worms will still be present at this time point. 
 
Upon infection, there were large increases in the number of proliferating cecal crypt cells in 
both groups of mice (figure 4.3 a), with approximately 2- and 3-fold increases in infected HO-
WT and HO-VC mice, respectively (compared with their uninfected counterpart). This can 
also be seen in figure 4.4, showing representative confocal images from each genotype and 
infection group, with an increase in proliferating cells depicted by an increase in the number 
of green, EdU-positive cells. However, when a Student’s t-test was performed, differences 
between the HO-WT cohorts did not reach statistical significance, although differences 
between HO-VC cohorts were very significant (p=0.002), and this may have been due to the 
dissimilarities in sample sizes between the two uninfected genotypes. 
 
In addition to proliferation, T. muris infection led to a higher position within the cecal crypt of 
the highest EdU-positive cell (figure 4.3 b), with positions being approximately 1.5- and 2-
fold higher in infected HO-WT and HO-VC mice, respectively, compared with their 
uninfected counterparts, and both of these were found to be statistically significant (p=0.05 
and p=0.0003, respectively). Following this, we then analysed the effect of T. muris infection 
on distribution of EdU-positive cells within each region of cecal crypts. As expected, infection 
led to increased migration of cells up the crypt, with a lower percentage of proliferating cells 
recorded in the stem cell region, and higher percentages found in the T.A and 21-30 region, 
regardless of genotype (figure 4.3c). Table 4.1 shows p-values obtained during data analysis 
of average percentages obtained for each region and confirms that T. muris infection led to 
increased migration from the stem cell region to the T.A region in both genotypes (p<0.05). 
However, differences in percentages of EdU-positive cells in the T.A region within HO-VC 
were more substantially significant (p<0.0001, compared to p=0.0312 within HO-WT), and 
infection also led to significantly more proliferating cells in the 21-30 region (p=0.0167). 
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Together with figure 4.3 (a) and (b), these results reiterate that infection leads to increased 
proliferation of IECs as well as increased cell migration up crypts. 
 
Figure 4.3 (d) shows the average cecal crypt depths of all four cohorts of mice, and shows T. 
muris infection induced an increase in crypt depth, and this can be clearly seen when 
comparing confocal images of HO-WT and HO-VC mice in figure 4.4 (a) and (c), and figure 
4.4 (b) and (d), respectively. Both genotypes within each infection group exhibited similar 
crypt depths, with approximately 1.5-fold increases in length obtained for both infected HO-
WT and HO-VC mice, both of which were found to be statistically significant (p=0.007 and 
p=0.0009, respectively). Although both genotypes within each infection group exhibited 
similar crypt depths, higher significance was found in HO-VC mice, and this may have been 
due to less variation within uninfected mice as demonstrated by the smaller error bars, when 
compared with uninfected HO-WT. Collectively, these results show that infection with T. 
muris led to increases in all four parameters measured; higher position and number of EdU-
positive cells per cecal crypt, increased migration of proliferating cells up the crypt and also 
crypt depth. This could indicate that proliferation and crypt cell migration were increased as a 
host response to the worms, and that the increase in crypt depth resulted from higher numbers 




Cell Position in Crypt 
0-10 0.0316 (↓) 0.0001 (↓) 
11-20 0.0312 (↑) <0.0001 (↑) 
21-30 0.4341 0.0167 (↑) 
30+ 0.6349 0.4608 
 
Table 4.1: P-values calculated using a two-way Student’s t-test to determine statistical 
significance for distribution of EdU-positive cells within cecal crypts, between uninfected and 
T. muris-infected mice within the same genotype. (Where statistical significance was found, 
the arrows denote the effect T. muris infection had within each zone: ↓ = Less cells were 

















































































































































Figure 4.3: Differences in (a) proliferating cell numbers, (b) highest proliferating cell 
position, (c) distribution of proliferating cells within cecal crypts and (d) crypt depth 
between uninfected and T. muris-infected wildtype (HO-WT) and conditional SOCS3 
knockdown mice (HO-VC) (±SEM). At 6-8 weeks + 35 days, ceca were removed from 
uninfected mice, and low dose T. muris-infected mice. Following paraffin embedding and 
sectioning, the Click-iT® EdU assay was performed for assessment of cecal crypt 
proliferation. Slides were imaged using a Zeiss confocal microscope. Confocal images were 
analysed blind, using multiple crypts per mouse (≥7), with averages taken for each genotype. 
(* = p<0.05, ** = p<0.01, *** = p<0.001, using a two-way Student’s t-test, within genotypes) 






























































































Figure 4.4: Visualisation of proliferating cells in the cecal crypts of uninfected HO-WT 
(a) and HO-VC mice (b), and HO-WT (c) and HO-VC (d) mice 35 days post- T. muris 
infection. At 6-8 weeks + 35 days, ceca were removed from uninfected mice, and low dose 
T.muris-infected mice. Following paraffin embedding and sectioning, the Click-iT® EdU 
assay was for assessment of cecal crypt proliferation. Slides were imaged using a Zeiss 
confocal microscope at 10x magnification, and confocal images were analysed blind. (Green= 




















4.2.3 Deletion of SOCS3 in IECs led to increased migration of cells up cecal crypts 
Following analysis of crypt dynamics upon infection with T. muris, we then focused on 
analysing the infected data specifically and assessing differences within this cohort of mice to 
determine whether SOCS3 is implicated in infection-induced cell proliferation of IECs, and 
whether SOCS3 may play a role in the “epithelial escalator” mechanism that occurs during 
expulsion of worms. Figure 4.5 (a) differs from that of uninfected mice in figure 4.2 (a) in that 
there appeared to be more EdU-positive cells in HO-VC mice than HO-WT, with each 
genotype having on average, 16±2 and 12±2 EdU-positive cells per cecal crypt, respectively. 
However, there was overlapping variability within each genotype, in figure 4.5 (a), and when 
a Student’s t-test was performed, this difference was not found to be statistically significant 
(p=0.18). 
 
Figure 4.5 (b) also differs from figure 4.2 (b), as there was an observable difference in cell 
position between the two genotypes (a difference also similar to that seen in 4.5a). The 
position of the highest EdU-positive cell in HO-VC mice was higher at cell position 20±2, 
compared to 16±1 in HO-WT mice, although this was not quite significant (p=0.07). As 
described previously in uninfected mice (figure 4.2c), we then analysed the percentage of 
EdU-positive cells in each “cell region” within the crypt. However, as there was an increase in 
both crypt depth and proliferating cells upon infection, additional regions were included (21-
30 and 30+). During analysis of effects of T. muris infection on proliferating cell distribution 
(figure 4.3c), we found that although there were fewer proliferating cells in the stem cell 
region, and a higher percentage of proliferating cells in the T.A region, regardless of 
genotype, differences between uninfected and infected mice were much more significant in 
HO-VC. Also, infection led to a significantly higher percentage of proliferating cells in the 
21-30 region in HO-VC mice only, possibly indicating that IEC-deletion of SOCS3 further 
increases infection-induced crypt cell migration. This led us to then specifically compare 
proliferating cell distribution in infected mice. Figure 4.5 (c) shows there was a higher 
percentage of proliferating cells in the stem cell region, and fewer in the T.A region in HO-
WT mice (66±5% and 32±5%, respectively), compared with HO-VC (54±5% and 39±3%, 
respectively). Despite differences in both of these crypt regions, no statistical significance was 
found. Only one mouse out of 12 was reported to have EdU-positive cells higher than crypt 
position 30, in both genotypes, so therefore differences in percentages in this region were 
negligible. In the 21-30 region however, HO-VC mice had a higher percentage of proliferating 
cells with 7±2%, compared 1±0.6% in HO-WT, with a Student’s t-test reaching statistical 
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significance (p=0.008), thus confirming our hypothesis suggested from results in figure 4.3 
(c). 
 
Finally, when measuring cecal crypt depths of infected mice, the results in figure 4.5 (d) 
contrasted those of uninfected mice in that there was less of a difference in depth between the 
two genotypes. Average crypt depths were 214±13µm and 211±14µm for HO-WT and HO-
VC mice, respectively. In summary, although figure 4.5 (a) and (b) show that IEC-deletion of 
SOCS3 did not definitively lead to a higher number or position of proliferating cells within 
cecal crypts following T. muris infection, figure 4.5 (c) showed that this deletion did lead to 
an increase in the percentage of cells further up the crypt, suggesting increased cell migration 
in these mice. However, as the results obtained here were not associated with an increase in 
crypt depth, this indicates that even following T. muris infection (an intestinal challenge 
known to induce proliferation, Artis et al. 1999), IEC deletion of SOCS3 did not lead to 
hyperplasia. These findings also mirror those seen by Cliffe et al. (2005) when describing the 
“epithelial escalator” mechanism that occurs during worm expulsion in the resistant BALB/c 
mouse strain, suggesting SOCS3 may contribute to susceptibility of mice to T. muris, and 












































































































Figure 4.5: Differences in (a) the number of proliferating cells, (b) the position of the 
highest proliferating cell, (c) distribution of proliferating cells within cecal crypts and (d) 
crypt depth between wildtype (HO-WT) and conditional SOCS3 knockdown mice (HO-
VC) infected with T. muris (±SEM). Mice were infected with a low dose of T. muris eggs 
(25-30 eggs) at 6-8 weeks of age, and ceca were removed 35 days post infection. Following 
paraffin embedding and microtome sectioning of the cecal tip, the Click-iT® EdU assay was 
performed according to manufacturer’s instructions for assessment of cecal crypt 
proliferation. Confocal images were analysed blind using multiple crypts per mouse, with 
averages then taken for the whole genotype. (* = p<0.01, using a two-way Student’s t-test) 
(HO-WT and HO-VC- n=12). (Figure 4.4c modified from Shaw et al., under revision in 







































































4.3 Investigating the roles of SOCS3 and IDO in Trichuris muris infection 
As shown above, SOCS3 is implemented in the proliferative response to T. muris infection 
and IEC-deletion of SOCS3 supported the “epithelial escalator” mechanism that was shown to 
aid worm expulsion (Cliffe et al. 2005). Work by Datta et al. (2005) found that IDO was one 
of several genes upregulated following T. muris infection and this protein has also been found 
to be implicated in the proliferative/expulsion response to this helminth (in addition to its role 
in tryptophan catabolism, cancer and immune tolerance, Higuchi and Hayaishi 1967, Munn et 
al. 1998, Uyttenhove et al. 2003). Bell and Else (2011) found that inhibition of IDO led to 
significant migration of cells up crypts and expulsion of worms without increasing crypt 
depth. As these mirror the results seen in our SOCS3-deleted mice, we investigated whether 
there was a relationship between SOCS3 and IDO. For this, we infected HO-WT and HO-VC 
mice with T. muris for 35 days and measured expression of IDO in the cecum using 
immunofluorescence and western blotting. 
 
4.3.1 Infection with T. muris led to an IDO response in the cecum of wildtype and SOCS3-
deleted mice 
Figure 4.6 shows confocal microscope images of immunofluorescence staining for IDO in 
HO-WT and HO-VC T. muris- infected mice and shows there was regional expression levels 
of IDO within the ceca of both genotypes, as depicted by the images with low and high levels 
of fluorescence.  Multiple images were taken per section from individual mice, and even 
within one section, regional differences in fluorescence were observed. Distribution of IDO 
was also changeable, ranging from local expression towards the bottom half of cecal crypts 
(HO-WT, second image), potentially from the goblet cells (as Bell and Else 2011, found), to 
widespread expression across the whole crypt (HO-VC, second image). This suggests that the 
T. muris-induced IDO response may be localised to the niche of the worm (i.e. the site of egg 
























Figure 4.6: Expression of indoleamine 2,3-dioxygenase, using immunofluorescence, in 
the ceca of wildtype (HO-WT) and conditional SOCS3 knockdown (HO-VC) T. muris-
infected mice. At 35 days post-infection, ceca were removed following administration of T. 
muris at a low dose, at 6-8 weeks of age. Following paraffin embedding and sectioning, 
deparaffinisation and rehydration of sections were performed before heat-induced epitope 
retrieval with sodium citrate buffer. Slides were incubated overnight at 4°C in 1:400 IDO 
primary antibody (green), with propidium iodide (red) used as a nuclear stain. Slides were 
imaged blind using a Zeiss confocal microscope, at 10x magnification. (Scale bar = 50µm, 














4.3.2 IDO protein expression was increased following T. muris infection 
As we were unable to determine differences in IDO expression in cecal crypts of HO-WT and 
HO-VC mice using immunofluorescence, we obtained mucosal cecal scrapes and performed 
western blotting to investigate expression of IDO protein in these mice. As previously shown 
by Datta et al. (2005) and Bell and Else (2011), IDO expression was increased following T. 
muris infection, and this was irrespective of genotype (figure 4.7a and b). However, this 
increase was only found to be statistically significant in HO-WT mice (p=0.03). Within 
uninfected mice, IDO protein expression was 2.4-fold higher in absence of IEC SOCS3, 
although this was not quite significant (p=0.07). This trend was not observed in infected mice, 
with approximate IDO protein fold-changes of 5 obtained for both genotypes, although there 
was a large amount of variability within HO-VC mice (figure 4.7b), likely due to 
dissimilarities in sample sizes between genotypes. This may also contribute to the 
insignificant differences calculated between uninfected mice. 
 
In conclusion, using western blotting, we confirmed T. muris-induced expression of IDO in 
our mice. As the “epithelial escalator” mechanism responsible for aiding expulsion of worms 
is associated with both reductions in IDO, and IEC SOCS3, it was perhaps to be assumed that 
infected HO-VC mice would express less IDO than infected HO-WT. However, due to 
differences in sample sizes between infection groups, as well as using heterogeneous mucosal 
samples, we were unable to confirm this. We did observe a tendency of increased IDO 





















Figure 4.7: Mucosal indoleamine 2,3-dioxygenase in uninfected and T. muris-infected 
wildtype (HO-WT) and conditional SOCS3 knockdown (HO-VC) mice, using western 
blotting. At 35 days post-infection, ceca were removed following administration of T. muris 
at a low dose, at 6-8 weeks of age, with RIPA buffer used to obtain cecal mucosal scrapes. 
Samples were run on 10% SDS-PAGE gels before transfer onto nitrocellulose membranes and 
incubation in IDO primary antibody at 1:750 overnight. Membranes were then incubated in 
secondary antibody for 1 hour at room temperature. Membrane imaging and densitometry was 
carried out using a ChemiDoc™ MP Imaging System and Image lab software, with values 
relative to uninfected HO-WT. (* = p<0.05, using a two-tailed t-test, within genotypes). (HO-
WT- n=5, HO-VC- n=2). (Figure 4.7b modified from Shaw et al., under revision in 


























































4.4 IDO Immunofluorescence in an AOM/DSS mouse tumour model 
The use of the tumour-inducing agent, AOM, with DSS as a tumour promoter, has become 
very common in the study of CAC. The use of both agents has shown to result in a higher 
incidence rate of colonic tumours, in a shorter period of time, compared to using either AOM 
or DSS alone (De Robertis et al. 2011). Following metabolic activation of AOM, 
macromolecules within the colon become alkylated, and methyl groups are added to guanine 
residues within DNA, forcing mutations to occur. Following inheritance and accumulation of 
these mutations, a multi-step process occurs, starting with the formation of aberrant crypt foci 
(ACF- early pre-neoplastic lesions). After proliferation of these foci, microadenomas form, 
before enlarging to polyps and ultimately, adenocarcinomas (De Robertis et al. 2011), which 
have been found to be similar in pathology to adenocarcinomas found in humans (Ward et al. 
1973). 
 
IDO has been found to be expressed in multiple cancer types in both humans and rodents 
(Yasui et al. 1986, Uyttenhove et al. 2003) and also by several antigen presenting cells 
(APCs) (Munn et al. 1999, Hwu et al. 2000). At tumour sites and tumour-draining lymph 
nodes, IDO exerts anti-proliferative effects on local T-cells due to depletion of the essential 
amino acid, tryptophan and increase in tryptophan catabolites (Fallarino et al. 2002, Frumento 
et al. 2002). This leads to suppression of the host immune system and induces a state of 
tolerance toward the tumour. Because of this, IDO expression (in particular high expression) 
can be associated with poor prognosis and metastasis in a multitude of tumours (Okamoto et 
al. 2005, Brandacher et al. 2006, Ino et al. 2006). 
 
Previous research has found that IEC-deletion of SOCS3 in mice led to an increase in 
proliferation and crypt hyperplasia following treatment with AOM/DSS (Rigby et al. 2007), 
and in patient biopsy samples, reduced expression of SOCS3 correlated with progression to 
CAC (Li et al. 2010), so therefore we wanted to investigate whether there was a relationship 
between SOCS3 and IDO in colon cancer in vivo.  
 
4.4.1 IEC-deletion of SOCS3 led to increased IDO in AOM/DSS colon tumours 
AOM/DSS is known to induce tumours in the colon of mice, and as anticipated, multiple 
tumours were seen in the colons of both HO-WT and HO-VC mice, as depicted by the 
asterisks in the left panels of images in figure 4.8. IDO has been found to be expressed in 
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colonic tumours (Uyttenhove et al. 2003, Brandacher et al. 2006), so we expected to see 
fluorescence corresponding to IDO in both groups of mice (as shown in figure 4.8a and b). 
However, the fluorescence seen in HO-VC mice was brighter than that of HO-WT mice, 
indicating that expression of IDO within tumours was further increased following IEC-
specific deletion of SOCS3, suggesting SOCS3 and IDO are implicated together in colon 
cancer. Given the previously known functions of IDO in cancer, this result could suggest a 














Figure 4.8: Expression of indoleamine 2,3-dioxygenase, using immunofluorescence, in 
the colon of wildtype (HO-WT) and conditional SOCS3 knockdown (HO-VC) mice in an 
AOM/DSS model. Embedded sections were received from P.K Lund, and AOM/DSS 
treatment was administered as described in Rigby et al. (2007). Deparaffinisation and 
rehydration of sections was performed before heat-induced epitope retrieval with sodium 
citrate buffer. Slides were incubated overnight at 4°C in 1:400 IDO primary antibody (green), 
with propidium iodide (red) used as a nuclear stain (right section = merged image). Slides 
were imaged blind using a Zeiss confocal microscope, at 10x magnification. (Scale bar = 


















Mice are often the model of choice in studies investigating intestinal structure and pathways 
involved in intestinal turnover (Potten and Loeffler 1990, Potten 1998). More specific to our 
research interests, mice have also been used for studying the functions of SOCS3, with IEC-
conditional knockout mice able to be generated through the use of the Cre-LoxP system (as 
SOCS3-/- mice are embryonic lethal, Roberts et al. 2001, Croker et al. 2003). This allows for 
the investigation of SOCS3’s associations with multiple cell signalling pathways and disease 
processes (such as cancer and IBD). However, very little research has been conducted into 
how SOCS3 is involved in normal homeostasis of the intestine. Therefore, we aimed to 
investigate SOCS3’s role through assessment of proliferation in mice with SOCS3 deleted 
specifically in IECs, in comparison with wildtype mice. Additionally, also using these same 
genotypes, we investigated how SOCS3 is implicated upon dysregulation of intestinal 
homeostasis. This was achieved through assessment of proliferation following infection with 
the helminth, T. muris, which naturally infects mice (cited by Cliffe and Grencis 2004) and is 
known to increase intestinal cell proliferation (Artis et al. 1999). Therefore, this is a more 
physiologically relevant model of proliferation than other methods which often involve 
chemical-induction of proliferation. 
 
We first investigated how intestinal SOCS3 affected basal proliferation in the unchallenged 
state, and found very little difference in the assessed cecal crypt properties between the two 
genotypes, an observation also seen by Rigby et al. (2007). This may indicate that at the basal 
level, intestinal SOCS3 levels must be reasonably low due to a lack of a different phenotype 
in its absence. Upon infection with T. muris however, both genotypes exhibited increases in 
the number of proliferating cells, increases in cell migration up cecal crypts, and also 
increases in crypt depth. This result has also been seen in other mice strains, such as 
susceptible AKR and SCID mice as well as resistant BALB/c mice (Artis et al. 1999, Cliffe et 
al. 2005). Increased intestinal cell turnover and migration has also been observed upon 
infection with several other intestinal parasites (cited by Artis et al. 1999), indicating this is a 
host response. This was confirmed by Artis et al. (1999), who also found that this response 
was IFN-γ-mediated, as depletion using an IFN-γ-neutralising antibody led to a decrease in 
proliferation. 
 
The responses seen may also be due to the dose of T. muris administered during infection. 
Low doses consist of approximately 25-30 eggs, compared to a high dose, where 
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approximately 200 eggs are administered, and depending on genetic background, mice either 
expel worms or develop chronic infection following a high dose, due to the dominance of Th2 
and Th1 immune responses, respectively. Th2 cytokines, such as interleukins-4, -5, -9, -10 
and -13 aid worm expulsion due to the individual roles in recruiting and promoting growth of 
B and T cells, and exerting anti-inflammatory effects by inhibiting cytokines associated with 
the Th1 response (Else and Grencis 1991).  However, due to the small quantity of eggs 
administered with a low dose, mice generate inappropriate immune responses, dominated by 
Th1 cytokines, such as IFN-γ, IL-18 and IL-12, which also promotes production of IFN-γ 
(Else and Grencis 1991, Bancroft et al. 1997, Helmby et al. 2001), and this results in 
insufficient expulsion of worms. Mice used here were infected with a low dose of T. muris 
eggs so therefore Th1 responses would have been prevalent. This would have led to higher 
increases in proliferation than if a high dose had been administered, as more susceptible mice 
exhibit higher levels of intestinal proliferation throughout infection in an attempt to aid 
expulsion (Cliffe et al. 2005), and C57BL/6 mice are resistant to T. muris at high doses 
(Richard et al. 2000). 
 
Focusing on SOCS3’s role in T. muris-induced proliferation, we found that infected HO-VC 
mice exhibited higher proportions of proliferating cells further up the cecal crypts and 
potentially higher average positions of proliferating cells and an increase in the number of 
proliferating crypt cells, indicating that following T. muris infection, deletion of SOCS3 
increased IEC turnover. This was not accompanied by an increase in crypt depth, and would 
have been indicative of hyperplasia- a state of increased proliferation that is detrimental, 
presumably due to an increase in surface area, and therefore the niche in which worms can 
attach. Also, these are phenotypes found to be displayed by resistant BALB/c mice and are 
associated with the “epithelial escalator” phenomenon, presumably where worms are 
displaced through migration of IECs up crypts and then shedding from the tip of the villi, 
resulting in more effective worm expulsion (Cliffe et al. 2005). SOCS3 has been shown to 
limit proliferation following intestinal challenge with AOM/DSS (Rigby et al. 2007), so the 
presence of SOCS3 may play a role in susceptibility to T. muris infection in mice and an 
inability to expel worms sufficiently. Shaw et al. (under revision in Immunology and Cell 
Biology) found that 35 days following low dose T. muris infection, IEC deletion of SOCS3 
led to a significantly higher proportion of mice with lower worm burdens (<10) compared 





Following the discovery that SOCS3 was implicated in the “epithelial escalator” process 
during T. muris infection, along with the results from Bell and Else (2011), who found that 
inhibition of IDO also aided worm expulsion, we aimed to investigate whether there was a 
relationship between SOCS3 and IDO during helminth infection in mice. There was a 
suggestion of differences in expression of IDO between infected HO-WT and HO-VC mice, 
as measured using immunofluorescence, although expression was variable within genotypes, 
and not just between. However, it can be difficult to draw conclusions from 
immunofluorescence experiments in some instances, as it is a semi-quantitative technique, and 
as we found, expression of proteins of interest (in our case, IDO) can be variable, even within 
one sample. In order to obtain a more definitive answer, a more quantitative experimental 
technique could be used, such as flow cytometry, for example. Goblet cells are a source of 
IDO within the gut (Bell and Else 2011), and using flow cytometry, goblet cells could be 
gated in the sample, by isolating trefoil factor 3-positive cells for example, as this protein is 
involved in protection of the intestinal epithelium and is a goblet cell marker (cited by Kim et 
al. 2014). Through inhibition of cell exportation and the use of an IDO antibody, we could 
compare IDO expression between the two genotypes, and also possibly pinpoint the cell 
source of potential differences. 
 
IDO and SOCS3 have been found to have an inverse relationship, in that production of 
SOCS3 leads to a decrease in IDO, due to proteasomal degradation of IDO by SOCS3 
(Orabona et al. 2008), and absence of SOCS3 (through siRNA) led to IDO production and 
subsequent tryptophan catabolism following activation of Stat3 by IL-6, both in dendritic cells 
(Orabona et al. 2005). Therefore, it was hypothesised that IEC deletion of SOCS3 (achieved 
here by using the Villin-driven Cre-LoxP system) would lead to an increase in IDO (as found 
in vitro in chapter 3). However, our results here, combined with previous findings, indicate 
that deletion of SOCS3 (in IECs), and inhibition of IDO (Bell and Else 2011), promotes 
increased IEC turnover and expulsion of T. muris worms. Collectively, this suggests that 
perhaps the role of IDO, and its relationship with SOCS3, could be context dependent. 
Additionally, for the immunofluorescence experiments, the cecal tip was removed and then 
embedded and sectioned before antigen retrieval and antibody staining for imaging. This is 
only a small part compared to the rest of the organ, and the variability in results suggests there 
may be a certain niche within the cecum where the T. muris worms occupy and that perhaps 
not all areas of the cecum are affected during infection. The results may also suggest that in 
addition to a specific cecal niche, IFN (which is increased during T. muris infection and is a 
potent inducer of IDO) may have a limited range of effect so it is possible that a more 
definitive answer of IEC deletion on T. muris-induced IDO expression could be obtained if 
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sections had been taken from the whole cecum (although in this case, the rest of the cecum 
was used for taking mucosal scrapes and determining worm burden, Shaw et al., under 
revision in Immunology and Cell Biology). 
 
Western blotting was also performed to help determine the relationship between intestinal 
SOCS3 and IDO at the protein level. We found that regardless of genotype, T. muris infection 
increased protein expression of IDO up to 5-fold, and this is supported by the findings of 
Datta et al. (2005) and, Bell and Else (2011). We also observed there was a tendency of 
increased IDO in HO-VC mice in the absence of infection; significance was not quite reached 
(p=0.07) although this may have been due to the differences in sample sizes between the two 
genotypes. Had the sample size of uninfected HO-VC been equal to that of uninfected HO-
WT (n=5), there may have been a larger (possibly significant) increase in IDO in HO-VC. 
This tendency however does help to confirm our in vitro findings that deletion of SOCS3 led 
to increased IDO expression in IECs, and is in agreement with findings of Orabona et al. 
(2008) that SOCS3 is responsible for proteasomal degradation of IDO in DCs. Additional 
experiments to further test this hypothesis would be to investigate whether overexpression of 
IEC SOCS3 resulted in reduced IDO compared to both HO-WT and HO-VC. The observation 
of increased IDO in uninfected HO-VC mice (compared to HO-WT) was not replicated in T. 
muris-infected mice, with both HO-WT and HO-VC expressing similar levels of IDO. This 
was due to the large amount of variability in IDO protein expression in infected HO-VC mice, 
most likely as a result of the small sample size. As the protein used in these experiments was 
from cecal mucosal scrapes, rather than the IECs specifically, there would have been a 
heterogeneous cell population (i.e. murine and bacterial) and this may have obscured proteins 
when assessed by western blotting. Also, immune cells are generally more responsive than 
IECs (otherwise IECs would be eliciting inappropriate immune responses when in contact 
with non-pathogenic microflora, resulting in increased inflammation, Otte et al. 2004), and are 
also known to induce IDO (Munn et al. 1999, Hwu et al. 2000), and this would have occurred 
in response to T. muris infection irrespective of genotype, so may have masked differences in 
IEC IDO. 
 
In addition to inhibiting intestinal proliferation, thereby preventing expulsion of worms during 
T. muris infection, IDO may also hinder expulsion through promoting tolerance, through 
depletion of the essential amino acid, tryptophan and increased tryptophan catabolites as a 
result, which leads to suppression of T cell proliferation (Fallarino et al. 2002, Frumento et al. 
2002), and also promotion of naive T cell differentiation into regulatory T cells (Tregs) 
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(Fallarino et al. 2006). Tregs also contribute to inducing tolerance through prevention of 
immune system activation (through secretion of anti-inflammatory cytokines, for example).  
IDO is implicated in cancer too for these same reasons- in addition to immune cells, tumour 
cells are also capable expressing IDO, in order to suppress the immune system and remain 
“undetected” so tumourigenesis (and potentially metastasis) can continue to occur. IDO has 
been found in a multitude of tumour types, with high levels of IDO associated with poor 
prognosis (Uyttenhove et al. 2003, Okamoto et al. 2005, Brandacher et al. 2006, Ino et al. 
2006). Additionally, SOCS3 is associated with cancer as reductions or silencing through 
promoter hypermethylation have been found in many cancer types (He et al. 2003, Weber et 
al. 2005, Ogata et al. 2006, Rigby et al. 2007). We used immunofluorescence to determine 
whether loss of SOCS3 led to increased IDO expression in an AOM/DSS mouse model. As 
expected, administration of AOM/DSS induced colonic tumours in mice, irrespective of 
genotype, with fluorescence corresponding to IDO expression also seen with both genotypes 
(HO-WT and HO-VC), and was thus in conjunction with previous findings of IDO expression 
in tumours, and in particular colonic tumours (Uyttenhove et al. 2003, Brandacher et al. 2006, 
Ogawa et al. 2012). However, when comparing the two genotypes, there appeared to be more 
fluorescence within tumours in HO-VC mice, indicating that deletion of IEC SOCS3 led to 
increased tumoural expression of IDO. These findings help establish the inverse relationship 
between SOCS3 and IDO, as SOCS3 is capable of ubiquitinylating and degrading IDO (in 
DCs) (Orabona et al. 2008), but following IEC deletion of SOCS3, the increase in 
fluorescence corresponding to an increase in tumoural IDO was most likely due to a lack of 
proteasomal degradation. This suggests that the role of SOCS3 as a tumour suppressor is not 
limited to inhibiting cell proliferation but also extends to IDO degradation, which helps to 
uphold immune surveillance against tumours. Conversely, reduction/loss of SOCS3 that can 
ultimately result in tumourigenesis is a crucial event that can lead to a lack of IDO 
proteasomal degradation, thus promoting immune tolerance towards the tumour(s). 
 
Several studies have demonstrated the tumour-promoter effects of IDO from the reduction in 
tumour size in vitro and in vivo, following either silencing of IDO through RNAi (Zheng et al. 
2006), or through administration of an IDO inhibitor, known as 1-methyl tryptophan (1-MT) 
(Friberg et al. 2002, Muller et al. 2005). 1-MT prevents IDO activity through competition 
inhibition; binding to IDO and preventing binding and subsequent catabolism of tryptophan 
(Cady and Sono 1991). More specifically, increased tumour volume was reported in mice 
injected with IDO-positive mast cell tumours, compared to mice injected with control mast 
cell tumours (using a mouse mastocytoma cell line, P815B) (Uyttenhove et al. 2003). Similar 
to the studies mentioned, tumour volume decreased in mice that had been injected with IDO-
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positive P815B cells and treated with 1-MT, relative to IDO-positive P815B cells alone. They 
determined that this reduction in tumour volume was T-cell-dependent, as there were no 
differences found (in tumour volume) between mice injected with IDO-positive P815B cells, 
and T-cell depleted mice who had been administered both IDO-positive P815B cells and 1-
MT. To assess the effects of IDO within the tumours of the AOM/DSS-treated mice, IDO 
could be depleted, using either RNAi or 1-MT. It is to be presumed that reduction/inhibition 
of IDO would result in decreased tumour size in the AOM/DSS mice, regardless of genotype. 
However, as previous findings revealed an increase in colonic tumour number and size in 
AOM/DSS mice following IEC deletion of SOCS3 (Rigby et al. 2007), this observation may 
also be replicated following treatment with 1-MT. 
 
From our in vivo experiments, we have been able to reveal further implications of SOCS3 
following induction of intestinal proliferation, through infection with the helminth, T. muris, 
and in CAC, following treatment with AOM/DSS. SOCS3’s role as a tumour suppressor was 
reiterated as results from our immunofluorescence experiments suggested that loss of IEC 
SOCS3 increased IDO expression, which is known to suppress anti-tumour immunity and 
potentially lead to increased tumour size. However, a functional outcome of IEC SOCS3 
deletion was observed during T. muris infection, due to increased crypt cell migration, which 
was associated with more efficient worm expulsion (Shaw et al., under revision in 
Immunology and Cell Biology). Infection with T. muris is a more physiologically relevant and 
less harsh method of promoting intestinal proliferation than using AOM/DSS, which may 
explain the difference in phenotypes obtained. In contrast, it may be that the role of SOCS3 in 
regulating intestinal homeostasis (and subsequent outcomes) is context dependent, depending 







The use of the fruit fly, Drosophila 
melanogaster, in establishing an in 
vivo model for determining the role 






In vitro and in vivo experiments investigating the role of SOCS3 in normal IEC homeostasis 
found that SOCS3 is responsible for limiting proliferation following the addition of multiple 
TLR ligands, and following helminth infection, respectively. Despite previously published 
findings and results shown here concerning SOCS3, very little research has been conducted 
into the functional outcomes of SOCS3 on organisms as a whole, rather than at the cellular or 
tissue level. Drosophila have been used for many decades as a model organism for several 
aspects of human health; one in particular being ageing and behaviour. Reasons for this 
include: significantly shorter lifespans (especially when compared to mice and humans), 
genetic and physiological similarities to humans and the large number of commercially 
available fly lines (Helfand and Rogina 2003, Apidianakis and Rahme 2011). Collectively, 
this produces an organism where the effects of any genetic manipulations can be seen 
throughout the whole lifespan.  
 
Our focus in this project has been on (intestinal) Jak/Stat, and more specifically SOCS 
proteins, with Drosophila possessing their own, simplified Jak/Stat pathway, in which 3 
SOCS proteins are associated (SOCS16D, SOCS44A and SOCS36E, Hou et al. 2002), all of 
which possess mammalian homologues. The discovery that multiple SOCS proteins are 
evolutionarily conserved and show homology between flies and mammals signifies the 
importance of these proteins in organism functioning. We chose to investigate the role of 
SOCS36E in the Drosophila midgut, with this protein being a functional homologue of 
mammalian SOCS3 (as well as SOCS1, SOCS2 and CIS) (Callus and Mathey-Prevot 2002), 
and also the most documented out of the three SOCS proteins. Like SOCS3, SOCS36E has 
been found to limit cell proliferation in Drosophila through inhibition of the Jak/Stat pathway 
(Callus and Mathey-Prevot 2002, Bina et al. 2010, Buchon et al. 2010), and dysregulation of 
IEC regulation and repair, as well as damage to the midgut, have shown to be detrimental to 
the lifespan and survival of Drosophila (Amcheslavsky et al. 2009, Apidianakis and Rahme 
2009, Apidianakis et al. 2009, Buchon et al. 2009b, Chatterjee and Ip 2009, Jiang et al. 2009 
Biteau et al. 2010). However, little has been published on the effects of Jak/Stat, or more 
specifically, SOCS36E, on fruit fly survival. This led us to use a Drosophila model of ISC-
specific knockdown of SOCS36E to determine how the impact of SOCS36E on cell 
proliferation affects ageing, through assessment of lifespan. We chose to use Drosophila as 
our model organism for survival and behavioural analysis rather than mice (in this chapter and 
the next chapter, respectively), with one reason being lower monetary and ethical costs for 
fruit flies studies, compared with using mice. Additionally, in order to obtain reliable 
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experimental findings for lifespan and behavioural analyses, it is preferable to use large 
sample sizes and also carry out experimental repeats. The average lifespan of a fruit fly is 
approximately 2-3 months, compared with an average lifespan of 1.5-2 years in a laboratory 
mouse (cited on WWW, Transgenic Animal Web). However, the longest lived laboratory 
mouse had a lifespan of 4 years (cited on WWW, Human Ageing Genomic Resources). 
Therefore, it is not feasible to perform these studies on mice, with respect to monetary and 
time costs. 
 
5.2 Assessment of ISC SOCS36E deficiency on lifespan 
5.2.1 ISC-specific knockdown of SOCS36E led to a shortening of both median and maximum 
lifespan. 
With regards to the experiments performed on Drosophila within this and the next chapter, 
three experimental genotypes were used. In order to generate the knockdown flies, we used 
the GAL4/UAS system, with the GAL4 gene able to restrict activation of gene transcription to 
a specific tissue or cell type. This can only occur when a GAL4-containing fly is crossed with 
an Upstream Activation Sequence (UAS)-containing fly. UAS is located next to the gene of 
interest and contains GAL4 binding sites (Brand and Perrimon 1993). In our case, we used a 
UAS-SOCS36E RNAi fly line crossed with an EsgGAL4 line, in order to target knockdown 
of SOCS36E specifically in the Esg+ ISCs in the midgut (Micchelli and Perrimon 2006). In 
order to ensure our knockdown was specific to adult flies, our EsgGAL4 flies were also 
coupled with GAL80ts which is temperature sensitive, so ensures that activation of gene 
transcription only occurs above the non-permissive temperature of 28°C when GAL4 is no 
longer repressed by GAL80ts (McGuire et al. 2003). Therefore, flies were only maintained at 
this temperature following eclosion. For control genotypes, both of the fly lines used to 
generate the knockdown flies, EsgGAL4, GAL80ts, and UAS-SOCS36E RNAi were 
individually crossed to wildtype, whiteDahomey (wDah) flies. 
 
A pilot lifespan experiment was first conducted using EsgGAL/SOCS flies and both control 
genotypes to determine the cell drivers were functioning and to see whether there were any 
initial differences in lifespan amongst the three genotypes. Figure 5.1 shows that the lifespan 
of all genotypes was similar until approximately day 30, indicative of no early non-ageing 
related deaths. EsgGAL/SOCS flies had both the lowest median and maximum lifespans, with 
table 5.1a displaying the percentage differences between these and both control genotypes. 
Additionally, as shown in table 5.1a, the median and maximum lifespans of both EsgGAL/+ 
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and SOCS/+ flies were not too dissimilar from each other, confirming their use as suitable 
controls in following experiments.  
 
To confirm the observed lifespan effects in SOCS36E knockdown flies, a chi-squared p-value 
log-rank test was performed to determine whether the differences seen in survival between 
EsgGAL/SOCS and the two control genotypes were statistically significant, with p-values of  
p<0.0001 generated, confirming that SOCS36E knockdown did negatively affect lifespan 
(shown in table 5.1b). Additionally, a p-value of p>0.05 was calculated between EsgGAL/+ 
and SOCS/+, affirming that any small differences found between the two control genotypes 
were not statistically significant. In conclusion, knocking down SOCS36E in ISCs led to a 
reduction in both median and maximum lifespan, when compared with both control 
genotypes. Also, we hypothesised that knockdown of SOCS36E may result in increased 
midgut proliferation due to decreased regulation of the Jak/Stat pathway. The reductions in 
median and maximum lifespans in EsgGAL/SOCS flies may suggest that they are reasonably 
healthy at young ages, but become more susceptible at older ages and are less able to cope 





Genotype Median Lifespan/ Days 
Maximum Lifespan/ 
Days 
EsgGAL/SOCS 43.5 50.5 
EsgGAL/+ 47.5 60.0 
SOCS/+ 49.0 56.0 




Median Lifespan/ Days 
Maximum Lifespan/ 
Days 
EsgGAL/+ +8.4% +15.8% 





for log-rank test on 
survivorship data 
EsgGAL/SOCS EsgGAL/+ SOCS/+ 
EsgGAL/SOCS x 2.11E-10 1.70E-08 
EsgGAL/+  x 0.43 
SOCS/+   x 
 
 
Table 5.1: (a) The median and maximum lifespans, and percentage differences in both 
lifespans between SOCS36E knockdown female flies and relevant controls. (b) P-values 
calculated using a chi-squared p-value log-rank test to determine statistical significances 


























Figure 5.1: Lifespan analysis of SOCS36E knockdown female flies, compared with 
control genotypes, EsgGAL/+ and SOCS/+. Deaths were recorded three to five times over a 
period of five days each week, with median and maximum lifespans determined by the time 
points when 50% (depicted by the red line above) and 10% of each genotype remained, 
respectively. (EsgGAL/SOCS- red, n=190, EsgGAL/+ - blue, n=170, and SOCS/+ - green, 
n=90). Differences in lifespans between EsgGAL/SOCS, and EsgGAL/+ and SOCS/+ were 




5.3 Measuring gut levels of SOCS36E using quantitative PCR 
5.3.1 SOCS36E mRNA levels were not reduced in both male and female EsgGAL/SOCS flies 
In order to be able to interpret the lifespan data, qPCR was carried out to confirm that the 
RNAi resulted in a knockdown of SOCS36E mRNA levels in male and female flies. Guts of 
10 day old experimental flies were dissected, and following RNA extraction and cDNA 
synthesis, qPCR was performed, with SOCS36E mRNA levels normalised to those of Actin 
5C, and results then compared to those of the EsgGAL/+ control genotype within each gender, 
in order to determine fold-changes. Figure 5.2 shows that there was no reduction in SOCS36E 
mRNA expression in both (a) female and (b) male EsgGAL/SOCS flies, compared with the 
two control genotypes. There was a 1.16-fold increase in SOCS36E mRNA in SOCS/+ 
relative to EsgGAL/+ females, which was a fairly small difference, thus further reiterating 
their use as comparative controls. However, figure 5.2 (a) shows there was actually an 
increase in SOCS36E mRNA levels in EsgGAL/SOCS females (58% and 35% higher than 
EsgGAL/+ and SOCS/+ females, respectively). Figure 5.2 (b) shows there was much less 
variability between all three experimental male genotypes, with EsgGAL/+ and SOCS/+ flies 
expressing almost identical amounts of SOCS36E mRNA, with a 1.01-fold increase found, 
similar to the result obtained in female flies. SOCS36E knockdown males were found to also 
have higher gut levels of SOCS36E, although the percentage differences were smaller than 
those calculated in females- 7% and 5% increases compared to EsgGAL/+ and SOCS/+, 
respectively. Despite the reported increases, statistical analysis using a one-way ANOVA 
revealed there were no significant differences between any of the three experimental 
genotypes, for both male and female flies (p>0.05). Therefore, using this particular method, 
we cannot confirm that the EsgGAL/SOCS flies did in fact have reduced SOCS36E mRNA 
levels in their ISCs. Consequently, qPCR may not have been a sensitive enough technique for 
detecting knockdown of SOCS36E in ISCs, due to ISCs making up a small proportion of the 
total number of midgut cells (approximately 10%, Ohlstein and Spradling 2006), with whole 
midgut mRNA levels assessed here. Despite this, we were able to obtain a behavioural 
phenotype through a reduction in lifespan in female flies, and, increased stress resistance in 
both male and females (explored further in Chapter 6), which is an indication of phenotypic 
differences between EsgGAL/SOCS flies and the control genotypes. Also, the increased stress 
resistance in male flies (in addition to females), suggests that the lack of a phenotype 
























Figure 5.2: Quantification of SOCS36E mRNA levels (±SEM) in the guts of experimental 
male and female flies, as measured by quantitative PCR. mRNA was extracted from 
dissected guts of 10 day old (a) female and (b) male flies, with expression levels of SOCS36E 
mRNA measured using qPCR, and calculated using the 2(-ΔΔCt) method, with values relative to 





















































































Although we were unable to confirm the ISC-knockdown of SOCS36E at a molecular level in 
both male and female flies, previous work using immunofluorescence has revealed basal 
midgut proliferation to be increased in knockdown flies, compared with controls, as assessed 
using an anti-PH3 antibody which is a marker of mitosis (Buchon, personal communication). 
Oral infection with Ecc15 is known to induce midgut proliferation (Buchon et al. 2009a), 
although upon infection in SOCS36E knockdown flies, this increase in proliferation was 
found to be enhanced (Buchon, personal communication, Obasse 2012). In infected 
knockdown flies, the increase in the number of mitotic cells was still sustained 2 days 
following infection, whereas in control flies, numbers started to decrease 16 hours post-
infection (Buchon, personal communication). Confocal images demonstrated the microbial-
induced increase in proliferation (as indicated by the increase in the number of nucleated 
midgut cells, top panels in figure 5.3) and also dysregulated organisation of the tight junction 
protein, discs large (Dlg) in SOCS36E knockdown flies (as depicted by the yellow 
arrowheads, white arrowheads= arranged Dlg arrangement). EsgGAL/SOCS flies also 
exhibited an increase in midgut diameter following Ecc15 infection, compared with 
uninfected EsgGAL/SOCS flies, as well as uninfected and infected control genotypes. This 
may be as a result of increased midgut proliferation in these flies (due to infection and 
SOCS36E knockdown) and also irregular midgut cell arrangements, caused by dysregulated 
expression and organisation of Dlg. Overall, these images indicate that SOCS36E is 
implicated in regulation of Drosophila midgut homeostasis, in terms of both proliferation and 


























Figure 5.3: Confocal images showing Dlg expression in the midgut of SOCS36E 
knockdown flies plus controls, both with (top panels) and without (bottom panels) Ecc15 
infection. One week old flies were dissected at 4 days post-Ecc15 infection and were fixed in 
4% paraformaldehyde before incubation overnight using an anti-Dlg primary antibody (at 
1:100 at 4°C, green). Following washes and incubation in secondary antibody, guts were 
mounted onto slides using 2% n-propylgallate containing the propidium iodide nuclear stain 
(PI, red). Slides were visualised using a Leica DMIRE2 TCS-SP2 confocal microscope. (Scale 






5.4 Assessment of microbe-mediated midgut homeostasis on lifespan in SOCS36E 
knockdown and control flies 
5.4.1 ISC-specific knockdown of SOCS36E led to a reduction in median lifespan in female 
flies, regardless of infection status 
Research into Drosophila midgut homeostasis has previously revealed that Jak/Stat is required 
for activation and regulation of ISC proliferation (Buchon et al. 2009b), differentiation of ECs 
and EECs (in conjunction with the Delta/Notch pathway, Jiang et al. 2009, Lin et al. 2010), 
and is also activated upon damage or midgut infection (Buchon et al. 2009a, 2009b, Jiang et 
al. 2009). Infection with the Gram-negative phytopathogen, Ecc15 in particular, is known to 
induce multiple components of the Jak/Stat pathway, which leads to proliferation and repair of 
midgut cells (Buchon et al. 2009a). Work carried out by Buchon (personal communication) 
also found that following ISC-specific knockdown of SOCS36E, basal and Ecc15-mediated 
midgut proliferation was increased, compared with control flies, with increased mitosis also 
sustained for up to 2 days following infection in knockdown flies. Therefore, we investigated 
whether Ecc15-induced proliferation, and ultimately, disruption to the microbiota would alter 
the reduction in lifespan induced by the knockdown of SOCS36E. Lifespan analysis was 
conducted using both male and female flies, larger population sizes, as well two cohorts of 
flies per genotype, per gender- an uninfected group, and an Ecc15-infected group of flies that 
were infected at approximately one and two weeks of age. 
 
Figure 5.4 shows that in both uninfected (a) and infected (b) females, ISC knockdown of 
SOCS36E led to a shortening of lifespan. However, infection alone had no effect on the 
SOCS36E knockdown-induced lifespan reduction, as both cohorts of EsgGAL/SOCS females 
had the same median and maximum lifespan. Additionally, all uninfected genotypes had 
virtually the same median and maximum lifespans as their infected counterparts, showing that 
microbially-induced midgut proliferation through Ecc15 infection had neither a positive, nor a 
negative effect on the lifespans of these particular genotypes.  
 
As seen in figure 5.1, the survival curves of all genotypes were similar until approximately 
day 30, confirming that no early non-ageing deaths had occurred in these flies. Table 5.2a 
shows the median and maximum lifespans of the uninfected and infected SOCS36E 
knockdown and control flies, and both cohorts of SOCS36E knockdown females had lower 
median and maximum lifespans compared with all control flies. Using the chi-squared p-value 
log-rank test, differences in survival between the uninfected and infected EsgGAL/SOCS 
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flies, and both uninfected and infected cohorts of control flies were found to be statistically 
significant (p<0.001, shown in table 5.2b). However, in contrast to data presented in table 




Genotype Median Lifespan/ Days Maximum Lifespan/ Days 
Uninfected EsgGAL/SOCS 48 54.5 
Uninfected EsgGAL/+ 52.0 59.0 
Uninfected SOCS/+ 52.0 59.0 
Infected EsgGAL/SOCS 48.0 54.5 
Infected EsgGAL/+ 52.0 59.0 
Infected SOCS/+ 52.0 61.5 
 
 
Table 5.2: (a) The median and maximum lifespans of both uninfected and infected cohorts of 
SOCS36E knockdown female flies and relevant controls. (b) P-values calculated using a chi-
squared p-value log-rank test to determine statistical significances between lifespan 





Chi-squared p-value for log-rank test on 
survivorship data 
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Figure 5.4: Lifespan analysis of (a) uninfected and (b) Ecc15-infected SOCS36E knockdown 
female flies, compared with control genotypes, EsgGAL/+ and SOCS/+. Deaths were recorded 
three to five times over a period of five days each week, with median and maximum lifespans 
determined by the time points when 50% (depicted by the red line above) and 10% of each genotype 
remained, respectively. (Uninfected: EsgGAL/SOCS- dark blue, EsgGAL/+ - blue, and SOCS/+ -
turquoise. Infected: EsgGAL/SOCS- green, EsgGAL/+ - yellow, and SOCS/+ - orange. (n=350 for 
each genotype). Differences in lifespans between EsgGAL/SOCS, and EsgGAL/+ and SOCS/+ within 













































As seen in figure 5.5, the repeat of figure 5.4, the survival curves of all genotypes were similar until 
approximately day 30. Table 5.3a shows the median and maximum lifespans of the uninfected and 
infected SOCS36E knockdown and control flies. However, in this experiment, only median lifespan 
was lower in both cohorts of SOCS36E knockdown females when compared with all control flies, not 
median and maximum lifespans as in table 5.2a. Despite this finding, in concurrence with the previous 
experiment, differences in survival between uninfected and infected EsgGAL/SOCS flies and both 
cohorts of control flies were statistically significant (p<0.001, using a chi-squared p-value log-rank 
test, shown in table 5.3b). Furthermore, all three uninfected genotypes had almost identical median 
and maximum lifespans compared to their infected counterparts, thus confirming that microbial-
induced proliferation through Ecc15 infection did not affect the lifespans of these particular flies. 
 
In conclusion, knocking down SOCS36E in the ISCs of female flies, thereby disrupting intestinal 
homeostasis, consistently led to a reduction in lifespan, although microbial-induced proliferation and 
microbiota perturbations through infection with the Gram-negative phytopathogen, Ecc15, had no 




Genotype Median Lifespan/ Days Maximum Lifespan/ Days 
Uninfected EsgGAL/SOCS 46.5 60.5 
Uninfected EsgGAL/+ 51.0 65.5 
Uninfected SOCS/+ 51.0 60.0 
Infected EsgGAL/SOCS 48.0 60.5 
Infected EsgGAL/+ 51.0 65.5 
Infected SOCS/+ 51.0 60.5 
 
Table 5.3: (a) The median and maximum lifespans of both uninfected and infected cohorts of 
SOCS36E knockdown female flies and relevant controls. (b) P-values calculated using a chi-squared 
p-value log-rank test to determine statistical significances between lifespan differences in the 





Chi-squared p-value for log-rank test on 
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Figure 5.5: Lifespan analysis of (a) uninfected and (b) Ecc15-infected SOCS36E 
knockdown female flies, compared with control genotypes, EsgGAL/+ and SOCS/+. 
Deaths were recorded three to five times over a period of five days each week, with median 
and maximum lifespans determined by the time points when 50% (depicted by the red line 
above) and 10% of each genotype remained, respectively. (Uninfected: EsgGAL/SOCS- dark 
blue, EsgGAL/+ - blue, and SOCS/+ -turquoise. Infected: EsgGAL/SOCS- green, EsgGAL/+ 
- yellow, and SOCS/+ - orange). (n=350 for each genotype). Differences in lifespans between 
EsgGAL/SOCS, and EsgGAL/+ and SOCS/+ within and across infection groups were 













































5.4.2 Neither SOCS36E knockdown, nor infection with Ecc15 in the midgut of male flies had 
an effect on lifespan. 
Lifespan analysis was also carried out in male flies, and figure 5.6 shows that for both 
uninfected (a) and infected (b) males, all genotypes had similar survival curves, indicating that 
as found in female flies, microbial-induced midgut proliferation through Ecc15 infection had 
no effect on lifespan, but also that the SOCS36E knockdown had gender specific effects, as in 
the male flies, uninfected EsgGAL/+ flies had the shortest median lifespan. Additionally, 
SOCS36E knockdown had no effect on maximum lifespan either as the maximum lifespans 
were approximately 48 days for all genotypes, with the exception of uninfected 
EsgGAL/SOCS and infected EsgGAL/+, which were 42.5 and 45.0 days, respectively (as 
shown in table 5.4a). 
 
Using the chi-squared p-value log-rank test, there were significant differences (p<0.05) 
between EsgGAL/SOCS and control flies (shown in table 5.4b). However, as neither a 
shortening nor an extension of lifespan was observed in EsgGAL/SOCS males compared to 
both controls, the statistical differences observed cannot be attributed to the knockdown of 
SOCS36E, in addition to Ecc15 infection. 
 
In conclusion, no lifespan differences were observed between uninfected and infected male 
flies, indicating that increases in midgut proliferation as a result of Ecc15 infection appeared 
to be neither beneficial nor harmful to survival of these flies; a finding also obtained in female 
flies. In contrast to the female flies though, EsgGAL/SOCS males did not exhibit a reduction 





Genotype Median Lifespan/ Days Maximum Lifespan/ Days 
Uninfected EsgGAL/SOCS 36.0 42.5 
Uninfected EsgGAL/+ 34.0 48.5 
Uninfected SOCS/+ 37.5 48.0 
Infected EsgGAL/SOCS 37.5 48.0 
Infected EsgGAL/+ 36.0 45.0 
Infected SOCS/+ 37.5 48.0 
 
Table 5.4: (a) The median and maximum lifespans of both uninfected and infected cohorts of 
SOCS36E knockdown male flies and relevant controls. (b) P-values calculated using a chi-
squared p-value log-rank test to determine statistical significances between lifespan 






Chi-squared p-value for log-rank test on 
survivorship data 
 























































Figure 5.6: Lifespan analysis of (a) uninfected and (b) Ecc15-infected SOCS36E 
knockdown male flies, compared with control genotypes, EsgGAL/+ and SOCS/+. Deaths 
were recorded three to five times over a period of five days each week, with median and 
maximum lifespans determined by the time points when 50% (depicted by the red line above) 
and 10% of each genotype remained, respectively. (Uninfected: EsgGAL/SOCS- dark blue 
(n=310), EsgGAL/+ - blue (n=350), and SOCS/+ -turquoise (n=350). Infected: 













































As in figure 5.6, figure 5.7 shows that for both uninfected (a) and infected (b) males, all 
genotypes had similar survival curves, confirming that neither SOCS36E knockdown, nor 
Ecc15 infection had an effect on lifespan in these male flies. Similar to results in table 5.4a, 
EsgGAL/+ control flies had the lowest median lifespan, although in this case, the flies were 
infected (as shown in table 5.5a). Consistent with both cohorts of EsgGAL/+ having the two 
lowest median lifespans, these flies also had the lowest maximum lifespans (40.0 and 41.0 
days for uninfected and infected EsgGAL/+ males, respectively). Surprisingly in this 
experiment, both sets of EsgGAL/SOCS were found to have the highest maximum lifespans 
(both at 50 days), contrasting results shown in table 5.4a where uninfected EsgGAL/SOCS 
had the lowest maximum lifespan, showing that maximum lifespan can be subject to more 
variation across experiments. 
 
As found in the previous male lifespan experiment, significant differences were found 
between EsgGAL/SOCS and control flies (p<0.05, using a chi-squared p-value log-rank test, 
shown in table 5.5b). Again however, neither cohort of EsgGAL/SOCS had consistent 
differences in lifespan compared with both control genotypes within the same infection group, 
so therefore the statistical differences observed could not be attributed to knockdown of ISC 
SOCS36E. 
 
In conclusion, disrupting the microbiota and inducing proliferation through infection with 
Ecc15 in male flies had no effect on survival, which is consistent with the findings in female 
flies. However, the negative effects that knocking down SOCS36E in ISCs had on lifespan 
was confined to female flies, as neither uninfected nor infected SOCS36E knockdown male 
flies had a reduced lifespan compared to control flies, suggesting that the impact of gut health 








Table 5.5: (a) The median and maximum lifespans of both uninfected and infected cohorts of 
SOCS36E knockdown male flies and relevant controls. (b) P-values calculated using a chi-
squared p-value log-rank test to determine statistical significances between lifespan 
differences in the experimental flies (on the following page).
Genotype Median Lifespan/ Days Maximum Lifespan/ Days 
Uninfected EsgGAL/SOCS 34.0 50.0 
Uninfected EsgGAL/+ 29.5 40.0 
Uninfected SOCS/+ 34.0 47.5 
Infected EsgGAL/SOCS 32.5 50.0 
Infected EsgGAL/+ 26.5 41.0 





Chi-squared p-value for log-rank test on 
survivorship data 
 






















































Figure 5.7: Lifespan analysis of (a) uninfected and (b) Ecc15-infected SOCS36E 
knockdown male flies, compared with control genotypes, EsgGAL/+ and SOCS/+. Deaths 
were recorded three to five times over a period of five days each week, with median and 
maximum lifespans determined by the time points when 50% (depicted by the red line above) 
and 10% of each genotype remained, respectively. (Uninfected: EsgGAL/SOCS- dark blue, 
EsgGAL/+ - blue, and SOCS/+ -turquoise. Infected: EsgGAL/SOCS- green, EsgGAL/+ - 














































5.5 Assessment of Ecc15-induced midgut proliferation 
As we were unable to confirm SOCS36E mRNA knockdown using qPCR, we assessed effects 
on midgut proliferation as previously performed by Buchon (personal communication). 
Although images by Obasse (2012) demonstrated microbe-mediated dysregulation of tight 
junction organisation and increased midgut diameter in SOCS36E knockdown flies relative to 
controls, thus disrupting midgut homeostasis, we wanted to confirm the persistence of midgut 
proliferation in SOCS36E knockdown flies, both at the basal level and following Ecc15 
infection in our lab. 
 
Using four different groups of flies (uninfected, and flies dissected either 1, 3 or 7 days post-
infection), we used immunofluorescence to determine differences in midgut proliferation 
between the three experimental genotypes, using an antibody recognising phosphorylated 
histone H3 (PH3); a marker of mitosis. Due to difficulties in accurately quantifying PH3+ 
cells, we chose to quantify those cells that were brightly fluorescing and therefore had 
pronounced levels of mitosis occurring. Consequently, there were very few prominent PH3+ 
cells observed, regardless of genotype, even using multiple fields of view per midgut. Figure 
5.8 (a) shows examples of images taken, with (b) displaying the results from image 
quantification, confirming the low numbers of PH3+ cells, ranging from 0 to 4.5. Within 
EsgGAL/SOCS, there does appear to be a trend of a slight increase in PH3+ cells with 
increasing time following Ecc15 infection. However, these increases are very small (with a 
difference of 1.5 cells between uninfected and 7 days post-infection), and overlapping error 
bars can be seen. A one-way ANOVA with Tukey-Kramer post-hoc test was performed and 
no significant differences were found between the four groups (p>0.05). The same statistical 
test was used within EsgGAL/+ and SOCS/+, as well as within each infection group, and no 
statistical differences were found either (p>0.05). In summary, this particular experimental 
method proved inconclusive in determining basal and infection-induced increases in midgut 
proliferation in SOCS36E knockdown flies. Although we were unable to confirm knockdown 
of SOCS36E using qPCR and immunofluorescence, our lifespan and stress resistance data 
(discussed further in Chapter 6), along with previous immunofluorescence performed in our 


























Figure 5.8: Confocal images (a) and quantification (±SEM) (b) of PH3+ mitotic midgut 
cells in EsgGAL/SOCS flies (left) and control genotypes, EsgGAL/+ (centre) and 
SOCS/+ (right). Flies were dissected at either 1, 3 or 7 days post-Ecc15 infection (with 
uninfected flies dissected at 7 days) and were fixed in 4% paraformaldehyde before incubation 
overnight using a mitotic marker- an anti-phospho-histone H3 antibody (at 1:1000 at 4°C, 
green). Vectashield with DAPI (blue) was used as a nuclear stain. Slides were visualised using 
a Zeiss confocal microscope. (Scale bar= 10µm, n=4 per group, per genotype). (Images shown 
taken from 7 days post-infection, at 63x magnification). 






































The use of Drosophila melanogaster as a model organism has proven to be beneficial to 
biomedical research, with reasons for their use including: relatively short lifespan 
(approximately 60-80 days) along with short generation times (especially when compared to 
humans where the gestation period is 9 months), fewer cost and ethical issues when compared 
to using organisms, such as mice or monkeys for scientific research, the evolutionary 
conservation of genes and their functions from Drosophila to mammals and also that flies can 
be easy to genetically manipulate, with gene expression able to be controlled through tissue-
specific and temperature sensitive driver lines. Collectively, these allow the study of gene 
effects over the lifespan of the fly, with results translating to health and ageing in humans. 
 
In recent years, Drosophila have also become a good model organism for studying health and 
disease of the G.I tract. This is due to similarities in gut structure, conservation of signalling 
pathways (such as Notch, Jak/Stat and JNK, for example) (Helfand and Rogina 2003, 
Apidianakis and Rahme 2011), and pathologies exhibited by mammals and Drosophila. For 
instance, both organisms possess ISCs, which following proliferation into a progenitor cell 
(enteroblasts in Drosophila, transit amplifying cells in mammals), differentiate into either 
absorptive or secretory intestinal cells, dependent on Delta/Notch and Jak/Stat signalling 
(Jiang et al. 2009, Lin et al. 2010). Also, tissues exist in Drosophila that are homologous to all 
sections of the mammalian G.I tract. For example, the crop is equivalent to the mammalian 
stomach, and specific to our research interests, the midgut and hindgut are similar to the small 
and large intestine, respectively (Apidianakis and Rahme 2011). With regards to pathologies, 
both mammals and flies possess equivalent signalling pathways for recognition of microbes 
and distinguishing between commensal and pathogenic microbes (the TLR pathway, and Toll 
pathway, respectively), and mutations in the respective pathways results in increased 
susceptibility and mortality following intestinal challenge (Rakoff-Nahoum et al. 2004, 
Dionne and Schneider 2008). Additionally, dysregulated intestinal homeostasis, either as a 
result of mutations or loss of cell junctions, or tumour suppressor genes (such as APC), or 
through increased activity in cell signalling pathways (such as JNK), can lead to 
hyperproliferation and cause irregular tissue architecture and multi-layering of cells 
(Hermiston and Gordon 1995, Licato et al. 1997, Biteau et al. 2008, Patel and Edgar 2014). It 
is well established that damage to the Drosophila midgut (for instance, through the use of 
DSS) as well as dysregulation of intestinal cell regulation and repair pathways have negative 
effects on lifespan and survival (Amcheslavsky et al. 2009, Apidianakis and Rahme 2009, 
Apidianakis et al. 2009, Buchon et al. 2009b, Chatterjee and Ip 2009, Jiang et al. 2009, Biteau 
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et al. 2010). Specific to this project, Buchon et al. (2009b) found that flies lacking the Jak/Stat 
activator, Upd3, and the transcription factor, Stat92E, in ECs and ISCs respectively, 
succumbed to infection with Ecc15, due to an inability to renew their midgut epithelium, thus 
demonstrating the importance of the Jak/Stat pathway in particular, in the Drosophila midgut. 
Although these studies demonstrate the important effects of dysregulated midgut signalling on 
survival, they do not give an indication as to how the ageing process is affected in these flies, 
as shortening of lifespan can either be due to specific functions limiting lifespan, or 
acceleration of the ageing process. As a result, decreased lifespan is often used as an indicator 
of organismal health, and these findings reveal that regulated intestinal homeostasis is 
essential for maintaining the wellbeing of flies, and this is also applicable to mammals 
(Rakoff-Nahoum et al. 2004) 
 
The focus of this project has been on SOCS proteins, a group of negative regulators of 
Jak/Stat signalling. Previous studies have shown that a reduction or loss of SOCS has been 
implicated in dysregulated cell homeostasis, which could ultimately lead to disease. For 
example, in a murine model of inflammation-induced carcinogenesis, IEC-specific knockout 
of SOCS3 led to crypt hyperproliferation, as well as tumour development (Rigby et al. 2007). 
Although not entirely within the scope of this project, deletion of SOCS3 in hepatocytes 
promoted hepatitis-induced hepatocarcinogenesis (Ogata et al. 2006), enforcing the 
importance SOCS proteins have in preventing infection/inflammation-induced carcinogenesis.  
Additionally, an increase in villus height, crypt depth and cell proliferation in both the 
jejunum and colon were found in SOCS2 null mice, compared to wild-type litter mates 
(Michaylira et al. 2006). Drosophila have their own SOCS proteins- SOCS16D, SOCS44A 
and SOCS36E (Hou et al. 2002), all of which possess mammalian homologues. The fact that 
multiple SOCS proteins are evolutionarily conserved between flies and mammals is indicative 
that these proteins have crucial functions within these organisms. Our main focus was 
SOCS36E, which is the most-documented Drosophila SOCS protein. It is a homologue of 
both human and murine SOCS5, but through its role in preventing phosphorylation of 
Stat92E, it is actually a functional homologue of SOCS1-3 and CIS (Callus and Mathey-
Prevot 2002). Like mammalian SOCS proteins, SOCS36E is activated by Jak/Stat and can 
inhibit Jak/Stat signalling in vivo, thereby producing a negative feedback loop. Additional 
roles include eye and wing development, and maintenance of germline stem cells (Stec and 
Zeidler 2011). As found with mammalian SOCS proteins, SOCS36E also functions as a 
tumour suppressor, due to its ability to inhibit EGFR signalling (Herranz et al. 2012). 
Additionally, knockdown of SOCS36E knockdown results in upregulated Jak/Stat signalling, 
and in haematopoietic tumours that develop in flies with constitutively active Hop (the 
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Drosophila homologue of Jak2, Binari and Perrimon 1994), deletion of SOCS36E led to an 
increase in the number and size of tumours (Stec and Zeidler 2011). Besides reports of 
SOCS36E increases upon Jak/Stat activation by Upds, particularly following infection 
(Buchon et al.2009a and b, Jiang et al. 2009), very little is known about SOCS36E in the 
Drosophila midgut, unlike SOCS proteins in the mammalian intestines. Consequently, 
dysregulation of mammalian SOCS3 is known to be implicated in diseases such as IBD and 
cancers of the G.I tract (Rigby et al. 2007, Li et al. 2009), which can lead to increased 
morbidity and mortality, so we made use of fruit flies’ relatively short lifespan and used 
Drosophila as a model to first investigate the effect disrupting intestinal homeostasis (through 
knockdown of SOCS36E specifically in ISCs) had on lifespan, through survival analysis. 
 
Survival analysis experiments showed a statistically significant decrease in both median and 
maximum lifespan in SOCS36E knockdown female flies, compared with controls. It has been 
previously shown that proliferation rates in the Drosophila midgut often increase with 
increasing age in flies (Biteau et al. 2008, Choi et al. 2008, Buchon et al. 2009b); an 
observation that is also conserved in the intestine of mammals (Holt and Yeh 1988, 1989, 
Ciccocioppo et al. 2002). Biteau et al. (2010) found that a moderate reduction in JNK and 
insulin/IGF (IIS) signalling in midgut progenitor cells, led to an extension in lifespan in 
Drosophila. They found that this lifespan extension correlated with a reduction in the age-
associated dysplasia caused by overproliferation and midgut degeneration that can often lead 
to premature death in flies. In spite of this, altered activity in these pathways, such as 
decreased neural IIS and increased neural JNK signalling (Wang et al. 2003, Broughton et al. 
2005, Ismail et al. 2015), has also led to increases in lifespan, so the extension reported by 
Biteau et al. (2010) could have been due to crosstalk between pathways, or even tissues. For 
instance, EECs in the midgut are capable of communicating with cells with the brain through 
recognition and production of neuropeptides (Veenstra 2008). If EECs are functioning 
efficiently as a result of adequate midgut homeostasis and health, signalling to the brain may 
result in healthy neuronal cells as well. Additionally, the effects of JNK activity appear to be 
tissue specific, as decreased midgut signalling was able to increase lifespan through limiting 
age-associated dysplasia, whereas increased JNK signalling in the brain can increase lifespan 
through increased stress resistance (Wang et al. 2003, Biteau et al. 2010). However, using this 
theory of increased midgut proliferation with increasing age, then an increase in Jak/Stat cell 
signalling (as theorised in the SOCS36E knockdown flies) leading to further proliferation of 
ISCs may have induced intestinal dysplasia sooner in the knockdown flies than in control 
flies, resulting in a reduction in median and maximum lifespans. Additionally, Jak/Stat 
signalling is known to function upstream of the Notch pathway (Jiang et al. 2009), and in 
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cooperation with the EGFR pathway (Buchon et al. 2010). Therefore, an increase in ISC 
proliferation, due to a knockdown of SOCS36E, could lead to increased proliferation through 
these pathways, thus further promoting dysplasia and potentially compromising the health and 
lifespan of the fly. Biteau et al. (2008) also found that older flies demonstrated higher levels 
of JNK signalling than younger flies, and one outcome of this pathway is the production of 
Upds (Jiang et al. 2009)- the activating ligand of the Drosophila Jak/Stat pathway- and this 
could potentially cause further Jak/Stat activation. 
 
As stated earlier, intestinal proliferation rates have been reported to increase with increasing 
age in both mammals and flies, and if sustained, may be the result of genetic mutations or, 
may increase the chance of mutations not being detected by components of DNA damage 
repair pathways or then at cell cycle checkpoints. This could result in these mutations being 
passed on to daughter cells, which may result in mutation accumulation and irreversible cell 
changes, then ultimately tumorigenesis (Rakoff-Nahoum 2006). Therefore, it is has been 
proposed that increasing age predisposes organisms to cancer (Xiao et al. 2001). In a study by 
Salomon et al. (2008), they reported tumours in the midgut of two commonly used wildtype 
laboratory strains of fruit fly (Canton-S and w1118) at 4 and 5 weeks of age. Although only a 
small percentage of flies had midgut tumours by 5 weeks of age (1.29% of 154 flies), their 
results did show an increase in tumour development with age. However, they only studied 
flies up to 5 weeks of age, so it would be assumed that there may be further increases in the 
number of flies that developed midgut tumours older than 5 weeks. Images also showed a 
reduction or obstruction of the lumen in flies at 4 weeks of age. This leaves the possibility that 
the flies used here could have developed severe dysplasia, and possibly severe enough to 
completely obstruct the midgut lumen, which would have a negative impact on lifespan, 
especially as the median lifespan for male and female flies was 5 and 7 weeks respectively, 
and the maximum lifespan was 6-7 weeks and 9 weeks for male and female flies respectively. 
Although these findings were reported in wildtype flies, other studies have also reported 
dysplasia in the midgut of various knockdown flies (for example Notch, Jak/Stat, APC), and 
this led to multilayering of cells in the midgut (an increase from the single layer of cells that 
normally line the midgut) and distorting of the epithelium (Lee et al. 2009, Patel and Edgar 
2014). Taking these findings into account, the SOCS36E knockdown female flies may have 
had a reduced lifespan caused by obstruction of the midgut lumen, although this is 
speculative. In order to test this hypothesis, we could replicate experiments performed by 
Salomon et al. (2008) in our flies, sectioning dissected midguts and then using microscopy to 
visualise them and measure lumen diameter, and possibly epithelium depth if multilayering 
had occurred. If obstruction of the gut lumen does occur, this could impact on feeding, 
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digestion and energy storage. To determine effects of ISC knockdown of SOCS36E on energy 
storage, various assays could be performed to determine content of nutrients, such as lipids, 
trehalose (one of the predominant sugar molecules in Drosophila) and glycogen with these 
and control flies. 
 
Considering findings from other groups of reduced lifespan as a result of dysregulated midgut 
homeostasis, it was therefore not completely surprising to find this phenotype in our flies. 
What was unexpected however, was the gender-specific effects the SOCS36E knockdown had 
on lifespan, in that only females were affected. Sexual dimorphism is known to occur in many 
behaviours studied in Drosophila, for example, locomotor activity (Martin et al. 1999), 
desiccation resistance (Chippindale et al. 1998), sleep (Liu et al. 2015), responses to ethanol 
(Devineni and Heberlein 2012), as well as longevity (Spencer et al. 2003, Magwere et al. 
2004). Specifically in intestinal studies, reduction of various components of the IIS and JNK 
pathway led to decreased intestinal proliferation and extended lifespan in older female flies, 
with no significant effects on lifespan observed in male flies (Biteau et al. 2010). Rera et al. 
(2011) also demonstrated a similar trend following induced expression of dPGC-1- a 
Drosophila homologue of mammalian PGC-1, part of a group of fundamental regulators of 
various energy metabolism processes, such as glucose homeostasis and respiration. Magwire 
et al. (2010) stated that differences in genetic background can cause different phenotypes 
when the same gene is altered, but as both male and female flies for all genotypes used here 
were backcrossed onto the same wDah background, this was not the case. A possible 
explanation is derived from the finding by Jiang et al. (2009) that female flies were able to 
renew their midgut epithelium faster than males, suggesting that females may have higher 
basal proliferation rates. The flies used in those experiments were from a different 
background, but if the findings are to be generalised, then it can be hypothesised that 
increased intestinal Jak/Stat signalling (achieved here through knockdown of SOCS36E) may 
predispose female flies to premature mortality, as a result of intestinal dysplasia. Although no 
lifespan effects were observed in our EsgGAL/SOCS male flies, behavioural phenotypes, such 
as increased stress resistance (discussed in Chapter 6) were found when compared with 
control male flies, which indicates that the lack of a lifespan phenotype was not due to the 
absence of SOCS36E knockdown. 
. 
Following assessment of lifespan in unchallenged flies, whereby knockdown of SOCS36E 
resulted in decreased lifespan in female flies, we then aimed to investigate how this reduction 
in Jak/Stat regulation impacts upon survival following microbial-induced proliferation. Flies 
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were infected with the Gram-negative phytopathogen, Ecc15, at approximately 1 and 2 weeks 
of age. Ecc15 itself is known to activate Jak/Stat signalling following damage induced to 
midgut cells caused by an oxidative burst targeted towards the pathogen, and subsequent 
epithelium repair due to release of Upds from damaged ECs (Buchon et al. 2009a, Jiang et al. 
2009). In both male and female flies, infection with Ecc15 had neither a positive, nor a 
negative effect on median or maximum lifespan. This was not entirely surprising as under 
normal circumstances, Ecc15 will not kill Drosophila, although it does induce an immune 
response which ultimately leads to proliferation of ISCs and repair of the epithelium (Basset 
et al. 2000, Buchon et al. 2009a). It has been previously shown that infecting flies with Ecc15 
leads to an increase in ROS in the midgut (which is damaging to the cells) (Ha et al. 2005). In 
the experiments in this project, flies were only infected twice over the space of a week, early 
on in the flies’ lifespan (at one and two weeks of age) and were in contact with the bacteria for 
two hours each time. Therefore, one reason Ecc15 infection had little effect on lifespan may 
have been because the flies’ contact with this bacteria was not long enough to produce the 
amount of ROS and subsequent cell damage that can lead to a reduction in lifespan. Also, it is 
not known how many flies in these experiments actually ingested the bacteria, and if they did, 
how much bacteria was ingested. To fully establish the impact SOCS36E and microbial-
mediated midgut proliferation has on survival, flies could be: infected with Ecc15 for longer 
periods of time and/or infected more frequently (e.g. once a week for at least 4 weeks), or 
infected with more pathogenic bacteria, such as Pseudomonas aeruginosa or Pseudomonas 
entomophila. Additionally, a feeding assay could be performed whereby a dye is incorporated 
into the bacterial suspension and the absorbance is measured in order to quantify the level of 
intake. Infection with Ecc15 could also be confirmed through measurement of ROS, 
comparing levels (of superoxide, for example, Ha et al. 2005) in infected flies with uninfected 
flies, or expression levels of Duox and catalase, which are known to induce and remove ROS, 
respectively. 
 
Proliferation in the midgut is known to increase following Ecc15 infection (Buchon 2009a), 
and Buchon (personal communication) found that increased proliferation was sustained two 
days post-infection in SOCS36E knockdown flies, even after the bacteria had been cleared 
from the midgut. This will lead to an increase in cells in the midgut, which would inevitably 
affect the morphology of the gut, and could lead to dysplasia. However, SOCS36E 
knockdown alone may cause an increase in cellular proliferation due to dysregulation of the 
Jak/Stat pathway so it is speculated that this may have occurred in these flies, hence why the 
uninfected EsgGAL/SOCS females exhibited a reduced median lifespan. Additionally, there 
have been no published studies quantifying the difference in proliferation caused either by 
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SOCS36E knockdown alone, or with Ecc15 infection. Buchon et al. (2009b) discovered that 
manipulation of midgut Jak/Stat signalling, either through depletion of Upd3 in ECs, or 
deletion of Stat92E, resulted in increased mortality, and therefore sensitivity to Ecc15 
following oral infection. However, we observed no difference in lifespan as a result of Ecc15-
induced proliferation, either alone or combined with SOCS36E knockdown, indicating 
dysregulated Jak/Stat signalling in our flies did not affect their resistance to this pathogen, 
presumably because Jak/Stat activity was still present. Regarding EsgGAL/SOCS flies, it may 
be that knockdown of SOCS36E was actually beneficial and perhaps led to a faster clearance 
of bacteria from the midgut, due to faster epithelial turnover and renewal, although this cannot 
be confirmed without further experiments, such as visualisation of Ecc15 in the midgut by 
using a GFP strain. Additional findings from Buchon et al. (2009a) show that the Jak/Stat 
pathway contributes to regulation of AMPs, as expression of Drosomycin-like 3 (Dro3, an 
antifungal peptide) was reduced following Ecc15 infection in flies with decreased Jak/Stat 
activity, through the use of Stat and Upd3 RNAi. This is in spite of the fact that Ecc15 is 
Gram-negative and activates the Imd pathway, and Dro3 is produced by the Toll pathway. 
Expression of Dro3 was also found to be weakly induced following the use of Hop loss-of-
function mutant flies, but was strongly induced in Hop gain-of-function mutants in the 
absence of infection, indicating regulation of Jak/Stat prevents misexpression of this peptide. 
Although Dro3 (along with other AMPs, Buchon et al. 2009a, Gendrin et al. 2009) will be 
produced as a result of infection regardless (another potential explanation for the lack of 
lifespan effect by Ecc15), it could be hypothesised that based on the findings of Buchon et al. 
(2009a), increases in Jak/Stat signalling, due to knockdown of SOCS36E in this case, may 
also strongly induce Dro3, thus alleviating any negative effects that both Ecc15 infection and 
SOCS36E knockdown combined may have had on lifespan, although again, this would need 
to be tested. 
 
Following the observation that knockdown of SOCS36E in the midgut led to lifespan 
reduction in female flies, we performed quantitative PCR in order to confirm the effects of the 
RNAi. We assessed SOCS36E mRNA levels in dissected guts in male and female 
experimental flies, and our results indicated SOCS36E mRNA was not lower in either 
EsgGAL/SOCS males or females, compared to controls. One suggestion for this may have 
been due to the specificity of the knockdown- the parental genetic cross performed to generate 
the EsgGAL/SOCS line would lead to a reduction of SOCS36E mRNA in the ISCs only. 
Although Drosophila have a higher proportion of ISCs (around 800-1000 ISCs in a population 
of approximately 10,000 cells= 8-10%, Ohlstein and Spradling 2006) compared with humans 
(who are estimated to have 4-6 ISCs amongst a small intestinal crypt of 450 cells and a 
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colonic crypt of 2250 cells= ≤1%, Potten 1991, Bach et al. 2000), 8-10% of the overall midgut 
is still a small proportion, and for this experiment, RNA was extracted from whole midguts. 
Additionally, ISCs are not regularly dispersed through the fly midgut due to different 
demands between niches (Ohlstein and Spradling 2006). Furthermore, midguts were dissected 
from live, anaesthetised flies so both processes of CO2 anaesthetisation and gut dissection 
would have induced stress and potentially damage to the flies, which are capable of activating 
JNK and Jak/Stat signalling, respectively (Biteau et al. 2008, Buchon et al. 2009b). JNK 
activity also leads to production of Upds (Jiang et al. 2009), which results in activation 
Jak/Stat signalling, which causes transcription of genes including SOCS36E as a result, 
potentially explaining the lack of significant differences in SOCS36E mRNA between 
knockdown and control flies. Upon dysregulation of cell signalling, there may be mechanisms 
in place to ensure homeostasis is preserved. For example, Xu et al. (2011) found that midgut 
Jak/Stat signalling is able to coordinate with the Wnt and EGFR pathways, as activation of 
one of these pathways is increased following dysregulation and diminishing activity in one of 
the other pathways, and this ensures efficient regulation of ISCs. Therefore, based on these 
findings, it could be speculated that midgut cells may upregulate SOCS36E expression in 
order to overcome knockdown of SOCS36E in ISCs, although to test this, a sensitive, cell-
specific technique would be needed to distinguish between cell types and compare expression 
of SOCS36E, such as flow cytometry. 
 
Immunofluorescence was also performed in order to confirm enhanced basal and microbial-
induced midgut proliferation in knockdown flies (relative to controls), as first revealed by 
Buchon (personal communication). This would confirm that knockdown of SOCS36E did in 
fact result in increased Jak/Stat signalling through reduced regulation, and would also produce 
a midgut phenotype in conjunction with the lifespan phenotype (in females). Unfortunately, 
this was not confirmed, but was not completely unsuccessful as fluorescent PH3+ 
proliferating cells were found, although these were low in number, with one possible cause 
being low sample size. Using immunofluorescence with the same fly genotypes, Obasse 
(2012) confirmed increases in midgut proliferation following Ecc15 infection, as shown by an 
increase in the number of nucleated cells, and this was regardless of genotype (as expected). 
However, infected knockdown flies also exhibited disorganised expression of the tight 
junction protein Dlg, as well as an increase in midgut diameter, possibly as a result of 
irregular cell arrangements and/or increased numbers of cells within the midgut. The altered 
Dlg expression could ultimately affect the barrier function of the midgut epithelium and result 
in increased permeability, which has shown to cause increased morbidity in mammalian 
systems (Song et al. 2009), as well as increased mortality in Drosophila (Rera et al. 2011). 
190 
 
This could be a possible explanation for the reduced lifespan in knockdown flies, but it does 
not explain why this phenotype was in female flies only. 
 
The experimental method we used here also meant that the dissected midguts were prone to 
damage so it may have been the case that higher proliferating midgut regions were lost in the 
process. To overcome this, dissected midguts could be paraffin embedded and sectioned (as 
performed previously with mice ceca) before antibody staining. Although many sections may 
need to be visualised in order to gauge the proliferation over multiple planes of the midgut, 
the tissue will be adhered to microscope slides, minimising damage or loss. Additionally, in 
place of using immunofluorescence, flies could be used that have GFP associated with the 
EsgGAL4 driver, so that any proliferating Esg+ cells would fluoresce, and the fluorescent 
intensities could then be compared between genotypes. A further technique that could be used 
is in situ hybridisation, which would involve using an RNA probe complementary to a 
sequence in the SOCS36E mRNA. Using microscopy, this would allow visualisation of 
SOCS36E mRNA expression in the midguts of our experimental flies, with the expectation 
that more probe-mRNA binding, and thus SOCS36E mRNA expression, would be found in 
both control genotypes. As previously stated, in the experiments we conducted, it was not 
known how many flies ingested the bacterial suspension and in what quantity, especially as 
the infection period was only 2 hours. It is possible that very few flies ingested the Ecc15, 
hence why there were no obvious differences between genotypes. Results may be improved 
using a longer infection period, or more pathogenic bacteria, which would induce a stronger 
proliferative response in the midgut. 
 
In conclusion, although we were unable to confirm SOCS36E knockdown through decreased 
midgut SOCS36E mRNA and increased midgut proliferation, we did obtain a phenotype and 
showed that this knockdown did lead to a gender-specific lifespan reduction in female flies; 
the cause of which will be explored in the next chapter. Our finding adds to, and is supported 
by the multitude of groups who have found dysregulation of midgut renewal pathways, and 
extensive damage to the midgut are detrimental to flies’ survival (Amcheslavsky et al. 2009, 
Apidianakis and Rahme 2009, Apidianakis et al. 2009, Biteau et al. 2010, Buchon et al. 
2009b, Chatterjee and Ip 2009, Jiang et al. 2009), and reiterates the importance of intestinal 
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Since the start of the 20th century, there has been substantial progression in hygiene and 
diagnosis and treatment of diseases in the western world, leading to increased standards of 
living and ultimately, life expectancy (WWW, Centers for Disease Control and Prevention). 
For instance, in the UK, life expectancy in males increased from 75.7 years in 2000-2002, to 
78.4 years in 2009-2011. Increases were also observed in females, although their life 
expectancies were higher than in males too, with 80.4 years in 2000-2002, to 82.4 in 2009-
2011 (WWW, Office for National Statistics). However, in many individuals, an increase in 
age is associated with senescence and decreasing functional health (Grotewiel et al. 2005). 
One common feature that often accompanies an increase in age is a decline in motor function, 
which can also be known as locomotor, or functional (age-related) senescence and in humans, 
this may manifest as a decline in walking speed, or stiffness or pain in the joints, which could 
ultimately lead to decreased amounts of movement and walking. Functional senescence is 
often the first sign of a decline or degeneration of the nervous system (Camicioli et al. 1999), 
and is a common cause of increased morbidity and mortality (as well as possible increases in 
healthcare costs), due to the increase in falls and hospitalisations in the elderly (Jones and 
Grotewiel 2011). Drosophila have proven to be a good model for assessing functional 
senescence as many behaviours, including locomotor behaviours, are known to decline with 
increasing age in flies (as in humans) (Grotowiel et al. 2005), and with relatively short 
lifespans, behaviours can be assessed at different time points during the lifespan. The time 
point(s) at which different environmental or genetic interventions have their effects on 
locomotor senescence can also be established. One method to measure locomotor senescence 
is the negative geotaxis assay, which assesses the neuromuscular health of Drosophila. 
Drosophila naturally display a reflex response of upward walking following forced falling, 
and this assay utilises this behaviour to test climbing ability in a variety of ways: the time 
taken to climb a predetermined distance, the distance climbed within a certain amount of time, 
or a combination of the two- the number of flies to climb a predetermined distance within a 
certain amount of time. All flies, regardless of gender or genotype, exhibit a decline in 
climbing ability with age, although different genotypes and mutations can lead to a delay or 
acceleration in this decline (Gargano et al. 2005). 
 
An increase in frequency of G.I disorders is also common in the elderly, with these including 
dysregulated homeostasis, in humans (Ciccocioppo et al. 2002) as well as rodents (Holt and 
Yeh 1988, 1989, Xiao et al. 2001), diminished regenerative potential following injury (Martin 
et al. 1998), and an increased incidence in cancer (James 1983, Geokas et al. 1985, Salles 
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2007). It is thought that ageing of intestinal cells, as well as the enteric nervous system, are 
major factors in the development of these conditions (Saffrey 2013).  Additionally, a lot of 
research has been carried out in recent years into the effects that changes in the gut, and in the 
gut microbiota, have on CNS function and behaviour, and vice versa- a bidirectional 
relationship named the gut-brain axis. Examples of findings include stress-induced microbiota 
changes as a result of maternal separation in young rat (O’Mahony et al. 2009), altered 
feeding behaviour in mice following infection with Helicobacter pylori, even after the 
infection had been resolved (Bercik et al. 2002), as well as depression and mood disorders 
often reported in individuals with IBD, and vice versa (cited by Bercik et al. 2010). Therefore 
using our Drosophila model, we aimed to investigate how ISC knockdown of SOCS36E 
impacts on muscle and motor function and senescence (assessed first using the negative 
geotaxis assay), and whether the midgut Jak/Stat pathway (as well as changes to the 
microflora through Ecc15 infection) is implicated in the gut-brain axis. 
 
6.2 Assessment of SOCS36E knockdown on healthspan by measuring negative geotaxis 
6.2.1 Neuromuscular function in female flies was not affected by SOCS36E knockdown and/or 
Ecc15 infection. 
The negative geotaxis assay was performed on all three experimental genotypes in females 
once a week, both in uninfected flies and flies infected with Ecc15 approximately at 1 and 2 
weeks of age. Figure 6.1 shows that in both uninfected (a) and infected (b) females, there was 
a decline in performance index (P.I), and therefore neuromuscular health, with increasing age. 
A one-way ANOVA revealed that as expected, the reductions in P.I over time were found to 
be statistically significant with earlier performance in the assay, regardless of genotype. For 
instance, with all female flies, the P.Is at days 7 and 42 were significantly higher and lower 
than those at the other 5 time points, respectively (p<0.05). With regards to overall P.I, 
SOCS36E knockdown had neither a positive nor a negative significant effect, when compared 
to both control genotypes. Knockdown of SOCS36E did however have a positive significant 
effect on performance at day 7 in female flies (p<0.05), but at all remaining time points, all 
genotypes had similar P.I values, both in uninfected and infected cohorts, so this may have 
been due to inter-vial variation. Therefore, this indicates that disrupting intestinal Jak/Stat 
through ISC-specific knockdown of SOCS36E did not affect flies’ performance in this assay, 





Ecc15 infection was found to positively affect negative geotaxis in SOCS/+ and 
EsgGAL/SOCS females at days 7 and 42, respectively (p<0.05, data not shown, statistical 
analysis shown in table 6.1).  However, these findings were obtained at individual, differing 
time points and not consistent across all three genotypes, and along with insignificant 
differences within genotypes upon infection, it can be concluded that microbial-induced 
proliferation through Ecc15  infection (along with SOCS36E knockdown) neither accelerated 
nor delayed the age-associated decline in P.I, and therefore did not affect neuromuscular 






























Figure 6.1: Assessment of neuromuscular health and functional senescence over time in 
uninfected and Ecc15-infected ISC SOCS36E knockdown female flies, plus controls. 
Performance index (±SEM) with increasing age of (a) uninfected and (b) infected 
EsgGAL/SOCS females (purple) compared with EsgGAL/+ (pink) and SOCS/+ (orange) 
control genotypes. Negative geotaxis was carried out once a week, using a minimum of 21 
flies and a maximum of 75 flies per genotype at each time point. (* = p<0.05, using a one-way 








































































0.1809 0.9726 0.6953 0.2303 
0.0486 
(+) 




0.0776 0.1397 0.0843 0.2806 0.4117 
 
Table 6.1:  P-values calculated using JMP, showing statistical significance (and near 
significance, in bold) between performance indexes in uninfected female flies and their 
infected counterparts (using a Student’s t-test).  (+) indicates a positive effect of Ecc15 




When the assay was repeated in female flies, knockdown of SOCS36E had a significant 
positive effect on overall P.I when compared to EsgGAL/+ (p=0.036). However, as overall 
performances between EsgGAL/SOCS and SOCS/+ were similar and not significant, the 
differences observed cannot be mainly attributed to the knockdown. In infected females, ISC 
knockdown of SOCS36E also had neither a positive nor a negative effect at individual time 
points of the assay (shown in figure 6.2b). Within the uninfected cohort (figure 6.2a), 
EsgGAL/SOCS flies did have the highest average P.I between 19 and 40 days, although no 
statistical significance was found between both genotypes, only compared with EsgGAL/+ 
(p<0.01). Therefore, this difference in P.I cannot be just as a result of SOCS36E knockdown, 
or may possibly be due to a somewhat less than healthy group of EsgGAL/+ females (an 
observation also discovered during the exploratory walking assay, discussed further on in this 
chapter).  
 
Figure 6.3 shows that performance in this assay was similar between all uninfected (a) and 
infected (b) flies, confirming Ecc15-induced midgut proliferation had no overall effect on P.I. 
As found in the first assay, infection had significant effects at individual time points, but not 
in all three genotypes at each time point (shown in figure 6.3a, b and c). For instance, Ecc15 
infection had a negative effect in EsgGAL/SOCS females at day 33 (figure 6.3a, p< 0.05), but 
positive effects on P.I in SOCS/+ at day 26, and EsgGAL/+ at day 33 (both p<0.01), 
suggesting infection may delay age-associated declines in this behaviour in control genotypes. 
  
In summary, using negative geotaxis, we showed that disrupting the Jak/Stat pathway through 
SOCS36E knockdown had no effect on neuromuscular health in female flies. Midgut infection 
with Ecc15 did not affect assay performance in these flies either, but may prolong further 
declines in senescence of this behaviour associated with increasing age. However, this can 












































Figure 6.2: Assessment of neuromuscular health and functional senescence over time in 
uninfected and Ecc15-infected ISC SOCS36E knockdown female flies, plus controls. 
Performance index (±SEM) with increasing age of (a) uninfected and (b) infected 
EsgGAL/SOCS females (purple) compared with EsgGAL/+ (pink) and SOCS/+ (orange) 
control genotypes. Negative geotaxis was carried out once a week, using a minimum of 21 
























































































Figure 6.3: Assessment of Ecc15 midgut infection on neuromuscular health and 
functional senescence over time using negative geotaxis in ISC SOCS36E knockdown 
female flies, plus relevant controls. Performance index (±SEM) with increasing age of (a) 
uninfected and infected EsgGAL/SOCS females, (b) uninfected and infected EsgGAL/+ 







































































































6.2.2 Neuromuscular function in male flies was not affected by SOCS36E knockdown and/or 
Ecc15 infection. 
The negative geotaxis assay was also carried out in male flies, and as found in the first assay 
conducted in female flies, there were no overall differences in P.I calculated between 
genotypes or infection groups (assessed using a one-way ANOVA). As expected, significant 
differences were found between P.Is at different time points within genotypes, and as in 
females flies, the trends observed were consistent across all three genotypes. However, 
statistical significance was only found between each of the first three time points, and the two 
final time points, suggesting a possible delay in the age-associated decline when compared to 
females. At day 7, SOCS36E knockdown in uninfected flies had a positive effect when 
performances were compared with EsgGAL/+ (p<0.05) and SOCS/+ flies (p<0.0001) (figure 
6.4). This replicates the findings from the first assay in female flies (figure 6.1a).  
 
Microbial-induced proliferation through Ecc15 infection again had very little effect on assay 
performance, with inconsistent effects observed again across genotypes and individual time 
points (data not shown, statistical analysis in table 6.2). For instance, infection had a 
significant negative effect on assay performance in EsgGAL/SOCS and SOCS/+ males at 
days 7 and 14 respectively (p<0.05), but also a positive effect in SOCS/+ males at day 35 
(p<0.05). 
 
To summarise, neither SOCS36E knockdown, nor Ecc15 infection-induced midgut 
proliferation had an overall effect on the performance index, and therefore locomotor 
senescence, of these male flies, replicating findings similar to those found in the first assay 






























Figure 6.4: Assessment of neuromuscular health and functional senescence over time in 
uninfected and Ecc15-infected ISC SOCS36E knockdown male flies, plus controls. 
Performance index (±SEM) with increasing age of (a) uninfected and (b) infected 
139EsgGAL/SOCS males (blue) compared with EsgGAL/+ (red) and SOCS/+ (green) control 
genotypes. Negative geotaxis was carried out once a week, using a minimum of 21 flies and a 
maximum of 75 flies per genotype at each time point. (* = p<0.05, using a one-way ANOVA 



















































































Table 6.2:  P-values calculated using JMP, showing statistical significance (and near 
significance, in bold) between performance indexes in uninfected male flies and their infected 
counterparts (using a Student’s t-test).  (+) indicates a positive effect of Ecc15 infection, (-) 




The negative geotaxis assay was repeated in uninfected and Ecc15-infected male flies, and as 
figure 6.5 (a) and (b) shows, knockdown of SOCS36E in ISCs had no significant effect, both 
on overall performance and at individual time points of the assay, regardless of infection 
status (both assessed using one-way ANOVAs). This confirmed that disrupting intestinal 
homeostasis via the Jak/Stat pathway did not accelerate nor delay the age-associated decline 
in neuromuscular health and functional senescence (in this assay) in male flies.  
 
Similar to the previous results in both male and female flies, no overall significant effect of 
microbial-induced midgut proliferation on assay performance was calculated for any of the 
three genotypes (p>0.05 using a one-way ANOVA). Additionally, with the exception of day 
11 in EsgGAL/+ males, where infection negatively affected P.I (p<0.05, data not shown, 
statistical analysis in table 6.3), assay performance was similar between all uninfected and 
infected males within each genotype. Together with results from figures 6.4 and 6.5, this 
reiterates that altering intestinal homeostasis in male flies by knocking down SOCS36E, as 
well as disrupting the microbiota through Ecc15 infection, had no significant overall effects 
on P.I and therefore locomotor senescence, as determined by the negative geotaxis assay. 
These results however are in conjunction with the lack of extension/shortening of lifespan in 
SOCS36E knockdown males (reported in the previous chapter), suggesting this protein is not 
involved in the health of male flies (at least through methods used here). Although we were 
unable to confirm reduced SOCS36E mRNA levels in these flies, they did exhibit increased 
stress resistance (shown later in this chapter) along with female flies, who did have a reduced 
lifespan. Therefore, these findings suggest that the lack of effect on lifespan, and lack of 













































Figure 6.5: Assessment of Ecc15 midgut infection on neuromuscular health and 
functional senescence over time using negative geotaxis in ISC SOCS36E knockdown 
male flies, plus relevant controls. Performance index (±SEM) with increasing age of (a) 
uninfected and (b) infected EsgGAL/SOCS males (blue) compared with EsgGAL/+ (red) and 
SOCS/+ (green) control genotypes. Negative geotaxis was carried out once a week, using a 




































































Genotype Age 3 11 18 25 32 



















Table 6.3:  P-values calculated using JMP, showing statistical significance (and near 
significance, in bold) between performance indexes in uninfected male flies and their infected 
counterparts (using a Student’s t-test).  (+) indicates a positive effect of Ecc15 infection, (-) 
indicates a negative effect of Ecc15 infection. 
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6.3 Assessment of exploratory walking senescence 
Another assay used to measure motor function is the exploratory walking assay, as developed 
by Martin (2004). This assesses the spontaneous walking behaviour of fruit flies and involves 
filming flies inside a piece of apparatus containing four chambers, with each chamber 
occupying one fly. The dimensions of each chamber do not permit flight so only walking 
behaviours are observed. The assay is incredibly useful as it allows the dissection and analysis 
of many walking behaviours, such as: the total distance travelled, walking velocity, the 
number of times walking direction changed, as well as the time taken to change walking 
direction. The walking behaviours can also be divided further, as initiation and cessation of 
walking, and changes in walking speed and direction have decision making and neurological 
implications. Locomotion has shown to be controlled through the central complex and 
mushroom bodies located in the Drosophila brain. Strauss and Heisenberg (1993) found 
impaired walking activity (including walking speed, and straight line walking) in 15 mutant 
fly strains that affected the central complex structure. Martin et al. (1998) found that 
disruption of mushroom bodies, either chemically or genetically, led to an increase in walking 
activity, demonstrating their role in limiting excessive walking, through terminating periods of 
activity. The walking behaviours assessed using the assay developed by Martin (2004) 
naturally senesce with increasing age in Drosophila, as well as in humans (Grotewiel et al. 
2005, Ismail et al. 2015). Therefore, this assay allows us to determine whether disrupting the 
homeostasis and microflora of flies, through knockdown of SOCS36E and infection with 
Ecc15 respectively, will ultimately affect the natural senescence of multiple parameters of 
spontaneous walking, and the possible motor or neurological implications it could lead to. We 
used this assay to measure total walking distance, walking velocity, rotation frequency (the 
number of times walking direction changed), and also latency to the first rotation (the time 
taken to first change walking direction). 
 
6.3.1 Both SOCS36E knockdown alone, and combined with Ecc15 infection had inconsistent 
effects on the age-associated decline in all walking parameters assessed in female flies 
The exploratory walking assay was performed once a week in uninfected and Ecc15-infected 
experimental female flies (as well as males) and involved randomly sampling flies across each 
genotype, assessing various parameters of walking at multiple time points over the flies’ 
lifespan. Figure 6.6 (a)-(d) compares all four parameters assessed in female flies, in both 
uninfected and infected cohorts. With the exception of rotation frequency at day 51 in 
uninfected flies, where SOCS36E knockdown had a positive effect (p<0.0001), no other 
significant differences (positive or negative) were observed between EsgGAL/SOCS flies and 
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both control genotypes, regardless of infection status. This indicates that the knockdown of 
SOCS36E in female flies did not affect any of the walking parameters assessed over the 
duration of their lifespan. Similar to the negative geotaxis results, infection with Ecc15 had 
neither positive nor negative overall effects on walking senescence in any genotype. There 
were a few select time points across parameters where infection had significant effects on 
assay performance. However, these effects were not consistent within parameters, or within 
genotypes across parameters (statistics shown in table 6.4, figures shown in Appendices 1, 3, 
5 and 7 for each parameter). Area under the curve analysis was also carried out to determine 
the total function in these female flies (Appendices 2, 4, 6 and 8), and in conjunction with the 
other results, there were no substantial differences observed, and any visible differences 
between genotypes or infection groups were not found to be statistically significant (tables 
A1-4 in Appendices).  
 
In conclusion, ISC knockdown of SOCS36E, and interruption of microflora and induction of 
proliferation in the midgut through Ecc15 infection did not alter the age-associated senescence 





















































































































































































































Figure 6.6: Assessment of senescence of (a) walking distance, (b) walking velocity, (c) 
rotation frequency and (d) latency to the first rotation in uninfected and Ecc15-infected 
SOCS36E knockdown female flies, plus controls. Data are shown as a mean value (±SEM) 
for each time point for uninfected and infected EsgGAL/SOCS females (purple) compared 
with EsgGAL/+ (blue) and SOCS/+ (orange) control genotypes. Flies were recorded for 15 
minutes each using a video camera, with a maximum of 15 flies used for each genotype at 
each time point. Videos were analysed using Ethovision XT software (Noldus). (**** = 


























































































Age 11 24 31 38 45 51 
Walking 
Distance 












0.9084 0.9578 0.1313 0.5565 0.1314 0.4634 
Latency to First 
Rotation 
0.9044 0.7471 0.3735 0.5618 0.5634 0.6195 
Walking 
Behaviour 
































Latency to First 
Rotation 








Table 6.4:  P-values calculated using JMP, showing significance (and near significance, in 
bold) between uninfected (a) EsgGAL/SOCS, (b) EsgGAL/+ and (c) SOCS/+ female flies and 
their infected counterparts (using a Student’s t-test).  (+) indicates a positive effect of Ecc15 













0.3447 0.7395 0.7799 
Walking 
Velocity 






0.6855 0.5628 0.8781 
Latency to First 
Rotation 




The walking assay was repeated in experimental female flies, and contrary to previous 
findings, there were overall negative effects of SOCS36E knockdown on walking distance, 
velocity and rotation frequency within Ecc15-infected females, when knockdown flies were 
compared with both control genotypes- EsgGAL/+ and SOCS/+ (p<0.05, using a one-way 
ANOVA with Tukey’s HSD). In uninfected females however, there were significant positive 
effects of SOCS36E knockdown for all assessed parameters, but only when compared with 
EsgGAL/+ females (distance, velocity and rotation frequency- p<0.0001, latency to the first 
rotation- p<0.05). As figures 6.7-6.11 show, uninfected EsgGAL/+ females exhibited 
unusually diminished assay performance. As the sharp behavioural decreases were not 
observed in the first experiments, nor observed in the other control flies, SOCS/+, the results 
obtained in this repeat were considered anomalous, and were not included when analysing 
effects of SOCS36E knockdown. Therefore, within uninfected flies, assay performance of 
EsgGAL/SOCS females was compared to that of SOCS/+ flies only. 
 
With the exception of latency to the first rotation, where no statistical differences were 
observed between uninfected EsgGAL/SOCS and SOCS/+ flies (figure 6.7d, left panel), 
knockdown of SOCS36E negatively affected the senescence of walking behaviours. These 
effects were observed at day 12 for walking distance and rotation frequency (p=0.0099), and 
day 16 for velocity (p=0.0078) (figure 6.7a-c, left panels), and therefore show that knockdown 
of ISC SOCS36E was disadvantageous at early time points of females’ lifespan. Regarding 
latency to the first rotation, these results mirrored those from the first experiment (figure 6.6d, 
left panel), so therefore indicates that dysregulation of intestinal homeostasis through 
SOCS36E knockdown alone had no effect on this behaviour. 
 
When determining the effect of ISC SOCS36E knockdown within female flies with induced 
midgut proliferation (through Ecc15 infection), results contrasted those of both uninfected 
females, and infected females from the first experiment (figure 6.6a-d, right panels). 
Compared to both control genotypes, EsgGAL/SOCS had significant reductions in walking 
distance, velocity and rotation frequency; all at days 19 and 26 (p<0.01). SOCS36E 
knockdown in infected females also led to increased latency to the first rotation, thus 
demonstrating further negative effects, at day 26 (p<0.0001 and p=0.0001 compared to 
EsgGAL/+ and SOCS/+, respectively). Collectively, these observations indicate that 
knockdown of ISC SOCS36E coupled with infection-induced midgut proliferation was 
detrimental to multiple parameters of walking, and accelerated the age-associated declines in 








































































































































































































































Figure 6.7: Assessment of senescence of (a) walking distance, (b) walking velocity, (c) 
rotation frequency and (d) latency to the first rotation in uninfected and Ecc15-infected 
SOCS36E knockdown female flies, plus controls. Data are shown as a mean value (±SEM) 
for each time point for uninfected and infected EsgGAL/SOCS females (purple) compared 
with EsgGAL/+ (blue) and SOCS/+ (orange) control genotypes. Flies were recorded for 15 
minutes each using a video camera, with a maximum of 15 flies used for each genotype at 
each time point. Videos were analysed using Ethovision XT software (Noldus). (** = p<0.01, 









































































We then assessed the effects of infection-induced midgut proliferation on exploratory walking 
within each genotype. Ecc15 infection negatively affected overall assay performance of 
EsgGAL/SOCS females for all walking parameters (p<0.0001 for distance, velocity, and 
rotation frequency, p=0.0019 for rotation latency), and also with rotation frequency in 
SOCS/+ flies (p=0.0458) (analysed using a Student’s t-test). As observed in figure 6.7 (a-d, 
right panels), assay performance of infected EsgGAL/+ females was similar to that of SOCS/+ 
flies. Within the EsgGAL/+ cohort, uninfected females had greatly reduced walking speed, 
walking distances and rotation frequencies at several time points in comparison to infected 
females (figures 6.8b and e, and 6.9b, right panel). Ecc15 infection was found to have overall 
significant positive effects on these three behaviours in EsgGAL/+ flies (p<0.0001), indicating 
that infection rescued the diminished walking phenotypes in these flies. Assay performance of 
uninfected EsgGAL/+ was so negatively affected, that Ecc15 infection had significant positive 
results at multiple time points within each walking parameter between days 16 and 40 
(p<0.05), often with overlapping time points between parameters. 
 
Supporting results shown in figure 6.7 (a-c, right panels), infection with Ecc15 had consistent 
negative effects in EsgGAL/SOCS females, reducing assay performance at days 19 and 26 for 
walking distance (p=0.0001 and p<0.0001, respectively, figure 6.8a), velocity (p=0.0001 and 
p<0.0001, respectively, figure 6.8d) and rotation frequency (p<0.0001, figure 6.9a). 
Significant decreases were also observed in velocity at day 40 (p=0.0213), and in rotation 
latency at days 26 and 40 (p=0.0002, as shown in figure 6.9d).  Therefore, results of figure 
6.7-6.9 indicate that infection-induced midgut proliferation in EsgGAL/SOCS females 
accelerated the age-associated senescence of all assessed walking behaviours. Similarly, 
negative effects of infection-induced proliferation were observed in SOCS/+ flies at days 12 
and 16 for walking distance (p=0.0007 and p=0.0088, respectively), velocity (p=0.0011 and 
p=0.0014, respectively) and rotation frequency (p=0.0025 and p=0.0108, respectively), as 
well as rotation latency at day 12 only (p=0.0067). Interestingly, Ecc15 infection also 
positively affected distance (p=0.0019), velocity (p=0.0052) and rotation frequency 
(p=0.0212) at day 40 too. As these phenotypes occurred earlier than those in EsgGAL/SOCS, 



























Figure 6.8: The effect of Ecc15 infection on the age-associated decline of walking 
distance and velocity in SOCS36E knockdown and control female flies.  Data are shown 
as a mean value (±SEM) for each time point for uninfected and infected (a) and (d) 
EsgGAL/SOCS, (b) and (e) EsgGAL/+ and (c) and (f) SOCS/+ female flies. (* = p<0.05, ** = 
p<0.01, *** = p<0.001, **** = p<0.0001, using a Student’s t-test). 





































































































































































































































Figure 6.9: The effect of Ecc15 infection on the age-associated decline of rotation 
frequency, and latency to the first rotation in SOCS36E knockdown and control female 
flies. Data are shown as a mean value (±SEM) for each time point for uninfected and infected 
(a) and (d) EsgGAL/SOCS, (b) and (e) EsgGAL/+ and (c) and (f) SOCS/+ female flies. (* = 
p<0.05, ** = p<0.01, *** = p<0.001, **** = p<0.0001, using a Student’s t-test). 






















































































































































































































Area under the curve analysis was conducted to determine the total function of each parameter 
within genotypes, and assess potential effects of ISC SOCS36E knockdown and/or infection-
induced midgut proliferation. Consistent with results in figures 6.7-6.9, knockdown of 
SOCS36E significantly decreased total function of distance walked (p<0.0001, figure 6.10a), 
walking velocity (p<0.0001, figure 6.10b) and rotation frequency (p<0.001, figure 6.11a) in 
Ecc15-infected females. SOCS36E knockdown also led to decreased total function of velocity 
within uninfected flies (p=0.0188, figure 6.10b), although within the EsgGAL/SOCS cohort, 
Ecc15 infection significantly decreased the total function for all four walking parameters that 
were assessed (p<0.01, as shown in tables 6.5 and 6.6). Furthermore, EsgGAL/SOCS 
exhibited the lowest total function for rotation latency within the uninfected cohort of flies 
(figure 6.10b), demonstrating a positive outcome of dysregulated midgut Jak/Stat signalling, 
as this was the only behaviour where increases have negative connotations. 
 
From the second set of results, it can be proposed that after discounting the data from 
uninfected EsgGAL/+ females, disrupting intestinal homeostasis through knockdown of 
SOCS36 in the ISCs of female flies led to decreases during early life in three of the four 
assessed parameters. Altering the midgut microbiota and inducing ISC proliferation through 
introduction of Ecc15 also had a negative effect on exploratory walking- both over time and 
on total function- and exacerbated the age-associated declines in these behaviours. Therefore, 
these results give an indication that changes within the midgut environment were implicated 
in neurological-regulated behaviours. However, when coupled with the data from the first 
experiment, the observed effects seen in figures 6.7-6.11 can only be confirmed with a further 



































Figure 6.10: Total function of (a) distance walked, and (b) walking velocity (±SEM) in 
uninfected and Ecc15-infected SOCS36E knockdown female flies, plus controls. Total 
function was determined using the area under the curve at each time point of the assay, with a 
maximum of 15 flies used at each time point for each genotype and infection group. (* = 
p<0.05, ** = p<0.001, *** = p<0.0001, using a one-way ANOVA with Tukey’s HSD. # = 



















































































































x <0.0001 0.0188 <0.0001   
EsgGAL/+ 
Uninfected 
<0.0001 x   <0.0001  
SOCS/+ 
Uninfected 




<0.0001   x <0.0001 <0.0001 
EsgGAL/+ 
Infected 
 <0.0001  <0.0001 x  
SOCS/+ 
Infected 
  0.0066 <0.0001  x 
 
 
Table 6.5:  P-values calculated using JMP, showing significance (in bold) between uninfected 
and Ecc15-infected knockdown females and their relevant controls (using a one-way ANOVA 
with Tukey’s HSD), as well as between uninfected female flies and their infected counterparts 



















x 0.0001 0.1184 <0.0001   
EsgGAL/+ 
Uninfected 
0.0001 x   <0.0001  
SOCS/+ 
Uninfected 




<0.0001   x <0.0001 <0.0001 
EsgGAL/+ 
Infected 
 <0.0001  <0.0001 x  
SOCS/+ 
Infected 
  0.0524 <0.0001  x 
(b) Walking Velocity 























Figure 6.11: Total function of (a) rotation frequency, and (b) latency to the first rotation 
(±SEM) in uninfected and Ecc15-infected SOCS36E knockdown female flies, plus 
controls. Total function was determined using the area under the curve at each time point of 
the assay, with a maximum of 15 flies used at each time point for each genotype and infection 
group. (* = p<0.01, ** = p<0.001, *** = p<0.0001, using a one-way ANOVA with Tukey’s 



























































































































x 0.0008 0.0091 0.0018   
EsgGAL/+ 
Uninfected 
0.0008 x   0.9261  
SOCS/+ 
Uninfected 




0.0018   x 0.5232 0.3510 
EsgGAL/+ 
Infected 
 0.9261  0.5232 x  
SOCS/+ 
Infected 
  0.9967 0.3510  x 
 
 
Table 6.6:  P-values calculated using JMP showing significance (in bold) between uninfected 
and Ecc15-infected knockdown females and their relevant controls (using a one-way ANOVA 
with Tukey’s HSD), as well as between uninfected female flies and their infected counterparts 




















x <0.0001 0.9143 <0.0001   
EsgGAL/+ 
Uninfected 
<0.0001 x   <0.0001  
SOCS/+ 
Uninfected 




<0.0001   X <0.0001 0.0001 
EsgGAL/+ 
Infected 
 <0.0001  <0.0001 x  
SOCS/+ 
Infected 
  0.0009 0.0001  x 
(b) Latency to the First Rotation 
(a) Rotation Frequency 
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6.3.6 Knockdown of SOCS36E alone, or coupled with infection-induced midgut proliferation, 
accelerated the age-associated declines in exploratory walking behaviours in male flies 
The exploratory walking assay was performed in experimental male flies, alongside female 
flies, and also assessed the effect of dysregulated ISC proliferation (through knockdown of the 
Drosophila Jak/Stat pathway inhibitor, SOCS36E), with or without non-lethal midgut 
infection (using the Gram-negative phytopathogen, Ecc15) on the same parameters of 
walking. The first set of male results contrasted those of the first female set in that knockdown 
of SOCS36E in infected flies was found to have overall negative effects on walking distance 
and rotation frequency, when compared with both control genotypes (p<0.05, and p<0.01, 
respectively). For these parameters, SOCS36E knockdown in uninfected flies led to 
significant decreases in assay performance at day 31, in relation to both controls (p<0.05, as 
shown in figure 6.12a and c). Upon infection with Ecc15 however, these decreases were 
observed one week earlier, at day 24 (p<0.01 and p<0.001 for distance and rotation frequency, 
respectively), along with a significant reduction in distance walked relative to controls at day 
31 as well (p<0.05). Consistent with these results, assay performance was also negatively 
affected for velocity and rotation latency at day 24 (p<0.01, shown in figure 6.12b and d). The 
results in figure 6.12 indicate that knockdown of ISC SOCS36E, either alone or coupled with 
Ecc15-infection induced midgut proliferation accelerated age-associated declines in several 
parameters of exploratory walking. However, where accelerations were observed in 









































































































































































































Figure 6.12: Assessment of senescence of (a) walking distance, (b) walking velocity, (c) 
rotation frequency and (d) latency to the first rotation in uninfected and Ecc15-infected 
SOCS36E knockdown male flies, plus controls. Data are shown as a mean value (±SEM) 
for each time point for uninfected and infected EsgGAL/SOCS males (blue) compared with 
EsgGAL/+ (red) and SOCS/+ (green) control genotypes. Flies were recorded for 15 minutes 
each using a video camera, with a maximum of 15 flies used for each genotype at each time 
point. Videos were analysed using Ethovision XT software (Noldus). (* = p<0.05, ** = 











































































Consistent with findings from figure 6.12, Ecc15 infection was found to exert significant 
negative effects on overall assay performance for all four parameters assessed within 
EsgGAL/SOCS flies (p<0.05). Also within this genotype, infection-induced proliferation led 
to significant declines at day 24 for distance walked (p=0.0009), walking velocity (p=0.0007) 
and rotation frequency (p<0.0001) (compared with uninfected EsgGAL/SOCS, shown in 
figure 6.13a and b, and figure 6.14a top panels, respectively). Rotation latency was also 
negatively affected at day 24 (p=0.0089, figure 6.14b, top panel), although this is a behaviour 
that displays age-associated increases. These results were exclusive to EsgGAL/SOCS males, 
as although infection negatively affected overall distance walked and rotation frequency in 
EsgGAL/+ flies (p=0.0138, and p=0.0358, respectively), no significant differences were 
observed at any of the five time points for all assessed parameters (figures 6.13 and 6.14, 
middle panels. The effects of infection in SOCS/+ were different again, both compared to 
EsgGAL/SOCS and EsgGAL/+ flies, and across parameters within the genotype, as Ecc15-
induced midgut proliferation had an overall positive effect on rotation frequency (p=0.0351), 
significantly increasing the average number of rotations at day 31 (p=0.0111, figure 6.14c, 
bottom panel), and also positively affecting walking distance and velocity at day 31 too 
























Figure 6.13: The effect of Ecc15 infection on the age-associated decline on walking 
distance and velocity in SOCS36E knockdown and control male flies.  Data are shown as 
a mean value (±SEM) for each time point for uninfected and infected (a) and (d) 
EsgGAL/SOCS, (b) and (e) EsgGAL/+ and (c) and (f) SOCS/+ male flies. (* = p<0.05, ** = 


















































































































































































































Figure 6.14: The effect of Ecc15 infection on the age-associated decline on rotation 
frequency, and latency to the first rotation in SOCS36E knockdown and control male 
flies. Data are shown as a mean value (±SEM) for each time point for uninfected and infected 
(a) and (d) EsgGAL/SOCS, (b) and (e) EsgGAL/+ and (c) and (f) SOCS/+ male flies. (* = 
p<0.05, ** = p<0.01, **** = p<0.0001, using a Student’s t-test). 
















































































































































































































In addition to effects of SOCS36E knockdown, and Ecc15 infection on age-associated 
declines in walking behaviour, we also assessed the impact of these factors on total function, 
using area under the curve analysis. Consistent with figures 6.12-6.14, the total function of all 
four parameters were negatively affected following knockdown of ISC SOCS36E within 
infected flies (distance, velocity and rotation latency: p<0.05, rotation frequency: p<0.01, 
compared with both infected control genotypes) (shown in figures 6.15 and 6.16, a and b). 
Knockdown alone appeared to have visibly negative effects on total function too, although 
where significance was reached, it did not occur between EsgGAL/SOCS flies and both 
EsgGAL/+ and SOCS/+ controls (figure 6.15a and b, and figure 6.16a, with statistical values 
shown in tables 6.7 and 6.8). In agreement with findings in figures 6.13 and 6.14 
demonstrating the effects of Ecc15 within each genotype, infection led to significant decreases 
in total functions of distance walked (p=0.0387), velocity (p=0.0172) and rotation frequency 
(p=0.0121). Furthermore, although infection-induced proliferation had positive effects on 
three of the four walking behaviours at day 31 in SOCS/+ males, the increases must not have 
been that substantial as a whole as total function was only significantly increased with rotation 
frequency (p=0.0336, figure 6.16a). Similarly, Ecc15 significantly decreased the overall 
distance walked and number of rotations exhibited by EsgGAL/+, although no differences in 
total function for all parameters were observed within this genotype. 
 
In conclusion, the results from this experiment demonstrated that disrupting midgut 
homeostasis through knockdown of SOCS36E can be detrimental to some parameters of 
walking, although all four parameters were negatively affected following increased midgut 
proliferation in these flies, due to accelerations of age-associated behavioural declines and the 
overall performance and total function of each parameter. Therefore, due to changes in 
neurally-regulated behaviours as a result of disrupted homeostasis, our findings suggest a role 




























Figure 6.15: Total function of (a) distance walked and (b) walking velocity (±SEM) in 
uninfected and Ecc15-infected SOCS36E knockdown male flies, plus controls. Total 
function was determined using the area under the curve at each time point of the assay, with a 
maximum of 15 flies used at each time point for each genotype and infection group. (* = 
p<0.05, ** = p<0.001, *** = p<0.0001, using a one-way ANOVA with Tukey’s HSD. # = 














































































































x 0.5138 0.0005 0.0172   
EsgGAL/+ 
Uninfected 
0.5138 x   0.4190  
SOCS/+ 
Uninfected 




0.0172   x 0.0205 <0.0001 
EsgGAL/+ 
Infected 
 0.4190  0.0205 x  
SOCS/+ 
Infected 
  0.2378 <0.0001  x 
 
 
Table 6.7:  P-values calculated using JMP showing significance (in bold) between uninfected 
and Ecc15-infected knockdown males and their relevant controls (using a one-way ANOVA 
with Tukey’s HSD), as well as between uninfected and infected knockdown male flies (using 




















x 0.0853 0.0009 0.0387   
EsgGAL/+ 
Uninfected 
0.0853 x   0.1420  
SOCS/+ 
Uninfected 




0.0387   x 0.0131 <0.0001 
EsgGAL/+ 
Infected 
 0.1420  0.0131 x  
SOCS/+ 
Infected 
  0.4606 <0.0001  x 
(b) Walking Velocity 



























Figure 6.16: Total function of (a) rotation frequency, and (b) latency to the first rotation 
(±SEM) in uninfected and Ecc15-infected SOCS36E knockdown male flies, plus controls. 
Total function was determined using the area under the curve at each time point of the assay, 
with a maximum of 15 flies used at each time point for each genotype and infection group. (* 
= p<0.05, ** = p<0.001, *** = p<0.0001, using a one-way ANOVA with Tukey’s HSD. # = 

















































Rotation Frequency  























































Table 6.8:  P-values calculated using JMP showing significance (in bold) between uninfected 
and Ecc15-infected knockdown males and their relevant controls (using a one-way ANOVA 
with Tukey’s HSD), as well as between uninfected and infected male flies (using a Student’s 



















x 0.1689 0.0086 0.0121   
EsgGAL/+ 
Uninfected 
0.1689 x   0.4006  
SOCS/+ 
Uninfected 




0.0121   x 0.001 <0.0001 
EsgGAL/+ 
Infected 
 0.4006  0.001 x  
SOCS/+ 
Infected 




















x 0.9142 0.9988 0.1137   
EsgGAL/+ 
Uninfected 
0.9142 x   0.4646  
SOCS/+ 
Uninfected 




0.1137   x 0.036 0.0058 
EsgGAL/+ 
Infected 
 0.4646  0.036 x  
SOCS/+ 
Infected 
  0.0924 0.0058  x 
(b) Latency to the First Rotation 
(a) Rotation Frequency 
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When the exploratory walking assay was repeated in male flies, the findings mirrored those 
found in the repeat results for females, in that uninfected EsgGAL/+ males displayed greatly 
diminished assay performance for multiple parameters (as shown in figures 6.17-6.21). As a 
result, this led to overall positive effects of SOCS36E knockdown (compared to uninfected 
EsgGAL/+ males) and also overall positive effects of Ecc15 infection (with infection 
appearing to rescue affected assay behaviour again, also seen in figures 6.8 and 6.9), for all 
four assessed walking behaviours (p<0.05). Although these findings indicate that the genotype 
in general was affected, rather than just EsgGAL/+ females, the cause is still unknown. 
Therefore, due to differences in assay performance between the two uninfected control 
genotypes in this set of experiments, and also between uninfected EsgGAL/+ males in both 
sets of experiments, we chose to regard this data as anomalous, and therefore were not 
included when considering effects of SOCS36E knockdown (with assay performance of 
uninfected EsgGAL/SOCS males compared to that of SOCS/+ flies only). 
 
Within uninfected male flies, knockdown of ISC SOCS36E alone had more of a negative 
effect on walking behaviour in this second set of experiments as knockdown was found to 
decrease the overall distance walked (p=0.0005), walking velocity (p=0.003) and rotation 
frequency (p<0.0001), when compared to SOCS/+. Figure 6.17 (a)-(c) (left panels) show that 
SOCS36E knockdown significantly reduced walking distance and rotation frequency at both 
19 and 26 days of age (p<0.05, and p<0.001, respectively), as well as walking speed at day 26 
(p=0.0004). These results indicate that this ISC-specific knockdown led to acceleration in the 
age-associated declines in multiple walking behaviours. Interestingly, both walking distance 
and velocity were positively affected at day 47 in EsgGAL/SOCS flies, and this was in 
comparison to both SOCS/+ (p=0.0392, and p=0.0279, respectively) and EsgGAL/+ controls 
(p=0.0168, and p=0.0184, respectively). As figure 6.17 (d) (left panel) shows, all three 
experimental genotypes exhibited similar rotation latencies over the course of the walking 
assay, and mirrors the findings depicted in figure 6.12 (d), thus indicating ISC knockdown of 
SOCS36E alone did not affect age-associated changes in this particular walking behaviour. 
 
Results of ISC SOCS36E knockdown in Ecc15-infected flies also differed from those in the 
first experiment in that the combined effects of these variables did not affect walking 
behaviours to the same extent, as no overall effects of SOCS36E knockdown (neither positive 
nor negative) on any parameter were found. Assay performance was negatively affected by 
SOCS36E knockdown in infected flies (figure 6.17a, b and c, right panels), although at 
different time points from those originally found; at 12 days of age, compared to day 24 (in 
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figure 6.12). However, these negative effects were observed in multiple parameters- distance 
(p<0.05), velocity (p<0.01) and rotation frequency (p<0.05) - therefore demonstrating 
SOCS36E knockdown and infection-induced midgut proliferation consistently diminished 
performance in this assay. These results are also in agreement with published findings that 
enteric infection early on in life can cause cognitive impairments, as well as increased 
morbidity (Bergstrom et al. 2012, Kolling et al. 2012). There were no significant effects 
observed of SOCS36E and Ecc15 infection on latency to the first rotation (figure 6.17d), 
unlike in figure 6.12 (d), where age-associated increases were found to be accelerated at 24 




































































































































































































Figure 6.17: Assessment of senescence of (a) walking distance, (b) walking velocity, (c) 
rotation frequency and (d) latency to the first rotation in uninfected and Ecc15-infected 
SOCS36E knockdown male flies, plus controls. Data are shown as a mean value (±SEM) 
for each time point for uninfected and infected EsgGAL/SOCS males (blue) compared with 
EsgGAL/+ (red) and SOCS/+ (green) control genotypes. Flies were recorded for 15 minutes 
each using a video camera, with a maximum of 15 flies used for each genotype at each time 
point. Videos were analysed using Ethovision XT software (Noldus). (* = p<0.05, ** = 









































































Unlike our previous findings, Ecc15 infection did not exert any overall significant positive or 
negative effects on any of the four parameters assessed in EsgGAL/SOCS flies. Consistent 
with figure 6.17 (a)-(c) though, where positive effects of SOCS36E knockdown alone were 
observed at day 47, Ecc15 infection was also found to significantly reduce distance walked 
(p=0.0378), and velocity (p=0.0258) in EsgGAL/SOCS males at this time point, with effects 
on rotation frequency not quite reaching significance (p=0.0575). Unlike figure 6.14 (d), 
where Ecc15 infection accelerated age-associated increases in first rotation latency at day 24, 
we found infection positively decreased rotation latency in EsgGAL/SOCS flies at day 19 
(p=0.036). 
 
Also contrasting previous results, infection-induced midgut proliferation elicited overall 
negative effects in SOCS/+ males for walking distance (p=0.0052), velocity (p=0.0182) and 
rotation frequency (p=0.0002), compared to positive effects found initially. The time points at 
which infection induced behavioural reductions were also consistent across these three 
parameters too, at 19, 26 and 40 days of age, along with rotation latency (shown in figure 
6.18c and f, bottom panels, and figure 6.19c, bottom panel). Therefore, similar to findings in 
EsgGAL/SOCS males in the first set of experiments, Ecc15 infection consistently accelerated 
























Figure 6.18: The effect of Ecc15 infection on the age-associated decline on walking 
distance and velocity in SOCS36E knockdown and control male flies.  Data are shown as 
a mean value (±SEM) for each time point for uninfected and infected (a) and (d) 
EsgGAL/SOCS, (b) and (e) EsgGAL/+ and (c) and (f) SOCS/+ male flies. (* = p<0.05, ** = 

















































































































































































































Figure 6.19: The effect of Ecc15 infection on the age-associated decline on rotation 
frequency, and latency to the first rotation in SOCS36E knockdown and control male 
flies. Data are shown as a mean value (±SEM) for each time point for uninfected and infected 
(a) and (d) EsgGAL/SOCS, (b) and (e) EsgGAL/+ and (c) and (f) SOCS/+ male flies. (* = 
p<0.05, ** = p<0.01, **** = p<0.0001, using a Student’s t-test). 

























































































































































































































The total function of each parameter in the experimental male flies was also assessed through 
area under the curve analysis, and in conjunction with our age-associated findings (figure 
6.17), knockdown of SOCS36E significantly reduced the total function of walking distance 
(p=0.0004), velocity (p=0.0017) and rotation frequency (p<0.0001), relative to SOCS/+ 
within uninfected males (shown in figure 6.20a and b, and 6.21a). In this experiment, no 
significant (positive nor negative) effects were observed upon knockdown of SOCS36E in 
Ecc15-infected males, when compared with both infected controls (and also individually). 
Although this is supported by findings in figure 6.17 (right panels) where less dramatic effects 
of knockdown in infected flies were observed relative to figure 6.12, this largely contrasts 
findings from the initial analysis of total function (figures 6.15 and 6.16). Further to infection 
only negatively affecting performance of EsgGAL/SOCS males at select time points (rather 
than overall as found previously), there were no differences upon Ecc15 infection within the 
EsgGAL/SOCS cohort. Infection-induced midgut proliferation consistently induced negative 
effects on total function in SOCS/+ males; for distance walked (p=0.0153), velocity 
(p=0.0326), rotation frequency (p<0.0001) and also latency to the first rotation (p=0.0225), 
supporting findings depicted in figures 6.18 and 6.19 (c) and (f) of infection effects during 
their lifespan. 
 
In conclusion, these repeated set of results showed that disrupting Jak/Stat signalling through 
ISC-specific knockdown of SOCS36E accelerated the age-associated senescence in multiple 
parameters of exploratory walking, and negatively affected the total functions of these 
behaviours too. Unlike previous results in both males and females, midgut infection with 
Ecc15 had very little effect on assay performance in EsgGAL/SOCS males, although negative 
effects were found at one time point in two of the four parameters (day 47).  Due to the 
disparities between the two sets of results and the diminished assay performance of uninfected 
EsgGAL/+ males, a third set of data would ideally be needed to confirm any effects SOCS36E 
knockdown and/or Ecc15 infection had on these walking behaviours. Although results 
differed between genders within experimental repeats, and also within genders across the two 
sets of results, it can be deduced that knockdown of SOCS36E alone, or coupled with Ecc15 
infection, did produce a negative phenotype in these experiments. As no effects were obtained 
in the negative geotaxis experiments, it can be concluded that SOCS36E knockdown, with or 




























Figure 6.20: Total function of (a) distance walked, and (b) walking velocity (±SEM) in 
uninfected and Ecc15-infected SOCS36E knockdown male flies, plus controls. Total 
function was determined using the area under the curve at each time point of the assay, with a 
maximum of 15 flies used at each time point for each genotype and infection group. (* = 
p<0.01, ** = p<0.001, *** = p<0.0001, using a one-way ANOVA with Tukey’s HSD. # = 


















































































































x <0.0001 0.0017 0.3658   
EsgGAL/+ 
Uninfected 
<0.0001 x   <0.0001  
SOCS/+ 
Uninfected 




0.3658   x 0.4168 0.4396 
EsgGAL/+ 
Infected 
 <0.0001  0.4168 x  
SOCS/+ 
Infected 
  0.0326 0.4396  x 
 
 
Table 6.9:  P-values calculated using JMP showing significance (in bold) between uninfected 
knockdown males and their relevant controls (using a one-way ANOVA with Tukey’s HSD), 
as well as between uninfected and Ecc15-infected control male flies (using a Student’s t-test), 



















x 0.0002 0.0004 0.9433   
EsgGAL/+ 
Uninfected 
0.0002 x   <0.0001  
SOCS/+ 
Uninfected 




0.9433   x 0.8530 0.8594 
EsgGAL/+ 
Infected 
 <0.0001  0.8530 x  
SOCS/+ 
Infected 
  0.0153 0.8594  x 
(b) Walking Velocity 
























Figure 6.21: Total function of (a) rotation frequency, and (b) latency to the first rotation 
(±SEM) in uninfected and Ecc15-infected SOCS36E knockdown male flies, plus controls. 
Total function was determined using the area under the curve at each time point of the assay, 
with a maximum of 15 flies used at each time point for each genotype and infection group. (* 
= p<0.001, ** = p<0.0001, using a one-way ANOVA with Tukey’s HSD. # = p<0.05, ## = 























































































































x 0.2359 0.3194 0.5043   
EsgGAL/+ 
Uninfected 
0.2359 x   0.0208  
SOCS/+ 
Uninfected 




0.5043   x 0.9961 0.1977 
EsgGAL/+ 
Infected 
 0.0208  0.9961 x  
SOCS/+ 
Infected 
  0.0225 0.1977  x 
 
 
Table 6.10:  P-values calculated using JMP showing significance (in bold) between 
uninfected knockdown males and their relevant controls (using a one-way ANOVA with 
Tukey’s HSD), as well as between uninfected and Ecc15-infected control male flies (using a 




















x 0.0008 <0.0001 0.4634   
EsgGAL/+ 
Uninfected 
0.0008 x   <0.0001  
SOCS/+ 
Uninfected 




0.4634   x 0.6181 0.9991 
EsgGAL/+ 
Infected 
 <0.0001  0.6181 x  
SOCS/+ 
Infected 
  0.0056 0.9991  x 
(b) Latency to the First Rotation 
(a) Rotation Frequency 
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6.4 Assessment of ISC-specific knockdown of SOCS36E on stress resistance 
Stress resistance studies have been performed on Drosophila for several decades, assessing 
such stressors as exposure to high and low temperatures, and resistance to starvation, 
dessication and oxidative stress. Such experiments can help determine the mechanisms and 
signalling pathways involved in increased sensitivity or tolerance of particular stressors. 
However, many results have revealed a common association of stress resistance with lifespan, 
in that an increase is often found with extended lifespan, as well as the reciprocal of decreased 
resistance coupled with shortened lifespan (Arking et al. 1991, Luckinbill 1998, Mockett et al. 
2001). Functional senescence has also been implicated in this relationship, with senescence of 
locomotor behaviours coupled with decreased lifespan and decreased oxidative stress 
resistance, and vice versa. However, this is not always the case, as gain of function in 
Superoxide dismutase 1 (Sod1, an antioxidant enzyme) led to extended lifespan and increased 
oxidative stress resistance, but had no effect on functional senescence (reviewed by Jones and 
Grotewiel 2011). Results obtained here showed that ISC-specific knockdown on SOCS36E 
neither delayed nor accelerated functional senescence (as assessed using negative geotaxis), 
and led to a decrease in median lifespan, although this was exclusive to female flies. 
Knockdown of SOCS36E (either alone or coupled with midgut infection) also produced a 
negative phenotype regarding spontaneous locomotor behaviour although these results were 
not as distinct. Therefore, we used our ISC-SOCS36E knockdown Drosophila model to 
determine whether intestinal Jak/Stat signalling is implicated in stress resistance, especially as 
regulated midgut homeostasis has already been shown to be essential for survival of fruit flies. 
Also, we aimed to investigate whether our model follows previous findings, and determine 
whether the shortening of lifespan (in female flies at least) would result in increased stress 
sensitivity. 
 
6.4.1 ISC-specific knockdown of SOCS36E was beneficial to male and female flies under 
starvation conditions. 
The first stressor investigated in experimental flies was resistance to starvation. From 4 days 
following eclosion, all flies were maintained in vials consisting of 1.5% agar, rather than 
standard food, with survival analysis then carried out daily for both genders as previously 
described. Figure 6.22 shows the survival analysis under starvation conditions for (a) female 
and (b) male experimental flies, with table 6.11 showing the median, maximum, and mean 
lifespans for all six groups of flies. Despite figure 6.22 (a) showing slight differences in the 
median lifespans of all three female genotypes, all three were calculated to have median 
lifespans of 2.5 days (shown in table 6.11). EsgGAL/SOCS females however, were found to 
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have a higher maximum lifespan of 4.5 days, compared with 3.5 for both control genotypes, 
and a slightly higher mean lifespan of 3.4 days, compared with 3.1 and 2.8 days for 
EsgGAL/+ and SOCS/+ females, respectively. Using the chi-squared p-value log-rank test, 
the differences in survival between EsgGAL/SOCS and SOCS/+ females were found to be 
statistically significant (p<0.0001). Unfortunately, differences between EsgGAL/SOCS and 
EsgGAL/+ females did not quite reach significance (p=0.055), perhaps due to the similarities 
in both median and mean lifespans, although these results could indicate that knockdown of 
SOCS36E could be slightly advantageous for female flies under starvation conditions. 
 
Figure 6.22 (b) shows a more clear-cut difference in median lifespans between 
EsgGAL/SOCS males and the two control genotypes (which were 3.5 and 2.5 days 
respectively). However, in spite of how survival results are depicted for EsgGAL/SOCS 
males, the median, maximum and mean lifespans for these flies were all calculated to be 3.5 
days (shown in table 6.11). The maximum lifespans of the control genotypes were also 3.5 
days (in contrast to the trend seen in females), with mean lifespans both found to be 3.0- half a 
day less than EsgGAL/SOCS. The increases in both median and mean lifespans in 
EsgGAL/SOCS were found to be highly significant when compared with both EsgGAL/+ and 
SOCS/+ males (p<0.0001, assessed using the chi-squared p-value log-rank test), showing that 
knockdown of SOCS36E was beneficial during starvation in both male and female flies. 
 







EsgGAL/SOCS Female 2.5 4.5 3.4 
EsgGAL/+ Female 2.5 3.5 3.1 
SOCS/+ Female 2.5 3.5 2.8 
EsgGAL/SOCS Male 3.5 3.5 3.5 
EsgGAL/+ Male 2.5 3.5 3.0 
SOCS/+ Male 2.5 3.5 3.0 
 
Table 6.11: Median, maximum and mean lifespans of both female and male SOCS36E 






















Figure 6.22: Survival analysis of (a) female and (b) male SOCS36E knockdown flies 
during starvation, compared with control genotypes, EsgGAL/+ and SOCS/+.  Survival 
of (a) EsgGAL/SOCS female flies (purple), compared with EsgGAL/+ (blue) and SOCS/+ 
(turquoise) control genotypes, along with (b) EsgGAL/SOCS male flies (green), compared 
with EsgGAL/+ (yellow) and SOCS/+ (orange) control genotypes. (Red line indicates median 
lifespan). (n=100). Differences in lifespans between EsgGAL/SOCS, and SOCS/+ in females, 
and between EsgGAL/SOCS, and EsgGAL/+ and SOCS/+ within males were calculated using 







































6.4.2 ISC-specific knockdown of SOCS36E was beneficial under conditions of oxidative 
stress. 
In this experiment, after 4 days post-eclosion on standard food, male and female experimental 
flies were transferred to vials containing 1.5% agar, with 5% sugar and 5% H2O2, with 
survival analysis then carried out daily. Figure 6.23 shows survival curves of all three 
experimental genotypes in (a) female and (b) male flies following exposure to H2O2, and as 
shown in figure 6.22 (a), the median lifespan of EsgGAL/SOCS females appears to be slightly 
higher than those of the control genotypes. However, as table 6.12 shows, all female flies had 
median lifespans of 2.5 days. All three female genotypes also exhibited maximum lifespans of 
3.5 days following exposure to H2O2, although mean lifespans differed in that EsgGAL/SOCS 
females had a mean lifespan of 3.4 days, with both control genotypes exhibiting mean 
lifespans of 3.1 days. Despite similarities in all three lifespan values for the knockdown and 
control females, a chi-squared p-value log-rank test found significant differences between the 
lifespans of EsgGAL/SOCS and both EsgGAL/+ (p<0.01) and SOCS/+ (p<0.001) females. 
This suggests that knockdown of SOCS36E led to an increase in average lifespan following 
an increase in oxidative stress through exposure to H2O2. 
 
Although figure 6.23 (b) does not to appear to show differences in median lifespan as distinct 
as those in 6.22 (b) between knockdown and control males, the median lifespan of 
EsgGAL/SOCS males was calculated to be one day higher than both controls, at 3.5 days 
(table 6.12). This echoes the results of table 6.11, along with all three cohorts of male flies 
having maximum lifespans of 3.5 days. When mean lifespans were compared, EsgGAL/SOCS 
males had the longest again with 3.7 days, compared with 3.2 and 3.5 days found in 
EsgGAL/+ and SOCS/+ males, respectively- a trend also seen in the female flies following 
H2O2 exposure. A chi-squared p-value log-rank test found statistical significance when 
EsgGAL/SOCS flies were compared with both EsgGAL/+ (p<0.0001) and SOCS/+ (p<0.05) 
males. These results confirm the ability that SOCS36E knockdown is able to prolong mean 
lifespan after exposure to H2O2 is not gender specific, although an increase in median lifespan 












EsgGAL/SOCS Female 2.5 3.5 3.4 
EsgGAL/+ Female 2.5 3.5 3.1 
SOCS/+ Female 2.5 3.5 3.1 
EsgGAL/SOCS Male 3.5 3.5 3.7 
EsgGAL/+ Male 2.5 3.5 3.2 
SOCS/+ Male 2.5 3.5 3.5 
 
 
Table 6.12: Median, maximum and mean lifespans of female and male SOCS36E knockdown 


























Figure 6.23: Survival analysis of (a) female and (b) male SOCS36E knockdown flies 
following H2O2 exposure, compared with control genotypes, EsgGAL/+ and SOCS/+.  
Survival of (a) EsgGAL/SOCS female flies (purple), compared with EsgGAL/+ (blue) and 
SOCS/+ (turquoise) control genotypes, along with (b) EsgGAL/SOCS male flies (green), 
compared with EsgGAL/+ (yellow) and SOCS/+ (orange) control genotypes. (Red line 
indicates median lifespan). (n=60). Differences in lifespans between EsgGAL/SOCS, and 








































6.4.3 ISC-knockdown of SOCS36E had no effect on chill coma recovery in female and male 
flies 
One approach to assessing flies’ resistance to cold stress is to measure the time it takes flies to 
recover following exposure to lower temperatures for a certain period of time, and was the 
chosen method here. Flies at 10 days of age were kept at 4°C for 4 hours, before transferral to 
25°C, where the time taken to recover and fully stand was recorded. Any flies that failed to 
recover after sixty minutes and were unresponsive to physical stimulation were counted as 
dead. Figure 6.24 shows the average chill coma recovery time for all three experimental 
female genotypes and shows that while knockdown of SOCS36E positively reduced recovery 
time compared to EsgGAL/+ (p=0.036), there was very little difference between 
EsgGAL/SOCS and SOCS/+ - 22.3±2 and 23.5±2 seconds, respectively (p=0.936). This 













Figure 6.24: Average recovery times of SOCS36E knockdown females, plus relevant 
controls, following chill coma. Flies were kept at 4°C for 4 hours before recovery at 25°C, 
with the time taken to fully stand recorded for each fly, in all three genotypes. 
(EsgGAL/SOCS- blue, n=46, EsgGAL/+ - red, n=43, and SOCS/+ - green, n=46). (* = 



















































Figure 6.25 shows the chill coma recovery times for the male experimental flies and as seen in 
figure 6.24, EsgGAL/+ had the highest recovery time with 30±3 seconds, although the 
difference in recovery time between EsgGAL/+, and EsgGAL/SOCS and SOCS/+ was 
smaller in males. This resulted in a lack of statistical significance between EsgGAL/+ and 
EsgGAL/SOCS males (p>0.05). Also similar to results obtained in female flies, chill coma 
recovery times for EsgGAL/SOCS and SOCS/+ were almost identical, with average times 
calculated as 27.8±3 and 27.1±3 seconds, respectively. Overall, results from figures 6.24 and 
6.25 indicate that ISC-knockdown of SOCS36E had neither a positive nor a negative effect on 
chill coma resistance. Collectively, these stress resistance experiments showed that whilst a 
shortening of lifespan was observed in female flies only following SOCS36E knockdown, this 
alteration of the Jak/Stat pathway was beneficial under conditions of starvation and oxidative 














Figure 6.25: Average recovery times of SOCS36E knockdown males, plus relevant 
controls, following chill coma. Flies were kept at 4°C for 4 hours before recovery at 25°C, 
with the time taken to fully stand recorded for each fly, in all three genotypes. 



















































6.5 Assessment of female fecundity as a potential mechanism for decreased lifespan in 
SOCS36E knockdown flies 
In contrast to stress resistance, fecundity has been found to have an inverse relationship with 
longevity, in that an extension in lifespan is associated with decreased fecundity, and vice 
versa (Chapman and Partridge 1996, Slack et al. 2010). As fecundity (in both males and 
females) is very energy-costly, it is thought that a decrease in fecundity (for example, through 
reduced egg laying in females), leads to increased energy availability which can be utilised for 
homeostatic processes and maintaining healthy tissues, thus lengthening the lifespan of the 
organism (Kirkwood 1977, Kirkwood and Holliday 1979, Kirkwood and Cremer 1982). 
Increased fecundity would require more energy than usual, which may be transferred away 
from other organ systems, potentially leaving the organism more susceptible to injury and 
infection in which they may not be able to sufficiently resolve, thus shortening lifespan 
(Kirkwood 1977, Kirkwood and Holliday 1979, Kirkwood and Cremer 1982). Additionally, 
increases in reproduction either early or late on in the flies’ lifespan, has shown to result in 
shortening and extension of flies’ lifespans, respectively (Clare and Luckinbill 1985). As the 
reduction in lifespan observed here was confined to female EsgGAL/SOCS, we measured 
fecundity in knockdown and control females by determining the number of eggs laid per 
female with increasing age, and per female on average, in order to determine whether an 
increase in fecundity could be a possible mechanism behind the lifespan phenotype in 
females. 
 
6.5.1 ISC-knockdown of SOCS36E had no effect on female fecundity 
Figure 6.26 shows the average number of eggs laid by each female (per genotype) (a) per day 
over the duration of the experiment, and (b) in total during their lifespan, with (a) showing at 
each of the five time points of the experiment, EsgGAL/SOCS females, on average, laid less 
eggs per day. Using a one-way ANOVA (with Tukey’s HSD), this observed reduction was 
statistically significant at 5 days of age, but only when compared with EsgGAL/+ (p=0.0083, 
SOCS/+ p=0.7582). Collectively, this continuous reduction led to EsgGAL/SOCS females 
laying less eggs overall, with 13±1 per female, compared with 20±3 and 17±2 for EsgGAL/+ 
and SOCS/+, respectively (as shown in figure 6.26b), although these differences were not 
statistically significant. In summary, although ISC-knockdown of SOCS36E in females 
appeared to negatively affect egg laying, both over time and for number of eggs laid per 
female, these observations were not found to be significant. Therefore, it can be concluded 

























Figure 6.26: Assessment of fecundity, as measured by egg laying, in SOCS36E 
knockdown female flies, compared with controls. The average number of eggs (±SEM) laid 
per female (a) per day, and (b) in total in EsgGAL/SOCS female flies (blue), compared with 
EsgGAL/+ (red) and SOCS/+ (green) control genotypes. 100 flies were used for each 
genotype at the start of the experiment, with analysis of fecundity carried out in conjunction 





















































































6.6 Assessment of barrier function using the Smurf assay 
It was presumed that due to the ISC-specific knockdown of SOCS36E, there would be an 
increase in proliferation of midgut cells in these flies and this could lead to an increase in total 
midgut cell number. This could ultimately affect the architecture of the midgut and could be 
detrimental to the health of the fly if food or pathogens normally confined to, and dealt with 
by the midgut enter the surrounding tissues due to a reduction or loss of midgut integrity. We 
aimed to assess barrier integrity through the Smurf assay, as developed by Rera et al. (2011), 
whereby blue food dye in incorporated into the food. Once ingested, this dye is confined to 
and is visible in the proboscis and crop (the equivalent of the mammalian stomach) in flies 
with intact midguts. However, in flies where midgut integrity is compromised, the dye enters 
surrounding tissues, causing the entire fly to become blue, and is thus termed a “Smurf” fly. 
 
wDah flies of varying ages were used initially to optimise the assay and determine whether 
there was a time point at which integrity was lost and “Smurf” flies became visible. Figure 
6.27 shows images taken of flies following time spent on standard food containing blue dye, 
and shows that at each of the three ages used (11, 24 and 68 days old), dye was confined to 
the proboscis and crop, with no differences observed between the two genders. Figure 6.27 (b) 
shows a “Smurf” fly that was observed at 11 days of age. However, this was considered to be 
anomalous as this was the only “Smurf” fly detected out of all flies tested, and was deemed to 
be unhealthy due to the somewhat shrivelled appearance of the fly shown in the image, and 
also because this fly died not long after the assay was performed. 
 
6.6.1 SOCS36E knockdown flies did not exhibit compromised barrier integrity 
Following results from wDah flies, experimental flies were first tested at 53 days of age, 
approximately 4 and 6 days after the median lifespans for SOCS/+ and EsgGAL/+, and 3 days 
after the maximum lifespan of EsgGAL/SOCS (table 5.1). As seen in figure 6.27, no “Smurf” 
flies were obtained in these old flies (figure 6.28a-c). The assay was repeated a final time at a 
later time point (62 days of age), however only using EsgGAL/+ flies, as there were no 
surviving flies for EsgGAL/SOCS and SOCS/+.  Even at this later time point (2 days after the 
maximum lifespan), no “Smurf” flies were obtained (figure 6.28d and e). The fly in figure 
6.28 (d) still had dye confined to the proboscis and crop, whereas the fly imaged in figure 6.28 
(e) had dye incorporated further into the abdomen, although this still had not infiltrated 
completely into surrounding tissues (as seen in figure 6.27b). These results suggest that ISC- 
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Figure 6.27: Assessment of midgut integrity in wDah flies at different ages, using the 
Smurf assay. Images of flies at 11 (a and b- male and female, respectively), 24 (c-male) and 
68 (d- female) days of age. Flies spent 9 hours on standard food including 2.5% w/v blue food 
dye before brief anaesthetisation and imaging, using a Nikon Coolpix 990 digital camera. 







Figure 6.28: Assessment of midgut integrity in SOCS36E knockdown flies, plus controls, 
using the Smurf assay. Images of (a) EsgGAL/SOCS, (b) EsgGAL/+ and (c) SOCS/+ female 
flies at 53 days of age, along with (d) and (e) EsgGAL/+ females at 62 days. Flies spent 9 
hours on standard food including 2.5% w/v blue food dye before brief anaesthetisation and 








In the human population, particularly in western societies, people are generally living longer, 
and this is due to improved nutrition, hygiene, housing conditions, for instance, as well as vast 
advances in the field of medicine in the last century (WWW, Centers for Disease Control and 
Prevention). Despite this, conditions common in elderly populations, such as cancer and 
neurodegenerative diseases are still prevalent. Therefore, living longer may not be beneficial 
if there is also an increase in morbidity. Functional senescence is an even more common 
feature that accompanies increasing age, that in itself, can lead to increased morbidity or 
mortality (Jones and Grotewiel 2011), and is often the first indication of a decline of the 
nervous system (Camicioli et al. 1999). Drosophila also exhibit age-associated functional 
senescence (Grotowiel et al. 2005), and due to their relatively short lifespans, locomotor 
behaviours in particular can be assessed at multiple time points over the duration of the 
lifespan. Additionally, due to the genetic tools available in the fly, it is easy to determine 
which organ systems are involved in locomotor functioning, and its age-associated decline. 
There are also a multitude of assays that can be used to dissect and analyse several behaviours 
that senesce with increasing age, such as negative geotaxis and assessment of spontaneous 
walking for locomotion, as well as other behaviours, such as olfaction and memory, for 
example. 
 
We first used the negative geotaxis assay to assess neuromuscular health of knockdown males 
and females (plus controls), both uninfected and following midgut infection, using a non-
lethal phytopathogen, Ecc15. From two sets of experiments, we found that ISC-knockdown of 
SOCS36E had little effect on the expected decline in assay performance with increasing age, 
in both males and females. There have been studies that have found proportional links 
between lifespan and negative geotaxis, for instance extended lifespan delays functional 
senescence, and vice versa (reviewed by Jones and Grotewiel 2011). However, there are also 
cases where flies exhibited increased oxidative stress and in some instances, an extension in 
lifespan, but neither an acceleration nor delay of functional senescence. Martin et al. (2009 a 
and b) found that whilst a loss of function of Sod1 and 2 (antioxidant enzymes) shortened 
lifespan and accelerated functional senescence, gain of function mutations in these enzymes 
led to an extension of lifespan (at least in the case of Sod1), but had no effect on senescence. 
In the flies used here, it may the case that although ISC-knockdown of SOCS36E reduced 
lifespan (in females only), the reduction was not as large as those often reported (Martin et al. 
2009 a, and b). The negative impact of the knockdown may have been confined to one 
particular organ/tissue/cell type, and therefore did not extend to the musculature or neurons 
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involved in this reflex behaviour. Additionally, it be may that there is little to no crosstalk 
between the midgut and both the motor neurons and somatic muscles in Drosophila, so the 
proposed increase in midgut Jak/Stat signalling due to SOCS36E knockdown did not lead to 
increased or a compensatory decrease in Jak/Stat signalling in either of these locations, 
resulting in normal muscle ageing and negative geotaxis performance. Negative geotaxis 
experiments using an array of genotypes have also found that rates of functional senescence is 
dependent on the genetic background of the fly. For instance, using several wildtype flies, all 
on different backgrounds, Gargano et al. (2005) found that Lausanne-S flies had the best 
performance in a negative geotaxis assay, followed by Samarkand, Oregon-R and Canton-S. 
Miquel et al. (1976) reported that age-related declines in negative geotaxis performance 
occurs between 14-21 days of age, whereas males used here did not show substantial 
performance declines until after 21 days. Multiple studies have also found that negative 
geotaxis declined to a minimum approximately at 35 days of age (reviewed by Grotowiel et 
al. 2005), while the P.I of all flies used here at 35 days was between 0.3 and 0.7. 
Unfortunately, there were not enough flies to perform the assay past 6-7 weeks of age, but 
even at this point, a P.I of 0 was never achieved, indicating that the neuromuscular health of 
these flies did not fully deteriorate. Therefore, results indicate that locomotor behaviour (as 
well as other behaviours assessed in biological models) can vary between experiments and 
that genotype is a strong influence on assay performance. Additionally, we came to the 
conclusion that the RNAi and infection we introduced were unable to noticeably improve or 
delay functional decline any further. 
 
Along with knockdown of SOCS36E, we also found that midgut infection with Ecc15 did not 
substantially affect functional senescence using this particular assay. There were individual 
time points where infection had an effect, although these were not consistent across 
experimental repeats in terms of the genotype affected, whether infection had a positive or 
negative effect (or none at all) and when in the flies’ lifespan this effect took place. Very few 
studies have been conducted investigating infection in Drosophila and how performance in 
the negative geotaxis assay is affected. Linderman et al. (2012) did find that infection with the 
Gram-positive bacteria, Listeria monocytogenes, reduced the climbing distance 4 seconds 
post-startle in Oregon-R flies, but not w1118. There are several reasons explaining the 
differences in phenotypes obtained. First, flies used by Linderman et al. (2012) were injected 
with L. monocytogenes, inducing a systemic infection, whereas flies we used were orally 
infected, thus confining Ecc15 to the midgut so it may well not be expected to affect motor 
neurons and musculature, especially when the midgut integrity of all genotypes was not 
compromised during their lifespan (as shown by the Smurf assay). Secondly, as discussed 
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previously, performance in the negative geotaxis assay is heavily dependent on the genetic 
background of the flies, and both sets of flies (Oregon-R flies and w1118) used by Linderman et 
al. (2012) were of a different background to flies used in this project (wDah).  Thirdly, unless 
repair of the midgut epithelium is impaired, Ecc15 is not lethal to fruit flies, whereas 
Drosophila strains will succumb to L. monocytogenes within a week of infection (Jensen et al. 
2006, Ayres et al. 2008- although systemic infection was also used in both cases here) so it is 
assumed that this bacteria may affect more systems within the fly than Ecc15. Also, as 
discussed in the previous chapter, in our experiments, flies were only infected at one and two 
weeks of ages, and were in contact with the bacteria for two hours each time. It may be that 
this contact was not long enough, and did not generate as much of an immune response, or a 
sufficient amount of ROS to elicit an effect in the musculature of the flies used here, 
especially as it is not known how many flies in these experiments actually ingested the 
bacteria, and if they did, how much bacteria was ingested. 
 
Although there were very few differences between all three genotypes in assay performance, 
in both uninfected and infected cohorts, this may have been due to the way in which negative 
geotaxis was assessed.  We quantified the number of flies that climbed a certain distance in a 
tube within a certain time frame, as well as the number that remained at the bottom, and used 
an equation to change these into an indicator of performance and therefore, locomotor 
function. Rhodenizer et al. (2008) determined that the age-associated decline in negative 
geotaxis was due to an increased latency to initiate climbing, but predominantly a decrease in 
climbing speed, therefore if we assessed both of those factors, we may observe differences in 
variables that affect climbing ability as a whole between genotypes/infection groups, and 
perhaps determine effects on functional senescence more definitively. 
 
In addition to escape responses, locomotion is a crucial part of many other behaviours in flies, 
including foraging for food, responses to stimuli and stress, and courtship and reproduction, 
for instance. As in innate escape responses (assessed here through the negative geotaxis 
assay), spontaneous locomotor behaviours will rely on musculature for movement towards or 
away from something, as well as the brain for speed and duration of walking. Locomotion has 
shown to be controlled through the central complex and mushroom bodies located in the 
Drosophila brain. Strauss and Heisenberg (1993) found impaired walking activity (including 
walking speed and straight line walking) in 15 mutant fly strains that affected the central 
complex structure. Regarding mushroom bodies, Martin et al. (1998) found that disruption, 
either chemically or genetically, led to an increase in walking activity, demonstrating that 
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mushroom bodies are responsible for limiting excessive walking, through terminating periods 
of activity. This finding is also conserved in crickets and grasshoppers (cited by Martin et al. 
1998). Therefore, we used the exploratory walking assay, as developed by Martin (2004), to 
assess the effects of both ISC-knockdown of SOCS36E, and midgut infection with Ecc15, on 
multiple parameters of (spontaneous) walking, in particular on the declines associated with 
increasing age, and ultimately on the CNS, and central complex and mushroom bodies within 
the fly brain. 
 
Considering the overall results from the assay as a whole, all flies exhibited age-associated 
declines in all walking behaviours, regardless of gender, genotype or infection status, 
strengthening the use of this particular assay in assessing functional senescence and consistent 
with results obtained in the wDah background (Ismail et al. 2015). In accordance with previous 
findings, flies did exhibit a decrease in total distance walked as age increased (Le Bourg and 
Minois 1999, cited in Grotewiel et al. 2005). This correlates with an age-associated reduction 
in walking speed, which also mirrors our results and those of Rhodenizer et al. (2008) 
obtained using negative geotaxis. However, Le Bourg (1987) (cited in Grotewiel et al. 2005) 
also found that activity consistently decreased with age in females, whereas in males, there 
were increases until 5 weeks of age, followed by decreases. Results obtained here showed that 
in the first set of experiments in females, function did decline from the first time point, but, 
there was much more variability in assay performance in the second set, in that declines were 
first observed at time points between 16 and 40 days of age, across all parameters and 
genotypes. In the first set of experiments in male flies, several genotypes demonstrated a 
decline in function from the first time point until 24 or 31 days of age, where plateaus in assay 
performance were seen (also across multiple genotypes and parameters of walking). 
Conversely, in the second set, declines were observed from the first time point for all 
parameters. There was a substantial amount of functional variability, within genotypes, 
infection groups and genders, even before cross-comparison, so it is not completely possible 
to make generalisations regarding functional senescence, particularly as locomotor behaviour 
is heavily influenced by genetic backgrounds (Fernández et al. 1999, Gargano et al. 2005) and 
from the results of both of locomotor assays, appears to be inherently variable. 
 
Considering Ecc15 midgut infection alone first, overall, results were not wholly consistent. In 
females, any effects on assay performance (whether positive or negative) in the first set of 
experiments were irregular in that they were not replicated across parameters within the same 
genotype, or in all three experimental genotypes for one or more parameters. In the second set 
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however, infection was found to have overall negative effects and reduce total function across 
all four parameters assessed in EsgGAL/SOCS, as well as have a negative effect during 
ageing, accelerating the age-associated decline of each behaviour (with this taking place at 19 
and 26 days of age, as well as at 40 days). Ecc15 infection also negatively affected 
exploratory activity in SOCS/+ females, both at ages coinciding with infection time points (12 
and 16 days) and overall total function. Similar to these results, from the first set of 
experiments in males, Ecc15 infection had an overall negative effect on exploratory activity 
and total function in EsgGAL/SOCS males, and also accelerated age-associated declines in 
each parameter (occurring at a similar time point, at 24 days of age). In contrast, results from 
the second experiments revealed infection affected locomotor activity in EsgGAL/SOCS 
males early on in their lifespan, at 12 days of age, and this was found for walking distance, 
velocity, and rotation frequency. In SOCS/+ however, results mirrored those of 
EsgGAL/SOCS females, with infection negatively affecting total function as well as bringing 
forward the time point of age-associated decline to 19 and 26 days. In EsgGAL/+ females and 
males, midgut infection actually rescued the diminished assay performance, so the negative 
effects observed were still in 2 out of the 3 genotypes, and therefore occurred irrespective of 
genotype, despite variety in the affected time points. Over the last few decades, a lot of 
research has been carried out into the effects that changes in the gut, and in the gut microbiota, 
have on CNS function and behaviour, and vice versa- a bidirectional relationship named the 
gut-brain axis. Many studies, using rodents in particular, have shown neural-related 
implications as a result of changes in the G.I tract. Examples include induction of anxiety-like 
behaviour (as well as colonic inflammation and an increase in circulating pro-inflammatory 
cytokines) following T. muris infection (Bercik et al. 2010). Bercik et al. (2009) also found 
that infection with Helicobacter pylori resulted in changes in feeding behaviour in mice, and 
altered mRNA expression in areas of the brain responsible for regulating feeding, and this was 
still evident two months following bacterial clearance. Regarding locomotor behaviours, 
experiments in rodents characterise decreased activity and increased hesitation as indicators of 
anxiety. Nonetheless, Lyte et al. (2006) found that Citrobacter rodentium infection led to 
decreases in walking distance and exploration in mice within 8 hours of infection. This was in 
conjunction with a lack of histological inflammation and production of inflammatory 
cytokines, indicating the observations arose from effects of C. rodentium on the brain, rather 
than as a result of morbidity. The same group found infection with a different intestinal 
pathogen, Campylobacter jejuni (a pathogen known to cause gastroenteritis in humans) also 
reduced exploratory behaviours in mice (Goehler et al. 2008), thus supporting results obtained 
here. Further support comes from similar studies that found stress early on in life can lead to 
mood, behavioural and microbiota changes. Rat pups that encountered maternal separation 
daily between 2 and 12 days old, demonstrated decreases in movement, an absence of 
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exploratory behaviours as well as increased colonic motility when assessed at 7-8 weeks of 
age (O’Mahony et al. 2009). Increased colonic motility is a common symptom of IBS- a 
disorder strongly linked with stress and mood disorders (cited by Whitehead et al. 1980). 
Additionally, Bailey and Coe (1999) found that the stress induced as a result of 3 days of 
maternal separation resulted in a decrease in Lactobacilli in rhesus macaque monkeys. In 
monkeys that were also colonised with pathogenic species (such as Shigella and 
Campylobacter), higher titres of these bacteria were observed where decreases of Lactobacilli 
also occurred. These results demonstrate the importance of a balanced, stable microflora and 
how in addition to dysbiosis, instability may also leave individuals more susceptible to 
intestinal infections (and the associated consequences/symptoms of those) due to less 
competition from beneficial bacteria and their advantages (reviewed by Scholtens et al. 2012). 
For instance, Lactobacilli can act as antibacterials, due to their ability to produce bacteriocins 
(cited by Bailey and Coe, 1999). In this project, flies were infected at two time points early on 
in their lifespans (7 and 14 days of age), and will have endured stress from multiple sources- 
brief anaesthetisation, starvation and exposure to bacteria during the infection process, 
production of ROS by the Duox enzyme during the immune response (Ha et al. 2005), and 
increases in midgut proliferation in order to replace damaged cells and aid in bacterial 
clearance (Buchon et al. 2009a). Therefore, our walking experiments allowed us to discover 
the gut-brain axis had been affected in our flies, as we observed significant negative effects on 
CNS-regulated walking behaviours following Ecc15 midgut infection. 
 
In addition to the negative effects of Ecc15 infection, we found that regarding SOCS36E, 
knockdown also led to accelerations in the age-associated decline of multiple walking 
parameters assessed and a reduction in total function of these behaviours, with Ecc15 
infection found to exacerbate these declines and cause them to occur earlier in the flies’ 
lifespan. These results suggest that Drosophila Jak/Stat signalling (in the midgut in particular) 
may be implicated in the gut-brain axis. There has been little research on midgut changes and 
locomotor behaviour in Drosophila, and very little direct research into the Jak/Stat pathway 
and the gut-brain axis, in any biological model, which led us to speculate during the 
interpretation of our results, based on similar findings in various studies (discussed in the 
remainder of this chapter). However, Rajan and Perrimon (2012) discovered that upon 
feeding, Upd2 (one of the Drosophila Jak/Stat ligands) was released from the fat body (the 
equivalent of the mammalian liver) and was able to activate Jak/Stat in neurons within the 
brain. This led to release of Drosophila insulin-like peptides (Dilps) from insulin-producing 
cells (IPCs, also located in the brain). Dilps are responsible for the promotion of growth and 
also fat storage, with these processes perturbed following reduction of Upd2 in the fat body 
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(through RNAi) (Rajan and Perrimon 2012). Although these functional changes arose as a 
result of altered nutritional status (from a more starved state to a fed state) rather than midgut 
infection as performed here, these findings demonstrate that a component of the Jak/Stat 
pathway originating outside of the brain, is able to influence CNS-regulated processes (i.e. 
growth and energy storage, Rajan and Perrimon 2012). 
 
We hypothesised that knockdown of SOCS36E in Esg+ midgut cells would lead to 
dysregulated Jak/Stat signalling due to a reduction in feedback inhibition, potentially leading 
to an increase in proliferation in these cells. This may have altered the architecture of the 
midgut due to an increase in the number of cells, and this was actually demonstrated by 
Obasse (2012) who found SOCS36E knockdown (particularly in Ecc15- infected flies) 
resulted in increased midgut diameter, and disruption of Dlg (a protein found in septate 
junctions of epithelial cells responsible for cell polarity, Woods et al. 1997). Using wildtype 
larvae (Oregon-R), Basset et al. (2000) reported there were some cases of Ecc15 translocation 
from the gut, with bacteria detected in the haemolymph and also in the respiratory tract. We 
attempted to assess midgut integrity of our experimental flies using the “Smurf” assay (Rera 
et al. 2011). Although we observed no differences between knockdown and control flies, the 
phenotype of increased permeability and the appearance of “Smurf” flies are closely 
associated with mortality. Therefore, as no “Smurf” flies were observed, and an associated 
increase in mortality was not observed at the time points assessed, it is to be assumed that the 
flies were healthy in that respect. Expression levels of additional midgut cell junctions, such 
as E-cadherin, could therefore be assessed in order to fully determine whether SOCS36E 
affected midgut integrity. Additionally, if an Ecc15-GFP strain was to be used, microscopy 
could be used to determine whether the bacterial had indeed entered the periphery in these 
flies, and also the brain in particular. 
 
The observation that early-life infection with Ecc15 in knockdown flies resulted in 
accelerations in the decline of all assessed walking parameters correlates with findings that 
early enteric infections and diseases can lead to impairments of cognitive development 
(reviewed by Kolling et al. 2012), and that enteric infections are known to cause morbidity 
and mortality (cited by Bergstrom et al. 2012). In addition to effects of enteric infection, 
SOCS36E in flies has also been found to be associated with cognition and brain function. 
Copf et al. (2011) found that overexpression of SOCS36E in the mushroom bodies of the 
brain impaired long-term memory. Although in this study the overexpression was directly 
targeted to the brain, our discovery that ISC-knockdown of SOCS36E negatively affected 
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walking behaviours that have been shown to be regulated by the mushroom bodies (Strauss 
and Heisenberg 1993, Martin et al. 1998), suggests that appropriately regulated Jak/Stat 
signalling may be essential for efficient functioning of the brain. In order to test this, the 
exploratory walking assay could be repeated using flies with knockdown of SOCS36E 
specifically targeted to the mushroom bodies to determine whether this would further 
exacerbate the declines in walking behaviours we observed here. 
 
We previously showed here that reductions in intestinal SOCS3 led to increases in the 
enzyme, IDO, both in vitro and in vivo (chapters 3 and 4, respectively). In addition to its role 
in catabolising the essential amino acid, tryptophan (Higuchi and Hayaishi 1967) and inducing 
tolerance (Munn et al. 1998, 1999, Fallarino et al. 2002), increases in IDO have been reported 
in many neurological disorders and is thought to be implicated in the gut-brain axis. For 
instance, increased IDO expression has been found in IBD sufferers (Wolf et al. 2004, 
Ferdinande et al. 2008), with depression also a common ailment in IBD too (cited by Bercik et 
al. 2010). Effects detrimental to neurological health often occur following IDO activation due 
to the depletion of tryptophan and production of neurotoxic metabolites downstream in the 
kynurenine pathway, which are capable of causing neuronal death (Grohmann et al. 2003). 
Conversion of tryptophan to kynurenine by IDO (and subsequent enzymes) reduces the 
amount of serotonin that can be produced from tryptophan, with decreases in serotonin also 
common in neurological disorders (such as depression, Myint and Kim 2003). Immune 
activation, for instance through bacterial infection, induces IDO (both in humans and mice, 
Wirleitner et al. 2003, Bell and Else 2011), and this can occur in the circulation (as well as in 
the brain) leading to an increase in peripheral tryptophan and tryptophan catabolites, which 
are capable of crossing the blood brain barrier.  
 
The enzyme tryptophan 2,3-dioxygenase ,TDO, like IDO, is responsible for catabolism of 
tryptophan and also converts tryptophan into kynurenine. Drosophila possess their own TDO, 
encoded by the gene vermilion (cited by Baglioni 1959), and this is a functional ortholog of 
both mammalian TDO and IDO (Green et al 2012), as shown by the inability of vermilion 
mutants to form formylkynurenine (the precursor of kynurenine) from tryptophan (Baglioni 
1960). Tryptophan depletion in flies can also be damaging, as prevention of this process 
through the use of two different inhibitors (α-methyl tryptophan, and 5-methyl tryptophan), 
and vermilion mutants, has been reported to extend both mean and maximum lifespan 
(Oxenkrug 2010, Oxenkrug et al. 2011). More specifically, ingestion of berberine (a 
compound also able to inhibit the conversion of tryptophan to kynurenine) also led to 
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extensions in mean, median and maximum lifespans, and increased locomotor activity, as 
assessed by vertical climbing (a method similar to negative geotaxis) (Navrotskaya et al. 
2012).  
 
Previous studies in mice have reported increases in IDO following SOCS3 silencing using 
siRNA, and increased proteasomal degradation of IDO following overexpression of SOCS3 
(Orabona et al. 2005, 2008), thus potentially producing a negative correlational relationship. 
Combined with our in vitro and in vivo findings (in chapters 3 and 4), and the described 
neurological implications of IDO, we propose that knockdown of SOCS36E in Esg+ cells 
may lead to increased levels of TDO in the midgut (potentially due to a reduction in 
degradation processes). This in turn may result in increased amounts of tryptophan 
catabolites, which upon crossing of the blood brain barrier, can have neurotoxic effects (and 
ultimately lead to neurodegeneration). However, to test this hypothesis, we would assess 
whether midgut and/or brain expression of TDO increased following knockdown of 
SOCS36E, both in uninfected flies, and Ecc15-infected flies (as several different pathogens 
have reported to induce IDO in mammals, Wirleitner et al. 2003, Bell and Else 2011), and if 
so, whether this would impact on CNS-regulated behaviours. 
 
Another proposed mechanism for our SOCS36E knockdown-mediated behavioural 
phenotypes involves neuropeptides, and these are peptide molecules produced either in the 
CNS and/or in the intestines or midgut (in mammals and Drosophila, respectively). Following 
recognition of changes in the local environment by neural or midgut cells, these peptides will 
carry out their own respective functions once converted from the prepropeptide form to a 
propeptide and coordinate systemic communication between cells. Each individual peptide 
can exhibit a multitude of functions, which all collectively involve regulation of development, 
fecundity, feeding and digestion, locomotor activity and cognitive function, which all 
ultimately impact on flies’ behaviour and/or lifespan (cited by Nässel and Winther 2010). As 
in mammals, the source of neuropeptides in the Drosophila gut is the EECs, which are 
exclusively found in the midgut (not in either the foregut or hindgut, Veenstra et al. 2008), 
and these make up one of the two midgut epithelium cell types in Drosophila, generated as a 
result of EB differentiation. The Jak/Stat pathway has been found to be involved in the 
differentiation of midgut cells, with many studies reporting active Jak/Stat signalling in ISCs 
and EBs only, not the differentiated ECs and EECs, with a reduction or loss of signalling 
leading to an accumulation of Esg+ cells, with no differentiation cell markers expressed 
(Buchon et al. 2009b, Jiang et al. 2009, Beebe et al. 2010, Lin et al. 2010). Other results, 
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however, are conflicting. For instance, Jiang et al. (2009) found that a reduction in Jak/Stat 
signalling, achieved through either the use of Stat92E or Dome (receptor) RNAi, or Stat92E 
mutant flies, resulted in an inability of midgut cells to differentiate into ECs. Although Lin et 
al. (2010) observed a reduction in the number of ECs in mutant flies for Dome, and Hop (Jak), 
the number of EECs were reduced as well. However, using Stat92E mutant flies, they were 
able to detect ECs in the midgut, but there were lower numbers of EECs present, thus 
concluding that low levels of Jak/Stat signalling resulted in EBs differentiating into EECs, 
with high levels favouring differentiation into ECs. In contrast to both Jiang et al. (2009) and 
Lin et al. (2010), Beebe et al. (2010) reported that Jak/Stat activity, in particular Stat92E, was 
required for the differentiation of EBs into both ECs and EECs. Due to the inconsistency of 
these findings, we cannot speculate whether or how differentiation would be affected as a 
result of SOCS36E knockdown in ISCs. If the amount of EECs were affected (due to 
increased numbers of progenitor cells, or ECs, for instance), this may ultimately impact on 
neuropeptide production and/or recognition, and thus, communication with the CNS, although 
this can only be speculated without performing cell lineage studies.  
 
There are studies however, that have reported altered locomotor activity as a result of altered 
neuropeptide expression. For example, although the flies used were of a different genetic 
background to our experimental flies, Song et al. (2014) reported an increase in locomotor 
activity following Drosophila tachykinin (DTK) RNAi in the brain and midgut combined- 
with DTKs comprising of a family of peptides expression in both the CNS and midgut, named 
for their function in gut muscle contraction (Siviter et al. 2000). The majority of studies have 
investigated neuropeptide expression in the CNS exclusively due to their roles in regulating 
locomotor behaviours, with DTK depletion in central complex neurons leading to increases in 
the number of activity-rest bouts, for example (Kahsai et al. 2010). This emphasises an area in 
locomotor research that could be explored further, particularly with regards to our interests of 
Jak/Stat signalling and the gut-brain axis. 
 
In addition to the locomotor experiments, experimental flies were exposed to several stressors 
in order to explore whether knockdown of SOCS36E in Esg+ cells affected their resistance, 
and whether the reduced lifespan in female EsgGAL/SOCS flies correlated to changes in 
stress resistance. A considerable amount of research has been conducted into associations 
between lifespan and stress resistance, and the ability to select for these phenotypes for 
several generations. Many studies have reported direct correlations between lifespan and 
resistance to different stressors, in that extended lifespan can be associated with increased 
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resistance to one or more stressors, and vice versa. For example, long-lived methuselah (a 
gene encoding a G protein-coupled receptor, Lin et al. 1998) mutant flies were found to have 
increased resistance to starvation, high temperatures and paraquat (an inducer of oxidative 
stress) (Lin et al. 1998, Cook-Wiens and Grotewiel 2002). Broughton et al. (2005) found that 
in addition to an extension of median and maximum lifespans, ablation of IPCs in the brain 
resulted in increased resistance to both starvation and oxidative stress. Conversely, 
knockdown of Sod1 and 2 reduced lifespan whilst leaving flies more sensitive and susceptible 
to oxidative stress (Martin et al. 2009a and b). Based on these findings, and those similar from 
other studies, it was to be assumed that for female EsgGAL/SOCS flies at least, that the 
reduced lifespan would result in decreased resistance to one or more of the stressors assessed. 
However, we discovered that SOCS36E knockdown proved to be advantageous following 
starvation and induced oxidative stress (through exposure to hydrogen peroxide) in both 
female and male flies, whilst no differences in chill coma recovery times were found between 
knockdown and control flies for both genders. These results indicate that the mechanism 
involved in starvation and/or oxidative stress resistance, and tolerance of cold/reduced 
temperatures may be independently regulated, and this has been demonstrated by Broughton 
et al. (2005). As stated above, ablation of IPCs in the Drosophila brain increased resistance to 
oxidative stress and starvation, but also increased susceptibility to heat and cold stress. There 
are additional studies where an inverse or lack of relationship between longevity and stress 
resistance was found. For instance, Force et al. (1995) discovered there were no changes in 
starvation resistance in flies with increased longevity. Conversely, Harshman et al. (1999) 
found that in Drosophila lines selected for female starvation resistance, males also exhibited 
increased resistance to starvation, with both genders also displaying increased resistance to 
dessication, oxidative stress and exposure to solvent fumes. However, these increases were 
not associated with extensions in lifespan. Similarly, Martin et al. (2009b) found that whilst 
overexpression of Sod2 in the muscles of flies would have been beneficial against oxidative 
damage, it did not lead to an extension of lifespan (nor a delay in functional senescence). 
Further experiments could be performed to deduce whether midgut Jak/Stat signalling is 
implicated in resistance to other stressors, such as heat and dessication. 
 
With respect to starvation resistance, many studies have reported increased resistance to be 
associated with an increase in body weight and/or increased lipid and carbohydrate 
content/storage in flies (Hoffmann and Harshman 1999). This may be one possible 
explanation for increased starvation resistance in SOCS36E knockdown flies, although could 
not be confirmed without performing additional experiments, comparing body weights 
between knockdown and control male and female flies, and also assays to determine 
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differences in stored lipids, trehalose and glycogen in these flies, as it is not known how the 
proposed increase in proliferating midgut cells would affect nutrient digestion and storage. 
Alternatively, another possible mechanism for increased starvation resistance may not be 
increased energy stores at all, but perhaps the rate at which this stored energy is consumed 
(reviewed by Rion and Kawecki 2007). If reserves are depleted at a slower rate in knockdown 
flies compared to controls, this will prolong the time in which these flies can survive without 
access to a food source.  
 
In the disposable soma theory of ageing, Salmon et al. (2001) discussed that decreases in 
lifespan can be due to lipid reserves shifting energy towards reproduction, leading to an 
increase in egg production, which suggests the converse may be true too. Therefore, we 
proposed that increased fecundity may be a factor implicated in the shortening of lifespan in 
SOCS36E knockdown female flies. We discovered that although no statistical significance 
was achieved, there was a tendency of EsgGAL/SOCS females to produce lower average 
numbers of eggs at each time point (with counts started from 5 days of age). In order to fully 
determine if this lack of fecundity phenotype is accurate, larger numbers of females could be 
used (≥300), and more frequent counts could be performed; every time females are transferred 
into fresh vials (every 2-3 days) rather than once a week as carried out here. Conversely, as 
fecundity and lifespan are often inversely correlated, and ISC knockdown of SOCS36E had 
negative effects on both of those parameters here (along with multiple walking behaviours), it 
may be that the tendency for EsgGAL/SOCS females to lay fewer eggs could just be the result 
of poor health and function, rather than associated with lifespan and/or stress resistance. 
However, before this theory can be confirmed, assessment of egg viability should be 
considered as reductions in eggs laid at each assessed time point, and in eggs laid per female 
by EsgGAL/SOCS flies may be insignificant if egg viability is similar between 
EsgGAL/SOCS females and the two control genotypes, or perhaps higher. 
 
Additionally, as resistance to both starvation and oxidative stress involved the midgut in this 
case (through reduced intake and digestion of food, and ingestion of hydrogen peroxide, 
respectively), the increased resistance to these two stressors exhibited by EsgGAL/SOCS flies 
may have been due to the proposed increase in turnover of midgut cells induced through 
knockdown of SOCS36E. Starvation has shown to cause atrophy of intestinal crypts and villi 
in mammals, due to increased cell death, and reduced cell proliferation as a result of increased 
cell cycle duration (Michael and Hodges 1973, Aldewachi et al. 1975). This can ultimately 
lead to a decrease in the weight of the intestinal tissue. Ortega et al. (1996) found that at a 
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cellular level, starvation diminished enzyme activity in the small intestine as well as impaired 
synthesis of both DNA and proteins, and also cell differentiation (as measured by the 
decreased expression of differentiation markers, Shaw et al. 2012). Collectively, these can 
impair intestinal function and lead to increased intestinal permeability and translocation of 
luminal contents, potentially resulting in increased morbidity and mortality (cited by Song et 
al. 2009). It was proposed that there would be increased midgut proliferation in 
EsgGAL/SOCS flies due to reduced regulation of Jak/Stat signalling, and this may have 
replenished cells damaged as a result of decreased nutrition (and the associated effects) sooner 
than in control flies. This could have helped to maintain the midgut epithelium and barrier 
function, until energy reserves became depleted and/or the rate of SOCS36E knockdown-
induced renewal became insufficient to overcome the rate of cell damage and death. 
 
In conclusion, we performed various behavioural assays in order to determine the effects of 
ISC-specific SOCS36E knockdown (and thus midgut homeostasis) on health and function 
using the model organism, Drosophila melanogaster. To summarise, we found that SOCS36E 
knockdown accelerated age-associated declines in spontaneous walking, although reflex-
induced locomotion was not affected, which suggested midgut Jak/Stat signalling was capable 
of influencing CNS- and not muscle-regulated behaviours, and that midgut Jak/Stat signalling 
may be implicated in the Drosophila gut-brain axis. Furthermore, this ISC-specific 
knockdown was found to be beneficial during conditions of starvation and oxidative stress, 
but these effects were not sustained when chill coma recovery times and fecundity in female 
flies were assessed. Collectively, these results suggest that, as with the homologues in 
mammalian systems, SOCS36E is a complex multi-functional protein that is capable of 
influencing multiple pathways and tissues, and therefore, more investigation is needed to fully 











One fundamental purpose of performing biomedical research is to try and uncover what is not 
known in human health and disease. However, due to many constraints, such as time, money 
ethics, and genetic and environmental variability, it is not always possible to carry out studies 
using human samples, or within humans themselves. There are a multitude of biological 
models available, ranging from culturing cells in plates and flasks to mammals such as 
rodents, dogs and monkeys, and these are used as alternatives to humans and have proven 
successful in a number of research fields (such as immunology). In relation to this project, our 
area of interest concerned suppressor of cytokine signalling proteins (SOCS3 specifically), 
which is implicated in many cellular functions such as negative regulation of the Jak/Stat 
pathway, cell proliferation, proteasomal degradation and apoptosis to name a few (Krebs and 
Hilton 2001).  
 
There has been a range of research investigating the role of SOCS3 and the regulation of 
Jak/Stat in particular, in the mammalian G.I tract, although the majority of studies relate to 
dysregulated homeostasis and disease processes. We chose to perform experiments in three 
different biological models: an in vitro model involving the use of an untransformed human 
intestinal epithelial cell line (HIECs), and two in vivo models using mice and Drosophila 
melanogaster. The use of multiple models allowed us to investigate the role of intestinal 
SOCS3 in different contexts. For instance, using HIEC cells, we were able to investigate the 
impact of intestinal SOCS3 on proliferation and cytokine production, both in the basal state 
and following microbial stimulation, whereas our in vivo models allowed us to investigate the 
impact of intestinal SOCS proteins on normal and microbial-induced proliferation at a tissue 
level and in the organism as a whole, in mice and Drosophila respectively.  
 
 
7.1 SOCS3 and Intestinal Homeostasis 
With regards to in vitro and mouse intestinal models, much research has been conducted into 
regulation of Jak/Stat signalling and proliferation by SOCS3. However, the vast majority of 
these findings are obtained either using cancer cell lines, or using disease models to induce 
dysregulation of homeostasis, such as the AOM/DSS colitis-associated carcinogenesis murine 
model. For instance, proliferation of IECs in vitro was reduced following overexpression of 
SOCS3 in the normal rat IEC cell line, and in the adenocarcinoma Caco-2 cell line (Rigby et 
al. 2007). Inflammation-mediated IEC repair using DSS in mice resulted in enhanced crypt 
proliferation and hyperplasia following IEC-specific SOCS3 deletion (Rigby et al. 2007). 
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Conversely, increased levels of SOCS3 have been found in IBD clinical studies, or IBD 
models, and SOCS3 is induced due to increased levels of IL-6, and consequently Stat3 
activity (Suzuki et al. 2001). However, due to SOCS3’s role in limiting proliferation, it is 
thought that the IBD-associated increases in its expression could be detrimental during IEC 
repair processes. Thagia et al. (2015) found that overexpression of SOCS3 led to reductions in 
microbial-mediated wound healing, as well as increases in flagellin-induced TNF-α 
production which would drive inflammation in an in vivo setting. Although such studies have 
been insightful, their results cannot be completely generalised to regulation of intestinal 
homeostasis in a non-pathological setting. Therefore, we aimed to use our three models to 
investigate the role of SOCS3 in normal intestinal homeostasis. 
 
In our in vitro model, we conducted experiments using the recently developed, untransformed 
HIEC cell line (Perreault and Beaulieu 1996), and found that there were very few differences 
in cell number following treatment with multiple TLR ligands. However, microbe-mediated 
proliferation was significantly increased following knockdown of SOCS3, suggesting that 
SOCS3 is able to maintain intestinal homeostasis through limiting TLR-induced proliferation, 
and this is supported by findings that SOCS3 can either limit TLR signalling directly through 
inhibition of MyD88, TRAF6 or TAK1 signal transduction proteins, or, inhibit pathways that 
are activated as a result of TLR signalling (such as IL-6) (Frobøse et al. 2006, Yoshimura et 
al. 2007). Despite these findings, knockdown of SOCS3 in unstimulated HIEC cells did not 
significantly increase cell number and thus proliferation either. These findings were also 
observed in unstimulated IEC SOCS3 knockout mice, in our experiments and also by Rigby et 
al. (2007), suggesting that in absence of proliferation-inducing agents, dysregulation of 
Jak/Stat signalling does not affect cell number, or that other mechanisms are in place to ensure 
homeostasis is maintained. For instance, in the Drosophila midgut, the Jak/Stat pathway 
operates in cooperation with the EGFR and Wnt, as activation is increased following 
dysregulation and diminishing activity in one of the other pathways, ensuring efficient 
regulation of ISCs (Xu et al. 2011). 
 
Both pro- and anti-inflammatory cytokines are produced as a result of microbe recognition, 
and their regulation is not only important for immune activation and microbe clearance, but 
also with respect to IEC homeostasis. For instance, increases in pro-inflammatory cytokines, 
particularly if coupled with decreased production of anti-inflammatory cytokines, can cause 
damage to cells, as well drive proliferation which can be detrimental if sustained. However, 
overexpression of anti-inflammatory cytokines can also be unfavourable as pathogens may 
275 
 
induce IEC damage if they remain undetected due to increased immune tolerance. From our 
results, it can be suggested that SOCS3 is implicated in mediating tolerance as TLR-mediated 
TNF-α and IL-10 expression was not significantly different from that of untreated SOCS3-
sufficient HIECs. Upon knockdown of SOCS3 however, expression of both TNF-α and IL-10 
was altered both in unstimulated and microbial-stimulated cells, indicating SOCS3 may limit 
increases in both proliferation and cytokine production that occur as a result of TLR 
signalling, and with respect to IECs in particular, help contribute to their hyporesponsive 
state. We also investigated the regulation of IDO expression by SOCS3, with IDO also 
implicated in immune tolerance. This is due to its enzymatic ability to catabolise tryptophan, 
which leads to suppression of T-cell proliferation, and induction of Tregs. Similar to previous 
results, microbial ligands did not induce significant fold-changes in IDO (with the exception 
of IFN-γ, which is a potent inducer of IDO, Yoshida et al. 1981, Yasui et al. 1986). IDO 
expression was significantly increased regardless of cell treatment, following SOCS3 
knockdown, in agreement with findings of Orabona et al. (2005), who discovered increases in 
IDO following reductions in SOCS3 using siRNA (although this was in DCs). Therefore, 
these findings suggest SOCS3 is able regulate immune tolerance at multiple levels, which 
ultimately also aims to protect the integrity of IECs. 
 
A number of studies have been conducted in Drosophila demonstrating the importance of 
regulated midgut homeostasis on host health, due to induction of dysregulation having 
negative effects, reducing the lifespan of the fly (Buchon et al. 2009b, Biteau et al. 2010, for 
example). In relation to mammalian systems, the Drosophila Jak/Stat pathway is considered 
to be “simplified” due to the presence of fewer components, and this can facilitate its 
investigation and manipulation. For instance, mammals have 8 SOCS proteins, whereas 
Drosophila have 3 (Greenhalgh et al. 2002, Hou et al. 2002). Within the midgut, the Jak/Stat 
pathway has been studied considerably due to its large involvement in differentiation as well 
as proliferation. Studies have revealed that Jak/Stat signalling is required for regulation of 
both basal and injury- or infection-induced proliferation (Buchon et al. 2009a, Jiang et al. 
2009), and that regulation of the Jak/Stat pathway is essential as flies lacking either the 
Jak/Stat activating ligand, Upd, or Stat92E exhibit increased mortality following infection 
with a (usually) non-lethal bacteria (Ecc15) (Buchon et al. 2009b). In addition to its regulation 
of ISC proliferation, the Drosophila Jak/Stat pathway is itself regulated by the gut microbiota, 
with increased bacterial loads found to result in increased turnover, and this process is further 
promoted during ageing (Buchon et al. 2009b). Therefore, these findings demonstrate the key 
role the Drosophila Jak/Stat pathway plays in not only maintaining gut homeostasis, but also 
the health and survival of the fly. Although SOCS36E (a functional homologue of mammalian 
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SOCS3, Callus and Mathey-Prevot 2002) is known to be induced following activation of 
midgut Jak/Stat signalling, research is often focused on other components of the pathway, 
such as Upd, Hop and Stat92E (Buchon et al. 2009b, Jiang et al. 2009, Beebe et al. 2010, Lin 
et al. 2010, for example), so we utilised the short lifespan of Drosophila and investigated the 
impact of SOCS36E on midgut homeostasis and how survival and ageing were affected. We 
discovered that knockdown of SOCS36E in ISCs led to significant reductions in the lifespan 
of female flies only, although work carried out here was unable to determine the mechanism 
behind this sexual dimorphism. However, this result further demonstrates the importance of 
regulated Jak/Stat signalling on midgut health, and thus, is in agreement with previous 
findings, contributing to this particular area of research. It also may translate to the effects that 
prolonged dysregulated Jak/Stat signalling has on the wellbeing of the host. 
 
Despite the negative implications of our behavioural and lifespan results, ISC knockdown of 
SOCS36E was beneficial to flies under conditions of starvation and oxidative stress (using 
H2O2), demonstrating that this dysregulated Jak/Stat signalling can have positive functional 
effects, and this was also observed in our T.muris mouse model. However, combined with the 
T. muris results, this could indicate that positive functional outcomes of reduced SOCS-
mediated dysregulation are possibly restricted to younger animals as they have a more 




7.2 SOCS3 and Cancer 
The role of SOCS proteins as tumour suppressors is well-established due to increased 
proliferation, hyperplasia and tumour development that can arise from its reduced expression 
or loss as a whole (for instance, through promoter hypermethylation-induced silencing, or 
through genetic tools such as RNAi or Cre-Lox recombinase techniques). Decreased SOCS3 
expression has been found in a range of tumour types, including those in the G.I tract, which 
is relevant to our area of interest (He et al. 2003, Weber et al. 2005, Ogata et al. 2006, Rigby 
et al. 2007, Li et al. 2009). Our initial experiments revealed certain differences between the 
normal HIEC cell line, and the commonly used, adenocarcinoma cell line, Caco-2, which 
were in agreement with studies in the literature. Specifically, we established the presumed low 
SOCS3 (mRNA) expression and increased proliferative nature (both basally and following 
microbial stimulation) of Caco-2 cells, and also discovered that similar SOCS3 mRNA levels 
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in the normal, untransformed HIEC cell line (achieved through siRNA knockdown) also 
induced increased TLR-mediated proliferative responses, indicating in these normal intestinal 
cells, a reduction in SOCS3 was sufficient to induce cancer-like phenotypes. As stated 
previously, we also assessed the SOCS3-mediated regulation of TLR-induced cytokines, and 
discovered that in both unstimulated and microbial-stimulated HIECs, SOCS3 reduction 
altered the cytokine profiles of these cells, as we observed decreases in IL-10 and increases in 
TNF-α and IDO- all phenotypes that have been observed in cancer (Uyttenhove et al. 2003, 
Mocellin et al. 2005, Zhang and Schluesener 2006, Oft 2014), thus indicating that these 
molecular changes associated with reductions or loss of SOCS3 may promote or enhance 
tumourigenesis. These results also open the door for investigation into SOCS3-mediated 
expression of additional cytokines (for example, other inflammatory cytokines, such as IFN-γ 
or IL-1), or potential mechanisms from the results we have shown here. For instance, in our 
SOCS3 knockdown HIECs (SOCS3Low), there were increases in TNF-α and IDO, as well as 
decreases in IL-10 mRNA expression. As these cytokines are able to counteract the activity of 
one another (e.g. TNF-α and IL-10), it would be interesting to see if our observations were 
related. To test this, we could repeat our TLR stimulation experiments, and inhibit TNF-α/ IL-
10/ IDO, and see if this would lead to subsequent changes in expression of the remaining two 
molecules.  
 
Treatment with AOM and DSS in mice is known to induce colonic tumours in a model of 
CAC regardless of genotype, and IEC-specific deletion of SOCS3 is known to enhance 
tumourigenesis in this model, therefore suggesting that upon promotion of intestinal turnover, 
proliferative responses were enhanced following dysregulation of Jak/Stat through loss of 
inhibitor, SOCS3. This was demonstrated in our in vitro HIEC model, but also in our T. muris 
mouse model. This was demonstrated by T. muris-induced alterations of crypt dynamics that 
are indicative of increased intestinal turnover, regardless of genotype (in agreement with other 
studies, Artis et al. 1999, Cliffe et al. 2005). Within our infected mice, enhanced IEC turnover 
in our SOCS3-deleted mice (HO-VC) was demonstrated by an increase in the number of 
proliferating cells in higher crypt positions (compared to SOCS3-sufficient mice, HO-WT). 
IDO is known to be induced during T. muris infection (in multiple genotypes, shown here and 
by Datta et al. 2005 and, Bell and Else 2011), and as demonstrated by our in vitro findings, 
and those in vivo in DCs (Orabona et al. 2005, Orabona et al. 2008), an indirectly proportional 
relationship exists between IDO and SOCS3. Although our methods used were not sensitive 
enough to detect changes in IDO expression between infected HO-WT and HO-VC mice, 
based on other findings, we could perhaps speculate that T. muris-induced IDO expression 
may be higher in the HO-VC mice (possibly as a result of decreased proteasomal degradation, 
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Orabona et al. 2005). Shaw et al. (under revision in Immunology and Cell Biology) obtained a 
positive functional phenotype in HO-VC by means of more efficient expulsion of T. muris 
worms. However, as IDO is known to limit cell proliferation (particularly T-cells) and 
promote immune tolerance (Munn et al. 1998, Bell and Else 2011), it is to be assumed that 
increased IDO as a result of infection and reduced IEC SOCS3, also coupled with enhanced 
turnover, may be unfavourable and potentially promote tumourigenesis if sustained 
(particularly in low dose, chronic T. muris infections). Research into helminth infection is 
expanding, in inflammatory and autoimmune disorders especially (such as IBD), due to its 
ability to shift immune dominance from Th1-mediated responses to Th2-mediated responses 
(Finlay et al. 2014). However, there have been reports of helminth-induced carcinogenesis, 
due to their capability to induce lesions in tissue, thus potentially perpetuating inflammation-
driven tumour development, for example (Kojima et al. 1981, Oikonomopoulou et al. 2014). 
Although in a different model system, infection with the Gram-negative bacteria, Ecc15, in 
Drosophila operates in similar ways to T. muris; increasing gut proliferation, inducing 
immune responses, with clearance/susceptibility also dependent on genotype. Using the 
Drosophila model ours is based on, Buchon (personal communication) found that Ecc15-
induced midgut proliferation was increased following knockdown of SOCS36E in ISCs, and 
this proliferative response was sustained in these flies even 2 days post-infection, whereas 
proliferation decreased and returned to more basal levels in wildtype flies. Collectively, these 
results could extend the role of SOCS3 in inflammation/colitis-associated carcinogenesis to 
include bacterial and helminth infection too. In order to test this, both HO-WT and HO-VC 
could be infected with T. muris for a longer period of time, with intestinal tissue then assessed 
for tumourigenesis, for instance through number and size of tumours if present. 
 
In addition to conservation of signalling pathways in the regulation of intestinal homeostasis, 
Drosophila are also able to develop midgut tumours following dysregulation of said 
pathways. For instance, Lee et al. (2009) discovered that loss of APC was also able to result in 
hyperplasia and multilayering of cells, distorting the midgut as a result. Interestingly, Salomon 
and Jackson (2008) proposed that ageing pre-disposed flies to tumourigenesis, as they 
reported the development of midgut tumours in unstimulated/ uninfected, wildtype flies by 4 
weeks of age, with the number of flies developing tumours increasing with increasing age. 
The presence of these tumours resulted in obstruction of the gut lumen, with tissue changes 
resembling those seen in dysplastic mammalian guts. These findings, coupled with those of 
mammalian studies reporting a reduction of loss of SOCS3 in tumours, and that female flies 
may exhibit higher rates of turnover in the midgut (Jiang et al. 2009), could suggest that our 
SOCS36E knockdown female flies could have been pre-disposed to hyperplasia and possibly 
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dysplasia, particularly as our female flies lived longer than flies studied by Salomon and 
Jackson (2008). Although this would require further investigation, it could potentially lead to 
expansion of Jak/Stat-mediated cancer research in an additional biological model. 
 
 
7.3 SOCS3 and the Gut-Brain Axis 
The gut microbiota has often been described as the “forgotten organ” due to the sheer number 
of bacterial cells and genes in relation to those of the host (Tancrède 1992, DuPont and 
DuPont 2011), and also due to the roles they are able to carry out in addition to those of the 
host cells within the intestine. These include the ability to regulate IEC homeostasis in model 
organisms (Rakoff-Nahoum et al. 2004, Buchon et al. 2009b), aiding in metabolism and 
digestion, that can lead to beneficial byproducts such as SCFAs (Nguyen et al. 2015) as well 
as production of antimicrobials (Yurist-Doutsch et al. 2014) and intestinal and immune 
development (Abrams et al. 1962, Rakoff-Nahoum et al. 2004, Natividad and Verdu 2013, 
Yurist-Doutsch et al. 2014). However, the effects of the microbiota are not exclusive to the 
G.I tract, with several studies demonstrating both positive and negative effects on CNS 
function and behaviour as a result of changes in the gut and gut microbiota, and vice versa. 
This bi-directional relationship that has been uncovered is termed the gut-brain axis, and 
results from communication between the gut and the brain, for example through neural 
pathways and signalling molecules such as cytokines, hormones and neuropeptides (Collins et 
al. 2012).  
 
We observed in our Drosophila model that knockdown of SOCS36E in ISCs, either with or 
without midgut infection-induced proliferation, resulted in exacerbation of age-associated 
declines in multiple walking behaviours that have been reported to be regulated in the 
Drosophila brain (Strauss and Heisenberg 1993, Martin et al. 1998), thus suggesting that 
midgut Jak/Stat signalling may be implicated in the gut-brain axis in flies. Additionally, 
Jak/Stat has been found to be present in human, mouse and Drosophila brains (Copf et al. 
2011, Hime and Abud 2013, Nicolas et al. 2013), which raises the possibility of signalling 
crosstalk between the gut and the brain. Dysregulated SOCS3 expression is also implicated in 
IBD (Suzuki et al. 2001, Li et al. 2010)- a disorder associated with the gut-brain axis, 
although very few direct or correlational studies have actually been conducted regarding 
SOCS proteins and the mammalian gut-brain axis. In Drosophila, there are select studies that 
could suggest a relationship involving Jak/Stat signalling does exist. For instance, the 
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nutritional status (i.e. fed or starved) of fruit flies is detected by the fat body (the equivalent of 
the mammalian liver), and following feeding, the Jak/Stat ligand, Upd2, is produced in the fat 
body, which then activates certain neurons in the brain, resulting in the production of 
Drosophila insulin-like peptides (Dilps) by insulin-producing cells (IPCs), also located in the 
brain (Rajan and Perrimon 2012). Dilps are responsible for the promotion of growth and also 
fat storage, with these processes perturbed following reduction of Upd2 in the fat body 
(through RNAi) (Rajan and Perrimon 2012). Positive changes in nutritional status produce 
Upd2 in the fat body, which presumably arise from the detection of food within the midgut. 
Upds are also produced in the midgut by ECs during injury and infection (Buchon et al. 
2009a, Jiang et al. 2009), so it would be interesting to determine whether the findings of Rajan 
and Perrimon (2012) would be observed, or perhaps altered as a result of Ecc15- and/or 
SOCS36E knockdown-induced midgut changes, which would be indicative of Jak/Stat 
signalling crosstalk and potentially more involvement in the Jak/Stat pathway. Furthermore, 
there are additional behaviours that are neuronally-regulated that we could assess in 
Drosophila (such as learning and memory) to further elucidate the role of midgut SOCS36E 
in the gut-brain axis.  
 
Mice have been studied extensively with regards to the gut-brain axis, particularly in terms of 
modification of the microbiota either through probiotic administration or enteric infection, and 
the subsequent behaviour and/or brain biochemical changes, aided by the number of 
behavioural and molecular experiments available to test this phenomenon. In relation to our 
mouse model, Bercik et al. (2010) found that in addition to the induction of intestinal 
inflammation, T. muris infection increased anxiety-like behaviours in mice as well as induced 
molecular changes in the brain. In our model, we showed T. muris infection resulted in 
alterations in crypt dynamics, in HO-WT mice; some of which were enhanced in HO-VC 
mice. Therefore, knowing that T. muris induces neural changes along with our observations of 
diminished walking behaviour following ISC knockdown of SOCS36E and midgut infection 
in flies, it would be interesting to determine whether the genotypic and phenotypic changes 
induced in our mouse model would impact on the functioning of the CNS. 
 
Finally, together with its role in cancer and immune tolerance, there are several studies 
implicating IDO in the gut-brain axis due to its ability to promote production of kynurenine 
from tryptophan, as opposed to serotonin, with decreased serotonin common in mood 
disorders, and increases in both IDO and depression reported in IBD too (Wolf et al. 2004, 
Ferdinande et al. 2008, Bercik et al. 2010). Our findings from our HIEC and mouse models, 
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along with those by Orabona et al. (2005) and (2008), demonstrated an indirectly proportional 
relationship between IDO. IDO expression in the circulation and brain can also be found 
following infection elsewhere (Stone and Darlington, 2013), so it could be proposed that gut 
infection (in either of our in vivo models) could result in increased systemic and/or neural IDO 
expression, which may be enhanced following knockdown of SOCS proteins, although this 
cannot be confirmed without further testing. 
 
In conclusion, there are numerous models that are used in biomedical research, each 
associated with several advantages and disadvantages. When translating findings to human 
health and disease, it can be beneficial to conduct experiments in multiple models, as identical 
or similar results may not be obtained, even under the same conditions (such as reducing 
intestinal SOCS, as carried out here). Due to the dominance of research on SOCS proteins in 
dysregulated gut homeostasis in disease, we investigated its role in normal homeostasis. We 
consistently found unfavourable effects following reduction of IEC SOCS, subsequently 
impacting on proliferation and cytokine profiles, tumour tolerance and, survival and the gut-
brain axis, in our HIEC, mouse and Drosophila models, respectively. Functional outcomes of 
IEC SOCS knockdown were revealed through enhanced T. muris-induced crypt cell turnover 
(and subsequent promotion of worm expulsion, Shaw et al., under revision in Immunology 
and Cell Biology), and increased stress resistance in Drosophila, which potentially suggests 
there may be short-term positive effects of reduced IEC SOCS when animals are relatively 
young, due to an increased capability to adapt to homeostatic and environmental changes, in 
comparison with older animals. Collectively, our results indicate that SOCS (SOCS3 and 
SOCS36E specifically) are complex, multi-faceted proteins whose roles are still yet to be fully 
elucidated. Overall, they demonstrate the importance of efficiently regulated IEC Jak/Stat 
signalling, and consequently homeostasis, not only within the G.I tract, but also in different 
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Appendix 1: The effect of Ecc15 infection on the age-associated decline on walking 
distance in SOCS36E knockdown and control female flies. Data are shown as a mean value 
(±SEM) for each time point for uninfected and infected (a) EsgGAL/SOCS, (b) EsgGAL/+ 




































































































Appendix 2: Total function of distance walked (±SEM) in uninfected and Ecc15-infected 
SOCS36E knockdown flies, plus controls. Total function was determined using the area 
under the curve at each time point of the assay, with a maximum of 15 flies used at each time 



















x 0.2412 0.9681 0.3211   
EsgGAL/+ 
Uninfected 
0.2412 x   0.2248  
SOCS/+ 
Uninfected 




0.3211   x 0.1534 0.5385 
EsgGAL/+ 
Infected 
 0.2248  0.1534 x  
SOCS/+ 
Infected 
  0.7722 0.5385  x 
 
Table A1:  P-values calculated using JMP, for differences in total function between 
uninfected and Ecc15-infected knockdown female flies and their relevant controls (using a 
one-way ANOVA with Tukey’s HSD), as well as between uninfected female flies and their 

































































Appendix 3: The effect of Ecc15 infection on the age-associated decline on walking 
velocity in SOCS36E knockdown and control female flies. Data are shown as a mean value 
(±SEM) for each time point for uninfected and infected (a) EsgGAL/SOCS, (b) EsgGAL/+ 
































































































































Appendix 4: Total function of walking velocity (±SEM) in uninfected and Ecc15-infected 
SOCS36E knockdown flies, plus controls. Total function was determined using the area 
under the curve at each time point of the assay, with a maximum of 15 flies used at each time 



















x 0.7689 0.9807 0.4137   
EsgGAL/+ 
Uninfected 
0.7689 x   0.4603  
SOCS/+ 
Uninfected 




0.4137   x 0.5860 0.7140 
EsgGAL/+ 
Infected 
 0.4603  0.5860 x  
SOCS/+ 
Infected 
  0.7766 0.7140  x 
 
Table A2:  P-values calculated using JMP, for differences in total function between 
uninfected and Ecc15-infected knockdown female flies and their relevant controls (using a 
one-way ANOVA with Tukey’s HSD), as well as between uninfected female flies and their 
































































Appendix 5: The effect of Ecc15 infection on the age-associated decline on rotation 
frequency in SOCS36E knockdown and control female flies.  Data are shown as a mean 
value (±SEM) for each time point for uninfected and infected (a) EsgGAL/SOCS, (b) 










































































































Appendix 6: Total function of rotation frequency (±SEM) in uninfected and Ecc15-
infected SOCS36E knockdown female flies, plus controls.  Total function was determined 
using the area under the curve at each time point of the assay, with a maximum of 15 flies 



















x 0.2283 0.9362 0.3026   
EsgGAL/+ 
Uninfected 
0.2283 x   0.1459  
SOCS/+ 
Uninfected 




0.3026   x 0.4007 0.9033 
EsgGAL/+ 
Infected 
 0.1459  0.4007 x  
SOCS/+ 
Infected 
  0.4233 0.9033  x 
 
Table A3:  P-values calculated using JMP, for differences in total function of rotation 
frequency between uninfected and Ecc15-infected knockdown female flies and their relevant 
controls (using a one-way ANOVA with Tukey’s HSD), as well as between uninfected female 











































































Appendix 7: The effect of Ecc15 infection on the age-associated increase on latency to 
the first rotation in SOCS36E knockdown and control female flies.  Data are shown as a 
mean value (±SEM) for each time point for uninfected and infected (a) EsgGAL/SOCS, (b) 




























































































































Appendix 8: Total function of rotation latency (±SEM) in uninfected and Ecc15-infected 
SOCS36E knockdown female flies, plus controls. Total function was determined using the 
area under the curve at each time point of the assay, with a maximum of 15 flies used at each 



















x 0.3959 0.6722 0.7194   
EsgGAL/+ 
Uninfected 
0.3959 x   0.6197  
SOCS/+ 
Uninfected 




0.7194   x 0.4831 0.0645 
EsgGAL/+ 
Infected 
 0.6197  0.4831 x  
SOCS/+ 
Infected 
  0.3452 0.0645  x 
 
Table A4:  P-values calculated using JMP, for differences in total function between 
uninfected and Ecc15-infected knockdown female flies and their relevant controls (using a 
one-way ANOVA with Tukey’s HSD), as well as between uninfected female flies and their 

















































- Heat the water and stir in the agar, then bring to the boil. 
- Once boiled, add the sugar and yeast. 
- Stir until the mixture has a smooth consistency and bring to the boil again. 
- Remove from heat and once settled, add the extra water as indicated. 
- Allow the mixture to cool to 60°C. 




Appendix 9: The recipe for standard 0.5 Sugar/ 1.0 Yeast Drosophila media, used for 
maintenance of both stock and experimental flies. 
Final Volume (L) 0.5 1 1.5 2 3 4 4.5 5 
Water (ml) 350 700 1050 1400 2100 2800 3150 3500 
         
Agar (g) 7.5 15 22.5 30 45 60 67.5 75 
Sugar (g) 25 50 75 100 150 200 225 250 
Yeast (g) 50 100 150 200 300 400 450 500 
         
Water to add at 
end (ml) 
76 170 265 359 548 737 832 926 
         
Nipagen (ml) 15 30 45 60 90 120 135 150 
Propionic Acid 
(ml) 
1.5 3 4.5 6 9 12 13.5 15 
